A Review of JACC Journal Articles on the Topic of Cardiac Imaging: 2011–2012  by unknown
Journal of the American College of Cardiology Vol. 62, No. 14, 2013
 2013 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.08.002JACC TOPIC COLLECTION: CARDIAC IMAGING
A Review of JACC Journal Articles on the
Topic of Cardiac Imaging: 2011–2012
The EditorsMolecular Hybrid Positron Emission Tomography/
Computed Tomography Imaging of Cardiac
Angiotensin II Type 1 Receptors
Objectives The goal of this study was to explore the
feasibility of targeted imaging of the angiotensin II type 1
receptor (AT1R) in cardiac tissue, using clinical hybrid
positron emission tomography/computed tomography
(PET/CT).
Background AT1R is an attractive imaging target due to
its key role in various cardiac pathologies, including post-
infarct left ventricular remodeling.
Methods Using the novel AT1R ligand [11C]-KR31173,
dynamic PET/CT was performed in young farm pigs under
healthy conditions (n ¼ 4) and 3 to 4 weeks after experi-
mental myocardial infarction (n ¼ 5). Ex vivo validation was
carried out by immunohistochemistry and polymerase chain
reaction. First-in-man application was performed in 4 healthy
volunteers at baseline and under AT1R blocking.
Results In healthy pigs, myocardial KR31173 retention was
detectable, regionally homogeneous, and speciﬁc for AT1R,
as conﬁrmed by blocking experiments. Metabolism in
plasma was low (85  2% of intact tracer after 60 min).
After myocardial infarction, KR31173 retention, corrected
for regional perfusion, revealed AT1R up-regulation in the
infarct area relative to remote myocardium, whereas reten-
tion was elevated in both regions when compared with
myocardium of healthy controls (8.7  0.8% and 7.1 
0.3%/min vs. 5.8  0.4%/min for infarct and remote,
respectively, vs. healthy controls; p < 0.01 each). Post-
mortem analysis conﬁrmed AT1R up-regulation in remote
and infarct tissue. First-in-man application was safe, and
showed detectable and speciﬁc myocardial KR31173 reten-
tion, albeit at a lower level than pigs (left ventricular average
retention: 1.2  0.1%/min vs. 4.4  1.2%/min for humans
vs. pigs; p ¼ 0.04).
Conclusions Noninvasive imaging of cardiac AT1R
expression is feasible using clinical PET/CT technology.
Results provide a rationale for broader clinical testing of
AT1R-targeted molecular imaging (1).As a service to our readers, we have compiled all the relevant manuscripts in individual
subject areas of cardiology. These collections should provide a single repository of
JACC publications in the speciﬁc areas. In addition, these compilations should put in
perspective the recent advancements and future directions in the important disciplines
of cardiovascular medicine.A New Drug Delivery System for Intravenous
Coronary Thrombolysis With Thrombus Targeting
and Stealth Activity Recoverable by Ultrasound
Objectives The purpose of this study was to develop a new
intelligent drug delivery system for intracoronary throm-
bolysis with a strong thrombolytic effect without increasing
bleeding risk.
Background Rapid recanalization of an occluded coronary
artery is essential for better outcomes in acute myocardial
infarction. Catheter-based recanalization is widely accepted,
but it takes time to transport patients. Although the current
ﬁbrinolytic therapy can be started quickly, it cannot achieve
a high reperfusion rate. Recently, we generated nanoparticles
comprising tissue-type plasminogen activator (tPA), basic
gelatin, and zinc ions, which suppress tPA activity by 50%
with 100% recovery by ultrasound (US) in vitro.
Methods The thrombus-targeting property of nanopar-
ticles was examined by an in vitro binding assay with von
Wilbrand factor and with a mouse arterial thrombosis model
in vivo. The thrombolytic efﬁcacy of nanoparticles was
evaluated with a swine acute myocardial infarction model.
Results Nanoparticles bound to von Wilbrand factor in vitro
and preferentially accumulated at the site of thrombus in
a mouse model. In a swine acute myocardial infarction model,
plasma tPA activity after intravenous injection of nanoparticles
was approximately 25% of tPA alone and was recovered
completely by transthoracic US (1.0 MHz, 1.0 W/cm2).
During US application, plasma tPA activity near the affected
coronary artery was recovered andwas higher than that near the
femoral artery. Although treatment with tPA alone (55,000
IU/kg) recanalized the occluded coronary artery in only 1 of
10 swine, nanoparticles containing the same dose of tPA with
US achieved recanalization in 9 of 10 swine within 30 min.
Conclusions We developed an intelligent drug delivery
system with promising potential for better intravenous
coronary thrombolysis (2).
Prognostic Value of Coronary Magnetic Resonance
Angiography for Prediction of Cardiac Events in
Patients With Suspected Coronary Artery Disease
Objectives This study sought to determine whether whole-
heart coronary magnetic resonance angiography (CMRA) can
predict cardiac events in patients with suspected coronary
artery disease.
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of stenosis on coronary computed tomography angiography
has a signiﬁcant prognostic impact on the prediction of car-
diac events. However, the prognostic value of whole-heart
CMRA is unknown.
Methods We studied 207 patients with suspected coronary
artery disease who underwent non-contrast-enhanced free-
breathing whole-heart CMRA acquired with a 1.5-T MR
system and 32-channel cardiac coils. The presence of sig-
niﬁcant coronary stenosis (50% diameter reduction) was
visually determined on sliding thin- maximum intensity
projection images. Follow-up information was obtained for
occurrence of severe cardiac events (cardiac death, myocar-
dial infarction, and unstable angina) and all cardiac events
(additionally including revascularization >90 days after
CMRA).
Results During a median follow-up of 25 months, 10
cardiac events, of which 5 were severe, were observed in 84
patients with signiﬁcant stenosis. Whereas, in 123 patients
without signiﬁcant stenosis, only 1 cardiac event with no
severe event was observed. Kaplan-Meier curves demon-
strated a signiﬁcant difference in event-free survival between
the 2 groups for severe events (annual event rate, 3.9% and
0%, respectively; log-rank test, p ¼ 0.003), as well as for all
cardiac events (6.3% and 0.3%; p < 0.001). Cox regression
analysis showed that presence of signiﬁcant stenosis on
CMRA was associated with a >20-fold hazard increase for
all cardiac events (hazard ratio: 20.78; 95% conﬁdence
interval: 2.65 to 162.70; p ¼ 0.001).
Conclusions Whole-heart CMRA is useful for predicting
the future risk for cardiac events in patients with suspected
coronary artery disease (3).Accelerated In Vivo Thrombin Formation
Independently Predicts the Presence and Severity
of CT Angiographic Coronary Atherosclerosis
Objectives This study sought to investigate the association
between thrombin generation in plasma and the presence
and severity of computed tomography angiographically de-
ﬁned coronary atherosclerosis in patients with suspected
coronary artery disease (CAD).
Background Besides its pivotal role in thrombus formation,
experimental data indicate that thrombin can induce an array
of pro-atherogenic and plaque-destabilizing effects.
Although thrombin plays a role in the pathophysiology of
atherosclerosis progression and vascular calciﬁcation, the
clinical evidence remains limited.
Methods Using 64-slice coronary computed tomographic
angiography, we assessed the presence and characteristics of
CAD in patients (n ¼ 295; median age 58 years) with stable
chest pain. Coronary artery calciﬁcation was graded as
absent (Agatston score 0), mild (Agatston score 1 to 100),
moderate (Agatston score 101 to 400), and severe (Agatston
score >400). Calibrated automated thrombography was
used to assess endogenous thrombin potential in plasmain vitro. Thrombin-antithrombin complex (TATc) levels
were measured as a marker for thrombin formation in vivo.
Results TATc plasma levels were substantially higher
in patients with CAD versus patients without CAD
(p ¼ 0.004). Signiﬁcant positive correlations were observed
between steadily increasing TATc levels and the severity of
CAD (r ¼ 0.225, p < 0.001). In multinomial logistic
regression models, after adjusting for established risk factors,
TATc levels predicted the degree of coronary artery calci-
ﬁcation: mild (odds ratio: 1.56, p ¼ 0.006), moderate (odds
ratio: 1.56, p ¼ 0.007), and severe (odds ratio: 1.67, p ¼
0.002). Trends were comparable between the groups when
stratiﬁed according to the degree of coronary luminal
stenosis.
Conclusions This study provides novel clinical evidence
indicating a positive independent association between en-
hanced in vivo thrombin generation and the presence and
severity of coronary atherosclerosis, which may suggest that
thrombin plays a role in the pathophysiology of vascular
calciﬁcation and atherosclerosis progression (4).The Napkin-Ring Sign Indicates Advanced
Atherosclerotic Lesions in Coronary CT
Angiography
Objectives This study sought to determine the accuracy of
plaque pattern assessment by coronary computed tomog-
raphy angiography (CCTA) to differentiate between early
and advanced atherosclerotic lesions as deﬁned by histology.
Background A ringlike attenuation pattern of coronary
atherosclerotic plaques termed as napkin-ring sign (NRS)
was described in CCTA of patients who had acute coronary
syndrome.
Methods All procedures were performed in accordance
with local and federal regulations and the Declaration of
Helsinki. Approval of the local ethics committees was ob-
tained. We investigated 21 coronary arteries of 7 donor
hearts. Overall, 611 histological sections were obtained and
coregistered with CCTA images. The CCTA cross sections
were read in random order for conventional plaque cate-
gories (noncalciﬁed [NCP], mixed [MP], calciﬁed [CP])
and plaque patterns (homogenous, heterogeneous with no
napkin-ring sign [non-NRS], and heterogeneous with
NRS).
Results No plaque was detected in 134 (21.9%), NCP in
254 (41.6%), MP in 191 (31.3%), and CP in 32 (5.2%)
CCTA cross sections. The NCP and MP were further
classiﬁed into homogenous plaques (n ¼ 207, 46.5%), non-
NRS plaques (n ¼ 200, 44.9%), and NRS plaques (n ¼ 38,
8.6%). The speciﬁcities of NCP and MP to identify
advanced lesions were moderate (57.9%, 95% conﬁdence
interval [CI]: 50.1% to 65.6%, and 72.1%, 95% CI: 64.7%
to 79.4%, respectively), which were similar to the homoge-
nous and heterogeneous plaques (62.6%, 95% CI: 54.8% to
70.3%, and 67.3%, 95% CI: 58.6% to 76.1%, respectively).
In contrast, the speciﬁcity of the NRS to identify advanced
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e31lesions was excellent (98.9%, 95% CI: 97.6% to 100%). The
diagnostic performance of the pattern-based scheme to
identify advanced lesions was signiﬁcantly better than that of
the conventional plaque scheme (area under the curve: 0.761
vs. 0.678, respectively; p ¼ 0.001).
Conclusions The assessment of the plaque pattern
improves diagnostic accuracy of CCTA to identify advanced
atherosclerotic lesions. The CCTA ﬁnding of NRS has
a high speciﬁcity and high positive predictive value for the
presence of advanced lesions (5).Arterial Spin Labeling MR Imaging Reproducibly
Measures Peak-Exercise Calf Muscle Perfusion:
A Study in Patients With Peripheral Arterial
Disease and Healthy Volunteers
Objectives This study hypothesized that arterial spin
labeling (ASL) magnetic resonance (MR) imaging at 3-T
would be a reliable noncontrast technique for measuring
peak exercise calf muscle blood ﬂow in both healthy
volunteers and patients with peripheral arterial disease
(PAD) and will discriminate between these groups.
Background Prior work demonstrated the utility of ﬁrst-
pass gadolinium-enhanced calf muscle perfusion MR
imaging in patients with PAD. However, patients with
PAD often have advanced renal disease and cannot receive
gadolinium.
Methods PAD patients had claudication and an ankle
brachial index of 0.4 to 0.9. Age-matched normal subjects
(NL) had no PAD risk factors and were symptom-free
with exercise. All performed supine plantar ﬂexion exer-
cise in a 3-T MR imaging scanner using a pedal ergometer
until exhaustion or limiting symptoms and were imaged at
peak exercise with 15 averaged ASL images. Peak perfu-
sion was measured from ASL blood ﬂow images by placing
a region of interest in the calf muscle region with the
greatest signal intensity. Perfusion was compared be-
tween PAD patients and NL and repeat testing was per-
formed in 12 subjects (5 NL, 7 PAD) for assessment of
reproducibility.
Results Peak exercise calf perfusion of 15 NL (age: 54  9
years) was higher than in 15 PAD patients (age: 64 5 years,
ankle brachial index: 0.70  0.14) (80  23 ml/min – 100 g
vs. 49  16 ml/min/100 g, p < 0.001). Five NL performed
exercise matched to PAD patients and again demonstrated
higher perfusion (84  25 ml/min – 100 g, p < 0.002). As
a measure of reproducibility, intraclass correlation coefﬁcient
between repeated studies was 0.87 (95% conﬁdence interval
[CI]: 0.61 to 0.96). Interobserver reproducibility was 0.96
(95% CI: 0.84 to 0.99).
Conclusions ASL is a reproducible noncontrast technique
for quantifying peak exercise blood ﬂow in calf muscle.
Independent of exercise time, ASL discriminates between
NL and PAD patients. This technique may prove useful for
clinical trials of therapies for improving muscle perfusion,
especially in patients unable to receive gadolinium (6).Ultrasound-Mediated Vascular Gene Transfection
by Cavitation of Endothelial-Targeted Cationic
Microbubbles
Objectives Ultrasound-mediated gene delivery can be
ampliﬁed by acoustic disruption of microbubble carriers that
undergo cavitation. We hypothesized that endothelial tar-
geting of microbubbles bearing cDNA is feasible and,
through optimizing proximity to the vessel wall, increases
the efﬁcacy of gene transfection.
Background Contrast ultrasound-mediated gene delivery is
a promising approach for site-speciﬁc gene therapy,
although there are concerns with the reproducibility of this
technique and the safety when using high-power ultrasound.
Methods Cationic lipid-shelled decaﬂuorobutane micro-
bubbles bearing a targeting moiety were prepared and
compared with nontargeted microbubbles. Microbubble
targeting efﬁciency to endothelial adhesion molecules (P-
selectin or intercellular adhesion molecule [ICAM]-1) was
tested using in vitro ﬂow chamber studies, intravital mic-
roscopy of tumor necrosis factor-alpha (TNF-a)–stimulated
murine cremaster muscle, and targeted contrast ultrasound
imaging of P-selectin in a model of murine limb ischemia.
Ultrasound-mediated transfection of luciferase reporter
plasmid charge coupled to microbubbles in the post-
ischemic hindlimb muscle was assessed by in vivo optical
imaging.
Results Charge coupling of cDNA to the microbubble
surface was not inﬂuenced by the presence of targeting
ligand, and did not alter the cavitation properties of cationic
microbubbles. In ﬂow chamber studies, surface conjugation
of cDNA did not affect attachment of targeted microbubbles
at microvascular shear stresses (0.6 and 1.5 dyne/cm2).
Attachment in vivo was also not affected by cDNA ac-
cording to intravital microscopy observations of venular
adhesion of ICAM-1–targeted microbubbles and by ultra-
sound molecular imaging of P-selectin–targeted micro-
bubbles in the post-ischemic hindlimb in mice. Transfection
at the site of high acoustic pressures (1.0 and 1.8 MPa) was
similar for control and P-selectin–targeted microbubbles but
was associated with vascular rupture and hemorrhage. At 0.6
MPa, there were no adverse bioeffects, and transfection was
5-fold greater with P-selectin–targeted microbubbles.
Conclusions We conclude that ultrasound-mediated trans-
fection at safe acoustic pressures can be markedly augmented
by endothelial juxtaposition (7).
Free-Breathing 3 T Magnetic Resonance
T2-Mapping of the Heart
Objectives This study sought to establish an accurate
and reproducible T2-mapping cardiac magnetic resonance
(CMR) methodology at 3 T and to evaluate it in healthy
volunteers and patients with myocardial infarct.
Background Myocardial edema affects the T2 relaxation
time on CMR. Therefore, T2-mapping has been established
to characterize edema at 1.5 T. A 3 T implementation
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monitoring therapy remains to be implemented, thoroughly
characterized, and evaluated in vivo.
Methods A free-breathing navigator-gated radial CMR pulse
sequence with an adiabatic T2 preparation module and an
empirical ﬁtting equation for T2 quantiﬁcation was optimized
using numerical simulations and was validated at 3 T in
a phantom study. Its reproducibility for myocardial T2 quan-
tiﬁcation was then ascertained in healthy volunteers and im-
proved using an external reference phantom with known T2. In
a small cohort of patients with established myocardial infarc-
tion, the local T2 value and extent of the edematous region were
determined and compared with conventional T2-weighted
CMR and x-ray coronary angiography, where available.
Results The numerical simulations and phantom study
demonstrated that the empirical ﬁtting equation is signiﬁ-
cantly more accurate for T2 quantiﬁcation than that for the
more conventional exponential decay. The volunteer study
consistently demonstrated a reproducibility error as low as
2  1% using the external reference phantom and an average
myocardial T2 of 38.5  4.5 ms. Intraobserver and inter-
observer variability in the volunteers were –0.04  0.89 ms
(p ¼ 0.86) and –0.23  0.91 ms (p ¼ 0.87), respectively. In
the infarction patients, the T2 in edema was 62.4  9.2 ms
and was consistent with the x-ray angiographic ﬁndings.
Simultaneously, the extent of the edematous region by T2-
mapping correlated well with that from the T2-weighted
images (r ¼ 0.91).
Conclusions The new, well-characterized 3 T method-
ology enables robust and accurate cardiac T2-mapping at 3
T with high spatial resolution, while the addition of
a reference phantom improves reproducibility. This tech-
nique may be well suited for longitudinal studies in patients
with suspected or established heart disease (8).Population-Based Reference Values for
3D Echocardiographic LV Volumes and
Ejection Fraction
Objectives The purpose of this study was to deﬁne age-,
sex-, and ethnicity-speciﬁc reference values for 3-dimensional
echocardiographic (3DE) left ventricular (LV) volumes and
LV ejection fraction (LVEF) in a large cohort of European
white and Indian Asian subjects.
Background Transthoracic 3DE imaging is recommended
for the routine evaluation of LV volumes and function.
However, there remains a lack of population-based reference
values for 3DE LV volumes and LVEF, hindering adoption
of this technique into routine clinical practice.
Methods We identiﬁed subjects from the LOLIPOP
(London Life Sciences Prospective Population) study who
were free of clinical cardiovascular disease, hypertension,
and type 2 diabetes. All subjects underwent transthoracic
2-dimensional and 3D echocardiography for quantiﬁcation
of LV end-systolic volume index, LV end-diastolic volume
index, and LVEF.Results 3DE image quality was satisfactory in 978 subjects
(89%) for the purposes of LV volumetric analysis. Indexed
3DE LV volumes were signiﬁcantly smaller in female
compared with male subjects and in Indian Asians compared
with European whites. Upper limit of normal (mean  2
SD) reference values for the LV end-systolic volume index
and LV end-diastolic volume index for the 4 ethnicity-sex
subgroups were, respectively, as follows: European white
men, 29 ml/m2 and 67 ml/m2; Indian Asian men, 26 ml/m2
and 59 ml/m2; European white women, 24 ml/m2 and 58
ml/m2; Indian Asian women, 23 ml/m2 and 55 ml/m2,
respectively. Compared with 3DE studies, 2-dimensional
echocardiography underestimated the LV end-systolic
volume index and LV end-diastolic volume index by an
average of 2.0 ml/m2 and 4.7 ml/m2, respectively. LVEF
was similar between in all 4 groups and between 2- and 3-
dimensional techniques, with a lower cutoff of 52% for the
whole cohort.
Conclusions These reference values are based on the largest
3DE study performed to date that should facilitate the
standardization of the technique and encourage its adoption
for the routine assessment of LV volumes and LVEF in the
clinical echocardiography laboratory. This study supports the
application of ethnicity-speciﬁc reference values for indexed
LV volumes (9).Anatomic Localization of Rapid Repetitive Sources
in Persistent Atrial Fibrillation: Fusion of Biatrial CT
Images With Wave Similarity/Cycle Length Maps
Objectives The aim of this study was to investigate the
anatomic distribution of critical sources in patients with
atrial ﬁbrillation (AF) by fusion of biatrial computed
tomography (CT) images with cycle length (CL) and wave
similarity (WS) maps.
Background Experimental and clinical studies show that
atrial ﬁbrillation (AF) may originate from rapid and repet-
itive (RR) sources of activation. Localization of RR sources
may be crucial for an effective ablation treatment. Atrial
electrograms showing rapid and repetitive activations can be
identiﬁed by combining WS and CL analysis.
Methods Patients with persistent AF underwent biatrial
electroanatomic mapping and pre-procedural CT cardiac
imaging. WS and CL maps were constructed in 17 patients
by calculating the degree of repetitiveness of activation
waveforms (similarity index [S]) and the cycle length at each
atrial site. WS/CL maps were then integrated with biatrial
3-dimensional CT reconstructions by a stochastic approach.
Results Repetitive sources of activation (S 0.5) were
present in most patients with persistent AF (94%) and were
mainly located at the pulmonary veins (82% of patients), at
the superior caval vein (41%), on the anterior wall of the
right atrium (23%), and at the left atrial appendage (23%).
Potential driver sources showing both rapid and repetitive
activations (CL ¼ 140.7  25.1 ms, S ¼ 0.65  0.15) were
present only in a subset of patients (65%) and were conﬁned
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appendage (12%). Differently, the repetitive activity of the
superior caval vein was characterized by a slow activation rate
(CL ¼ 184.7  14.6 ms).
Conclusions The identiﬁcation and localization of RR
sources is feasible by fusion of biatrial anatomic images with
WS/CL maps. Potential driver sources are present only in
a subset of patients with persistent AF and are mainly
located in the pulmonary vein region (10).
Journey in Evolution of Nuclear Cardiology:
Will There Be Another Quantum Leap With the
F-18–Labeled Myocardial Perfusion Tracers?
The ﬁeld of nuclear cardiac imaging has evolved from being
rather subjective, more “art than a science,” to a more objective,
digital-based quantitative technique, providing insight into the
physiological processes of cardiovascular disorders and pre-
dicting patient outcome. In a mere 4 decades of its clinical use,
the technology used to image myocardial perfusion has made
quantum leaps from planar to single-photon emission
computed tomography (SPECT) and now to a more con-
temporary rapid SPECT, positron emission tomography
(PET), and hybrid SPECT-computed tomography (CT)
and PET-CT techniques. Meanwhile, radiotracers have
ﬂourished from potassium-43 and red blood cell–tagged
blood pool imaging to thallium-201 and technetium-99m–
labeled SPECT perfusion tracers along with rubidium-82,
ammonia N-13, and more recently F-18 ﬂuorine-labeled
PET perfusion tracers. Concurrent with this expansion is
the introduction of new quantitative methods and software for
image processing, evaluation, and data interpretation. Tech-
nical advances, particularly in obtaining quantitative data, have
led to a better understanding of the physiological mechanisms
underlying cardiovascular diseases beyond discrete epicardial
coronary artery disease to coronary vasomotor function in the
early stages of the development of coronary atherosclerosis,
hypertrophic cardiomyopathy, and dilated nonischemic
cardiomyopathy. Progress in the areas of molecular and hybrid
imaging are equally important areas of growth in nuclear
cardiology. However, this paper focuses on the past and future
of nuclear myocardial perfusion imaging and particularly
perfusion tracers (11).
New Unipolar Electrogram Criteria to Identify
Irreversibility of Nonischemic Left Ventricular
Cardiomyopathy
Objectives This study sought to assess the value of left
ventricular (LV) endocardial unipolar electroanatomical
mapping (EAM) in identifying irreversibility of LV systolic
dysfunction in patients with left ventricular nonischemic
cardiomyopathy (LVCM).
Background Identifying irreversibility of LVCM would be
helpful but cannot be reliably accomplished by bipolar
EAM or cardiac magnetic resonance identiﬁcation of
macroscopic scar.Methods Detailed endocardial LV EAM was performed in
3 groups: 1) 24 patients with irreversible LVCM (I-LVCM)
but with no or minimal macroscopic scar (<15% LV surface)
evidenced on bipolar voltage EAM and/or cardiac magnetic
resonance; 2) 14 patients with reversible ventricular premature
depolarization–mediated LVCM (R-LVCM); and 3) 17
patients with structurally normal hearts. LV endocardial
unipolar electrogram amplitude and area of unipolar ampli-
tude abnormality were deﬁned after excluding macroscopic
scar.
Results Unipolar amplitude differed in the 3 groups:
median of 7.6 (interquartile range [IQR]: 5.5 to 9.7) mV in
I-LVCM group, 13.2 (IQR: 10.4 to 16.2) mV in R-LVCM
group, and 16.3 (IQR: 13.6 to 19.8) mV in structurally
normal hearts group (p < 0.001). Areas of unipolar abnor-
mality represented a large proportion of total LV surface in
I-LVCM, 64.7% (IQR: 47.5% to 75.9%) compared with
R-LVCM, 5.2% (IQR: 0.0% to 19.1%) and structu-
rally normal hearts, 0.1% (IQR: 0.0% to 0.9%), groups
(p < 0.001). A unipolar abnormality area cutoff of 32% of
total LV surface was 96% sensitive and 100% speciﬁc in
identifying irreversible cardiomyopathy among patients with
LV dysfunction (I-LVCM and R-LVCM), p < 0.001.
Conclusions Detailed unipolar voltage mapping can iden-
tify irreversible myocardial dysfunction consistent with
ﬁbrosis, even in the absence of bipolar EAM or cardiac
magnetic resonance abnormalities, and may serve as valuable
prognostic tool in patients presenting with LVCM to
facilitate clinical decision making (12).Prognostic Value of Multidetector Coronary
Computed Tomography Angiography in Relation to
Exercise Electrocardiogram in Patients With
Suspected Coronary Artery Disease
Objectives This study was designed to determine the
prognostic value of multidetector coronary computed
tomography angiography (CTA) in relation to exercise
electrocardiography (XECG) ﬁndings.
Background The prognostic usefulness of coronary CTA
ﬁndings of coronary artery disease in relation to XECG
ﬁndings has not been explored systematically.
Methods Patients with suspected coronary artery disease
who had undergone both coronary CTA and XECG (<90
days between tests) from 2003 through 2009 were enrolled
retrospectively. Coronary CTA results were classiﬁed
according to the severity of maximal stenosis (normal,
mild: <40% of luminal stenosis, moderate: 40% to 69%,
severe: 70%), XECG results were categorized as positive
and negative, and Duke XECG score was calculated.
Clinical follow-up data were collected for major adverse
cardiac events (MACE): cardiac death, nonfatal myocardial
infarction, unstable angina requiring hospitalization, and
revascularization after 90 days from index coronary CTA.
C-statistics were calculated to compare discriminatory values
of each test.
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12% demonstrated positive XECG results. By coronary
CTA, patients were categorized as normal (56%) or having
mild (26%), moderate (13%), or severe (5%) disease.
During a median follow-up of 3.3 years (interquartile
range: 2.3 to 4.6), 97 MACE were observed and the 5-
year cumulative event rate was 3.6% (95% conﬁdence
interval: 3.0 to 4.3). Although both XECG (C-statistic:
0.790) and coronary CTA (C-statistic: 0.908) improved
risk stratiﬁcation beyond clinical risk factors (C-statistic:
0.746, p < 0.05 for all), XECG in addition to coronary
CTA (C-statistic: 0.907) did not provide better discrim-
ination than coronary CTA alone (p ¼ 0.389). In
subgroup analyses, coronary CTA stratiﬁed risk of MACE
in groups with both positive and negative XECG results
(all p < 0.001 for trend). However, positive XECG results
predicted risk of MACE on coronary CTA only in the
moderate stenosis group (hazard ratio: 2.58, 95% conﬁ-
dence interval: 1.29 to 5.19, p ¼ 0.008) and severe stenosis
group (hazard ratio: 2.28, 95% conﬁdence interval: 1.19 to
4.38, p ¼ 0.013).
Conclusions In patients with suspected coronary artery
disease, coronary CTA discriminates future risk of MACE
in patients independent of XECG results. Compared with
coronary CTA, XECG has an additive prognostic value only
in patients with moderate to severe stenosis on coronary
CTA (13).Coronary Computed Tomographic Angiography as
a Gatekeeper to Invasive Diagnostic and Surgical
Procedures: Results From the Multicenter
CONFIRM (Coronary CT Angiography Evaluation for
Clinical Outcomes: An International Multicenter)
Registry
Objectives This study sought to examine patterns of
follow-up invasive coronary angiography (ICA) and revas-
cularization (REV) after coronary computed tomography
angiography (CCTA).
Background CCTA is a noninvasive test that permits
direct visualization of the extent and severity of coronary
artery disease (CAD). Post-CCTA patterns of follow-up
ICA and REV are incompletely deﬁned.
Methods We examined 15,207 intermediate likelihood
patients from 8 sites in 6 countries; these patients were
without known CAD, underwent CCTA, and were fol-
lowed up for 2.3  1.2 years for all-cause mortality. Coro-
nary artery stenosis was judged as obstructive when 50%
stenosis was present. A multivariable logistic regression was
used to estimate ICA use. A Cox proportional hazards
model was used to estimate all-cause mortality.
Results During follow-up, ICA rates for patients with no
CAD to mild CAD according to CCTA were low (2.5%
and 8.3%), with similarly low rates of REV (0.3% and 2.5%).
Most ICA procedures (79%) occurred 3 months of
CCTA. Obstructive CAD was associated with higher ratesof ICA and REV for 1-vessel (44.3% and 28.0%), 2-vessel
(53.3% and 43.6%), and 3-vessel (69.4% and 66.8%)
CAD, respectively. For patients with <50% stenosis, early
ICA rates were elevated; over the entirety of follow-up,
predictors of ICA were mild left main, mild proximal
CAD, respectively, or higher coronary calcium scores. In
patients with <50% stenosis, the relative hazard for death
was 2.2 (p ¼ 0.011) for ICA versus no ICA. Conversely, for
patients with CAD, the relative hazard for death was 0.61
for ICA versus no ICA (p ¼ 0.047).
Conclusions These ﬁndings support the concept that
CCTA may be used effectively as a gatekeeper to ICA (14).Incremental Prognostic Value of Assessing Left
Ventricular Myocardial Mechanics in Patients With
Chronic Systolic Heart Failure
Objectives This study sought to examine the ability of left
ventricular (LV) global longitudinal strain (GLS) to assess
disease severity in patients with chronic systolic heart failure
(HF).
Background Left ventricular GLS is a sensitive measure of
LV mechanics. Its relationship with standard clinical
markers and long-term adverse events in chronic systolic HF
is not well established.
Methods In 194 chronic systolic HF patients, we performed
comprehensive echocardiography with assessment of GLS by
velocity vector imaging averaged from apical 4-chamber and
2-chamber views. Death, cardiac transplantation, and HF
hospitalization were tracked for 5 years.
Results In our study cohort (age 57  14 years, left
ventricular ejection fraction [LVEF] 26  6%, median
N-terminal pro-B-type natriuretic peptide [NT-proBNP]
1,158 pg/ml), the mean GLS was 7.1  3.3%. The GLS
worsened with increasing New York Heart Association
functional class (rank-sum p < 0.0001) and higher NT-
proBNP (r ¼ 0.42, p < 0.0001). The GLS correlated with
LV cardiac structure (LV mass index: r ¼ 0.35, p < 0.0001;
LV end-diastolic volume index: r ¼ 0.43, p < 0.0001) and
LVEF (r ¼ 0.66, p < 0.0001). A lower magnitude of GLS
was associated with worsening LV diastolic function (E/e’
septal: r ¼ 0.33, p < 0.0001), right ventricular (RV) systolic
function (RV s’: r ¼ 0.30, p < 0.0001), and RV diastolic
function (RV e’/a’: r¼ 0.16, p¼ 0.033). GLS predicted long-
term adverse events (hazard ratio: 1.55, 95% conﬁdence
interval: 1.21 to 2.00; p < 0.001). Worsening strain
(GLS6.95%) predicted adverse events after adjustment for
age, sex, ischemic etiology, E/e’ septal, and NT-proBNP
(hazard ratio: 2.04, 95% conﬁdence interval: 1.09 to 3.94;
p ¼ 0.025) and age, sex, ischemic etiology, and LVEF
(hazard ratio: 2.15, 95% conﬁdence interval: 1.19 to 4.02;
p ¼ 0.011).
Conclusions In chronic systolic HF, worsening LV GLS is
associated with more severe LV diastolic dysfunction and
RV systolic and diastolic dysfunction, and provides incre-
mental prognostic value to LVEF (15).
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Embolization on Myocardium and Microvasculature
During Primary Percutaneous Coronary Intervention
Objectives The authors sought to investigate the impact
of distal embolization (DE) on myocardial damage and
microvascular reperfusion, according to time-to-treatment,
using contrast-enhanced cardiac magnetic resonance (CE-
CMR).
Background DE, occurring during primary percutaneous
coronary intervention (p-PCI), appears to increase myocardial
necrosis and to worsen microvascular perfusion, as shown by
surrogate markers. However, data regarding the behavior of
DE on jeopardized myocardium, and in particular on necrosis
extent and distribution, are still lacking.
Methods In 288 patients who underwent p-PCI within 6 h
from symptom onset, the authors prospectively assessed the
impact of DE on infarct size and microvascular damage,
using CE-CMR. The impact of DE was assessed according
to time-to-treatment: for group 1, <3 h; for group 2, 3
and 6 h.
Results DE occurred in 41 (14.3%) patients. Baseline
clinical characteristics were not different between the 2
groups. At CE-CMR, patients with DE showed larger
infarct size (p ¼ 0.038) and more often transmural necrosis
compared with patients without DE (p ¼ 0.008) when
time-to-treatment was <3 h, but no impact was proven after
this time (p ¼ NS). Patients with DE showed more often
microvascular obstruction, as evaluated at ﬁrst-pass
enhancement, than patients without DE (100% vs. 66.5%,
p ¼ 0.001) up to 6 h from symptom onset.
Conclusions These ﬁndings suggest that the detrimental
impact of DE occurring during p-PCI on myocardial da-
mage is largely inﬂuenced by ischemic time, increasing the
extent of necrosis in patients presenting within the ﬁrst
hours after symptom onset, and having limited or no impact
after this time window (16).
Quantitative and Qualitative Changes in
DES-Related Neointimal Tissue Based on
Serial OCT
Objectives The study evaluated serial quantitative and
qualitative changes in vascular responses to drug-eluting
stents (DES) using optical coherence tomography (OCT).
Background Serial changes in stent strut coverage and
neointima characteristics in DES-treated lesions have not
been sufﬁciently investigated using OCT.
Methods Serial OCT was performed in 72 patients with
76 DES-treated lesions at 9 months and 2 years after
DES implantation (sirolimus-eluting stent, n ¼ 23;
paclitaxel-eluting stent, n ¼ 20; zotarolimus-eluting
stent, n ¼ 25; everolimus-eluting stent, n ¼ 8). Serial
changes in quantitative parameters (neointimal thickness,
stent strut coverage, and apposition at each strut)
and qualitative characteristics of the neointima were
evaluated.Results Mean neointimal thickness signiﬁcantly increased
from 164 mm to 214 mm between 9 months and 2 years
(p < 0.001), and the percentage of uncovered stent struts
signiﬁcantly decreased (from 4.4% to 2.3%, p < 0.001).
Completely covered lesions were more frequently observed at
2 years (44.7% vs. 59.2%, p¼ 0.07). However, the percentage
of malapposed struts (0.6% vs. 0.9%, p¼ 0.24) and incidence
of intracoronary thrombi (10.5% vs. 9.2%, p > 0.99) were
similar. On qualitative evaluation of neointimal morphology,
lipid-laden neointima (27.6% vs. 14.5%, p ¼ 0.009) and
thin-cap neoatheroma (13.2% vs. 3.9%, p¼ 0.07) were more
frequently detected at 2-year follow-up compared with 9
months. In matched cross-sectional evaluation, the change of
neointimal morphology from homogeneous to heterogeneous
or lipid-laden pattern was observed in 23 (30.3%) of 76
lesions. There was a signiﬁcant increase in percent neointimal
hyperplasia cross-sectional area in those lesions.
Conclusions This OCT study suggested that neointimal
coverage improved from 9 months to 2 years without
signiﬁcant changes in the incidence of malapposed struts
and intracoronary thrombus. Additionally, in-stent neo-
atherosclerosis including transformation to lipid-laden
neointima might progress during extended follow-up
periods after DES implantation (17).Selective Factor XIIa Inhibition Attenuates Silent
Brain Ischemia: Application of Molecular Imaging
Targeting Coagulation Pathway
Objectives The purpose of this study was use molecular
imaging targeting coagulation pathway and inﬂammation to
better understand the pathophysiology of silent brain
ischemia (SBI) and monitor the effects of factor XIIa
inhibition.
Background SBI can be observed in patients who undergo
invasive vascular procedures. Unlike acute stroke, the diffuse
nature of SBI and its less tangible clinical symptoms make
this disease difﬁcult to diagnose and treat.
Methods We induced SBI in mice by intra-arterial injec-
tion of ﬂuorescently labeled microbeads or fractionated clot
into the carotid artery. After SBI induction, diffusion-
weighted magnetic resonance imaging was performed to
conﬁrm the presence of microinfarcts in asymptomatic mice.
Molecular imaging targeting the downstream factor XIII
activity (single-photon emission computed tomography/
computed tomography) at 3 h and myeloperoxidase activity
(magnetic resonance imaging) on day 3 after SBI induction
were performed, without and with the intravenous admin-
istration of a recombinant selective factor XIIa inhibitor
derived from the hematophagous insect Triatoma infestans
(rHA-Infestin-4). Statistical comparisons between 2 groups
were evaluated by the Student t test or Mann-Whitney U
test.
Results In SBI-induced mice, we found abnormal activa-
tion of the coagulation cascade (factor XIII activity) and
increased inﬂammation (myeloperoxidase activity) close to
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tration signiﬁcantly reduced ischemic damage (53% to 85%
reduction of infarct volume, p < 0.05) and pathological
coagulation (35% to 39% reduction of factor XIII activity,
p < 0.05) without increasing hemorrhagic frequency.
Myeloperoxidase activity, when normalized to the infarct
volume, did not signiﬁcantly change with rHA-Infestin-4
treatment, suggesting that this treatment does not further
decrease inﬂammation other than that resulting from the
reduction in infarct volume.
Conclusions Focal intracerebral clotting and inﬂammatory
activity are part of the pathophysiology underlying SBI.
Inhibiting factor XIIa with rHA-Infestin-4 may present
a safe and effective treatment to decrease the morbidity of
SBI (18).Inﬂuence of Ejection Fraction on the Prognostic
Value of Sympathetic Innervation Imaging With
Iodine-123 MIBG in Heart Failure
Objectives The aim of this study was to determine whether
left ventricular ejection fraction (LVEF) inﬂuences the rela-
tionship between abnormal myocardial sympathetic innerva-
tion imaging by iodine 123 meta-iodobenzylguanidine
(123I-mIBG) and outcomes in patients with heart failure
(HF).
Background In systolic HF, both abnormal 123I-mIBG
imaging and reduced LVEF are associated with higher risk of
cardiovascular events. Whether 123I-mIBG imaging has the
same predictive value across the LVEF spectrum is unclear.
Methods Among 985 patients in the ADMIRE-HF
(AdreView Myocardial Imaging for Risk Evaluation in
Heart Failure) trial with New York Heart Association
functional class II or III HF and site-reported LVEF 35%,
the core laboratory–determined LVEFs were available for
901 subjects, ranging from 20% to 58% (mean LVEF 34 
7%), and was >35% in 386 subjects.
Results The mean age of the study population was 62  12
years, 80% were male, and the majority had New York Heart
Association functional class II symptoms and HF of non-
ischemic etiology. At all levels of LVEF, the 123I-mIBG
heart-to-mediastinum ratio of <1.6 was associated with
a higher risk of death or potentially lethal arrhythmic event
and of the composite of cardiovascular death, arrhythmic
event, and HF progression. Comparing subjects with
LVEF 35% and >35%, there was no evidence of effect
modiﬁcation of LVEF on the risk associated with low heart-
to-mediastinum ratio for death or arrhythmic event
(adjusted hazard ratio: 2.39 [95% conﬁdence interval (CI):
1.03 to 5.55] vs. 5.28 [95% CI: 1.21 to 23.02]; interaction
p ¼ 0.48) and for the composite (adjusted hazard ratio: 1.80
[95% CI: 1.01 to 3.23] vs. 2.41 [95% CI: 1.11 to 5.23];
interaction; p ¼ 0.86). For death or arrhythmic event, the
heart-to-mediastinum ratio appeared to improve the risk
discrimination beyond clinical and biomarker data among
both LVEF groups, with improvement in the model C-statistic (0.67 vs. 0.69, p ¼ 0.03) and integrated discrimi-
nation improvement (p ¼ 0.0008).
Conclusions 123I-mIBG imaging has prognostic value
across a spectrum of LVEFs. Further studies may be war-
ranted to prospectively test the prognostic value of 123I-
mIBG imaging in patients with HF and an LVEF >35%
(19).Correlation of Trabeculae and Papillary Muscles
With Clinical and Cardiac Characteristics and Impact
on CMR Measures of LV Anatomy and Function
Objectives The goal of this study was to assess the rela-
tionship of left ventricular (LV) trabeculae and papillary
muscles (TPM) with clinical characteristics in a community-
based, free-living adult cohort and to determine the effect of
TPM on quantitative measures of LV volume, mass, and
ejection fraction (EF).
Background Hypertrabeculation has been associated with
adverse cardiovascular events, but the distribution and clin-
ical correlates of the volume and mass of the TPM in
a normal left ventricle have not been well characterized.
Methods Short-axis cine cardiac magnetic resonance
images, obtained using a steady-state free precession
sequence from 1,494 members of the Framingham Heart
Study Offspring cohort, were analyzed with software that
automatically segments TPM. Absolute TPM volume,
TPM as a fraction of end-diastolic volume (EDV) (TPM/
EDV), and TPM mass as a fraction of LV mass were
determined in all offspring and in a referent group of
offspring free of clinical cardiovascular disease and
hypertension.
Results In the referent group (mean age 61  9 years; 262
men and 423 women), mean TPM was 23  3% of LV
EDV in both sexes (p ¼ 0.9). TPM/EDV decreased with
age (p < 0.02) but was not associated with body mass index.
TPM mass as a fraction of LV mass was inversely correlated
with age (p < 0.0001), body mass index (p < 0.018), and
systolic blood pressure (p < 0.0001). Among all 1,494
participants (699 men), LV volumes decreased 23%, LV
mass increased 28%, and EF increased by 7.5 EF units
(p < 0.0001) when TPM were considered myocardial mass
rather than part of the LV blood pool.
Conclusions Global cardiac magnetic resonance LV
parameters were signiﬁcantly affected by whether TPM was
considered as part of the LV blood pool or as part of LV
mass. Our cross-sectional data from a healthy referent group
of adults free of clinical cardiovascular disease demonstrated
that TPM/EDV decreases with increasing age in both sexes
but is not related to hypertension or obesity (20).Quantitative Assessment of Mitral Regurgitation:
How Best to Do It
Decisions regarding surgery for mitral regurgitation (MR)
are predicated on the accurate quantiﬁcation of MR severity.
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regurgitant volume and fraction, and effective regurgitant
oriﬁce area have prognostic signiﬁcance and are recom-
mended to be obtained from patients with more than mild
MR. New tools for MR quantiﬁcation have been provided by
3-dimensional echocardiography, cardiac magnetic resonance,
and cardiac computed tomography, but limited guidance on
appropriate image acquisition and post-processing techniques
has hindered their clinical application and reproducibility.
This review describes optimal image acquisition and post-
processing methods for quantiﬁcation of MR (21).
Coronary Flow Reserve During Dipyridamole Stress
Echocardiography Predicts Mortality
Objectives The goal of this study was to evaluate the ability
of coronary ﬂow reserve (CFR) over regional wall motion to
predict mortality in patients with known or suspected
coronary artery disease (CAD).
Background CFR evaluated using pulsed Doppler echo-
cardiography testing on left anterior descending artery is
the state-of-the-art method during vasodilatory stress
echocardiography.
Methods In a prospective, multicenter, observational
study, we evaluated 4,313 patients (2,532 men; mean age
65  11 years) with known (n ¼ 1,547) or suspected
(n ¼ 2,766) CAD who underwent high-dose dipyridamole
(0.84 mg/kg over 6 min) stress echocardiography with
CFR evaluation of left coronary descending artery (LAD)
by Doppler. Overall mortality was the only endpoint
analyzed.
Results Stress echocardiography was positive for ischemia
in 765 (18%) patients. Mean CFR was 2.35  0.68. At
individual patient analysis, 1,419 (33%) individuals had
CFR 2. During a median follow-up of 19 months (1st
quartile 8; 3rd quartile 36), 146 patients died. The 4-year
mortality was markedly higher in subjects with CFR 2
than in those with CFR >2, both considering the group
with ischemia (39% vs. 7%; p < 0.0001) and the group
without ischemia at stress echocardiography (12% vs. 3%;
p < 0.0001). At multivariable analysis, CFR on LAD 2
(hazard ratio [HR]: 3.31; 95% conﬁdence interval [CI]:
2.29 to 4.78; p < 0.0001), ischemia at stress echocardi-
ography (HR: 2.40, 95% CI: 1.65 to 3.48, p < 0.0001), left
bundle branch block (HR: 2.26, 95% CI: 1.50 to 3.41; p <
0.0001), age (HR: 1.08, 95% CI: 1.06–1.10; p < 0.0001),
resting wall motion score index (HR: 3.52, 95% CI: 2.38 to
5.21; p < 0.0001), male sex (HR: 1.74, 95% CI: 1.12 to
2.52; p ¼ 0.003), and diabetes mellitus (HR: 1.47, 95% CI:
1.03 to 2.08; p ¼ 0.03) were independent predictors of
mortality.
Conclusions CFR on LAD is a strong and independent
indicator of mortality, conferring additional prognostic value
over wall motion analysis in patients with known or sus-
pected CAD. A negative result on stress echocardiography
with a normal CFR confers an annual risk of death <1% in
both patient groups (22).Noninvasive Diagnosis of Ischemia-Causing
Coronary Stenosis Using CT Angiography:
Diagnostic Value of Transluminal Attenuation
Gradient and Fractional Flow Reserve Computed
From Coronary CT Angiography Compared to
Invasively Measured Fractional Flow Reserve
Objectives The aim of this study was to compare the
diagnostic performance of coronary computed tomography
angiography (CCTA)-derived computed fractional ﬂow
reserve (FFRCT) and transluminal attenuation gradient
(TAG) for the diagnosis of lesion-speciﬁc ischemia.
Background Although CCTA is commonly used to detect
coronary artery disease (CAD), it cannot reliably assess the
functional signiﬁcance of CAD. Novel technologies based
on CCTA were developed to integrate anatomical and
functional assessment of CAD; however, the diagnostic
performance of these methods has never been compared.
Methods Fifty-three consecutive patients who underwent
CCTA and coronary angiography with FFR measurement
were included. Independent core laboratories determined
CAD severity by CCTA, TAG, and FFRCT. The TAG
was deﬁned as the linear regression coefﬁcient between
intraluminal radiological attenuation and length from the
ostium; FFRCT was computed from CCTA data using
computational ﬂuid dynamics technology.
Results Among 82 vessels, 32 lesions (39%) had ischemia by
invasive FFR (FFR 0.80). Sensitivity, speciﬁcity, positive
and negative predictive values, and positive and negative
likelihood ratio of TAG ( 0.654 HU/mm) for detection
of ischemia were 38%, 88%, 67%, 69%, 3.13, and 0.71,
respectively; and those of FFRCT were 81%, 94%, 90%, 89%,
13.54, and 0.20, respectively. Receiver-operating character-
istic curve analysis showed a signiﬁcantly larger area under the
curve (AUC) for FFRCT (0.94) compared to that for TAG
(0.63, p < 0.001) and CCTA stenosis (0.73, p < 0.001). In
vessels with noncalciﬁed plaque or partially calciﬁed plaque,
FFRCT showed a larger AUC (0.94) compared to that of
TAG (0.63, p < 0.001) or CCTA stenosis (0.70, p < 0.001).
In vessels with calciﬁed plaque, AUC of FFRCT (0.92) was
not statistically larger than that of TAG (0.75, p ¼ 0.168) or
CCTA stenosis (0.80, p ¼ 0.195).
Conclusions Noninvasive FFR computed from CCTA
provides better diagnostic performance for the diagnosis of
lesion-speciﬁc ischemia compared to CCTA stenosis and
TAG (23).
Combined CT Coronary Angiography and Stress
Myocardial Perfusion Imaging for Hemodynamically
Signiﬁcant Stenoses in Patients With Suspected
Coronary Artery Disease: A Comparison With
Fractional Flow Reserve
Objectives We sought to determine the accuracy of
combined coronary computed tomography angiography
(CTA) and computed tomography stress myocardial perfu-
sion imaging (CTP) in the detection of hemodynamically
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a reference standard in patients with suspected coronary
artery disease.
Background CTP can be qualitatively assessed by visual
interpretation or quantiﬁed by the transmural perfusion ratio
determined as the ratio of subendocardial to subepicardial
contrast attenuation. The incremental value of each tech-
nique in addition to coronary CTA to detect hemodynam-
ically signiﬁcant stenoses is not known.
Methods Forty symptomatic patients underwent FFR and
320-detector computed tomography assessment including
coronary CTA and CTP. Myocardial perfusion was assessed
using the transmural perfusion ratio and visual perfusion
assessment. Computed tomography images were assessed by
consensus of 2 observers. Transmural perfusion ratio <0.99
was used as the threshold for abnormal perfusion. FFR 0.8
indicated hemodynamically signiﬁcant stenoses.
Results Coronary CTA detected FFR-signiﬁcant stenoses
with 95% sensitivity and 78% speciﬁcity. The additional use
of visual perfusion assessment and the transmural perfusion
ratio both increased the speciﬁcity to 95%, with sensitivity of
87% and 71%, respectively. The area under the receiver-
operating characteristic curve for coronary CTA þ visual
perfusion assessment was signiﬁcantly higher than both
coronary CTA (0.93 vs. 0.85, p ¼ 0.0003) and coronary
CTA þ the transmural perfusion ratio (0.93 vs. 0.79,
p ¼ 0.0003). Per-vessel and per-patient accuracy for coro-
nary CTA, coronary CTA þ the transmural perfusion ratio,
and coronary CTA þ visual perfusion assessment was 83%
and 83%, 87% and 92%, and 92% and 95%, respectively.
Conclusions In suspected coronary artery disease,
combined coronary CTA þ CTP identiﬁes patients with
hemodynamically signiﬁcant stenoses with >90% accuracy
compared with FFR. When interpreted with coronary CTA,
visual perfusion assessment provided superior incremental
value in the detection of FFR-signiﬁcant stenoses com-
pared with the quantitative transmural perfusion ratio
assessment (24).Does Rubidium-82 PET Have Superior Accuracy to
SPECT Perfusion Imaging for the Diagnosis of
Obstructive Coronary Disease?
A Systematic Review and Meta-Analysis
Objectives The purpose of this study was to evaluate the
accuracy of rubidium (Rb)-82 positron emission tomography
(PET) for the diagnosis of obstructive coronary artery
disease (CAD) in comparison to single-photon emission
tomography (SPECT).
Background Myocardial perfusion imaging is widely used
in the assessment of patients with known or suspected
CAD. PET using Rb-82 has potential advantages over
SPECT that may make it more accurate and that reduce
radiation exposure compared with SPECT but has increased
costs. Comparisons of these technologies are highly relevant
for policy makers and practice guidelines. However, studiesdirectly comparing Rb-82 PET with contemporary SPECT
have been limited.
Method The authors therefore undertook a systematic review
of studies where either Rb-82 PET or technetium-
99m SPECT with both attenuation correction and
electrocardiography-gating were used as a diagnostic test for
obstructive CAD with invasive coronary angiogram as a
reference standard. These technologies were then compared.
Results Fifteen PET and 8 SPECT studies (1,344 and
1,755 patients, respectively) met inclusion criteria and pooled
accuracy using weighted averages according to the size of the
patient population was determined for PET and SPECT with
sensitivities of 90% (conﬁdence interval [CI]: 0.88 to 0.92)
and 85% (CI: 0.82 to 0.87) and speciﬁcities of 88% (CI: 0.85
to 0.91) and 85% (CI: 0.82 to 0.87), respectively. Summary
receiver-operating characteristic curves were computed: area
under the curve was 0.95 and 0.90 for PET and SPECT,
respectively (p < 0.0001). There was heterogeneity among
study populations and some studies were limited by referral
bias.
Conclusions Rb-82 PET is accurate for the detection of
obstructive CAD and, despite advances in SPECT tech-
nology, remains superior. More widespread use of Rb-82
PET may be beneﬁcial to improve CAD detection (25).Development of a Novel Echocardiography Ramp
Test for Speed Optimization and Diagnosis of Device
Thrombosis in Continuous-Flow Left Ventricular
Assist Devices: The Columbia Ramp Study
Objectives This study sought to develop a novel approach
to optimizing continuous-ﬂow left ventricular assist device
(CF-LVAD) function and diagnosing device malfunctions.
Background In CF-LVAD patients, the dynamic interac-
tion of device speed, left and right ventricular decompres-
sion, and valve function can be assessed during an
echocardiography-monitored speed ramp test.
Methods We devised a unique ramp test protocol to be
routinely used at the time of discharge for speed optimi-
zation and/or if device malfunction was suspected. The
patient’s left ventricular end-diastolic dimension, frequency
of aortic valve opening, valvular insufﬁciency, blood pressure,
and CF-LVAD parameters were recorded in increments of
400 rpm from 8,000 rpm to 12,000 rpm. The results of the
speed designations were plotted, and linear function slopes
for left ventricular end-diastolic dimension, pulsatility index,
and power were calculated.
Results Fifty-two ramp tests for 39 patients were prospec-
tively collected and analyzed. Twenty-eight ramp tests were
performed for speed optimization, and speed was changed
in 17 (61%) with a mean absolute value adjustment of
424  211 rpm. Seventeen patients had ramp tests performed
for suspected device thrombosis, and 10 tests were suspicious
for device thrombosis; these patients were then treated with
intensiﬁed anticoagulation and/or device exchange/emergent
transplantation. Device thrombosis was conﬁrmed in 8 of 10
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plantation. All patients with device thrombosis, but none of
the remaining patients had a left ventricular end-diastolic
dimension slope >0.16.
Conclusions Ramp tests facilitate optimal speed changes
and device malfunction detection and may be used to
monitor the effects of therapeutic interventions and need for
surgical intervention in CF-LVAD patients (26).Lessons From the Past and Promises for the Future
for Carotid Intima-Media Thickness
Carotid intima-media thickness (CIMT) measurements
have been used in cardiovascular research for more than 2
decades. There is a wealth of evidence showing that CIMT
can be assessed in a reproducible manner and that increased
CIMT relates to unfavorable risk factor levels and athero-
sclerosis elsewhere in the arterial system and to the risk of
vascular events. Change in CIMT over time can be readily
assessed, and trials showed that the rate of change is
modiﬁable by treatment. Several issues important for the
cardiovascular research community and its application in
clinical practice are still outstanding. Promising future areas
for CIMT measurements are: 1) application in studies
among children and adolescents; 2) use of CIMT trials
positioned decisively before the start of a morbidity and
mortality trial; and 3) the use of CIMT measurement in risk
stratiﬁcation in those with an intermediate 10-year risk
estimate (27).Detection of Antecedent Myocardial Ischemia With
Multiselectin Molecular Imaging
Objectives Our aim was to develop an echocardiographic
molecular imaging approach for detecting recent myocardial
ischemia by using recombinant P-selectin glycoprotein
ligand (PSGL)-1 as a targeting ligand, which is a feasible
approach for human use.
Background Ischemic memory imaging using human
PSGL-1 as a targeting moiety may extend the time window
for postischemic detection by targeting the early (P-selectin)
and late (E-selectin) endothelial ischemic response.
Methods Lipid microbubbles bearing recombinant human
PSGL-1 (MBYSPSL) or P-selectin antibody (MBAb) were
prepared. Targeted attachment was evaluated by using ﬂow
chamber and intravital microscopy. In vivo ultrasound
molecular imaging was ﬁrst performed in the hindlimb in
wild-type and P-selectin–deﬁcient (P/) mice 45 to 360
min after brief ischemia-reperfusion injury. Myocardial
contrast echocardiography molecular imaging was performed
1.5, 3, 6, and 18 h after brief left anterior descending
coronary artery ischemia-reperfusion.
Results Microbubble attachment to P-selectin–immuno-
globulin G fusion protein in ﬂow chamber experiments
(shear stress 0.5 to 8.0 dyne/cm2) and to activated venular
endothelium on intravital microscopy were similar forMBAb and MBYSPSL. Intense enhancement was seen for
MBAb and MBYSPSL in postischemic muscle and was
more stable over time for MBYSPSL. On myocardial
contrast echocardiography, both MBYSPSL and MBAb
produced similar signal enhancement at 90 min and 3 h after
ischemia, which spatially correlated with the postischemic
risk area. Signal signiﬁcantly decreased but was still present
at 6 to 18 h.
Conclusions Echocardiographic molecular imaging with
a human multi-selectin–targeted contrast agent bearing
recombinant human PSGL-1 can detect myocardial is-
chemia hours after resolution. This approach may potentially
be used for rapid bedside evaluation of patients with recent
chest pain (28).Quantitative Assessment of Mitral Regurgitation:
Validation of New Methods
Accurate assessment of mitral regurgitation (MR) severity is
important for clinical decision making, prognostication, and
decisions regarding timing of surgical intervention. The
most common method for noninvasive assessment of MR
has been with 2-dimensional transthoracic echocardiog-
raphy, which is often used as a qualitative tool. Several newer
noninvasive modalities including 3-dimensional echocardi-
ography, cardiac magnetic resonance imaging, and cardiac
computed tomography have also become available for this
purpose; however, their role in routine clinical practice is not
clearly deﬁned. In this review, we provide an overview of
these newer modalities for quantitative assessment of MR
severity (29).Quantiﬁcation of Absolute Myocardial Perfusion in
Patients With Coronary Artery Disease:
Comparison Between Cardiovascular Magnetic
Resonance and Positron Emission Tomography
Objectives The aim of this study was to compare fully
quantitative cardiovascular magnetic resonance (CMR) and
positron emission tomography (PET) myocardial perfusion
and myocardial perfusion reserve (MPR) measurements in
patients with coronary artery disease (CAD).
Background Absolute quantiﬁcation of myocardial perfu-
sion and MPR with PET have proven diagnostic and
prognostic roles in patients with CAD. Quantitative CMR
perfusion imaging has been established more recently and
has been validated against PET in normal hearts. However,
there are no studies comparing fully quantitative CMR
against PET perfusion imaging in patients with CAD.
Methods Forty-one patients with known or suspected CAD
prospectively underwent quantitative 13N-ammonia PET and
CMR perfusion imaging before coronary angiography.
Results The CMR-derived MPR (MPRCMR) corre-
lated well with PET-derived measurements (MPRPET)
(r ¼ 0.75, p < 0.0001). MPRCMR and MPRPET for
the 2 lowest scoring segments in each coronary territory
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CMR perfusion values correlated signiﬁcantly, but
weakly, with PET values both at rest (r ¼ 0.32;
p ¼ 0.002) and during stress (r ¼ 0.37; p < 0.0001). Area
under the receiver-operating characteristic curve for
MPRPET to detect signiﬁcant CAD was 0.83 (95%
conﬁdence interval: 0.73 to 0.94) and for MPRCMR was
0.83 (95% conﬁdence interval: 0.74 to 0.92). An
MPRPET 1.44 predicted signiﬁcant CAD with 82%
sensitivity and 87% speciﬁcity, and MPRCMR 1.45
predicted signiﬁcant CAD with 82% sensitivity and 81%
speciﬁcity.
Conclusions There is good correlation between MPRCMR
and MPRPET. For the detection of signiﬁcant CAD,
MPRPET and MPRCMR seem comparable and very accu-
rate. However, absolute perfusion values from PET and
CMR are only weakly correlated; therefore, although quanti-
tative CMR is clinically useful, further reﬁnements are still
required (30).
CD14DDCD16D Monocytes Independently
Predict Cardiovascular Events: A Cohort Study of
951 Patients Referred for Elective Coronary
Angiography
Objectives The aim of this study was to analyze the yet ill-
deﬁned relationship of distinct human monocyte subsets
with cardiovascular outcomes in a broad patient population
at cardiovascular risk.
Background Monocytes, the most abundant immune cell
type found in atherosclerotic plaques, are crucial promoters of
atherogenesis. Three distinct human monocyte subsets exist:
classical CD14þþCD16, intermediate CD14þþCD16þ,
and nonclassical CD14þCD16þþ monocytes. Immuno-
modulation of distinct monocyte subsets has recently been
discussed as a new therapeutic avenue in atherosclerosis.
Methods Cardiovascular events in 951 subjects referred for
elective coronary angiography were prospectively analyzed.
Monocyte subset analysis was performed using ﬂow cytom-
etry, blinded to patients’ clinical characteristics, and patients
were categorized according to quartiles of total monocyte and
monocyte subset counts. The primary endpoint was deﬁned
a priori as the ﬁrst occurrence of cardiovascular death, acute
myocardial infarction, or nonhemorrhagic stroke. End-
point adjudication was done blinded to monocyte subset
distribution.
Results During a mean follow-up period of 2.6  1.0 years,
93 patients experienced the primary endpoint. In univariate
Kaplan-Meier analysis, counts of total (p ¼ 0.010), classical
CD14þþCD16 (p ¼ 0.024), and intermediate
CD14þþCD16þ (p < 0.001) monocytes predicted the
primary endpoint, whereas nonclassical monocytes did not
(p ¼ 0.158). After full adjustment for confounders,
CD14þþCD16þ monocytes remained the only monocyte
subset independently related to cardiovascular events (fourth
vs. ﬁrst quartile: hazard ratio: 3.019; 95% conﬁdence interval:
1.315 to 6.928; p ¼ 0.009).Conclusions CD14þþCD16þ monocytes independently
predicted cardiovascular events in subjects referred for elec-
tive coronary angiography. Future studies will be needed to
elucidate whether CD14þþCD16þ monocytes may be-
come a target cell population for new therapeutic strategies
in atherosclerosis (31).Cardiac Outcomes With Submaximal Normal
Stress Echocardiography: A Meta-Analysis
Objectives The aim of the study was to evaluate the risk of
cardiac events in patients with normal stress echocardiog-
raphy (SE) who attained maximal age-predicted heart rate
(APHR) compared with those who did not in the setting of
both normal and abnormal SE.
Background SE is an important tool in the risk stratiﬁca-
tion and prognosis of patients with known or suspected
coronary artery disease (CAD). The prognostic value of
a normal but submaximal SE (<85% of maximal APHR) is
conﬂicting.
Methods PubMed, EMBASE, and CENTRAL were
searched from 1980 to September 2011 for SE studies
reporting cardiac outcomes in patients with known or sus-
pected CAD stratiﬁed by achieved APHR. Both hard events
(cardiac death and myocardial infarction) and total cardiac
events (revascularization procedures in addition to hard
events) were analyzed separately. Data on all-cause mortality
were obtained when available.
Results Fourteen studies with 11,542 patients followed
up for a mean duration of 32 months fulﬁlled the
inclusion criteria. In 8 studies with 4,577 patients, the
risk of hard events with normal SE (both exercise and
dobutamine) was 70% higher in patients who achieved
submaximal compared with those with maximal APHR
(annualized event rate 2.08% vs. 0.77%; p ¼ 0.0008;
95% conﬁdence interval [CI]: 1.25 to 2.31). In 7 studies
with 5,798 patients, the risk of total cardiac events with
normal SE (both exercise and dobutamine) was 127%
higher in patients who achieved submaximal compared
with those with maximal APHR (annualized event rate
1.87% vs. 1.02%; p < 0.0001; 95% CI: 1.54 to 3.34).
The risk of total cardiac events was 278% higher in
patients with abnormal SE with submaximal APHR
compared with those with normal SE with submaximal
APHR (p < 0.0001; 95% CI: 2.81 to 5.08). There was
a trend toward increased all-cause mortality in patients
with normal SE with submaximal compared with
maximal APHR (relative risk: 1.36; p ¼ 0.15; 95% CI:
0.89 to 2.09).
Conclusions Patients with submaximal APHR in the
setting of normal SE have a higher risk of cardiovas-
cular events than those who attained maximal stress
test. Thus, the results of submaximal APHR in the
setting of normal SE should be taken into consider-
ation for more accurate risk stratiﬁcation and prognosis
(32).
JACC Vol. 62, No. 14, 2013 The Editors
October 1, 2013:e29–141 JACC Topic Collection: Cardiac Imaging
e41Effects of Bariatric Surgery on Cardiac Ectopic Fat:
Lesser Decrease in Epicardial Fat Compared to
Visceral Fat Loss and No Change in Myocardial
Triglyceride Content
Objectives This study investigated the effect of bariatric
surgery (BS)–induced weight loss on cardiac ectopic fat
using 3T magnetic resonance imaging in morbid obesity.
Background Heart disease is one of the leading causes of
mortality and morbidity in obese patients. Deposition of
cardiac ectopic fat has been related to increased heart risk.
Whether sustained weight loss can modulate epicardial fat or
myocardial fat is unknown.
Methods Twenty-three morbidly obese patients underwent
1H-magnetic resonance spectroscopy to determine
myocardial triglyceride content (MTGC), magnetic reso-
nance imaging to assess epicardial fat volume (EFV), cardiac
function, and computed tomography visceral abdominal fat
(VAF) measurements at baseline and 6 months after BS.
Results The BS reduced body mass index signiﬁcantly,
from 43.1  4.5 kg/m2 to 32.3  4.0 kg/m2, subcutaneous
fat from 649  162 cm2 to 442  127 cm2, VAF from 190
 83 cm2 to 107  44 cm2, and EFV from 137  37 ml to
98  25 ml (all p < 0.0001). There was no signiﬁcant
change in MTGC: 1.03  0.2% versus 1.1  0.2%
(p ¼ 0.85). A signiﬁcant reduction in left ventricular mass
(118  24 g vs. 101  18 g) and cardiac output (7.1  1.6 l/
min vs. 5.4  1.0 l/min) was observed and was statistically
associated with weight loss (p < 0.05). The loss in EFV was
limited (27  11%) compared to VAF diminution (40
 19%). The EFV variation was not correlated with
percentage of body mass index or VAF loss (p ¼ 0.007).
The ratio of %EFV to %VAF loss decreased with sleep
apnea syndrome (1.34  0.3 vs. 0.52  0.08, p < 0.05).
Conclusions Six-month BS modulates differently cardiac
ectopic fat deposition, with a signiﬁcant decrease in epi-
cardial fat and no change in myocardial fat. Epicardial fat
volume loss was limited in patients with sleep apnea.
(Impact of Bariatric Surgery on Epicardial Adipose Tissue
and on Myocardial Function; NCT01284816) (33).Cardiovascular Disease in the Developing World:
Prevalences, Patterns, and the Potential of Early
Disease Detection
Over the past decade or more, the prevalence of traditional
risk factors for atherosclerotic cardiovascular diseases has
been increasing in the major populous countries of the
developing world, including China and India, with conse-
quent increases in the rates of coronary and cerebrovascular
events. Indeed, by 2020, cardiovascular diseases are pre-
dicted to be the major causes of morbidity and mortality in
most developing nations around the world. Techniques
for the early detection of arterial damage have provided
important insights into disease patterns and pathogenesis
and especially the effects of progressive urbanization oncardiovascular risk in these populations. Furthermore,
certain other diseases affecting the cardiovascular system
remain prevalent and important causes of cardiovascular
morbidity and mortality in developing countries, including
the cardiac effects of rheumatic heart disease and the vascular
effects of malaria. Imaging and functional studies of early
cardiovascular changes in those disease processes have also
recently been published by various groups, allowing con-
sideration of screening and early treatment opportunities. In
this report, the authors review the prevalences and patterns
of major cardiovascular diseases in the developing world, as
well as potential opportunities provided by early disease
detection (34).Mortality Rates in Smokers and Nonsmokers in the
Presence or Absence of Coronary Artery Calciﬁcation
Objectives The aim of this study was to further explore the
interplay between smoking status, coronary artery calcium
(CAC), and all-cause mortality.
Background Prior studies have not directly compared the
relative prognostic impact of CAC in smokers versus
nonsmokers. In particular, although a calcium score of zero
(CAC ¼ 0) is a known favorable prognostic marker, whether
smokers with CAC ¼ 0 have as good a prognosis as
nonsmokers with CAC ¼ 0 is unknown. Given that
computed tomography (CT) screening for lung cancer
appears effective in smokers, the relative prognostic impli-
cations of visualizing any CAC versus no CAC on such
screening also deserve study.
Methods Our study cohort consisted of 44,042 asymp-
tomatic individuals referred for noncontrast cardiac CT (age
54  11 years, 54% men). Subjects were followed for a mean
of 5.6 years. The primary endpoint was all-cause mortality.
Results Approximately 14% (n ¼ 6,020) of subjects were
active smokers at enrollment. There were 901 deaths
(2.05%) overall, with increased mortality in smokers versus
nonsmokers (4.3% vs. 1.7%, p < 0.0001). Smoking
remained a risk factor for mortality across increasing strata
of CAC scores (1 to 100, 101 to 400, and >400). At each
stratum of elevated CAC score, mortality in smokers was
consistently higher than mortality in nonsmokers from the
CAC stratum above. In multivariable analysis within these
strata, we found mortality hazard ratios of 3.8 (95% conﬁ-
dence interval [CI]: 2.8 to 5.2), 3.5 (95% CI: 2.6 to 4.9), and
2.7 (95% CI: 2.1 to 3.5), respectively, in smokers compared
with nonsmokers. However, among the 19,898 individuals
with CAC ¼ 0, the mortality hazard ratio for smokers
without CAC was 3.6 (95% CI: 2.3 to 5.7), compared with
nonsmokers without CAC.
Conclusions Smoking is a risk factor for death across the
entire spectrum of subclinical coronary atherosclerosis.
Smokers with any CAC had signiﬁcantly higher mortality
than smokers without CAC, a ﬁnding with implications
for smokers undergoing lung cancer CT-based screening.
However, the absence of CAC might not be as useful
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has mortality rates similar to nonsmokers with mild-to-
moderate atherosclerosis (35).Comparison of the Prognostic Value of Normal
Regadenoson With Normal Adenosine Myocardial
Perfusion Imaging With Propensity Score Matching
Objectives The aim of this study was to test the hypothesis
that patients with normal regadenoson myocardial perfusion
imaging (MPI) have a low rate of cardiac events, similar to
patients with normal adenosine MPI.
Background Regadenoson, a new selective adenosine A2A
receptor agonist, is now a widely used stress agent for MPI.
The low rate of cardiac events in patients with normal
adenosine MPI is well-documented, but the prognostic
implications of a normal regadenoson MPI have not been
examined and compared with those with adenosine.
Methods Data on primary composite endpoint (cardiac
death, myocardial infarction, and coronary revascularization)
were collected for 2,000 patients (1,000 regadenoson, and
1,000 adenosine stress) with normal myocardial perfusion
and left ventricular ejection fraction referred for vasodilator
MPI. In addition, propensity scores were used to assemble
a balanced cohort of 505 pairs of patients who were balanced
on 36 baseline characteristics.
Results The primary endpoint occurred in 21 (2.1%;
1.1%/year) patients in the regadenoson group and 33
(3.3%; 1.7%/year) patients in the adenosine group (hazard
ratio [HR] for regadenoson vs. adenosine: 0.62; 95%
conﬁdence interval [CI]: 0.36 to 1.08; p ¼ 0.090). In the
propensity-matched pairs, the primary endpoint occurred
in 7 (1.4%; 0.7%/year) patients in the regadenoson group
and 13 (2.6%; 1.3%/year) patients in the adenosine group
(matched HR: 0.58; 95% CI: 0.23 to 1.48; p ¼ 0.257).
Cardiac deaths were infrequent in the entire sample and in
the propensity-matched groups; the cardiac death rate was
0.9%/year and 1.15%/year in the regadenoson and adeno-
sine groups (HR: 0.77; 95% CI: 0.42 to 1.43; p ¼ 0.404) in
the pre-match sample and 0.5%/year and 0.7%/year in the
matched groups, respectively (HR: 0.83; 95% CI: 0.25 to
2.73; p ¼ 0.763).
Conclusions Major cardiac events are infrequent in
patients with normal regadenoson MPI. These ﬁndings
provide assurance that normal MPI using a simpler stress
protocol with regadenoson provides prognostic data similar
to normal adenosine MPI (36).Prognostic Value of Coronary CT Angiography and
Calcium Score for Major Adverse Cardiac Events in
Outpatients
Objectives This study sought to evaluate the prognostic
value of coronary artery calcium score (CACS) and coronary
computed tomography angiography (CTA) for major
adverse cardiac events (MACE).Background The prognostic value of CACS has been well
described. Few studies use the rich information of coronary
CTA to predict future clinical outcomes and compare
CACS with coronary CTA.
Methods We followed up 5,007 outpatients who were
suspected of having coronary artery disease (CAD) and who
underwent cardiac CTA. Cardiac CT was assessed for
CACS and the extent, the location, the stenosis severity,
and the composition of the plaque in coronary CTA. The
endpoint was MACE, deﬁned as composite cardiac death,
nonfatal myocardial infarction, or coronary revascularization.
Results Follow-up was completed in 4,425 patients
(88.4%), with a median follow-up period of 1,081 days. At
the end of the follow-up period, 363 (8.2%) patients had
experienced MACE. Cumulative probability of 3-year
MACE increased across CT strata for CACS (CACS 0,
2.1%; CACS 1 to 100, 12.9%; CACS 101 to 400, 16.3%;
and CACS >400, 33.8%; log-rank p < 0.001); for coronary
CTA (no plaque 0.8%, nonobstructive disease 3.7%, 1-vessel
disease 27.6%, 2-vessel disease 35.5%, and 3-vessel disease
57.7%; log-rank p < 0.001); and for characteristics of the
plaques (5.5% for calciﬁed plaque, 22.7% for noncalciﬁed
plaque, and 37.7% for mixed plaque; log-rank p < 0.001).
The area under the receiver-operating characteristic curves
showed the incremental value of CACS and coronary CTA
for predicting MACE: 0.71 for clinical risk factors, which
improved to 0.82 by adding CACS and further improved to
0.93 by adding coronary CTA (both p < 0.001).
Conclusions The CACS and coronary CTA ﬁndings have
prognostic value and have incremental value over routine risk
factors for MACE, and coronary CTA is superior to CACS.
Cardiac CT seems to be a promising noninvasive modality
with signiﬁcant prognostic value (37).Coronary Vascular Dysfunction and Prognosis in
Patients With Chronic Kidney Disease
Objectives This study sought to evaluate whether impaired
vasodilator function, an early manifestation of coronary artery
disease, which precedes angiographic stenosis, accounts for
increased risk among patients with moderate to severe renal
dysfunction.
Background Patients with renal dysfunction are at increased
risk of adverse cardiac outcomes, even in the absence of overt
myocardial ischemia or infarction.
Methods We included 866 consecutive patients with
moderate to severe renal dysfunction referred for rest and
stress myocardial perfusion positron emission tomography
and followed them for a median of 1.28 years (interquartile
range: 0.64 to 2.34). Regional myocardial perfusion abnor-
malities were assessed by semiquantitative visual analysis of
positron emission tomography images. Rest and stress
myocardial blood ﬂow were calculated using factor analysis
and a 2-compartment kinetic model; they were also used to
compute coronary ﬂow reserve (stress/rest myocardial blood
ﬂow). The primary endpoint was cardiac death.
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adjusting for clinical risk, left ventricular ejection fraction, as
well as the magnitude of scar and/or ischemia, coronary ﬂow
reserve below the median (<1.5) was associated with a 2.1-
fold increase in the risk of cardiac death (95% conﬁdence
interval [CI]: 1.3 to 3.5, p ¼ 0.004). Incorporation of
coronary ﬂow reserve into cardiac death risk assessment
models resulted in an increase in the C-index from 0.75 to
0.77 (p ¼ 0.05) and in a net reclassiﬁcation improvement of
0.142 (95% CI: 0.076 to 0.219). Among patients at inter-
mediate risk based on all data other than coronary ﬂow
reserve, the net reclassiﬁcation improvement was 0.489 (95%
CI: 0.192 to 0.836). Corresponding improvements in
risk assessment for mortality from any cause were also
demonstrated.
Conclusions The presence of coronary vascular dysfunction
in patients with moderate to severe renal dysfunction, as
assessed by positron emission tomography, is a powerful,
independent predictor of cardiac mortality and provides
meaningful incremental risk stratiﬁcation over conventional
markers of clinical risk (38).Bicuspid Aortic Valve: Inter-Racial Difference in
Frequency and Aortic Dimensions
Objectives The objective of this study was to examine the
similarities and differences in Caucasian (C) and African-
American (AA) patients with bicuspid aortic valve (BAV)
with respect to morphology, severity of aortic stenosis/
insufﬁciency, and aortic dilation.
Background BAV is a common congenital valve abnor-
mality, accounting for a large number of valve replacements.
Methods A total of 229 patients with the diagnostic code
BAV were identiﬁed retrospectively from our computerized
adult echocardiographic database, which consists of 91,896
studies performed at the University of Chicago Medical
Center from 1998 to 2009, representing 40,878 patients. Of
those, 183 patients with BAV were included in this retro-
spective BAV single-center cohort study and reanalyzed
with a comprehensive assessment of aortic dimensions,
aortic valve morphology and function, clinical cardiovascular
risk factors, and patient characteristics.
Results Of the 183 patients with BAV, 138 were C and 45
were AA. Our echocardiographic database encompasses
approximately 65% AA, 31% C, and 4% other races, for an
estimated frequency of BAV in AA patients of 0.17% and
a frequency in C patients of 1.1% (p ¼ 0.001). There were
no signiﬁcant inter-racial differences regarding sex, height,
weight, hyperlipidemia, diabetes, tobacco use, cardiac
medications, and left ventricular ejection fraction. The AA
cohort was older (age 50  17 years vs. 43  17 years,
p < 0.05) and had a higher prevalence of hypertension (51%
vs. 24%, p < 0.05). After adjusting for comorbidities, aortic
dimensions were larger in C (C vs. AA: annulus, 2.4  0.4
vs. 2.1  0.4 cm; sinuses of Valsalva, 3.4  0.7 vs. 3.1  0.6
cm; sinotubular junction, 3.0  0.6 vs. 2.6  0.5 cm;and ascending aorta, 3.5  0.7 vs. 3.2  0.5 cm; all
p values <0.05).
Conclusions This is the ﬁrst study to report racial differences
among patients with BAV with reduced aortic dimensions in
AA patients despite the presence of more risk factors,
suggestive of marked heterogeneity in the BAV population
and indicating race as a potential disease modiﬁer in BAV (39).The Limit of Plausibility for Predictors of
Response: Application to Biventricular Pacing
Objectives We sought a method for any reader to quantify
the limit, imposed by variability, to sustainably observable
R2 between any baseline predictor and response marker. We
then apply this to echocardiographic measurements of me-
chanical dyssynchrony and response.
Background Can mechanical dyssynchrony markers
strongly predict ventricular remodeling by biventricular
pacing (cardiac resynchronization therapy)?
Methods First, we established the mathematical depres-
sion of observable R2 arising from: 1) spontaneous vari-
ability of response markers; and 2) test–retest variability of
dyssynchrony measurements. Second, we contrasted pub-
lished R2 values between externally monitored randomized
controlled trials and highly skilled single-center studies
(HSSCSs).
Results Inherent variability of response markers causes
a contraction factor in R2 of 0.48 (change in left ventricular
ejection fraction [DLVEF]), 0.50 (change in end-systolic
volume [DESV]), and 0.40 (change in end-diastolic volume
[DEDV]). Simultaneously, inherent variability of mechanical
dyssynchrony markers causes a contraction factor of between
0.16 and 0.92 (average, 0.6). Therefore the combined con-
traction factor, that is, limit on sustainably observable R2
between mechanical dyssynchrony markers and response, is
w0.29 (DLVEF), w0.24 (DESV), and w0.30 (DEDV).
Many R2 values published in HSSCSs exceeded these
mathematical limits; none in externally monitored trials did
so. Overall, HSSCSs overestimate R2 by 5- to 20-fold
(p ¼ 0.002). Absence of bias-resistance features in study
design (formal enrollment and blinded measurements) was
associated with more overstatement of R2.
Conclusions Reports of R2 > 0.2 in response prediction
arose exclusively from studies without formally documented
enrollment and blinding. The HSSCS approach over-
estimates R2 values, frequently breaching the mathematical
ceiling on sustainably observable R2, which is far below 1.0,
and can easily be calculated by readers using formulas pre-
sented here. Community awareness of this low ceiling may
help resist future claims. Reliable individualized response
prediction, using methods originally designed for group-
mean effects, may never be possible because it has 2
currently unavailable and perhaps impossible prerequisites:
1) excellent blinded test–retest reproducibility of dyssyn-
chrony; and 2) response markers reproducible over time
within nonintervened individuals. Dispassionate evaluation,
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before any further claims of strong prediction. Prediction
studies should be designed to resist bias (40).
Patterns and Predictors of Stress Testing Modality
After Percutaneous Coronary Stenting:
Data From the NCDR
Objectives We evaluated temporal trends and geographic
variation in choice of stress testing modality after percuta-
neous coronary intervention (PCI), as well as associations
between modality and procedure use after testing.
Background Stress testing is frequently performed post-PCI,
but the choices among available modalities (electrocardiog-
raphy only, nuclear, or echocardiography; pharmacological
or exercise stress) and consequences of such choices are not
well characterized.
Methods CathPCI Registry data were linked with iden-
tiﬁable Medicare claims to capture stress testing use between
60 and 365 days post-PCI and procedures within 90 days
after testing. Testing rates and modality used were modeled
on the basis of patient, procedure, and PCI facility factors,
calendar quarter, and Census Divisions using Poisson and
logistic regression. Post-test procedure use was assessed
using Gray’s test.
Results Among 284,971 patients, the overall stress testing
rate after PCI was 53.1 per 100 person-years. Testing rates
declined from 59.3 in quarter 1 (2006) to 47.1 in quarter 4
(2008), but the relative use of modalities changed little.
Among exercise testing recipients, adjusted proportions re-
ceiving electrocardiography-only testing varied from 6.8%
to 22.8% across Census Divisions; and among exercise tes-
ting recipients having an imaging test, the proportion re-
ceiving echocardiography (versus nuclear) varied from 9.4%
to 34.1%. Post-test procedure use varied among modalities;
exercise electrocardiography-only testing was associated with
more subsequent stress testing (13.7% vs. 2.9%; p < 0.001),
but less catheterization (7.4% vs. 14.1%; p < 0.001) than
imaging-based tests.
Conclusions Modest reductions in stress testing after PCI
occurring between 2006 and 2008 cannot be ascribed to
trends in use of any single modality. Additional research
should assess whether this trend represents better patient
selection for testing or administrative policies (e.g., restricted
access for patients with legitimate testing needs). Geo-
graphic variation in utilization of stress modalities and dif-
ferences in downstream procedure use among modalities
suggest a need to identify optimal use of the different test
modalities in individual patients (41).
Spontaneous Coronary Artery Dissection: Long-
Term Follow-Up of a Large Series of Patients
Prospectively Managed With a “Conservative”
Therapeutic Strategy
Objectives This study sought to assess the long-term
clinical outcome of patients with spontaneous coronaryartery dissection (SCD) managed with a conservative
strategy.
Background SCD is a rare, but challenging, clinical entity.
Methods A prospective protocol, including a conservative
management strategy, was followed. Revascularization was
only considered in cases with ongoing/recurrent ischemia.
Inﬂammatory/immunologic markers were systematically
obtained.
Results Forty-ﬁve consecutive patients (incidence 0.27%)
were studied during a 6-year period. Of these, 27 patients
(60%) had “isolated” SCD (I-SCD), and 18 had SCD
associated with coronary artery disease (A-SCD). Age was 53
 11 years, and 26 patients were female. Most patients
presented with an acute myocardial infarction. SCD had
a diffuse angiographic pattern (length: 31  23 mm). In 11
patients, the diagnosis was conﬁrmed by intracoronary
imaging techniques. Sixteen patients (35%) required revas-
cularization during initial admission. One patient died after
surgery, but no additional patient experienced recurrent
myocardial infarction. No signiﬁcant inﬂammatory/immu-
nologic abnormalities were detected. At follow-up (median
730 days), only 3 patients presented with adverse events (1
died of congestive heart failure, and 2 required revasculari-
zation). No patient experienced a myocardial infarction or
died suddenly. Event-free survival was similar (94% and 88%,
respectively) in patients with I-SCD and A-SCD. Notably,
at angiographic follow-up, spontaneous “disappearance” of
the SCD image was found in 7 of 13 (54%) patients.
Conclusions In this large prospective series of consecutive
patients with SCD, a “conservative” therapeutic strategy
provided excellent long-term prognosis. Clinical outcome
was similar in patients with I-SCD and A-SCD. The
natural history of SCD includes spontaneous healing with
complete resolution (42).The Impact of Sex Differences on Fractional Flow
Reserve–Guided Percutaneous Coronary
Intervention: A FAME (Fractional Flow Reserve
Versus Angiography for Multivessel Evaluation)
Substudy
Objectives This study sought to evaluate the impact of sex
differences on fractional ﬂow reserve (FFR)-guided percu-
taneous coronary intervention (PCI).
Background The FAME (Fractional Flow Reserve Versus
Angiography for Multivessel Evaluation) study demon-
strated that FFR-guided PCI improves outcomes compared
with an angiography-guided strategy. The role of FFR-
guided PCI in women versus men has not been evaluated.
Methods We analyzed 2-year data from the FAME study
in the 744 men and 261 women with multivessel coronary
disease, who were randomized to angiography- or FFR-
guided PCI. Statistical comparisons based on sex were
stratiﬁed by treatment method.
Results Although women were older and had signiﬁcantly
higher rates of hypertension than men did, there were no
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vs. 20.2%, p ¼ 0.923) and its individual components at 2
years. FFR values were signiﬁcantly higher in women than in
men (0.75  0.18 vs. 0.71  0.17, p ¼ 0.001). The
proportion of functionally signiﬁcant lesions (FFR  0.80)
was lower in women than in men for lesions with 50% to 70%
stenosis (21.1% vs. 39.5%, p < 0.001) and for lesions with
70% to 90% stenosis (71.9% vs. 82.0%, p ¼ 0.019). An FFR-
guided strategy resulted in similar relative risk reductions for
death, myocardial infarction, and repeat revascularization in
men and in women. There were no interactions between sex
and treatment method for any outcome variables.
Conclusions In comparison with men, angiographic
lesions of similar severity are less likely to be ischemia-
producing in women. An FFR-guided PCI strategy is
equally beneﬁcial in women as it is in men (43).Visual-Functional Mismatch Between Coronary
Angiography and Fractional Flow Reserve
Objectives The goal of this study was to identify clinical
and lesion-speciﬁc local factors affecting visual-functional
mismatch.
Background Although lesion severity determined by
coronary angiography has not been well correlated with
physiological signiﬁcance, the mechanism of the discordance
remains poorly understood.
Methods The authors assessed quantitative coronary angi-
ography, intravascular ultrasound (IVUS), and fractional
ﬂow reserve (FFR) in a prospective cohort of 1,000 patients
with 1,129 coronary lesions. Three-dimensional computa-
tional simulation studies were performed.
Results Lesions with angiographic diameter stenosis
(DS) 50% and FFR >0.80 (“mismatches”) were seen in
57% of non–left main lesions and in 35% of the left main
lesions, respectively (p ¼ 0.032). Conversely, among the
lesions with DS <50% and FFR <0.80 (“reverse
mismatches”) 16% were found in the non–left main
lesions and 40% in the left main lesions (p < 0.001). The
independent predictors for mismatch were advanced age,
non–left anterior descending artery location, absence of
plaque rupture, short lesion length, large minimal lumen
area, smaller plaque burden, and greater minimal lumen
diameter. Conversely, reverse mismatch was indepen-
dently associated with younger age, left anterior de-
scending artery location, the presence of plaque rupture,
a smaller minimal lumen area, and larger plaque burden.
In a computational simulation study, FFR was inﬂuenced
by DS, lesion length, different lesion shape, plaque
eccentricity, surface roughness, and various shapes of
plaque rupture.
Conclusions There were high frequencies of visual-
functional mismatch between angiography and FFR. The
discrepancy was related to the clinical and lesion-speciﬁc
factors frequently unrecognizable by angiography, thus sug-
gesting that coronary angiography cannot accurately predictFFR. (Natural History of FFR-Guided Deferred Coronary
Lesions [IRIS FFR-DEFER]; NCT01366404) (44).
Valve Prosthesis–Patient Mismatch (VP–PM):
A Long-Term Perspective
The concept/phenomenon of valve prosthesis/patient
mismatch (VP–PM), described in 1978, has stood the test of
time. From that time to 2011, VP–PM has received a great
deal of attention but studies have come to varying conclu-
sions. This is largely because of the determination of pros-
thetic heart valve area [called effective oriﬁce area index
(EOAi)] by projection rather than by actual measurement,
variable criteria to assess severity of EOAi and the timing of
determination of EOAi. All prosthetic heart valves have
some degree of VP–PM which must be placed in a proper
clinical perspective. This can be done by determining its
effects on function and outcomes. For mortality one needs to
focus especially on severe/critical degree of VP–PM and
determine the cause of death was due to VP–PM. For the
period “beyond 2011” a road map is suggested that will have
uniformity of assessment of VP–PM and a focusing on the
important goals of VP–PM (45).
Impact of a Continuous Quality Improvement
Initiative on Appropriate Use of Coronary
Computed Tomography Angiography: Results From
a Multicenter, Statewide Registry, the Advanced
Cardiovascular Imaging Consortium
Objectives The purpose of the study was to determine the
effectiveness of a collaborative educational, continuous quality
improvement (CQI) initiative to increase appropriate use of
coronary computed tomography angiography (CCTA).
Background Potential overuse of CCTA has prompted
multisociety appropriate use criteria (AUC) publications.
Methods This prospective, observational study was con-
ducted with pre-intervention (July 2007 to June 2008),
intervention (July 2008 to June 2010), and follow-up (July
2010 to December 2010) periods during which patients were
enrolled in the Advanced Cardiovascular Imaging Consor-
tium (ACIC) at 47 Michigan hospitals. Continuous edu-
cation was provided to referring physicians. The possibility
of losing third-party payer coverage in the absence of
a measurable change in AUC was emphasized. AUC was
compared between the 3 periods.
Results The study group included 25,387 patients.
Compared with the pre-intervention period, there was a
23.4% increase in appropriate (61.3% to 80%, p < 0.0001),
60.3% decrease in inappropriate (14.6% to 5.8%,
p < 0.0001), 40.8% decrease in uncertain (10.3% to 6.1%,
p < 0.0001), and 41.7% decrease in unclassiﬁable (13.9%
to 8.1%, p < 0.0001) scans during follow-up. Between pre-
intervention and follow-up, change in CCTA referrals by
provider specialty were cardiology (appropriate: 60.4% to
79.5%; inappropriate: 13% to 5.2%; p < 0.0001), internal
medicine/family practice (appropriate: 51.1% to 70.4%;
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medicine (appropriate: 83.6% to 91.6%; inappropriate:
9.1% to 0.6%; p < 0.0001), and other (appropriate: 61.1%
to 83.2%; inappropriate: 18.6% to 5.9%; p < 0.0001).
Conclusions Application of a systematic CQI and emphasis
on possible loss of coverage were associated with a signiﬁcant
improvement in the proportion of CCTA examinations
meeting AUC across referring physician specialties (46).
Duration of Myocardial Early Systolic Lengthening
Predicts the Presence of Signiﬁcant Coronary
Artery Disease
Objectives This study sought to investigate whether the
duration of left ventricular (LV) early systolic lengthening
could accurately identify patients with signiﬁcant coronary
artery disease (CAD).
Background Ischemic myocardium with reduced active
force will lengthen when LV pressure rises during early
systole before onset of systolic shortening.
Methods We included 88 patients with suspected CAD
referred to elective diagnostic coronary angiography. Two of
these patients were excluded from the study due to evidence
of previous myocardial infarction on contrast-enhanced
magnetic resonance imaging. Speckle tracking echocardi-
ography was performed before coronary angiography and at
follow-up scheduled 1 year after revascularization, and global
longitudinal strain and duration of average LV early systolic
lengthening were recorded.
Results Forty-three of 86 patients had signiﬁcant CAD.
The duration of early systolic lengthening was signiﬁcantly
prolonged in patients with signiﬁcant CAD compared
with patients without signiﬁcant coronary artery stenoses
(76  37 ms vs. 38  23 ms, p < 0.001). Correspondingly,
global systolic strain was signiﬁcantly lower in patients with
CAD (17.7  3.0% vs. 19.5  2.6%, p ¼ 0.003).
Prolonged duration of early systolic lengthening showed the
best accuracy in detecting CAD, with an area under the
receiver-operating characteristic curve of 0.83. The area
under the curve for global strain was 0.68. At 1-year follow-
up, the duration of early systolic lengthening was signiﬁ-
cantly reduced (64  37 ms vs. 76  37 ms, p ¼ 0.041) in
the patients treated with revascularization.
Conclusions Duration of myocardial early systolic length-
ening was prolonged in patients with signiﬁcant CAD; this
might be a useful parameter to identify patients who might
beneﬁt from reperfusion therapy (47).
Longitudinal Left Ventricular Function for
Prediction of Survival in Systemic Light-Chain
Amyloidosis: Incremental Value Compared With
Clinical and Biochemical Markers
Objectives The aim of the study was to determine whe-
ther longitudinal left ventricular (LV) function provides
prognostic information in a large cohort of patients with
systemic light-chain (AL) amyloidosis.Background AL amyloidosis is associated with a high
incidence of cardiovascular events. Reduced myocardial
longitudinal function is one of the hallmarks of myocardial
involvement in this rare disease.
Methods Two hundred six consecutive patients with
biopsy-proven AL amyloidosis were investigated in this
prospective observational study. Echocardiographic imaging
parameters, mean tissue Doppler-derived longitudinal strain
(LS), and two-dimensional global longitudinal strain (2D-
GLS) of the LV, cardiac serological biomarkers, and
comprehensive clinical disease characteristics were assessed.
The primary endpoint was all-cause mortality or heart
transplantation.
Results After a median follow-up of 1,207 days, LS and
2D-GLS were signiﬁcant predictors of survival in AL
amyloidosis. The cutoff values discriminating survivors
from nonsurvivors were 10.65% for LS and 11.78%
for 2D-GLS. In a multivariable echocardiographic Cox
model, only diastolic dysfunction and 2D-GLS remained
as independent predictors of survival. In comprehensive
clinical models, 2D-GLS (p < 0.0001), diastolic
dysfunction (p < 0.01), the pathologic free light chains
(p < 0.05), cardiac troponin-T (cTnT) (p < 0.01), and
the Karnofsky index (p < 0.001) remained as indepen-
dent predictors. 2D-GLS delineated a superior prog-
nostic value compared with that derived from pathologic
free light chains or cTnT in patients evaluated before
ﬁrstline chemotherapy (n ¼ 113; p < 0.0001), and
remained the only independent predictor besides the
Karnofsky index in subjects with preserved LV ejection
fraction (50%; n¼ 127; p< 0.01). LS and 2D-GLS both
offered signiﬁcant incremental information (p < 0.001)
for the assessment of outcome compared with clinical
variables (age, Karnofsky index, and New York Heart
Association functional class) and serological biomarkers.
Conclusions In the largest serial investigation reported so
far, reduced LV longitudinal function served as an inde-
pendent predictor of survival in AL amyloidosis and offered
incremental information beyond standard clinical and sero-
logical parameters (48).Cardiac Magnetic Resonance and the Need for
Routine Cardiac Catheterization in Single
Ventricle Patients Prior to Fontan: A Comparison of
3 Groups: Pre-Fontan CMR Versus Cath Evaluation
Objectives This study investigated whether cardiac
magnetic resonance (CMR) and echocardiography (echo)
can replace catheterization (cath) for routine evaluation prior
to Fontan and under what circumstances CMR and cath are
used together.
Background Routine cath prior to Fontan has been uti-
lized for years; noninvasive methods, however, may be
sufﬁcient.
Methods This study reviews clinical data in 119 consecu-
tive patients investigating 3 groups: those who underwent
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cath and CMR (CþM; n ¼ 37) prior to Fontan.
Results No clinically signiﬁcant differences were noted in
patient characteristics, hemodynamics, or clinical status prior
to or after surgery between the C and MR groups. CMR
added information in 82%. There were no discrepant ﬁndings
between CMR and cath data in the CþM group. Diagnostic
success was 95% in all groups. Of those undergoing Fontan
completion, the CþM group had similar outcomes to C and
MR; C and CMR were utilized in combination to assess
aortopulmonary collaterals or the need for an intervention or
evaluate its success. Echo could not delineate pulmonary
arterial anatomy in 46% to 53% of patients. The CþM and
C groups were exposed to 6.8  4.1 mSv of radiation.
Conclusions Single ventricle patients not requiring an
intervention can undergo successful Fontan completion with
CMR and echo alone with similar short-term outcomes to
C, which was used as a control, preventing an invasive test
and exposure to radiation. CMR can add information in
a signiﬁcant number of patients. Cath and CMR are utilized
together for interventions and assessment of aortopulmonary
collaterals (49).Progression of Myocardial Fibrosis Assessed With
Cardiac Magnetic Resonance in Hypertrophic
Cardiomyopathy
Objectives This study sought to assess the rate of
progression of ﬁbrosis by 2 consecutive cardiac magnetic
resonance (CMR) examinations and its relation with clinical
variables.
Background In hypertrophic cardiomyopathy (HCM)
myocardial ﬁbrosis, detected by late gadolinium enhance-
ment (LGE), is associated to a progressive ventricular
dysfunction and worse prognosis.
Methods A total of 55 HCM patients (37 males; mean age
43  18 years) underwent 2 CMR examinations (CMR-1
and CMR-2) separated by an interval of 719  410 days.
Extent of LGE was measured, and the rate of progression
of LGE (LGE-rate) was calculated as the ratio between
the increment of LGE (in grams) and the time (months)
between the CMR examinations.
Results At CMR-1, LGE was detected in 45 subjects, with
an extent of 13.3  15.2 g. At CMR-2, 53 (96.4%) patients
had LGE, with an extent of 24.6  27.5 g. In 44 patients,
LGE extent increased signiﬁcantly (1 g). Patients with
apical HCM had higher increments of LGE (p ¼ 0.004)
and LGE-rate (p < 0.001) than those with other patterns of
hypertrophy. The extent of LGE at CMR-1 and the apical
pattern of hypertrophy were independent predictors of the
increment of LGE. Patients with worsened New York Heart
Association functional class presented higher increase of
LGE (p ¼ 0.031) and LGE-rate (p < 0.05) than those with
preserved functional status.
Conclusions Myocardial ﬁbrosis in HCM is a progressive
and fast phenomenon. LGE increment, related to a worseclinical status, is more extensive in apical hypertrophy than
in other patterns (50).Yield of Screening for Coronary Artery Calcium in
Early Middle-Age Adults Based on the 10-Year
Framingham Risk Score: The CARDIA Study
Objectives The purpose of this study was to assess the
prevalence and distribution of coronary artery calcium (CAC)
across Framingham Risk Score (FRS) strata and therefore
determine FRS levels at which asymptomatic, young to early
middle-age individuals could potentially beneﬁt from CAC
screening.
Background High CAC burden is associated with
increased risk of coronary events beyond the FRS. Expert
panel recommendations for CAC screening are based on
data obtained in middle-age and older individuals.
Methods We included 2,831 CARDIA (Coronary Artery
Risk Development in Young Adults) study participants with
an age range of 33 to 45 years. The number needed to screen
([NNS] number of people in each FRS stratum who need to
be screened to detect 1 person with a CAC score above the
speciﬁed cut point) was used to assess the yield of screening
for CAC. CAC prevalence was compared across FRS strata
using a chi-square test.
Results CAC scores >0 and 100 were present in 9.9%
and 1.8% of participants, respectively. CAC prevalence and
amount increased across higher FRS strata. A CAC score
>0 was observed in 7.3%, 20.2%, 19.1%, and 44.8% of
individuals with FRSs of 0 to 2.5%, 2.6% to 5%, 5.1% to
10%, and >10%, respectively (NNS ¼ 14, 5, 5, and 2,
respectively). A CAC score of 100 was observed in 1.3%,
2.4%, and 3.5% of those with FRSs of 0 to 2.5%, 2.6% to
5%, and 5.1% to 10%, respectively (NNS ¼ 79, 41, and 29,
respectively), but in 17.2% of those with an FRS >10%
(NNS ¼ 6). Similar trends were observed when ﬁndings
were stratiﬁed by sex and race.
Conclusions In this young to early middle-age cohort, we
observed concordance between CAC prevalence/amount
and FRS strata. Within this group, the yield of screening
and possibility of identifying those with a high CAC burden
(CAC score of 100) is low in those with an FRS of 10%,
but considerable in those with an FRS >10% (51).Effects of p38 Mitogen-Activated Protein Kinase
Inhibition on Vascular and Systemic Inﬂammation
in Patients With Atherosclerosis
Objectives This study sought to determine the effects of
a p38 mitogen-activated protein kinase inhibitor, losmapi-
mod, on vascular inﬂammation, by 18F-ﬂuorodeoxyglucose
(FDG) positron emission tomography/computed tomog-
raphy imaging.
Background The p38 mitogen-activated protein kinase
cascade plays an important role in the initiation and progres-
sion of inﬂammatory diseases, including atherosclerosis.
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therapy (n ¼ 99) were randomized to receive losmapimod
7.5 mg once daily (lower dose [LD]), twice daily (higher
dose [HD]) or placebo for 84 days. Vascular inﬂammation
was assessed by FDG positron emission tomography/
computed tomography imaging of the carotid arteries and
aorta; analyses focused on the index vessel (the artery with
the highest average maximum tissue-to-background ratio
[TBR] at baseline). Serum inﬂammatory biomarkers and
FDG uptake in visceral and subcutaneous fat were also
measured.
Results The primary endpoint, change from baseline in
average TBR across all segments in the index vessel, was
not signiﬁcantly different between HD and placebo
(DTBR: 0.04 [95% conﬁdence interval [CI]: 0.14
to þ0.06], p ¼ 0.452) or LD and placebo (DTBR: 0.02
[95% CI: 0.11 to þ0.06], p ¼ 0.579). However, there was
a statistically signiﬁcant reduction in average TBR in active
segments (TBR 1.6) (HD vs. placebo: DTBR: 0.10
[95% CI: 0.19 to 0.02], p ¼ 0.0125; LD vs. placebo:
DTBR: 0.10 [95% CI: 0.18 to 0.02], p ¼ 0.0194). The
probability of a segment being active was also signiﬁcantly
reduced for HD when compared with placebo (OR: 0.57
[95% CI: 0.41 to 0.81], p ¼ 0.002). Within the HD group,
reductions were observed in placebo-corrected inﬂammatory
biomarkers including high-sensitivity C-reactive protein
(% reduction: 28% [95% CI: 46 to 5], p ¼ 0.023) as
well as FDG uptake in visceral fat (DSUV: 0.05 [95%
CI: 0.09 to 0.01], p ¼ 0.018), but not subcutaneous fat.
Conclusions Despite nonsigniﬁcant changes for the
primary endpoint of average vessel TBR, HD losmapimod
reduced vascular inﬂammation in the most inﬂamed regions,
concurrent with a reduction in inﬂammatory biomarkers and
FDG uptake in visceral fat. These results suggest a systemic
anti-inﬂammatory effect. (A Study to Evaluate the Effects of
3 Months Dosing With GW856553, as Assessed FDG-
PET/CT Imaging; NCT00633022) (52).Acute Left Ventricular Remodeling Following
Myocardial Infarction: Coupling of Regional Healing
With Remote Extracellular Matrix Expansion
Objectives This prospective study aimed to assess regional
and temporal patterns of extracellular matrix (ECM) cha-
nges post-myocardial infarction (MI).
Background A fundamental process in the development of
ischemic left ventricular (LV) dysfunction is LV remodeling,
characterized by structural and functional abnormalities
throughout the myocardium including the noninfarcted
(remote) myocardium and interstitium.
Methods Contrast-enhanced cardiac magnetic resonance
(CMR) was performed on MI patients acutely (mean: 5 days
post-MI, n ¼ 25) and repeated subacutely (mean: 139 days
post-MI, n ¼ 21), and was also performed in a separate
group of 15 patients with chronic MI (mean: 2,580 days
post-MI, n ¼ 15). Twenty volunteers without a history ofMI acted as controls. CMR was used to evaluate LV
morphology and function, with post-contrast T1 mapping
to semiquantitatively assess changes in the ECM. Putative
mediators of myocardial inﬂammation and ﬁbrosis, in-
cluding macrophage migration inhibitory factor (MIF), were
also measured.
Results Age, sex, and diabetic and hypertensive status did
not differ between MI groups and controls. Compared with
controls, patients early post-acute MI demonstrated reduced
LV ejection fraction (50.25  7.29% vs. 66.7  6.2%
[controls], p < 0.0001). Myocardium remote to the in-
farction early post-acute MI, compared with controls,
demonstrated reduced systolic thickening (60  5.0% vs.
106  7.6%, p  0.0002), and lower post-contrast
myocardial T1 times suggestive of ECM expansion (437
 113 ms vs. 549  119 ms, p ¼ 0.01). In a subgroup
analysis between early post-acute MI and controls of similar
age and sex, the remote sector post-contrast myocardial T1
times remained signiﬁcantly shorter post-acute MI
compared with controls (420  121 ms vs. 529  113 ms,
p ¼ 0.03). Serum levels of MIF inversely correlated with
global myocardial T1 time in patients early post-acute MI
(r ¼ 0.6, p ¼ 0.01), suggesting a coupling of regional
healing with acute LV remodeling.
Conclusions Within a week of acute MI, the remote
myocardium exhibits systolic dysfunction and expansion of
the ECM, which is coupled with physiological infarct
healing. Further prospective studies with larger sample sizes
are needed to verify these important ﬁndings (53).Conformational Pulsatile Changes of the Aortic
Annulus: Impact on Prosthesis Sizing by Computed
Tomography for Transcatheter Aortic Valve
Replacement
Objectives This study sought to investigate pulsatile
changes of the aortic annulus and their impact on prosthesis
selection by computed tomography (CT).
Background Precise noninvasive prosthesis sizing is
a prerequisite for transcatheter aortic valve replacement.
Methods A total of 110 patients with severe aortic stenosis
(mean age: 82.9  8 years, mean aortic valve area: 0.69
 0.18 cm2) underwent electrocardiogram-gated CT. Aortic
annulus dimensions were planimetrically quantiﬁed as area-
derived diameter (DA ¼ 2 U(CSA/p), where CSA is
the cross-sectional area) and perimeter-derived diameter
(DP ¼ P/p, where P is the length of the perimeter) in 5%
increments of the RR interval. Hypothetical prosthesis sizing
was based on DA and DP (23-mm prosthesis for <22 mm;
26 mm: 22 to 25 mm; 29 mm: >25 mm) and compared
between maximum and traditional cardiac CT reconstruction
phases at 35% and 75% of RR. Agreement for prosthesis
selection was calculated by k statistics.
Results DA and DP were increased and eccentricity was
reduced during systole, with DA-MAX and DP-MAX
most often observed at 20% of RR. DP was consistently
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and 1.7  0.5 mm by DA-MIN versus DA-MAX and DP-
MIN versus DP-MAX. Agreement for prosthesis sizing was
found in 93 of 110 patients (k ¼ 0.75) by DA-75% and in
80 of 110 patients (k ¼ 0.53) by DA-MAX compared with
DA-35%; and in 94 of 110 patients (k ¼ 0.73) by DP-75%
and in 93 of 110 patients (k ¼ 0.73) by DP-MAX compared
with DP-35%. With sizing by DA-75% or DP-75%,
nominal prosthesis diameter was smaller than DA-MAX
or DP-MAX in 15 and 6 patients respectively.
Conclusions Aortic annulus morphology exhibits confor-
mational pulsatile changes throughout the cardiac cycle due
to deformation and stretch. These changes affect prosthesis
selection. Prosthesis selection by diastolic perimeter- or area-
derived dimensions harbors the risk of undersizing (54).Coronary Calciﬁcation and the Risk of Heart
Failure in the Elderly: The Rotterdam Study
Objectives The purpose of this study was to determine the
association of coronary artery calciﬁcation (CAC) with
incident heart failure in the elderly and examine its inde-
pendence of overt coronary heart disease (CHD).
Background Heart failure is often observed as a ﬁrst
manifestation of coronary atherosclerosis rather than
a sequela of overt CHD. Although numerous studies have
shown that CAC, an established measure of coronary ath-
erosclerosis, is a strong predictor of CHD, the association
between CAC and future heart failure has not been studied
prospectively.
Methods In the Rotterdam Study, a population-based
cohort, 1,897 asymptomatic participants (mean age,
69.9 years; 58% women) underwent CAC scoring and
were followed for the occurrence of heart failure and
CHD.
Results During a median follow-up of 6.8 years, there
were 78 cases of heart failure and 76 cases of nonfatal
CHD. After adjustment for cardiovascular risk factors,
increasing CAC scores were associated with heart failure
(p for trend ¼ 0.001), with a hazard ratio of 4.1 (95%
conﬁdence interval [CI]: 1.7 to 10.1) for CAC scores >400
compared with CAC scores of 0 to 10. After censoring
participants for incident nonfatal CHD, increasing extent
of CAC remained associated with heart failure (p for
trend ¼ 0.046), with a hazard ratio of 2.9 (95% CI: 1.1 to
7.4) for CAC scores >400. Moreover, adding CAC to
cardiovascular risk factors resulted in an optimism-
corrected increase in the c-statistic by 0.030 (95% CI:
0.001 to 0.050) to 0.734 (95% CI: 0.698 to 0.770) and
substantially improved the risk classiﬁcation of subjects
(continuous net reclassiﬁcation index ¼ 34.0%).
Conclusions CAC has a clear association with the risk of
heart failure, independent of overt CHD. Because heart
failure is highly prevalent in the elderly, it might be
worthwhile to include heart failure as an outcome in future
risk assessment programs incorporating CAC (55).Quantiﬁcation of Extracellular Matrix Expansion by
CMR in Inﬁltrative Heart Disease
Objectives The aim of this study was to perform direct
quantiﬁcation of myocardial extracellular volume fraction
(ECF) with T1-weighted cardiac magnetic resonance
(CMR) imaging in patients suspected to have inﬁltrative
heart disease.
Background Inﬁltrative heart disease refers to accumula-
tion of abnormal substances within the myocardium.
Qualitative assessment of late gadolinium enhancement
(LGE) remains the most commonly used method for CMR
evaluation of patients suspected with myocardial inﬁltration.
This technique is widely available and can be performed in
a reproducible and standardized manner. However, the
degree of extracellular matrix expansion due to myocardial
inﬁltration in the intercellular space has, to date, not been
amenable to noninvasive quantiﬁcation with LGE.
Methods We performed 3-T CMR in 38 patients (mean
age 68  15 years) who were referred for assessment of
inﬁltrative heart disease and also in 9 healthy volunteers as
control subjects. The T1 quantiﬁcation by Look-Locker
gradient-echo before and after contrast determined
segmental myocardial partition coefﬁcients. The ECF was
obtained by referencing the tissue partition coefﬁcient for
gadolinium to the plasma volume fraction in blood, derived
from serum hematocrit. Cine CMR and LGE imaging in
matching locations were also performed.
Results Seventeen patients (45%) had cardiac amyloidosis
(CA) (biopsy-conﬁrmed or clinically highly probable), 20
(53%) had a non-amyloid cardiomyopathy, and 1 had
lysosomal storage disease. Median global ECF was
substantially higher in CA patients (0.49) compared with
non-amyloid cardiomyopathy patients (0.33, p < 0.0001)
and volunteers (0.24, p ¼ 0.0001). The ECF strongly
correlated with visually assessed segmental LGE (r ¼ 0.80,
p < 0.0001) and LV mass index (r ¼ 0.69, p < 0.0001),
reﬂecting severity of myocardial inﬁltration. In patients
with CA, ECF was highest in segments with LGE,
although it remained elevated in segments without quali-
tative LGE.
Conclusions The CMR ECF quantiﬁcation identiﬁed
substantial expansion of the interstitial space in patients with
CA compared with volunteers. Further studies using this
technique for diagnosis and assessment of the severity of
myocardial inﬁltration are warranted (56).
Loss of Adrenergic Augmentation of Diastolic
Intra-LV Pressure Difference in Patients With
Diastolic Dysfunction: Evaluation by Color M-Mode
Echocardiography
Objectives The aim of this study was to evaluate the
hypothesis that the adrenergic response of the intraven-
tricular pressure difference (IVPD) is reduced in patients
with preserved ejection fraction (EF) and diastolic dys-
function (DD).
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extending from the left atrium (LA) to the left ventricular
(LV) apex. In response to adrenergic stimulation, as occurs
during exercise, the IVPD increases allowing rapid ﬁlling
without an abnormal increase in LA pressure. Patients with
heart failure with a reduced EF have impaired adrenergic
augmentation of the IVPD.
Methods We studied 166 consecutive patients undergoing
dobutamine stress echocardiography who had no inducible
ischemia and an EF 50%, of which 21 had normal dia-
stolic function, 14 had impaired relaxation (grade 1), 80 had
pseudonormal ﬁlling (grade 2), and 51 had restrictive ﬁlling
(grade 3). Color M-mode Doppler (CMMD) images of
mitral inﬂow were obtained at rest and during low (10 mg/
kg/min) and peak (20 to 40 mg/kg/min) doses of dobut-
amine. The total IVPD from the LA to LV apex, LA to
mid-LV, and mid-LV to the LV apex were calculated using
the CMMD data to integrate the Euler equation.
Results Total IVPD was not different between groups
at rest. With dobutamine, the total IVPD increased by
2.20  1.95 mm Hg in normal subjects and by only 0.73 
1.33 mmHg, 1.84  1.63 mmHg, and 1.08 1.57 mmHg
in patients with grades 1, 2, and 3 DD, respectively. This
difference was due to a failure in augmentation of IVPD from
the mid-LV to the LV apex, indicating reduced apical
ventricular suction with DD, whereas the IVPD from the LA
to the mid-LV responded similarly to dobutamine in normal
subjects and those with DD.
Conclusions In patients with preserved EF, DD is asso-
ciated with a reduced adrenergic augmentation of the IVPD
from the mid-LV to the LV apex, reﬂecting less apical
suction (57).
Detection of High-Risk Atherosclerotic Plaque:
Report of the NHLBI Working Group on Current
Status and Future Directions
The leading cause of major morbidity and mortality in most
countries around the world is atherosclerotic cardiovascular
disease, most commonly caused by thrombotic occlusion of
a high-risk coronary plaque resulting in myocardial infarc-
tion or cardiac death, or embolization from a high-risk
carotid plaque resulting in stroke. The lesions prone to
result in such clinical events are termed vulnerable or high-
risk plaques, and their identiﬁcation may lead to the devel-
opment of pharmacological and mechanical intervention
strategies to prevent such events. Autopsy studies from
patients dying of acute myocardial infarction or sudden
death have shown that such events typically arise from
speciﬁc types of atherosclerotic plaques, most commonly the
thin-cap ﬁbroatheroma. However, the search in human
beings for vulnerable plaques before their becoming symp-
tomatic has been elusive. Recently, the PROSPECT
(Providing Regional Observations to Study Predictors of
Events in the Coronary Tree) study demonstrated that
coronary plaques that are likely to cause future cardiacevents, regardless of angiographic severity, are characterized
by large plaque burden and small lumen area and/or are
thin-cap ﬁbroatheromas veriﬁed by radiofrequency intra-
vascular ultrasound imaging. This study opened the door to
identifying additional invasive and noninvasive imaging
modalities that may improve detection of high-risk athero-
sclerotic lesions and patients. Beyond classic risk factors,
novel biomarkers and genetic proﬁling may identify those
patients in whom noninvasive imaging for vulnerable plaque
screening, followed by invasive imaging for risk conﬁrmation
is warranted, and in whom future pharmacological and/or
device-based focal or regional therapies may be applied to
improve long-term prognosis (58).
IVUS Detection of Vasa Vasorum Blood Flow
Distribution in Coronary Artery Vessel Wall
There is an increased body of evidence to suggest that the
vasa vasorum play a major role in the progression and
complications of vulnerable plaque leading to acute coronary
syndrome. We propose that detecting changes in the ﬂow in
the vascular wall by intravascular ultrasound signals can
quantify the presence of vasa vasorum. The results obtained
in a porcine model of atherosclerosis suggest that intravas-
cular ultrasound-based estimates of blood ﬂow in the arterial
wall can be used in vivo in a clinical research setting to
establish the density of vasa vasorum as an indicator of
plaque vulnerability (59).
Silent Brain Injury After Cardiac Surgery: A Review:
Cognitive Dysfunction and Magnetic Resonance
Imaging Diffusion-Weighted Imaging Findings
The appearance of cognitive dysfunction after cardiac
surgery in the absence of focal neurologic signs, a poorly
understood but potentially devastating complication, almost
certainly results from procedure-related brain injury. Con-
ﬁrmation of the occurrence of perioperative silent brain
injury has been developed through advances in magnetic
resonance imaging (MRI) techniques. These techniques
detect new brain lesions in 25% to 50% of patients after both
coronary artery bypass graft and valve surgery. Use of post-
operative cognitive dysfunction as a marker of brain injury
is problematic because of potential difﬁculties in ascertain-
ment. It can be hypothesized that post-operative appearance
of MRI lesions may serve as a more objective marker of brain
injury in research efforts. If MRI examination can be used in
this way, then 2 vitally important questions can be ad-
dressed. 1) What is the frequency of important, but silent,
brain injury during cardiac surgery? 2) Does long-term
cognitive impairment ensue? This review brieﬂy discusses
clinical features of post-operative cognitive dysfunction and
reviews the evidence supporting a possible association with
MRI evidence of perioperative brain injury and its potential
for long-term dementia. We conclude that this association is
plausible, but not yet ﬁrmly established (60).
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Magnetic Resonance Myocardial Perfusion
Imaging Against Fractional Flow Reserve for the
Detection of Signiﬁcant Coronary Artery Disease
Objectives The goal of this study was to determine the
diagnostic accuracy of dynamic 3-dimensional (3D) whole
heart myocardial perfusion cardiovascular magnetic reso-
nance (CMR) against invasively determined fractional ﬂow
reserve (FFR) and to establish the correlation between
myocardium at risk deﬁned by using the invasive Duke
Jeopardy Score (DJS) and noninvasive 3D whole heart
myocardial perfusion CMR.
Background 3D whole heart myocardial perfusion CMR
overcomes the limited spatial coverage of conventional two-
dimensional perfusion CMR methods and allows estimation
of the extent of ischemia. The method has shown good
diagnostic accuracy for the detection of coronary artery
disease (CAD) as deﬁned by using quantitative coronary
angiography. However, quantitative coronary angiography
does not provide a functional assessment of CAD as avail-
able from pressure wire–derived FFR. In the catheter labo-
ratory, the DJS can complement FFR to estimate the
myocardium at risk.
Methods Fifty-three patients referred for angiography
underwent rest and adenosine stress 3D whole heart
myocardial perfusion CMR at 3-T. Perfusion was scored
visually on a patient and coronary territory basis, and is-
chemic burden was calculated by quantitative segmentation
of the volume of hypoenhancement. FFR was measured in
vessels with 50% severity stenosis and an FFR <0.75
considered as hemodynamically signiﬁcant. The DJS was
calculated from the coronary angiograms to quantify the
myocardium at risk.
Results FFR was measured in 64 of 159 coronary vessels,
and 39 had an FFR <0.75. Sensitivity, speciﬁcity, and
diagnostic accuracy of CMR for the detection of signiﬁcant
CAD were 91%, 90%, and 91%, on a patient basis and 79%,
92%, and 88%, respectively, by coronary territory. There was
a strong correlation between the DJS and ischemic burden
on CMR (p < 0.0001; Pearson’s r ¼ 0.82).
Conclusions 3D whole heart myocardial perfusion CMR
accurately detects functionally signiﬁcant CAD as deﬁned by
using FFR and provides an assessment of ischemic burden in
agreement with the invasive DJS. The accurate detection of
signiﬁcant CAD combined with an estimation of ischemic
burden by using 3D myocardial perfusion CMR holds
promise for noninvasive guidance of therapy and risk strat-
iﬁcation of patients with CAD (61).
Does the Left Atrial Appendage Morphology
Correlate With the Risk of Stroke in Patients
With Atrial Fibrillation? Results From a Multicenter
Study
Objectives This study investigated the left atrial appendage
(LAA) by computed tomography (CT) and magneticresonance imaging (MRI) to categorize different LAA
morphologies and to correlate the morphology with the
history of stroke/transient ischemic attack (TIA).
Background LAA represents one of the major sources of
cardiac thrombus formation responsible for TIA/stroke in
patients with atrial ﬁbrillation (AF).
Methods We studied 932 patients with drug-refractory AF
who were planning to undergo catheter ablation. All patients
underwent cardiac CT or MRI of the LAA and were
screened for history of TIA/stroke. Four different
morphologies were used to categorize LAA: Cactus,
Chicken Wing, Windsock, and Cauliﬂower.
Results CT scans of 499 patients and MRI scans of 433
patients were analyzed (age 59  10 years, 79% were male,
and 14% had CHADS2 [Congestive heart failure, Hyper-
tension, Age >75, Diabetes mellitus, and prior Stroke or
transient ischemic attack] score 2). The distribution of
different LAA morphologies was Cactus (278 [30%]),
Chicken Wing (451 [48%]), Windsock (179 [19%]), and
Cauliﬂower (24 [3%]). Of the 932 patients, 78 (8%) had
a history of ischemic stroke or TIA. The prevalence of pre-
procedure stroke/TIA in Cactus, Chicken Wing, Windsock,
and Cauliﬂower morphologies was 12%, 4%, 10%, and 18%,
respectively (p ¼ 0.003). After controlling for CHADS2
score, gender, and AF types in a multivariable logistic
model, Chicken Wing morphology was found to be 79% less
likely to have a stroke/TIA history (odd ratio: 0.21, 95%
conﬁdence interval: 0.05 to 0.91, p ¼ 0.036). In a separate
multivariate model, we entered Chicken Wing as the
reference group and assessed the likelihood of stroke in other
groups in relation to reference. Compared with Chicken
Wing, Cactus was 4.08 times (p ¼ 0.046), Windsock was
4.5 times (p ¼ 0.038), and Cauliﬂower was 8.0 times
(p ¼ 0.056) more likely to have had a stroke/TIA.
Conclusions Patients with Chicken Wing LAA
morphology are less likely to have an embolic event even
after controlling for comorbidities and CHADS2 score. If
conﬁrmed, these results could have a relevant impact on
the anticoagulation management of patients with a low-
intermediate risk for stroke/TIA.(62)Coronary Vasomotor Control in Obesity and Morbid
Obesity: Contrasting Flow Responses With
Endocannabinoids, Leptin, and Inﬂammation
Objectives This study sought to investigate abnormalities
in coronary circulatory function in 2 different disease entities
of obese (OB) and morbidly obese (MOB) individuals and
to evaluate whether these would differ in severity with
different proﬁles of endocannabinoids, leptin, and C-reac-
tive protein (CRP) plasma levels.
Background There is increasing evidence that altered
plasma levels of endocannabinoids, leptin, and CRP may
affect coronary circulatory function in OB and MOB.
Methods Myocardial blood ﬂow (MBF) responses to cold
pressor test from rest and during pharmacologically induced
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emission tomography/computed tomography. Study partic-
ipants (n ¼ 111) were divided into 4 groups based on their
body mass index (BMI) (kg/m2): 1) control group (BMI: 20
to 24.9, n ¼ 30); 2) overweight group (BMI: 25 to 29.9,
n ¼ 31), 3) OB group (BMI: 30 to 39.9, n ¼ 25); and 4)
MOB group (BMI 40, n ¼ 25).
Results The cold pressor test–induced change in
endothelium-related MBF response (DMBF) progressively
declined in overweight and OB groups when compared with
the control group [median: 0.19 (interquartile range [IQR]
0.08, 0.27) and 0.11 (0.03, 0.17) vs. 0.27 (0.23, 0.38) ml/g/
min; p  0.01, respectively], whereas it did not differ
signiﬁcantly between OB and MOB groups [median: 0.11
(IQR: 0.03, 0.17) and 0.09 (–0.01, 0.19) ml/g/min;
p ¼ 0.93]. Compared with control subjects, hyperemic MBF
subjects comparably declined in the overweight, OB, and
MOB groups [median: 2.40 (IQR 1.92, 2.63) vs. 1.94 (1.65,
2.30), 2.05 (1.67, 2.38), and 2.14 (1.78, 2.76) ml/g/min;
p  0.05, respectively]. In OB individuals, DMBF was
inversely correlated with increase in endocannabinoid
anandamide (r ¼ –0.45, p ¼ 0.044), but not with leptin
(r ¼ –0.02, p ¼ 0.946) or with CRP (r ¼ –0.33, p ¼ 0.168).
Conversely, there was a signiﬁcant and positive correlation
among DMBF and elevated leptin (r ¼ 0.43, p ¼ 0.031) and
CRP (r ¼ 0.55, p ¼ 0.006), respectively, in MOB indi-
viduals that was not observed for endocannabinoid anan-
damide (r ¼ 0.07, p ¼ 0.740).
Conclusions Contrasting associations of altered coronary
endothelial function with increases in endocannabinoid
anandamide, leptin, and CRP plasma levels identify and
characterize OB and MOB as different disease entities
affecting coronary circulatory function (63).Transradial Versus Transfemoral Artery Approach
for Coronary Angiography and Percutaneous
Coronary Intervention in the Extremely Obese
Objectives This study sought to evaluate the safety and
efﬁcacy of transradial versus transfemoral access for coronary
angiography and percutaneous coronary intervention in
patients with a body mass index 40 kg/m2.
Background Coronary angiography is most commonly
performed via femoral artery access; however, the optimal
approach in extremely obese (EO) patients remains unclear.
Methods Between January 2007 and August 2010, a cohort
of consecutive EO patients who underwent coronary angi-
ography was identiﬁed in our center’s registry of angiography
and percutaneous coronary intervention procedures. Of
21,103 procedures, 564 (2.7%) were performed in unique
EO patients: 203 (36%) via the transradial approach; and
361 (64%) via the transfemoral approach.
Results The primary outcome, a combined endpoint of
major bleeding, access site complications, and nonaccess site
complications, occurred in 7.5% of the transfemoral group
and 2.0% of the transradial group (odds ratio [OR]: 0.30,95% conﬁdence interval [CI]: 0.10 to 0.88, p ¼ 0.029), an
endpoint driven by reductions in major bleeding (3.3% vs.
0.0%, OR: 0.12, 95% CI: 0 to 0.71, p ¼ 0.015), as well as
access site injuries (4.7% vs. 0.0%, OR: 0.08, 95% CI: 0 to
0.48, p ¼ 0.002). There were no differences in nonaccess
site complications (1.7% vs. 2.0%, OR: 1.50, 95% CI: 0.41
to 5.55), but transradial access procedures were associated
with an increase in procedure time and patient radiation
dose (p < 0.05).
Conclusions Transfemoral access for coronary angiography
and percutaneous coronary intervention was associated with
more bleeding and access site complications when compared
with a transradial approach. Important reductions in
procedural associated morbidity may be possible with
a transradial approach in EO patients (64).Radiation Dose Reduction in the Invasive
Cardiovascular Laboratory: Implementing a
Culture and Philosophy of Radiation Safety
Objectives This paper investigates the effects of sustained
practice and x-ray system technical changes on the radiation
dose administered to adult patients during invasive cardio-
vascular procedures.
Background It is desirable to reduce radiation dose asso-
ciated with medical imaging to minimize the risk of adverse
radiation effects to both patients and staff. Several clinical
practice and technical changes to elevate radiation awareness
and reduce patient radiation dose were implemented under
the guidance of a cardiovascular invasive labs radiation safety
committee. Practice changes included: intraprocedure radi-
ation dose announcements; reporting of procedures for
which the air-kerma exceeded 6,000 mGy, including
procedure air-kerma in the clinical report; and establishing
compulsory radiation safety training for fellows. Technical
changes included establishing standard x-ray imaging
protocols, increased use of x-ray beam spectral ﬁlters,
reducing the detector target dose for ﬂuoroscopy and
acquisition imaging, and reducing the ﬂuoroscopy frame rate
to 7.5 s1.
Methods Patient- and procedure-speciﬁc cumulative skin
dose was calculated from air-kerma values and evaluated
retrospectively over a period of 3 years. Data were catego-
rized to include all procedures, percutaneous coronary
interventions, coronary angiography, noncardiac vascular
angiography and interventions, and interventions to treat
structural heart disease. Statistical analysis was based on
a comparison of the cumulative skin dose for procedures
performed during the ﬁrst and last quarters of the 3-year
study period.
Results A total of 18,115 procedures were performed by 27
staff cardiologists and 65 fellows-in-training. Considering all
procedures, the mean cumulative skin dose decreased from
969 to 568 mGy (40% reduction) over 3 years.
Conclusions This work demonstrates that a philosophy
of radiation safety, implemented through a collection of
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a signiﬁcant decrease in the radiation dose administered to
patients during invasive cardiovascular procedures (65).
Sustained Acceleration in Carotid Atherosclerotic
Plaque Progression With Intraplaque Hemorrhage:
A Long-Term Time Course Study
Objectives This study sought to determine the immediate
and long-term effects of intraplaque hemorrhage (IPH) on
plaque progression in the carotid artery.
Background Previous studies have associated IPH in the
carotid artery with more rapid plaque progression. However,
the time course and long-term effect remain unknown.
Carotid magnetic resonance imaging is a noninvasive
imaging technique that has been validated with histology for
the accurate in vivo detection of IPH and measurement of
plaque burden.
Methods Asymptomatic subjects with 50% to 79% carotid
stenosis underwent carotid magnetic resonance imaging at
baseline and then serially every 18 months for a total of 54
months. Subjects with IPH present in at least 1 carotid
artery at 54 months were selected. Subsequently, presence/
absence of IPH and wall volume were determined inde-
pendently in all time points for both sides. A piece-wise
progression curve was ﬁt by using a linear mixed model to
compare progression rates described as annualized changes
in wall volume between periods deﬁned by their relationship
to IPH development.
Results From 14 subjects who exhibited IPH at 54
months, 12 arteries were found to have developed IPH
during the study period. The progression rates were
–20.5  13.1, 20.5  13.6, and 16.5  10.8 mm3/year
before, during, and after IPH development, respectively.
The progression rate during IPH development tended to be
higher than the period before (p ¼ 0.080) but comparable to
the period after (p ¼ 0.845). The progression rate in the
combined period during/after IPH development was
18.3  6.5 mm3/year, which indicated signiﬁcant progres-
sion (p ¼ 0.008 compared with a slope of 0) and was higher
than the period before IPH development (p ¼ 0.018). No
coincident ischemic events were noted for new IPH.
Conclusions The development of IPH posed an immediate
and long-term promoting effect on plaque progression. IPH
seems to alter the biology and natural history of carotid
atherosclerosis. Early identiﬁcation of patients with IPH
may prove invaluable in optimizing management to mini-
mize future sequelae (66).
Real-Time 3D Echocardiographic Quantiﬁcation
of Left Atrial Volume: Multicenter Study for
Validation With CMR
Objectives We studied in a multicenter setting the accuracy
and reproducibility of 3-dimensional echocardiography
(3DE)–derived measurements of left atrial volume (LAV)
using new, dedicated volumetric software, side by side with2-dimensional echocardiography (2DE), using cardiac
magnetic resonance (CMR) imaging as a reference.
Background Increased LAV is associated with adverse
cardiovascular outcomes. Although LAV measurements are
routinely performed using 2DE, this methodology is limited
because it is view dependent and relies on geometric
assumptions regarding left atrial shape. Real-time 3DE is
free of these limitations and accordingly is an attractive
alternative for the evaluation of LAV. However, few studies
have validated 3DE-derived LAV measurements against an
accepted independent reference standard, such as CMR
imaging.
Methods We studied 92 patients with a wide range of
LAV who underwent CMR (1.5-T) and echocardiographic
imaging on the same day. Images were analyzed to obtain
maximal and minimal LAV: CMR images using standard
commercial tools, 2DE images using a biplane area-length
technique, and 3DE images using Tomtec LA Function
software. Intertechnique comparisons included linear
regression and Bland-Altman analyses. Reproducibility of all
3 techniques was assessed by calculating the percentage of
absolute differences in blinded repeated measurements.
Kappa statistics were used to compare 2DE and 3DE
classiﬁcation of normal/enlarged against the CMR
reference.
Results 3DE-derived LAV values showed higher correlation
with CMR than 2DE measurements (r ¼ 0.93 vs. r ¼ 0.74
for maximal LAV; r ¼ 0.88 vs. r ¼ 0.82 for minimal LAV).
Although 2DE underestimated maximal LAV by 31  25 ml
and minimal LAV by 16 32 ml, 3DE resulted in a minimal
bias of 1  14 ml for maximal LAV and 0  21 ml for
minimal LAV. Interobserver and intraobserver variability of
2DE and 3DE measurements of maximal LAV were similar
(7% to 12%) and approximately 2 times higher than CMR
(4% to 5%). 3DE classiﬁed enlarged atria more accurately
than 2DE (kappa: 0.88 vs. 0.71).
Conclusions Compared with CMR reference, 3DE-
derived LAV measurements are more accurate than 2DE-
based analysis, resulting in fewer patients with undetected
atrial enlargement (67).
LV Mass Assessed by Echocardiography and CMR,
Cardiovascular Outcomes, and Medical Practice
The authors investigated 3 important areas related to the
clinical use of left ventricular mass (LVM): accuracy of
assessments by echocardiography and cardiac magnetic reso-
nance (CMR), the ability to predict cardiovascular outcomes,
and the comparative value of different indexing methods. The
recommended formula for echocardiographic estimation of
LVM uses linear measurements and is based on the
assumption of the left ventricle (LV) as a prolate ellipsoid of
revolution. CMR permits a modeling of the LV free of
cardiac geometric assumptions or acoustic window depen-
dency, showing better accuracy and reproducibility. However,
echocardiography has lower cost, easier availability, and better
The Editors JACC Vol. 62, No. 14, 2013
JACC Topic Collection: Cardiac Imaging October 1, 2013:e29–141
e54tolerability. From the MEDLINE database, 26 longitudinal
echocardiographic studies and 5 CMR studies investigating
LVM or LV hypertrophy as predictors of death or major
cardiovascular outcomes were identiﬁed. LVM and LV
hypertrophy were reliable cardiovascular risk predictors using
both modalities. However, no study directly compared the
methods for the ability to predict events, agreement in
hypertrophy classiﬁcation, or performance in cardiovascular
risk reclassiﬁcation. Indexing LVM to body surface area was
the earliest normalization process used, but it seems to
underestimate the prevalence of hypertrophy in obese and
overweight subjects. Dividing LVM by height to the allo-
metric power of 1.7 or 2.7 is the most promising normali-
zation method in terms of practicality and usefulness from
a clinical and scientiﬁc standpoint for scaling myocardial mass
to body size. The measurement of LVM, calculation of LVM
index, and classiﬁcation for LV hypertrophy should be stan-
dardized by scientiﬁc societies across measurement techniques
and adopted by clinicians in risk stratiﬁcation and therapeutic
decision making (68).Regression of Inﬂammation in Atherosclerosis by
the LXR Agonist R211945: A Noninvasive
Assessment and Comparison With Atorvastatin
Objectives The aim of this study was to noninvasively
detect the anti-inﬂammatory properties of the novel liver X
receptor agonist R211945.
Background R211945 induces reversal cholesterol trans-
port and modulates inﬂammation in atherosclerotic plaques.
We aimed to characterize with 18F-ﬂuorodeoxyglucose
(FDG)–positron emission tomography (PET)/computed
tomography (CT) and dynamic contrast-enhanced cardiac
magnetic resonance (DCE-CMR) inﬂammation and neo-
vascularization, respectively, in atherosclerotic plaques with
R211945 treatment compared with atorvastatin treatment
and a control.
Methods Twenty-one atherosclerotic New Zealand white
rabbits were divided into 3 groups (control, R211945 [3 mg/kg
orally], and atorvastatin [3 mg/kg orally] groups). All groups
underwent 18F-FDG–PET/CT and DCE-CMR at baseline
and at 1 and 3 months after treatment initiation. Concomitantly,
serum metabolic parameters and histology were assessed. For
statistical analysis, continuous DCE-CMR and PET/CT
outcomes were modeled as linear functions of time by using
a linear mixed model, whereas the histological data, animal
characteristics data, and nonlinear regression imaging data were
analyzed with a 2-tailed Student t test.
Results 18F-FDG–PET/CT detected a decrease in mean
and maximum standard uptake values (SUV) over time in
the R211945 group (both p ¼ 0.001), indicating inﬂam-
mation regression. The atorvastatin group displayed no
signiﬁcant change (p ¼ 0.371 and p ¼ 0.600, respectively),
indicating no progression or regression. The control group
demonstrated an increase in SUV (p ¼ 0.01 and p ¼ 0.04,
respectively), indicating progression. There was a signiﬁcantinteraction between time and group for mean and maximum
SUV (p ¼ 0.0003 and p ¼ 0.0016, respectively) . DCE-
CMR detected a trend toward difference (p ¼ 0.06) in the
area under the curve in the atorvastatin group, suggesting
a decrease in neovascularization. There was no signiﬁcant
interaction between time and group (p ¼ 0.6350 and
p ¼ 0.8011, respectively). Macrophage and apolipoprotein B
immunoreactivity decreased in the R211945 and atorvastatin
groups (p < 0.0001 and p ¼ 0.0004, respectively), and
R211945 decreased oxidized phospholipid immunoreactivity
(p ¼ 0.02).
Conclusions Noninvasive imaging with 18F-FDG–PET/
CT and DCE-CMR and histological analysis demonstrated
signiﬁcant anti-inﬂammatory effects of the LXR agonist
R211945 compared with atorvastatin. The results suggest
a possible role for LXR agonists in the treatment of
atherosclerosis (69).MR Cine DENSE Dyssynchrony Parameters for the
Evaluation of Heart Failure: Comparison With
Myocardial Tissue Tagging
Objectives We sought to assess the effectiveness of auto-
mated mechanical dyssynchrony (MD) parameters based on
regional heterogeneity of strain (circumferential [CURE],
longitudinal [LURE], and radial uniformity ratio estimates)
relative to parameters based on regional time to peak con-
traction with cardiac magnetic resonance (CMR) cine
DENSE (Displacement Encoding with Stimulated Echoes)
validated with myocardial tissue tagging (MTT) strain data.
Background Dyssynchrony measures based on the Fourier
transformation (FT) of regional strain, such as CURE
(previously evaluated in cardiac resynchronization therapy
candidates), directly assess MD and yield straightforward
global dyssynchrony indexes; however, performance relative
to the 12-segment standard deviation of time to peak strain
(SD12) or maximal regional delay in time to peak strain is
unknown.
Methods Cine DENSE and MTT were obtained with
CMR (1.5-T Siemens Avanto, Siemens, Erlangen,
Germany) in 13 canines: 3 normal control subjects, 5 with
tachycardia pacing-induced heart failure (HF) and left
bundle branch ablation (LBBB-HF), and 5 with HF and
narrow QRS (NQRS-HF). Strain and dyssynchrony pa-
rameters were determined with both CMR methods.
Results Both HF groups had reduced peak strains and left
ventricular ejection fraction compared with normal cases.
There was strong agreement between cine DENSE and MTT
on the basis of intraclass correlation coefﬁcients (CURE: 0.99,
95% CI: 0.96 to 1.00; LURE: 0.92, 95% CI: 0.77 to 0.98;
circumferential strain [ECC]: 0.95, 95% CI: 0.72 to 0.99;
longitudinal strain [ELL]: 0.82, 95% CI: 0.42 to 0.97). The
FT-based metrics (scale 0 to 1), in particular CURE,
discriminated highly between LBBB-HF and NQRS-HF
groups (median difference): CURE: 0.60, 95% CI: 0.43
to 0.76; LURE: 0.39, 95% CI: 0.19 to 0.58; radial uniformity
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conﬁdence intervals for group differences in time-to-peak
parameters were wide, indicating less consistent discrimina-
tion (median difference): SD12-ECC: 52.5, 95% CI: 4.0 to
109.2; SD12-ELL: 40.9, 95% CI: 5.3 to 87.1; SD12-radial
strain: 42.0, 95% CI: 0.4 to 83.6). Correlations between FT-
based and time-to-peak parameters were signiﬁcant (CURE/
SD12-ECC: r ¼ 0.62, p ¼ 0.03; LURE/SD12-ELL:
r ¼ 0.76, p ¼ 0.005) but not as tight as correlations between
time-to-peak parameters.
Conclusions Automated FT-based circumferential, radial,
and longitudinal dyssynchrony measures compare favorably
with time-to-peak parameters. Cine DENSE was effective
for this application and validated with MTT. Further
clinical evaluation in cardiac resynchronization therapy
candidates with CMR or other imaging modalities is
warranted (70).Associations of LV Hypertrophy With Prevalent and
Incident Valve Calciﬁcation: Multi-Ethnic Study of
Atherosclerosis
Objectives The aim of this study was to evaluate the rela-
tionship between percentage of predicted left ventricular
mass (%PredLVM) and valve calciﬁcation in the MESA
(Multi-Ethnic Study of Atherosclerosis) study.
Background Cardiac valve calciﬁcation has been associated
with left ventricular hypertrophy (LVH), which portends
cardiovascular events. However, this relationship and its
mediators are poorly understood.
Methods The MESA study is a longitudinal cohort study
of men and women 45 to 84 years of age without clinical
cardiovascular disease in whom serial cardiac magnetic
resonance and computed tomography imaging were per-
formed. The relationships between baseline %PredLVM
and the prevalence, severity, and incidence of aortic valve
(AVC) and mitral annulus calciﬁcation (MAC) were
determined by regression modeling.
Results Prevalent AVC was observed in 630, and MAC
was observed in 442 of 5,042 subjects (median 55.9 and
71.1 Agatston units, respectively). After adjustment for age,
sex, body mass index (BMI), ethnicity, socioeconomic
status, physical activity, diabetes, cholesterol levels, blood
pressure, smoking, kidney function, serum lipids, and anti-
hypertensive and statin medications, %PredLVM was
associated with prevalent AVC (odds ratio [OR]: 1.18/SD
increase in %PredLVM [95% conﬁdence interval (CI): 1.08
to 1.30]; p ¼ 0.0004) and MAC (OR: 1.18 [95% CI: 1.06
to 1.32]; p ¼ 0.002). Similarly, %PredLVM was associa-
ted with increased severity of prevalent AVC (risk dif-
ference ¼ 0.26 [95% CI: 0.15 to 0.38]; p < 0.0001) and
MAC (risk difference ¼ 0.20 [95% CI: 0.03 to 0.37];
p ¼ 0.02). During follow-up (mean 2.4  0.9 years), 153
subjects (4%) developed AVC, and 198 (5%) developed
MAC. The %PredLVM was associated with incident AVC
(OR: 1.24 [95% CI: 1.04 to 1.47]; p ¼ 0.02) and MAC (OR:1.18 [95% CI: 1.01 to 1.40]; p ¼ 0.04). Further adjustment for
inﬂammatory markers and coronary artery calciﬁcation did not
attenuate these associations. Speciﬁcally, concentric LVH most
strongly predicted incident valve calciﬁcation.
Conclusions Within the MESA cohort, LVH was asso-
ciated with prevalence, severity, and incidence of valve
calciﬁcation independent of hypertension and other identi-
ﬁed confounders (71).
Prospectively ECG-Triggered Rapid kV-Switching
Dual-Energy CT for Quantitative Imaging of
Myocardial Perfusion
Dual-energy computed tomography (DECT) has recently
been introduced for clinical use. One potential application of
DECT is myocardial perfusion imaging through the sig-
niﬁcant reduction of beam-hardening artifacts by using
monochromatic image reconstruction; analysis of these im-
ages can improve the accuracy of quantitative measurement
of myocardial perfusion. Single-source DECT enabled by
rapid switching between the low and high tube potentials
(kV) can minimize misregistration of the high and low kV
projection datasets from cardiac motion. We have recently
implemented prospective electrocardiography-triggering
capability in our rapid kV-switching computed tomog-
raphy (CT) scanner to reduce the high effective dose from
a quantitative CT myocardial perfusion imaging study with
DECT. Our initial investigation suggests that prospectively
electrocardiography-triggered rapid kV-switching DECT
can eliminate beam hardening and provide a more repro-
ducible myocardial perfusion measurement compared with
the traditional single-energy CT protocol (72).
Virtual Electrophysiological Study in
a 3-Dimensional Cardiac Magnetic Resonance
Imaging Model of Porcine Myocardial Infarction
Objectives This study sought to test the hypothesis that
“virtual” electrophysiological studies (EPS) on an anatomic
platform generated by 3-dimensional magnetic resonance
imaging reconstruction of the left ventricle can reproduce
the reentrant circuits of induced ventricular tachycardia (VT)
in a porcine model of myocardial infarction.
Background Delayed-enhancement magnetic resonance
imaging has been used to characterize myocardial infarction
and “gray zones,” which are thought to reﬂect heterogeneous
regions of viable and nonviable myocytes.
Methods Myocardial infarction by coronary artery occlu-
sion was induced in 8 pigs. After a recovery period,
3-dimensional cardiac magnetic resonance images were ob-
tained from each pig in vivo. Normal areas, gray zones, and
infarct cores were classiﬁed based on voxel intensity. In the
computer model, gray zones were assigned slower conduc-
tion and longer action potential durations than those for
normal myocardium. Virtual EPS was performed and
compared with results of actual in vivo programmed stim-
ulation and noncontact mapping.
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166.2 cm3, with 4.9% to 17.5% of voxels classiﬁed as infarct
zones. Six of the 7 pigs in which VT developed during actual
EPS were also inducible with virtual EPS. Four of the 6 pigs
that had simulated VT had reentrant circuits that approxi-
mated the circuits seen with noncontact mapping, whereas
the remaining 2 had similar circuits but propagating in
opposite directions.
Conclusions This initial study demonstrates the feasibility
of applying a mathematical model to magnetic resonance
imaging reconstructions of the left ventricle to predict VT
circuits. Virtual EPS may be helpful to plan catheter ablation
strategies or to identify patients who are at risk of future
episodes of VT (73).Assessment of Myocardial Scarring Improves Risk
Stratiﬁcation in Patients Evaluated for Cardiac
Deﬁbrillator Implantation
Objectives We tested whether an assessment of myo-
cardial scarring by cardiac magnetic resonance imaging
(MRI) would improve risk stratiﬁcation in patients eva-
luated for implantable cardioverter-deﬁbrillator (ICD)
implantation.
Background Current sudden cardiac death risk stratiﬁca-
tion emphasizes left ventricular ejection fraction (LVEF);
however, most patients suffering sudden cardiac death have
a preserved LVEF, and many with poor LVEF do not
beneﬁt from ICD prophylaxis.
Methods One hundred thirty-seven patients undergoing
evaluation for possible ICD placement were prospectively
enrolled and underwent cardiac MRI assessment of LVEF
and scar. The pre-speciﬁed primary endpoint was death or
appropriate ICD discharge for sustained ventricular
tachyarrhythmia.
Results During a median follow-up of 24 months the
primary endpoint occurred in 39 patients. Whereas the rate of
adverse events steadily increased with decreasing LVEF,
a sharp step-up was observed for scar size >5% of left
ventricular mass (hazard ratio [HR]: 5.2; 95% conﬁdence
interval [CI]: 2.0 to 13.3). On multivariable Cox proportional
hazards analysis, including LVEF and electrophysiological-
study results, scar size (as a continuous variable or dichoto-
mized at 5%) was an independent predictor of adverse
outcome. Among patients with LVEF >30%, those with
signiﬁcant scarring (>5%) had higher risk than those with
minimal or no (5%) scarring (HR: 6.3; 95% CI: 1.4 to
28.0). Those with LVEF >30% and signiﬁcant scarring had
risk similar to patients with LVEF30% (p ¼ 0.56). Among
patients with LVEF 30%, those with signiﬁcant scarring
again had higher risk than those with minimal or no scarring
(HR: 3.9; 95% CI: 1.2 to 13.1). Those with LVEF 30%
and minimal scarring had risk similar to patients with LVEF
>30% (p ¼ 0.71).
Conclusions Myocardial scarring detected by cardiac MRI
is an independent predictor of adverse outcome in patientsbeing considered for ICD placement. In patients with
LVEF >30%, signiﬁcant scarring (>5% LV) identiﬁes
a high-risk cohort similar in risk to those with LVEF 30%.
Conversely, in patients with LVEF 30%, minimal or no
scarring identiﬁes a low-risk cohort similar to those with
LVEF >30% (74).Impact of Ischemia-Guided Revascularization With
Myocardial Perfusion Imaging for Patients With
Multivessel Coronary Disease
Objectives The aim of this study was to evaluate the impact
of ischemia-guided (IG) revascularization.
Background The importance of IG revascularization has
not been well-determined.
Methods The outcomes of IG revascularization, in which
revascularization was performed in the matched coronary
artery with the perfusion abnormality on myocardial perfu-
sion image (MPI), were retrospectively compared with those
of non-IG revascularization in a registry of 5,340 patients
with multivessel coronary disease comprising 2,587 percu-
taneous coronary interventions (PCIs) with drug-eluting
stents and 2,753 coronary artery bypass graft (CABG)
surgeries after adjustment with inverse-probability-of-
treatment weighting.
Results The MPI was performed in 42.3% of patients, and
IG revascularization was performed in 17.3%, including
12.4% in PCI and 21.8% in CABG patients (p < 0.001).
The incidence of major adverse cardiac and cerebrovascular
events (MACCE) including death, myocardial infarction,
stroke, or repeat revascularization was signiﬁcantly lower in
the IG than in the non-IG group (16.2% vs. 20.7%; adjusted
hazard ratio [aHR]: 0.73; 95% conﬁdence interval [CI]: 0.60
to 0.88; p ¼ 0.001), primarily driven by the lower repeat
revascularization rate (9.9% vs. 22.8%; aHR: 0.66; 95% CI:
0.49 to 0.90; p ¼ 0.009). Subgroup analysis showed that IG
reduced the risk of MACCE in PCI (17.4% vs. 22.8%; aHR:
0.59; 95% CI: 0.43 to 0.81; p ¼ 0.001) but not in CABG
(16.0% vs. 18.5%; aHR: 0.87; 95% CI: 0.67 to 1.14;
p ¼ 0.31) patients.
Conclusions Ischemia-guided revascularization with MPI,
particularly in PCI-treated patients, seems to decrease the
risk of repeat revascularization and MACCE for patients
with multivessel disease (75).The Immediate and Long-Term Impact of Pregnancy
on Aortic Growth Rate and Mortality in Women
With Marfan Syndrome
Objectives The study sought to assess the impact of preg-
nancy on the rate of aortic growth as well as on short-
and long-term clinical outcomes in women with Marfan
syndrome.
Background There is a paucity of data on peripartum and
long-term clinical outcomes in women with Marfan syn-
drome who are followed prospectively during pregnancy.
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data review of all adult females with a conﬁrmed diagnosis of
Marfan syndrome was performed.
Results Of the 98 women identiﬁed, 69 (72%) experienced
a total of 199 pregnancies resulting in 170 (86%) live births.
The median number of pregnancies per women was 3
(interquartile range: 1 to 12). Obstetrical complications
occurred in 17 (10%) and adverse fetal outcomes in 22
(13%). No woman experienced aortic dissection or required
cardiac surgery during pregnancy. Aortic growth rate
increased during pregnancy and did not return to baseline
following pregnancy completion. Despite the lack of cata-
strophic peripartum complications, the prevalence of both
aortic dissection and elective aortic surgery during long-term
follow-up was higher in those women who had a prior
pregnancy. Risk factors for adverse cardiac outcome included
greater aortic diameter, greater rate of aortic growth during
pregnancy, increased number of pregnancies, lack of beta-
blocker use during pregnancy, and lack of prospective
pregnancy follow-up.
Conclusions There is a low incidence of aortic complica-
tions during pregnancy in women with Marfan syndrome
and an aortic diameter <4.5 cm. However, pregnancy does
increase the risk of aortic complications in the long-term in
this group of patients (76).Ischemia Change in Stable Coronary Artery
Disease Is an Independent Predictor of
Death and Myocardial Infarction
Objectives The aim of this study was to evaluate the
independent prognostic signiﬁcance of ischemia change in
stable coronary artery disease (CAD).
Background Recent randomized trials in stable CAD have
suggested that revascularization does not improve
outcomes compared with optimal medical therapy (MT).
In contrast, the nuclear substudy of the COURAGE
(Clinical Outcomes Utilizing Revascularization and
Aggressive Drug Evaluation) trial found that revasculari-
zation led to greater ischemia reduction and suggested that
this may be associated with improved unadjusted outcomes.
Thus, the effects of MT versus revascularization on is-
chemia change and its independent prognostic signiﬁcance
requires further investigation.
Methods From the Duke Cardiovascular Disease and
Nuclear Cardiology Databanks, 1,425 consecutive patients
with angiographically documented CAD who underwent 2
serial myocardial perfusion single-photon emission com-
puted tomography scans were identiﬁed. Ischemia change
was calculated for patients undergoing MT alone, percuta-
neous coronary intervention, or coronary artery bypass
grafting. Patients were followed for a median of 5.8 years
after the second myocardial perfusion scan. Cox proportional
hazards regression modeling was used to identify factors
independently associated with the primary outcome of death
or myocardial infarction (MI). Formal risk reclassiﬁcationanalyses were conducted to assess whether the addition of
ischemia change to traditional predictors resulted in im-
proved risk classiﬁcation for death or MI.
Results More MT patients (15.6%) developed 5%
ischemia worsening compared with those undergoing
percutaneous coronary intervention (6.2%) or coronary artery
bypass grafting (6.7%) (p < 0.001). After adjustment for
established predictors, 5% ischemia worsening remained
a signiﬁcant independent predictor of death or MI (hazard
ratio: 1.634; p ¼ 0.0019) irrespective of treatment arm.
Inclusion of 5% ischemia worsening in this model resulted
in signiﬁcant improvement in risk classiﬁcation (net reclas-
siﬁcation improvement: 4.6%, p ¼ 0.0056) and model
discrimination (integrated discrimination improvement:
0.0062, p ¼ 0.0057).
Conclusions In stable CAD, ischemia worsening is an
independent predictor of death or MI, resulting in signiﬁ-
cantly improved risk reclassiﬁcation when added to previ-
ously known predictors (77).Direct Measurement of Multiple Vena Contracta
Areas for Assessing the Severity of Mitral
Regurgitation Using 3D TEE
Objectives The aim of this study was to determine whether
direct measurement of multiple-jet vena contracta (VC)
areas by real-time 3-dimensional (3D) transesophageal
echocardiography is an accurate method for measuring the
severity of mitral regurgitation (MR) in patients with
multiple MR jets.
Background Because of the conﬂicting requirements of
Doppler and imaging physics, measuring VC using
2-dimensional (2D) echocardiography is a difﬁcult proce-
dure for assessing MR severity. A real-time 3D echocar-
diographic measurement of the VC area has been validated
in a single jet of MR, but the applicability of this method for
multiple jets is unknown.
Methods Two-dimensional and 3D transesophageal
echocardiography was performed in 60 patients with
multiple functional MR jets. MR severity was assessed
quantitatively using the effective regurgitant oriﬁce area
derived from 3D left ventricular volume and thermodilution
data (EROAstd). Manual tracings of multiple 3D VC areas
in a cross-sectional plane through the VC were obtained,
and the sum of the areas was compared using EROAstd.
Similarly, 2D measurement of VC diameter was obtained
from a 2D transesophageal echocardiographic view to opti-
mize the largest legion size in each jet. All VC diameters
were summed and compared with EROAstd.
Results The correlation of the sum of the multiple 3D VC
areas with EROAstd (r ¼ 0.90, p < 0.01) was higher than
that of the sum of the multiple 2D VC diameters (r ¼ 0.56,
p < 0.01), particularly with MR degrees greater than mild
(r ¼ 0.80, p < 0.01 vs. r ¼ 0.05, p ¼ 0.81) and in cases of 3
or more regurgitant jets (r ¼ 0.91, p < 0.01 vs. r ¼ 0.46,
p ¼ 0.05).
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using 3D transesophageal echocardiography allows for
assessing MR severity in patients with multiple jets,
particularly for MR degrees greater than mild and in cases of
more than 2 jets, for which geometric assumptions may be
challenging (78).A Long-Term Prognostic Value of Coronary CT
Angiography in Suspected Coronary Artery Disease
Objectives The aim of this study was to assess the long-
term prognostic role of multidetector computed tomog-
raphy coronary angiography (CTA) in patients with
suspected coronary artery disease (CAD).
Background Use of CTA is increasing in patients with
suspected CAD. Although there is a large body of data sup-
porting the prognostic role of CTA for major adverse cardiac
events in the intermediate term, its long-term prognostic role
in patients with suspected CAD is not well studied.
Methods Between February 2005 and March 2008, 1,304
consecutive patients were prospectively studied with CTA
for detecting the presence and assessing extent of CAD
(disease extension and coronary plaque scores). Patients were
classiﬁed according to the presence of normal coronaries and
nonobstructive (<50%) and obstructive (>50%) coronary
lesions. The composite rates of hard cardiac events (cardiac
deaths and nonfatal myocardial infarctions) and all cardiac
events (including late revascularization) were the endpoints
of the study.
Results Seventy patients were excluded because their CTA
data were uninterpretable. Of the remaining 1,234 patients,
clinical follow-up (mean 52  22 months) was obtained for
1,196 (97%). A total of 475 events were recorded, with 136
hard events (18 cardiac deaths and 118 nonfatal myocardial
infarctions) and 123 late revascularizations. A total of 216
patients with early elective revascularizations were excluded
from the survival analysis. Signiﬁcant independent predic-
tors of events in multivariate analysis were multivessel
disease and left main CAD. Cumulative event-free survival
was 100% for hard and all events in patients with normal
coronary arteries, 88% for hard events and 72% for all events
in patients with nonobstructive CAD, and 54% for hard
events and 31% for all events in patients with obstructive
CAD. Multivessel CAD was associated with a higher rate of
hard cardiac events.
Conclusions CTA provides prognostic information in
patients with suspected CAD and unknown cardiac disease,
showing excellent long-term prognosis when there is no
evidence of atherosclerosis and allowing risk stratiﬁcation
when CAD is present (79).Role of Echocardiography in Percutaneous Mitral
Valve Interventions
Intraprocedural imaging continues to evolve in parallel with
advances in percutaneous mitral valve interventions. Thisdidactic review uses several illustrations and rich intra-
procedural videos to further describe and demonstrate the
role of the most up-to-date echocardiographic and advanced
imaging technologies in the patient selection and intra-
procedural guidance of percutaneous mitral valve interven-
tions. We will focus on 3 interventions: 1) percutaneous
balloon mitral valvuloplasty for mitral stenosis; 2) trans-
catheter edge-to-edge repair of mitral valve regurgitation;
and 3) transcatheter closure of periprosthetic mitral reg-
urgitation. In addition, we discuss potential pitfalls of
3-dimensional transesophageal echocardiography and show
examples of this technique (80).Geometric Assessment of Asymmetric Septal
Hypertrophic Cardiomyopathy by CMR
Objectives The aim of this study was to analyze the
geometric pattern of hypertrophy (HT) in patients with
asymmetrical septal hypertrophic cardiomyopathy (HCM)
using cardiac magnetic resonance (CMR) and to test the
hypothesis that at least in some patients, the HT follows
a longitudinal spiral pattern.
Background The highly heterogeneous phenotypic expres-
sion of HCM is a well-known phenomenon. CMR has
emerged as a robust 3-dimensional (3D) tomographic
imaging technique that is increasingly used to explore
phenotypic expression.
Methods Short-axis cine CMR was used to study the 3D
extent of HT (i.e., radial, circumferential, and longitu-
dinal extent, as well as the relation between circumfer-
ential and longitudinal extent). Inclusion criteria were
septal wall thickness (WT) 15 mm and septal to free
wall WT ratio >1.3.
Results CMR was performed in 132 patients. Maximal
WT was 22  5 mm, with a circumferential extent of
131  51, and a longitudinal extent of 64  19%, resulting
in a hypertrophied left ventricular (LV) surface of 26  15%.
Linear regression analysis showed in 86% of patients
a consistent course of HT along the longitudinal direction.
The HT invariably started at the basal anteroseptum and
rotated, except in 2 patients, in a counterclockwise direction
(CC-spiral patients) with a mean global rotation of
116  68 (range 5 to 350). After the CC-spiral patients
were divided according to magnitude of rotation quartiles
(Q1: 5 to 70, Q2: 75 to 105, Q3: 110 to 150, and Q4:
155 to 350), Q4 patients were signiﬁcantly older and had
more LV outﬂow tract obstruction and hypertension than
patients without the spiraling pattern. In 11 patients,
continuation of HT into an apical form of HCM was found.
Conclusions Using 3D analysis, we found that the majority
of patients with asymmetrical septal HCM in fact showed
a spiral pattern of HT following a counterclockwise (or “left-
handed”) spiral trajectory. The variation in magnitude of
rotation among patients, however, was highly variable.
Further research is warranted to better understand the
signiﬁcance of the current ﬁndings, in particular to relate
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namic consequences, and patient outcome (81).Carotid Plaque Burden as a Measure of Subclinical
Atherosclerosis: Comparison With Other Tests for
Subclinical Arterial Disease in the High Risk
Plaque BioImage Study
Objectives The purpose of this study was to compare
carotid plaque burden, carotid intima-media thickness
(cIMT), ankle-brachial index (ABI), and abdominal aortic
diameter (AAD) to coronary artery calcium score (CACS)
in people without known cardiovascular disease.
Background The clinical utility of risk factors to predict
cardiovascular events is limited. Detection of subclinical
atherosclerosis by noninvasive tests such as CACS, cIMT,
carotid plaque burden, AAD, and ABI may improve risk
prediction above that of established risk scoring models,
namely, Framingham Risk Score.
Methods The High Risk Plaque BioImage study investi-
gated 6.101 asymptomatic persons and reports baseline
CACS, cIMT, ABI, and AAD. In addition, we present
ﬁndings from a new 3-dimensional–based ultrasound ap-
proach, where the carotid artery was investigated in cross
section from proximal in the neck to as distal as possible.
From the resulting 10-s video, plaque was outlined on cross-
sectional images and all plaque areas were summarized into
“plaque burden.”
Results The mean age was 68.8 years, and 65.3% of
subjects had intermediate Framingham Risk Score (6% to
20% 10-year risk). Carotid plaques were identiﬁed in 78% of
cases, abnormal ABI in 10%, AAD >20 mm in 28%, and
coronary calcium in 68% of participants. Carotid plaque
burden was found to correlate stronger with CACS (chi-
square 450, p < 0.0001) than did cIMT (chi-square 24,
p < 0.0001), AAD (chi-square 2.9, p ¼ 0.091), and ABI
(chi-square 35.2, p < 0.0001).
Conclusions In the BioImage study, a new 3-dimensional–
based ultrasound method identiﬁed more carotid plaques
than in previous studies. Compared to other methods, carotid
plaque burden was the strongest cross-sectional predictor
of CACS, and its clinical utility as predictor of future
cardiovascular events is being evaluated in the BioImage
study. (BioImage Study: A Clinical Study of Burden
of Atherosclerotic Disease in an At-Risk Population;
NCT00738725) (82).Implantation of a Drug-Eluting Stent With
a Different Drug (Switch Strategy) in Patients
With Drug-Eluting Stent Restenosis: Results
From a Prospective Multicenter Study (RIBS III
[Restenosis Intra-Stent: Balloon Angioplasty
Versus Drug-Eluting Stent])
Objectives This study sought to assess the effectiveness of a
strategy of using drug-eluting stents (DES) with a differentdrug (switch) in patients with DES in-stent restenosis
(ISR).
Background Treatment of patients with DES ISR remains
a challenge.
Methods The RIBS-III (Restenosis Intra-Stent: Balloon
Angioplasty Versus Drug-Eluting Stent) study was a pro-
spective, multicenter study that aimed to assess results of
coronary interventions in patients with DES ISR. The use of
a different DES was the recommended strategy. The main
angiographic endpoint was minimal lumen diameter at
9-month follow-up. The main clinical outcome measure was
a composite of cardiac death, myocardial infarction, and
target lesion revascularization.
Results This study included 363 consecutive patients with
DES ISR from 12 Spanish sites. The different-DES
strategy was used in 274 patients (75%) and alternative
therapeutic modalities (no switch) in 89 patients (25%).
Baseline characteristics were similar in the 2 groups,
although lesion length was longer in the switch group. At
late angiographic follow-up (77% of eligible patients,
median: 278 days) minimal lumen diameter was larger
(1.86  0.7 mm vs. 1.40  0.8 mm, p ¼ 0.003) and
recurrent restenosis rate lower (22% vs. 40%, p ¼ 0.008) in
the different-DES group. At the last clinical follow-up (99%
of patients, median: 771 days), the combined clinical
endpoint occurred less frequently (23% vs. 35%, p ¼ 0.039)
in the different-DES group. After adjustment using
propensity score analyses, restenosis rate (relative risk: 0.41,
95% conﬁdence interval [CI]: 0.21 to 0.80, p ¼ 0.01),
minimal lumen diameter (difference: 0.41 mm, 95%
CI: 0.19 to 0.62, p ¼ 0.001), and the event-free survival
(hazard ratio: 0.56, 95% CI: 0.33 to 0.96, p ¼ 0.038)
remained signiﬁcantly improved in the switch group.
Conclusions In patients with DES ISR, the implantation
of a different DES provides superior late clinical and
angiographic results than do alternative interventional
modalities (83).Radiation Exposure During Percutaneous Coronary
Interventions and Coronary Angiograms Performed
by the Radial Compared With the Femoral Route
Objectives This study aimed to compare radiation exposure
of patients undergoing percutaneous coronary interventions
(PCI) and coronary angiograms (CAG) accessed by the
femoral route with the radial route (operator’s choice).
Background There are limited and contradictory data on
the radiation exposure of patients during PCI and CAG
performed by the radial route compared with the femoral
route.
Methods Data on the radiation exposure of patients from
3,973 PCI and CAG procedures between June 22, 2004,
and December 31, 2008, were prospectively collected and
analyzed. A prediction model was made for radiation
exposure (dose-area product in Gy$cm2) based upon the
femoral access group, and the group of radial performed
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observed and expected radiation exposure.
Results Median exposures of patients undergoing a PCI via
the femoral route (n ¼ 2,309) was 75 (interquartile range
[IQR]: 44 to 135) Gy$cm2 compared with 72 (IQR: 42 to
134) Gy$cm2 for radial performed procedures (n ¼ 1,212)
(p ¼ 0.30). Median exposure for CAGs was 44 (IQR: 31 to
69) Gy$cm2 and 40 (IQR: 25 to 65) Gy$cm2 for, respec-
tively, femoral (n ¼ 314) and radial performed procedures
(n ¼ 138) (p ¼ 0.31). Also, the observed radiation exposure
in patients undergoing radial PCI or CAGs was not higher
than the expected exposure of patients as predicted by the
femoral access-based prediction model (71.5  2.3 Gy$cm2
vs. 79.9  1.8 Gy$cm2).
Conclusions The study shows that even after correction for
the complexity of the procedures, selected procedures per-
formed by the radial route are not associated with higher
radiation exposure of patients than selected procedures
performed by the femoral route (84).Post-Conditioning Reduces Infarct Size and Edema
in Patients With ST-Segment Elevation Myocardial
Infarction
Objectives This study aimed to determine whether post-
conditioning at the time of percutaneous coronary inter-
vention could reduce reperfusion-induced myocardial edema
in patients with acute ST-segment elevation myocardial
infarction (STEMI).
Background Myocardial edema is a reperfusion injury with
potentially severe consequences. Post-conditioning is a car-
dioprotective therapy that reduces infarct size after reperfu-
sion, but no previous studies have analyzed the impact of
this strategy on reperfusion-induced myocardial edema in
humans.
Methods Fifty patients with STEMI were randomly
assigned to either a control or post-conditioned group.
Cardiac magnetic resonance imaging was performed within
48 to 72 h after admission. Myocardial edema was measured
by T2-weighted sequences, and infarct size was determined
by late gadolinium enhancement sequences and creatine
kinase release.
Results The post-conditioned and control groups were
similar with respect to ischemia time, the size of the area at
risk, and the ejection fraction before percutaneous coronary
intervention. As expected, post-conditioning was associated
with smaller infarct size (13  7 g/m2 vs. 21  14 g/m2; p ¼
0.01) and creatine kinase peak serum level (median [inter-
quartile range]: 1,695 [1,118 to 3,692] IU/l vs. 3,505 [2,307
to 4,929] IU/l; p ¼ 0.003). At reperfusion, the extent of
myocardial edema was signiﬁcantly reduced in the post-
conditioned group as compared with the control group (23
 16 g/m2 vs. 34  18 g/m2; p ¼ 0.03); the relative increase
in T2W signal intensity was also signiﬁcantly lower
(p ¼ 0.02). This protective effect was conﬁrmed after
adjustment for the size of the area at risk.Conclusions This randomized study demonstrated that
post-conditioning reduced infarct size and edema in
patients with reperfused STEMI. (Post Cond No Reﬂow;
NCT01208727) (85).A Policy for Science
Policy and science often interact. Typically, we think of
policymakers looking to scientists for advice on issues
informed by science. We may appreciate less the opposite
look: where people outside science inform policies that affect
the conduct of science. In clinical medicine, we are forced to
make decisions about practices for which there is insufﬁ-
cient, inadequate evidence to know whether they improve
clinical outcomes, yet the health care system may not be
structured to rapidly generate needed evidence. For example,
when the Centers for Medicare and Medicaid Services noted
insufﬁcient evidence to support routine use of computed
tomography angiography and they called for a national
commitment to completion of randomized trials, their call
ran into substantial opposition. I use the computed to-
mography angiography story to illustrate how we might
consider a “policy for science” in which stakeholders would
band together to identify evidence gaps and to use their
inﬂuence to promote the efﬁcient design, implementation,
and completion of high-quality randomized trials. Such
a policy for science could create a culture that incentivizes
and invigorates the rapid generation of evidence, ultimately
engaging all clinicians, all patients, and indeed all stake-
holders into the scientiﬁc enterprise (86).Impact of Noninsulin-Dependent Type 2 Diabetes
on Carotid Wall 18F-Fluorodeoxyglucose Positron
Emission Tomography Uptake
Objectives In this study, the impact of noninsulin-
dependent type 2 diabetes mellitus on carotid wall 18F-ﬂu-
orodeoxyglucose (FDG) uptake in patients with documented
or suspected cardiovascular disease was evaluated.
Background Inﬂammation is a pivotal process in the
progression of atherosclerosis, which can be noninvasively
imaged by FDG positron emission tomography (FDG-PET).
Methods Carotid artery wall FDG uptake was quantiﬁed in
134 patients (age 60.2  9.7 years; diabetic subjects, n ¼ 43).
The pre-scan glucose (gluc) level corrected mean of the
maximum standardized uptake value (SUV) values (mean-
SUVgluc), mean of the maximum target-to-background
ratio (meanTBRgluc), and single hottest segment
(SHSgluc) of FDG uptake in the artery wall were calculated.
Associations between FDG uptake, the presence of risk
factors for atherosclerosis, and diabetes were then assessed by
multiple regression analysis with backward elimination.
Results The study demonstrated a signiﬁcant associa-
tion between diabetes and FDG uptake in the arterial
wall (diabetes meanSUVgluc b ¼ 0.324, meanTBRgluc
b ¼ 0.317, and SHSgluc b ¼ 0.298; for all, p < 0.0001). In
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(meanSUVgluc b ¼ 0.4, meanTBRgluc b ¼ 0.357, and
SHSgluc b ¼ 0.388; for all, p < 0.015) and smoking (mean-
TBRgluc, b ¼ 0.312; SHSgluc, b ¼ 0.324; for all, p < 0.04)
were signiﬁcantly associated with FDG uptake.
Conclusions Type 2 diabetes was signiﬁcantly associated
with carotid wall FDG uptake in patients with known or sus-
pected cardiovascular disease. In diabetic patients, obesity and
smoking add to the risk of increased FDG uptake values (87).
Myocardial Edema as Detected by Pre-Contrast
T1 and T2 CMR Delineates Area at Risk Associated
With Acute Myocardial Infarction
Objectives The aim of this study was to determine whether
cardiac magnetic resonance (CMR) in vivo T1 mapping can
measure myocardial area at risk (AAR) compared with
microspheres or T2 mapping CMR.
Background If T2-weighted CMR is abnormal in the
AAR due to edema related to myocardial ischemia, then T1-
weighted CMR should also be able to detect and accurately
quantify AAR.
Methods Dogs (n ¼ 9) underwent a 2-h coronary occlusion
followed by 4 h of reperfusion. CMR of the left ventricle was
performed for mapping of T1 and T2 prior to any contrast
administration. AAR was deﬁned as regions that had a T1 or
T2 value (ms) >2 SD from remote myocardium, and regions
with microsphere blood ﬂow (ml/min/g) during oc-
clusion <2 SD from remote myocardium. Infarct size was
determined by triphenyltetrazolium chloride staining.
Results The relaxation parameters T1 and T2 were increased
in the AAR compared with remote myocardium (mean SD:
T1, 1,133 55ms vs. 915 33ms; T2, 71 6 ms vs. 49 3
ms). On a slice-by-slice basis (n¼ 78 slices), AAR by T1 and
T2 mapping correlated (R2 ¼ 0.95, p < 0.001) with good
agreement (mean 2 SD: 0.4 16.6% of slice). On a whole-
heart analysis, T1 measurements of left ventricular mass,
AAR, and myocardial salvage correlated to microsphere
measures (R2 ¼ 0.94) with good agreement (mean  2 SD:
–1.4  11.2 g of myocardium). Corresponding T2 measure-
ments of left ventricular mass, AAR, and salvage correlated to
microsphere analysis (R2 ¼ 0.96; mean  2 SD: agreement
1.6 9.2 g of myocardium). This yielded a median infarct size
of 30% of the AAR (range 12% to 52% of AAR).
Conclusions For determining AAR after acute myocardial
infarction, noncontrastT1mapping andT2mapping sequences
yield similar quantitative results, and both agree well with
microspheres.The relaxationpropertiesT1 andT2both change
in away that is consistentwith the presence ofmyocardial edema
following myocardial ischemia/reperfusion (88).
Molecular Imaging of Fibrin Deposition in
Deep Vein Thrombosis Using Fibrin-Targeted
Near-Infrared Fluorescence
Objectives The goal of this study was to develop and
validate a new ﬁbrin-targeted imaging agent that enableshigh-resolution near-infrared ﬂuorescence (NIRF) imaging
of deep vein thrombosis (DVT).
Background NIRF imaging of ﬁbrin could enable highly
sensitive and noninvasive molecular imaging of thrombosis
syndromes in vivo.
Methods A ﬁbrin-targeted peptide was conjugated to
a near-infrared ﬂuorophore Cy7, termed FTP11-Cy7. The
NIRF peptide is based on a ﬁbrin-speciﬁc imaging agent
that has completed Phase II clinical magnetic resonance
imaging trials. In vitro binding of FTP11-Cy7 to human
plasma clots was assessed by using ﬂuorescence reﬂectance
imaging. Next, FTP11-Cy7 was intravenously injected in
mice with femoral DVT induced by topical 7.5% ferric
chloride treatment. Intravital ﬂuorescence microscopy and
noninvasive ﬂuorescence molecular tomography–computed
tomography were performed in 32 mice with DVT, followed
by histological analyses.
Results In vitro human clot-binding analyses showed
a 6-fold higher NIRF clot target-to-background ratio
(TBR) of FTP11-Cy7 than free Cy7 (6.3  0.34 vs.
1.2  0.03; p < 0.0001). The thrombus TBR of acute and
subacute femoral DVT with FTP11-Cy7 obtained by using
intravital ﬂuorescence microscopy was >400% higher than
control free Cy7. Binding of FTP11-Cy7 to thrombi was
blocked by a 100-fold excess of unlabeled competitor
peptide both in vitro and in vivo (p < 0.001 for each).
Histological analyses conﬁrmed that FTP11-Cy7 speciﬁcally
accumulated in thrombi. Noninvasive ﬂuorescence molecular
tomography–computed tomography imaging of ﬁbrin in
jugular DVT demonstrated strong NIRF signal in thrombi
compared with sham-operated jugular veins (mean TBR 3.5
 0.7 vs. 1.5  0.3; p < 0.05).
Conclusions The ﬁbrin-targeted NIRF agent FTP11-Cy7
was shown to avidly and speciﬁcally bind human and murine
thrombi, and enable sensitive, multimodal intravital and
noninvasive NIRF molecular imaging detection of acute and
subacute murine DVT in vivo (89).Feasibility and Accuracy of 3DTEE Versus CT for
the Evaluation of Aortic Valve Annulus to Left Main
Ostium Distance Before Transcatheter Aortic
Valve Implantation
Objectives The aims of this study were to analyze in a large
series of patients undergoing transcatheter aortic valve
implantation (TAVI): 1) the accuracy of 3-dimensional
transesophageal echocardiographic (3DTEE) measurement
of left coronary cusp (LCC) length and of the distances from
left main coronary ostium (LM) to the aortic annulus (AA)
pre-operatively and to the aortic prosthesis post-operatively;
and 2) the role of the 3DTEE measurements in predicting
the prosthetic deployment and the association between
prosthesis position and aortic regurgitation (AR) and/or
prosthesis-patient mismatch (PPM).
Background Coronary ostia occlusion is a possible com-
plication in TAVI; therefore, the careful pre-operative
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operative analysis of the relationship between the pros-
thesis and LM, may inﬂuence the procedural outcomes.
Even though multidetector computed tomography
(MDCT) is the gold standard pre-operatively, sometimes it
cannot be performed and it is rarely repeated post-
operatively.
Methods In 122 patients undergoing TAVI, pre-operative
AA-LM and LCC measurements obtained by 3DTEE and
MDCT were compared. Post-operatively, the feasibility of
3DTEE evaluation of the prosthesis-LM distance was
performed. The relationship between 3DTEE overlap of the
prosthesis with the anterior mitral leaﬂet and AR/PPM was
assessed.
Results Pre-operatively, 3DTEE AA-LM (r ¼ 0.83) and
LCC (r ¼ 0.69) signiﬁcantly correlated with MDCT. Post-
operatively, 3DTEE prosthesis-LM distance was 2.1  1.9
mm. The prosthesis reached or exceeded LM in 6 and 10
cases, respectively. Prosthesis overlap with mitral leaﬂet was
4.7  1.8 mm. Signiﬁcant correlation between the 3DTEE
computed and nominal length of the prosthesis was found
(r ¼ 0.61). No correlations were found between prosthesis–
mitral leaﬂet overlap and aortic regurgitation or PPM.
Conclusions AA-LM distance and LCC length may be
accurately estimated by 3DTEE, which may represent
a valid alternative to MDCT. Pre- and post-3DTEE data
concerning the aortic root, such as LM, aortic valve, and
prosthetic morphology, give new insights into TAVI and its
complications (90).
Low Quality and Lack of Clarity of Current
Informed Consent Forms in Cardiology:
How to Improve Them
Guidelines on informed consent for clinical practice exhort
physicians to use standard plain language to enhance patient
comprehension and facilitate shared decision making. The
aim of this study was to assess and improve quality and
readability of current informed consent forms used in
cardiology. We evaluated the currently used informed
consent forms, previously written in Italian and English, of 7
common imaging examinations, according to the recom-
mendations of scientiﬁc societies. For each text, we also
developed a revised informed consent form according to
reference standards, including Federal Plain Language
guidelines. Regarding readability scores, we analyzed each
text (standard and revised) with Flesch-Kincaid (F-K) grade
level (higher numbers indicating harder-to-read text) and
the Italian language-tailored Gulpease level (from 0 [difﬁ-
cult] to 100 [easy]). Overall quality and readability was poor
for both the original English and Italian versions, and
readability was improved with the revised form, with higher
readability evidenced by changes in both F-K grade level
(standard 10.2  2.37% vs. revised 6.5  0.41%; p < 0.001)
for English and Gulpease (standard 45.7  2% vs. revised
84.09  2.98%; p < 0.0001) for Italian. In conclusion,current informed consent forms are complex, incomplete,
and unreadable for the average patient. Substantial quality
improvement and higher readability scores can be achieved
with revised forms that explicitly discuss risks and are
prepared following standard recommendations of plain
writing (91).
Indications for TEE Before Cardioversion for
Atrial Fibrillation: Implications for
Appropriateness Criteria
The purpose of this study was to evaluate appropriateness of
transesophageal echocardiography (TEE) before direct
current cardioversion (DCC), investigate indications for
TEE, and analyze if indications are predictive of outcome.
According to American College of Cardiology Foundation/
American Society of Echocardiography 2011 Appropriate-
ness Criteria, TEE is appropriate in the evaluation of
patients with atrial ﬁbrillation (AF) to facilitate clinical
decision making with regards to anticoagulation and/or
DCC. However, it is unclear in which instances physicians
utilize TEE. We reviewed 671 TEE studies in 604 AF
patients (age 66  13 years, 67% male) in which TEE was
performed before DCC for left atrial thrombus (LAT)/
sludge. Studies were divided by the main indication for TEE
into the following 8 categories: 1) congestive heart failure
(CHF)/hemodynamic compromise; 2) symptomatic; 3) new
onset AF; 4) hospitalized and symptomatic; 5) high stroke
risk; 6) subtherapeutic anticoagulation; 7) miscellaneous;
and 8) inappropriate for TEE. The main indications for
TEE before DCC were symptomatic (26.4%) and CHF/
hemodynamic compromise (26.1%). We deemed 2.7% of
the studies as inappropriate. LAT/sludge was found in 8.2%
of studies. Incidence of LAT/sludge differed signiﬁcantly
between indications (p ¼ 0.0021) and the highest incidences
occurred in the high stroke risk (17.6%) and hospitalized
and symptomatic (14.1%) categories. No LAT/sludge was
found in the miscellaneous or inappropriate groups. Stroke
occurred in 2.5% (n ¼ 15) of all patients and in all groups
except for miscellaneous and inappropriate (p ¼ 0.3). TEE
is appropriately used prior to DCC for patients with the
main indications of symptomatic and CHF/hemodynamic
compromise. In a minority of studies, TEE utilization was
inappropriate. Incidence of LAT/sludge differed between
indications (92).
Normalized End-Systolic Volume and Pre-Load
Reserve Predict Ventricular Dysfunction Following
Surgery for Aortic Regurgitation Independent of
Body Size
Pre-operative end-systolic volume (ESV) is predictive of
outcome after surgery for severe aortic regurgitation. ESV is
inﬂuenced by body size and reﬂects function and afterload,
but not pre-load. Left ventricular (LV) chamber size and
function were measured in 40 patients (ages 10 to 64 years)
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and expressed as z-scores in addition to simple indexing. A
functional pre-load index, a marker of pre-load reserve, was
calculated. Independent risk factors for post-operative LV
dysfunction included higher post-operative ESV z-score
(odds ratio [OR]: 3.3, p ¼ 0.006) and lower functional pre-
load index (OR: 0.3, p ¼ 0.03). ESV per square meter had
similar power to the ESV z-score. The ESV uncorrected for
body size underestimated risk in smaller patients and over-
estimated risk in larger patients (p < 0.002). Pre-load
reserve is an independent risk factor for LV dysfunction
after aortic valve surgery in patients with severe aortic
regurgitation. Failure to correct ESV for body size intro-
duces systematic bias to risk assessment (93).Scout View X-Ray Attenuation Versus Weight-
Based Selection of Reduced Peak Tube Voltage in
Cardiac CT Angiography
Objectives The study evaluated the relationship between
cardiac computed tomography (CT) scout view x-ray
attenuation and CT image noise compared with weight or
body mass index (BMI).
Background Decreasing peak tube voltage from 120 to 100
kVp on the basis of body size reduces radiation exposure.
Methods to better predict CT image noise may lead to more
effective selection of reduced tube voltage in cardiac CT.
Methods Image quality was graded subjectively (1 [excel-
lent] to 4 [nondiagnostic]) and objectively (SD of the aortic
attenuation value) in cardiac CT angiograms (N ¼ 106)
acquired at either 100 or 120 kVp. X-ray attenuation char-
acteristics on the scout view (120 kVp, 30 mA) were
measured within a 3-cm region of interest across the chest in
the frontal x-ray. Receiver-operating characteristic curve
analysis was performed comparing scout view attenuation
versus weight and BMI in predicting CT image noise and
quality.
Results CT image noise correlated with both BMI
(r ¼ 0.40; p < 0.001) and the scout view attenuation value
(r ¼ 0.52; p < 0.001). In linear regression models with
controlling for BMI (or weight) and tube potential, scout
view attenuation was the best predictor of the CT image
noise (p < 0.001), and increased model ﬁt statistic from
0.23 to 0.41 (p model <0.001). At 120 kVp, scout view
attenuation predicted CT image noise <30 Hounsﬁeld
units (HU) more accurately than BMI (area under the
curve: 0.89 vs. 0.77). For CT images acquired at 120 kVp,
those with a scout view attenuation <120 HU had
signiﬁcantly lower noise and higher signal-to-noise ratios,
with similar mean aortic attenuation values. A majority
(89.3%) of “low-noise” CT images at 120 kVp had scout
view attenuation values of <120 HU.
Conclusions Scout view attenuation predicts cardiac CT
image noise better than weight or BMI and could enable
broader application of reduced x-ray tube voltage as a radi-
ation sparing technique (94).Aortic Valve Calcium Independently Predicts
Coronary and Cardiovascular Events in a Primary
Prevention Population
Objectives This study sought to test whether aortic valve
calcium (AVC) is independently associated with coronary and
cardiovascular events in a primary-prevention population.
Background Aortic sclerosis is associated with increased
cardiovascular morbidity and mortality among the elderly,
but the mechanisms underlying this association remain
controversial. Also, it is unknown whether this association
extends to younger individuals.
Methods We performed a prospective analysis of 6,685
participants in MESA (Multi-Ethnic Study of Atheroscle-
rosis). All subjects, ages 45 to 84 years and free of clinical
cardiovascular disease at baseline, underwent computed
tomography for AVC and coronary artery calcium scoring.
The primary, pre-speciﬁed combined endpoint of cardio-
vascular events included myocardial infarctions, fatal and
nonfatal strokes, resuscitated cardiac arrest, and cardiovas-
cular death, whereas a secondary combined endpoint of
coronary events excluded strokes. The association between
AVC and clinical events was assessed using Cox propor-
tional hazards regression with incremental adjustments for
demographics, cardiovascular risk factors, inﬂammatory
biomarkers, and subclinical coronary atherosclerosis.
Results Over a median follow-up of 5.8 years (inter-
quartile range: 5.6 to 5.9 years), adjusting for demo-
graphics and cardiovascular risk factors, subjects with AVC
(n ¼ 894, 13.4%) had higher risks of cardiovascular
(hazard ratio [HR]: 1.50; 95% conﬁdence interval [CI]:
1.10 to 2.03) and coronary (HR: 1.72; 95% CI: 1.19 to
2.49) events compared with those without AVC. Adjust-
ments for inﬂammatory biomarkers did not alter these
associations, but adjustment for coronary artery calcium
substantially attenuated both cardiovascular (HR: 1.32;
95% CI: 0.98 to 1.78) and coronary (HR: 1.41; 95%
CI: 0.98 to 2.02) event risk. AVC remained predictive of
cardiovascular mortality even after full adjustment (HR:
2.51; 95% CI: 1.22 to 5.21).
Conclusions In this MESA cohort, free of clinical
cardiovascular disease, AVC predicts cardiovascular and
coronary event risk independent of traditional risk factors
and inﬂammatory biomarkers, likely due to the strong
correlation between AVC and subclinical atherosclerosis.
The association of AVC with excess cardiovascular mortality
beyond coronary atherosclerosis risk merits further investi-
gation. (Multi-Ethnic Study of Atherosclerosis [MESA];
NCT00005487) (95).
Myocardial Oxygenation in Coronary Artery Disease:
Insights From Blood Oxygen Level–Dependent
Magnetic Resonance Imaging at 3 Tesla
Objectives The purpose of this study was to assess the
diagnostic accuracy of blood oxygen-level dependent
(BOLD) MRI in suspected coronary artery disease (CAD).
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deoxyhemoglobin, BOLD magnetic resonance imaging can
detect myocardial ischemia. We applied BOLD imaging
and ﬁrst-pass perfusion techniques to: 1) examine the
pathophysiological relationship between coronary stenosis,
perfusion, ventricular scar, and myocardial oxygenation; and
2) evaluate the diagnostic performance of BOLD imaging in
the clinical setting.
Methods BOLD and ﬁrst-pass perfusion images were
acquired at rest and stress (4 to 5 min intravenous adenosine,
140 mg/kg/min) and assessed quantitatively (using a BOLD
signal intensity index [stress/resting signal intensity], and
absolute quantiﬁcation of perfusion by model-independent
deconvolution). A BOLD signal intensity index threshold
to identify ischemic myocardium was ﬁrst determined in
a derivation arm (25 CAD patients and 20 healthy volun-
teers). To determine diagnostic performance, this was then
applied in a separate group comprising 60 patients with
suspected CAD referred for diagnostic angiography.
Results Prospective evaluation of BOLD imaging yielded an
accuracy of 84%, a sensitivity of 92%, and a speciﬁcity of 72%
for detecting myocardial ischemia and 86%, 92%, and 72%,
respectively, for identifying signiﬁcant coronary stenosis.
Segment-based analysis revealed evidence of dissociation
between oxygenation and perfusion (r ¼ 0.26), with
a weaker correlation of quantitative coronary angiography
with myocardial oxygenation (r ¼ 0.20) than with per-
fusion (r ¼ 0.40; p ¼ 0.005 for difference). Hypertension
increased the odds of an abnormal BOLD response, but
diabetes mellitus, hypercholesterolemia, and the presence
of ventricular scar were not associated with signiﬁcant
deoxygenation.
Conclusions BOLD imaging provides valuable insights
into the pathophysiology of CAD; myocardial hypo-
perfusion is not necessarily commensurate with deoxygen-
ation. In the clinical setting, BOLD imaging achieves
favorable accuracy for identifying the anatomic and func-
tional signiﬁcance of CAD (96).Head-to-Head Comparison of Left Ventricular
Function Assessment with 64-Row Computed
Tomography, Biplane Left Cineventriculography,
and Both 2- and 3-Dimensional Transthoracic
Echocardiography: Comparison With Magnetic
Resonance Imaging as the Reference Standard
Objectives This study was designed to compare the accuracy
of 64-row contrast computed tomography (CT), invasive
cineventriculography (CVG), 2-dimensional echocardiog-
raphy (2D Echo), and 3-dimensional echocardiography (3D
Echo) for left ventricular (LV) function assessment with
magnetic resonance imaging (MRI).
Background Cardiac function is an important determinant
of therapy and is a major predictor for long-term survival in
patients with coronary artery disease. A number of methods
are available for assessment of function, but there are limiteddata on the comparison between these multiple methods in
the same patients.
Methods A total of 36 patients prospectively underwent
64-row CT, CVG, 2D Echo, 3D Echo, and MRI (as the
reference standard). Global and regional LV wall motion
and ejection fraction (EF) were measured. In addition,
assessment of interobserver agreement was performed.
Results For the global EF, Bland-Altman analysis showed
signiﬁcantly higher agreement between CT and MRI
(p < 0.005, 95% conﬁdence interval: 14.2%) than for CVG
(20.2%) and 3DEcho (21.2%). Only CVG (59.5 13.9%,
p ¼ 0.03) signiﬁcantly overestimated EF in comparison with
MRI (55.6  16.0%). CT showed signiﬁcantly better agree-
ment for stroke volume than 2DEcho, 3DEcho, and CVG. In
comparison with MRI, CVGdbut not CTdsigniﬁcantly
overestimated the end-diastolic volume (p < 0.001), whereas
2D Echo and 3D Echo signiﬁcantly underestimated the EDV
(p < 0.05). There was no signiﬁcant difference in diagnostic
accuracy (range: 76% to 88%) for regional LV function
assessment between the 4 methods when compared withMRI.
Interobserver agreement for EF showed high intraclass corre-
lation for 64-rowCT,MRI, 2DEcho, and 3DEcho (intraclass
correlation coefﬁcient >0.8), whereas agreement was lower for
CVG (intraclass correlation coefﬁcient ¼ 0.58).
Conclusions 64-row CT may be more accurate than CVG,
2D Echo, and 3D Echo in comparison with MRI
as the reference standard for assessment of global LV
function (97).Performance of 3-Dimensional Echocardiography
in Measuring Left Ventricular Volumes and
Ejection Fraction: A Systematic Review and
Meta-Analysis
Objectives The primary aim of this systematic review is to
objectively evaluate the test performance characteristics of
three-dimensional echocardiography (3DE) in measuring
left ventricular (LV) volumes and ejection fraction (EF).
Background Despite its growing use in clinical laborato-
ries, the accuracy of 3DE has not been studied on a large
scale. It is unclear if this technology offers an advantage over
traditional two-dimensional (2D) methods.
Methods We searched for studies that compared LV
volumes and EF measured by 3DE and cardiac magnetic
resonance (CMR) imaging. A subset of those also compared
standard 2D methods with CMR. We used meta-analyses to
determine the overall bias and limits of agreement of LV end-
diastolic volume (EDV), end-systolic volume (ESV), and EF
measured by 3DE and 2D echocardiography (2DE).
Results Twenty-three studies (1,638 echocardiograms)
were included. The pooled biases  2 SDs for 3DE
were 19.1  34.2 ml, 10.1  29.7 ml, and 0.6
 11.8% for EDV, ESV, and EF, respectively. Nine studies
also included data from 2DE, where the pooled biases
were 48.2  55.9 ml, 27.7  45.7 ml, and 0.1  13.9%
for EDV, ESV, and EF, respectively. In this subset, the
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statistically signiﬁcant (p ¼ 0.01 for both EDV and ESV).
The difference in variance was statistically signiﬁcant
(p < 0.001) for all 3 measurements.
Conclusions Three-dimensional echocardiography under-
estimates volumes and has wide limits of agreement, but
compared with traditional 2D methods in these carefully
performed studies, 3DE is more accurate for volumes and
more precise in all 3 measurements (98).
Long-Term Follow-Up of Biopsy-Proven Viral
Myocarditis: Predictors of Mortality and
Incomplete Recovery
Objectives This study sought to evaluate the long-term
mortality in patients with viral myocarditis, and to estab-
lish the prognostic value of various clinical, functional, and
cardiovascular magnetic resonance (CMR) parameters.
Background Long-term mortality of viral myocarditis, as
well as potential risk factors for poor clinical outcome, are
widely unknown.
Methods A total of 222 consecutive patients with biopsy-
proven viral myocarditis and CMR were enrolled. A total
of 203 patients were available for clinical follow-up, and 77
patients underwent additional follow-up CMR. The median
follow-up was 4.7 years. Primary endpoints were all-cause
mortality and cardiac mortality.
Results We found a relevant long-term mortality in
myocarditis patients (19.2% all cause, 15% cardiac, and 9.9%
sudden cardiac death [SCD]). The presence of late gado-
linium enhancement (LGE) yields a hazard ratio of 8.4 for
all-cause mortality and 12.8 for cardiac mortality, indepen-
dent of clinical symptoms. This is superior to parameters like
left ventricular (LV) ejection fraction, LV end-diastolic
volume, or New York Heart Association (NYHA) func-
tional class, yielding hazard ratios between 1.0 and 3.2 for
all-cause mortality and between 1.0 and 2.2 for cardiac
mortality. No patient without LGE experienced SCD, even
if the LV was enlarged and impaired. When focusing on the
subgroup undergoing follow-up CMR, we found an initial
NYHA functional class>I as the best independent predictor
for incomplete recovery (p ¼ 0.03).
Conclusions Among our population with a wide range of
clinical symptoms, biopsy-proven viral myocarditis is asso-
ciated with a long-term mortality of up to 19.2% in 4.7 years.
In addition, the presence of LGE is the best independent
predictor of all-cause mortality and of cardiac mortality.
Furthermore, initial presentation with heart failure may be
a good predictor of incomplete long-term recovery (99).
Usefulness of Fluorine-18 Positron Emission
Tomography/Computed Tomography for
Identiﬁcation of Cardiovascular Implantable
Electronic Device Infections
Objectives This study evaluated the usefulness of ﬂuoro-
desoxyglucose marked by ﬂuorine-18 (18F-FDG) positronemission tomography (PET) and computed tomography
(CT) in patients with suspected cardiovascular implantable
electronic device (CIED) infection.
Background CIED infection is sometimes challenging to
diagnose. Because extraction is associated with signiﬁcant
morbidity/mortality, new imaging modalities to conﬁrm the
infection and its dissemination would be of clinical value.
Methods Three groups were compared. In Group A, 42
patients with suspected CIED infection underwent 18F-
FDG PET/CT. Positive PET/CT was deﬁned as abnormal
uptake along cardiac devices. Group B included 12 patients
without infection who underwent PET/CT 4 to 8 weeks
post-implant. Group C included 12 patients implanted for
>6 months without infection who underwent PET/CT for
another indication. Semi-quantitative ratio (SQR) was ob-
tained from the ratio between maximal uptake and lung
parenchyma uptake.
Results In Group A, 32 of 42 patients with suspected
CIED infection had positive PET/CT. Twenty-four
patients with positive PET/CT underwent extraction with
excellent correlation. In 7 patients with positive PET/CT, 6
were treated as superﬁcial infection with clinical resolution.
One patient with positive PET/CT but negative leukocyte
scan was considered false positive due to Dacron pouch. Ten
patients with negative-PET/CT were treated with antibi-
otics and none has relapsed at 12.9  1.9 months. In Group
B, patients had mild uptake seen at the level of the
connector. There was no abnormal uptake in Group C
patients. Median SQR was signiﬁcantly higher in Group A
(A ¼ 2.02 vs. B ¼ 1.08 vs. C ¼ 0.57; p < 0.001).
Conclusions PET/CT is useful in differentiating between
CIED infection and recent post-implant changes. It may
guide appropriate therapy (100).Impact of Aortic Regurgitation After Transcatheter
Aortic Valve Implantation: Results From the
REVIVAL Trial
Objectives Understanding the severity of aortic regurgita-
tion (AR) after transcatheter aortic valve implantation, its
impact on left ventricular (LV) structure and function, and
the structural factors associated with worsening AR could
lead to improvements in patient selection, implantation
technique, and valve design.
Background Initial studies in patients at high risk of
surgical aortic valve replacement have reported both central
valvular and paravalvular AR after transcatheter aortic valve
implantation.
Methods Transthoracic echocardiograms were quantiﬁed
from 95 patients in the REVIVAL (TRanscatheter Endo-
Vascular Implantation of VALves) trial. Transthoracic
echocardiograms were obtained before implantation of the
Edwards-Sapien valve (Edwards Lifesciences, Irvine, Cal-
ifornia) and thereafter at selected intervals. Measurements
included LV internal diameters and volumes, ejection frac-
tion, aortic valve area, and the degree of aortic regurgitation.
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calciﬁcation, as well as left ventricular outﬂow tract, aortic
annulus, and aortic root diameters were also made.
Results Eighty-four patients remained after 11 were
excluded; 26 (29.8%) died over a period of 3 years. At 24 h
post-implantation, 75% had some degree of AR, mostly
paravalvular. By 1 year, the mean AR grade increased
slightly, but not signiﬁcantly (1.1  0.8 to 1.3  0.9), and all
measures of LV structure and function improved (LV
ejection fraction, 50.7  16.1% to 59.4  14.0%). Native
aortic leaﬂet calciﬁcation and annulus diameter correlated
signiﬁcantly with the severity of AR at 1 year (p < 0.05).
Conclusions AR after transcatheter aortic valve implanta-
tion is frequent but is rarely more than mild. Although AR
progresses, it is not associated with a harmful impact on LV
structure and function over the ﬁrst year. Native valve
calciﬁcation and aortic annulus diameter inﬂuence the
degree of AR at 6 months (101).CMR Imaging Assessing Viability in Patients With
Chronic Ventricular Dysfunction Due to Coronary
Artery Disease: A Meta-Analysis of Prospective
Trials
Objectives The purpose of this study was to compare the
diagnostic accuracy of cardiac magnetic resonance (CMR)
assessing myocardial viability in patients with chronic left
ventricular (LV) dysfunction due to coronary artery disease
using 3 techniques: 1) end-diastolic wall thickness
(EDWT); 2) low-dose dobutamine (LDD); and 3) contrast
delayed enhancement (DE).
Background CMR has been proposed to assess myocardial
viability over the past decade. However, the best CMR
strategy to evaluate patients being contemplated for revas-
cularization has not yet been determined. Some centers
advocate DE CMR due to its high sensitivity to identify
scar, whereas others favor the use of LDD CMR for its
ability to identify contractile reserve.
Methods A systematic review of MEDLINE, Cochrane,
and Embase for all the prospective trials assessing myocar-
dial viability in subjects with chronic LV dysfunction using
CMR was performed using a standard approach for meta-
analysis for diagnostic tests and a bivariate analysis of
sensitivity, speciﬁcity, positive predictive value (PPV), and
negative predictive value (NPV).
Results A total of 24 studies of CMR evaluating myocardial
viability with 698 patients fulﬁlled the inclusion criteria.
Eleven studies used DE, 9 studies used LDD, and 4 studies
used EDWT. Our meta-analysis indicates that among CMR
methods, DE CMR provides the highest sensitivity as well as
the highest NPV (95% and 90%, respectively) for predicting
improved segmental LV contractile function after revascu-
larization, followed by EDWT CMR, whereas LDD CMR
demonstrated the lowest sensitivity/NPV among all modali-
ties. On the other hand, LDD CMR offered the highest
speciﬁcity and PPV (91% and 93%, respectively), followed byDE CMR, whereas EDWT showed the lowest of these
parameters.
Conclusions DE CMR provides the highest sensitivity
and NPV, whereas LDD CMR provides the best speci-
ﬁcity and PPV. In light of these ﬁndings, integrating these
2 methods should provide increased accuracy in evaluating
patients with chronic LV dysfunction being considered for
revascularization (102).
Diagnostic Performance of CMR Imaging
Compared With EMB in Patients With
Suspected Myocarditis
Objectives The goal of this study was to assess the diagnostic
performance of cardiac magnetic resonance (CMR) compared
with endomyocardial biopsy in patients with suspected acute
myocarditis (AMC) and chronic myocarditis (CMC).
Background Several studies have reported an encouraging
diagnostic performance of CMR in myocarditis. However,
the comparison of CMR with clinical data only and the use
of preselected patient populations are important limitations
of the majority of these reports.
Methods One hundred thirty-two consecutive patients with
suspected AMC (deﬁned by symptoms14 days; n¼ 70) and
CMC (deﬁned by symptoms>14 days; n¼ 62) were included.
Patients underwent cardiac catheterization with left ventricular
endomyocardial biopsy and CMR, including T2-weighted
imaging for assessment of edema, T1-weighted imaging
before and after contrast administration for evaluation of
hyperemia, and assessment of late gadolinium enhancement.
CMR results were considered to be consistent with the diag-
nosis of myocarditis if 2 of 3 CMR techniques were positive.
Results Within the total population, myocarditis was the
most common diagnosis on endomyocardial biopsy analysis
(62.9%). Viral genomes were detected in 30.3% (40 of 132) of
patients within the total patient population and signiﬁcantly
more often in patients with AMC than CMC (40.0% vs.
19.4%; p ¼ 0.013). For the overall cohort of patients with
either suspected AMC or CMC, the diagnostic sensitivity,
speciﬁcity, and accuracy of CMR were 76%, 54%, and 68%,
respectively. The best diagnostic performance was observed in
patients with suspected AMC (sensitivity, 81%; speciﬁcity,
71%; and accuracy, 79%). In contrast, diagnostic performance
of CMR in suspected CMC was found to be unsatisfactory
(sensitivity, 63%; speciﬁcity, 40%; and accuracy, 52%).
Conclusions The results of this study underline the
usefulness of CMR in patients with suspected AMC. In
contrast, the diagnostic performance of CMR in patients
with suspected CMC might not be sufﬁcient to guide
clinical management (103).
Feasibility of [18F]-2-Fluoro-A85380-PET Imaging
of Human Vascular Nicotinic Acetylcholine
Receptors In Vivo
Objectives The aim of this feasibility study was to evaluate
[18F]-2-Fluoro-A85380 for in vivo imaging of arterial
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Furthermore, potentially different vascular uptake patterns
of this new tracer were evaluated in healthy volunteers and in
patients with neurodegenerative disorders.
Background [18F]-2-Fluoro-A85380 was developed for
in vivo positron emission tomography (PET) imaging of
nAChR subunits in the human brain. These nAChRs are
also found in arteries and seem to mediate the deleterious
effects of nicotine as a part of tobacco smoke in the vascu-
lature. It has been previously shown that uptake patterns of
the radiotracer in the brain differs in patients with neuro-
degenerative disorders compared with healthy controls.
Methods [18F]-2-Fluoro-A85380 uptake was quantiﬁed in
the ascending and descending aorta, the aortic arch, and the
carotids in 5 healthy volunteers and in 6 patients with either
Parkinson’s disease or multiple system atrophy, respectively,
as the maximum target-to-background ratio. The maximal
standardized uptake value values, the single hottest segment,
and the percent active segments of the [18F]-2-Fluoro-
A85380 uptake in the arteries were also assessed.
Results [18F]-2-Fluoro-A85380 uptake was clearly visu-
alized and maximum target-to-background ratio uptake
values corrected for the background activity of the tracer
showed speciﬁc tracer uptake in the arterial walls. Signiﬁ-
cantly higher uptake values were found in the descending
aorta. Comparison between volunteers and patients revealed
signiﬁcant differences, with lower [18F]-2-Fluoro-A85380
uptake in the patient group when comparing single arterial
territories but not when all arterial territories were pooled
together.
Conclusions [18F]-2-Fluoro-A85380 can provide speciﬁc
information on the nAChR distribution in human arteries.
Vascular nAChR density seems to be lower in patients with
Parkinson’s disease or multiple system atrophy. Once
conﬁrmed in larger study populations and in the experi-
mental setting, this approach might provide insights into the
pathogenic role of nAChRs in the human vasculature (104).Image Quality and Radiation Exposure With
Prospectively ECG-Triggered Axial Scanning for
Coronary CT Angiography: The Multicenter,
Multivendor, Randomized PROTECTION-III Study
Objectives The purpose of this study was to evaluate image
quality and radiation dose using a prospectively electrocar-
diogram (ECG)–triggered axial scan protocol compared
with standard retrospective ECG-gated helical scanning for
coronary computed tomography angiography.
Background Concerns have been raised regarding radiation
exposure during coronary computed tomography angiog-
raphy. Although the use of prospectively ECG-triggered
axial scan protocols may effectively lower radiation dose
compared with helical scanning, it is unknown whether
image quality is maintained in a clinical setting.
Methods In a prospective, multicenter, multivendor tr-
ial, 400 patients with low and stable heart rates wererandomized to either an axial or a helical coronary computed
tomography angiography scan protocol. The primary end-
point was to demonstrate noninferiority in image quality
with the axial scan protocol, which was assessed on a 4-point
scale (1 ¼ nondiagnostic, 4 ¼ excellent image quality). Se-
condary endpoints included radiation dose and the rate of
downstream testing during 30-day follow-up.
Results Image quality in patients scanned with the axial
scan protocol (score 3.36  0.59) was not inferior compared
with helical scan protocols (3.37  0.59) (p for non-
inferiority <0.004). Axial scanning was associated with
a 69% reduction in radiation exposure (dose-length product
[estimated effective dose] 252  147 mGy $ cm [3.5  2.1
mSv] vs. 802  419 mGy $ cm [11.2  5.9 mSv] for axial
vs. helical scan protocols, p < 0.001). The rate of down-
stream testing did not differ (13.8% vs. 15.9% for axial vs.
helical scan protocols, p ¼ 0.555).
Conclusions In patients with stable and low heart rates, the
prospectively ECG-triggered axial scan protocol maintained
image quality but reduced radiation exposure by 69%
compared with helical scanning. Axial computed tomog-
raphy data acquisition should be strongly recommended in
suitable patients to avoid unnecessarily high radiation
exposure. (Prospective Randomized Trial on Radiation
Dose Estimates of CT Angiography in Patients Scanned
With a Sequential Scan Protocol [PROTECTION-III];
NCT00612092) (105).Targeted Left Ventricular Lead Placement to Guide
Cardiac Resynchronization Therapy: The TARGET
Study: A Randomized, Controlled Trial
Objectives This study sought to assess the impact of tar-
geted left ventricular (LV) lead placement on outcomes of
cardiac resynchronization therapy (CRT).
Background Placement of the LV lead to the latest sites of
contraction and away from the scar confers the best response to
CRT.We conducted a randomized, controlled trial to compare
a targeted approach to LV lead placement with usual care.
Methods A total of 220 patients scheduled for CRT
underwent baseline echocardiographic speckle-tracking 2-
dimensional radial strain imaging and were then random-
ized 1:1 into 2 groups. In group 1 (TARGET [Targeted
Left Ventricular Lead Placement to Guide Cardiac
Resynchronization Therapy]), the LV lead was positioned at
the latest site of peak contraction with an amplitude of
>10% to signify freedom from scar. In group 2 (control)
patients underwent standard unguided CRT. Patients were
classiﬁed by the relationship of the LV lead to the optimal
site as concordant (at optimal site), adjacent (within 1
segment), or remote (2 segments away). The primary
endpoint was a 15% reduction in LV end-systolic volume
at 6 months. Secondary endpoints were clinical response
(1 improvement in New York Heart Association func-
tional class), all-cause mortality, and combined all-cause
mortality and heart failure–related hospitalization.
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TARGET group, there was a greater proportion of
responders at 6 months (70% vs. 55%, p ¼ 0.031), giving an
absolute difference in the primary endpoint of 15% (95%
conﬁdence interval: 2% to 28%). Compared with controls,
TARGET patients had a higher clinical response (83% vs.
65%, p ¼ 0.003) and lower rates of the combined endpoint
(log-rank test, p ¼ 0.031).
Conclusions Compared with standard CRT treatment, the
use of speckle-tracking echocardiography to the target LV
lead placement yields signiﬁcantly improved response and
clinical status and lower rates of combined death and heart
failure–related hospitalization. (Targeted Left Ventricular
Lead Placement to Guide Cardiac Resynchronization
Therapy [TARGET] study); ISRCTN19717943) (106).Coronary Arterial 18F-Sodium Fluoride Uptake:
A Novel Marker of Plaque Biology
Objectives With combined positron emission tomography
and computed tomography (CT), we investigated coronary
arterial uptake of 18F-sodium ﬂuoride (18F-NaF) and 18F-
ﬂuorodeoxyglucose (18F-FDG) as markers of active plaque
calciﬁcation and inﬂammation, respectively.
Background The noninvasive assessment of coronary artery
plaque biology would be a major advance particularly in the
identiﬁcation of vulnerable plaques, which are associated
with speciﬁc pathological characteristics, including micro-
calciﬁcation and inﬂammation.
Methods We prospectively recruited 119 volunteers
(72  8 years of age, 68% men) with and without aortic
valve disease and measured their coronary calcium score and
18F-NaF and 18F-FDG uptake. Patients with a calcium
score of 0 were used as control subjects and compared with
those with calciﬁc atherosclerosis (calcium score >0).
Results Inter-observer repeatability of coronary 18F-NaF
uptake measurements (maximum tissue/background ratio)
was excellent (intra-class coefﬁcient 0.99). Activity was
higher in patients with coronary atherosclerosis (n ¼ 106)
versus control subjects (1.64  0.49 vs. 1.23  0.24;
p ¼ 0.003) and correlated with the calcium score (r ¼ 0.652,
p < 0.001), although 40% of those with scores >1,000
displayed normal uptake. Patients with increased coronary
18F-NaF activity (n ¼ 40) had higher rates of prior
cardiovascular events (p ¼ 0.016) and angina (p ¼ 0.023)
and higher Framingham risk scores (p ¼ 0.011). Quantiﬁ-
cation of coronary 18F-FDG uptake was hampered by
myocardial activity and was not increased in patients with
atherosclerosis versus control subjects (p ¼ 0.498).
Conclusions 18F-NaF is a promising new approach for the
assessment of coronary artery plaque biology. Prospective
studies with clinical outcomes are now needed to assess
whether coronary 18F-NaF uptake represents a novel
marker of plaque vulnerability, recent plaque rupture, and
future cardiovascular risk. (An Observational PET/CT
Study Examining the Role of Active Valvular Calciﬁcationand Inﬂammation in Patients With Aortic Stenosis;
NCT01358513) (107).
The PROFI Study (Prevention of Cerebral
Embolization by Proximal Balloon Occlusion
Compared to Filter Protection During Carotid
Artery Stenting): A Prospective Randomized Trial
Objectives The objective of this study was to compare the
cerebral embolic load of ﬁlter-protected versus proximal
balloon–protected carotid artery stenting (CAS).
Background Randomized trials comparing ﬁlter-protected
CAS with carotid endarterectomy revealed a higher peri-
procedural stroke rate after CAS. Proximal balloon occlusion
may be more effective in preventing cerebral embolization
during CAS than ﬁlters.
Methods Patients undergoing CAS with cerebral embolic
protection for internal carotid artery stenosis were randomly
assigned to proximal balloon occlusion or ﬁlter protection.
The primary endpoint was the incidence of new cerebral
ischemic lesions assessed by diffusion-weighted magnetic
resonance imaging. Secondary endpoints were the number
and volume of new ischemic lesions and major adverse
cardiovascular and cerebral events (MACCE).
Results Sixty-two consecutive patients (mean age: 71.7
years, 76.4% male) were randomized. Compared with ﬁlter
protection (n ¼ 31), proximal balloon occlusion (n ¼ 31)
resulted in a signiﬁcant reduction in the incidence of new
cerebral ischemic lesions (45.2% vs. 87.1%, p ¼ 0.001). The
number (median [range]: 2 [0 to 13] vs. 0 [0 to 4],
p ¼ 0.0001) and the volume (0.47 [0 to 2.4] cm3 vs. 0 [0 to
0.84] cm3, p ¼ 0.0001) of new cerebral ischemic lesions
were signiﬁcantly reduced by proximal balloon occlusion.
Lesions in the contralateral hemisphere were found in 29.0%
and 6.5% of patients (ﬁlter vs. balloon occlusion, respec-
tively, p ¼ 0.047). The 30-day MACCE rate was 3.2% and
0% for ﬁlter versus balloon occlusion, respectively (p ¼ NS).
Conclusions In this randomized trial of patients under-
going CAS, proximal balloon occlusion as compared with
ﬁlter protection signiﬁcantly reduced the embolic load to the
brain (108).
Differences in Neointimal Thickness Between the
Adluminal and the Abluminal Sides of Malapposed
andSide-BranchStruts in a Polylactide Bioresorbable
Scaffold: Evidence In Vivo About the Abluminal
Healing Process
Objectives The goal of this study was to describe the
neointimal healing on the abluminal side (ABL) of malap-
posed (ISA) struts and nonapposed side-branch (NASB)
struts in terms of coverage by optical coherence tomography
(OCT) and in comparison with the adluminal side (ADL).
Background The neointimal healing on the ABL of ISA
and NASB struts has never to our knowledge been explored
in vivo and could be involved in the correction of acute
malapposition. The bioresorbable vascular scaffold (BVS) is
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ABL with OCT.
Methods Patients enrolled in the ABSORB B (ABSORB
Clinical Investigation Cohort B) study were treated with
implantation of a BVS and imaged with OCT at 6 months.
Thickness of coverage on the ADL and ABL of ISA and
NASB struts was measured by OCT.
Results Twenty-eight patients were analyzed; 114 (2.4%)
struts were malapposed or at side branches. In 76 ISA struts
(89.4%) and 29 NASB struts (100%), the thickness of ABL
coverage was >30 mm. Coverage was thicker on the ABL
than on the ADL side (101 vs. 71 mm; 95% conﬁdence
interval [CI] of the difference: 20 to 40 mm). In 70 struts
(60.7%, 95% CI: 50.6% to 70.0%), the neointimal coverage
was thicker on the ABL, versus only 20 struts (18.5%, 95%
CI: 11.6% to 28.1%) with thicker neointimal coverage on
the ADL side (odds ratio: 3.35, 95% CI: 2.22 to 5.07).
Conclusions Most of the malapposed and side-branch
struts are covered on the ABL side 6 months after BVS
implantation, with thicker neointimal coverage than on the
ADL side. The physiological correction of acute malap-
position involves neointimal growth from the strut to the
vessel wall or bidirectional.(ABSORB Clinical Investigation,
Cohort B [ABSORB B]; NCT00856856) (109).Femoral Plaque Echogenicity and Cardiovascular
Risk in Claudicants
Objectives The present study was designed to verify
whether the evaluation of femoral plaque echogenicity might
be a useful tool for cardiovascular risk assessment in patients
affected by lower extremity peripheral arterial disease.
Background Lower extremity peripheral arterial disease is
a common manifestation of atherosclerosis and is associated
with a high risk of developing major cardiovascular events.
Vulnerable atherosclerotic plaque plays a central role in the
occurrence of acute ischemic events in different vascular
territories. Furthermore, atherosclerosis is a systemic disease,
and the presence of an unstable atherosclerotic plaque in
a certain vascular district, characterized by low echogenicity
at B-mode ultrasound, is associated to a greater prevalence of
unstable plaques in other vascular beds.
Methods Femoral plaque echogenicity of 246 claudicants
with ankle/brachial index 0.90 was evaluated at B-mode
ultrasound by visual analysis and by calculating the grayscale
median (GSM) value. In these patients, the occurrence of
myocardial infarction and stroke was prospectively assessed.
Results Femoral GSM values and plaque types assessed by
visual analysis were highly correlated by Spearman analysis
(rho ¼ 0.905, p < 0.001). During a median follow-up of 30
months, 32 patients (13%) had a major cardiovascular event.
Compared with patients without events, those who experi-
enced an event during the follow-up had a lower femoral
plaque GSM value (42.9  26.2 vs. 58.8  19.3, p ¼ 0.002)
and a higher prevalence of hypoechoic femoral plaque at
visual analysis (68.8% vs. 19.6%, p < 0.001). At Coxanalysis, femoral GSM showed an inverse relationship with
cardiovascular risk, even after adjustment for possible
confounders (hazard ratio: 0.96, 95% conﬁdence interval
[CI]: 0.95 to 0.98, p < 0.001). Furthermore, patients with
hypoechoic femoral plaques at visual analysis had a 7.24-fold
increased cardiovascular risk compared with patients with
hyperechoic plaques after adjustment for possible
confounders (95% CI: 3.23 to 16.22, p < 0.001).
Conclusions This study demonstrates that the presence of
hypoechoic atherosclerotic femoral plaques is associated with
higher cardiovascular risk in lower extremity peripheral
arterial disease patients (110).Prevalence of Nonstenosing, Complicated
Atherosclerotic Plaques in Cryptogenic Stroke
Objectives Our goal was to assess the prevalence of
complicated American Heart Association (AHA) lesion type
VI plaques in the carotid arteries of patients with crypto-
genic stroke.
Background In up to 40% of ischemic stroke patients, no
deﬁnite cause can be established despite extensive workup
(i.e., cryptogenic stroke). To test the hypothesis if non-
stenosing complicated carotid plaques may be the underlying
etiology in some of these patients, we used high-resolution
black-blood carotid magnetic resonance imaging (MRI),
which can quantitatively assess plaque composition and
morphology with good correlation to histopathology.
Speciﬁcally, we focused on AHA type VI plaques, which are
characterized by hemorrhage, thrombus, or ﬁbrous cap
rupture.
Methods Thirty-two consecutive patients (22 male; mean
age 71.7  11.9 years) with cryptogenic stroke and non-
stenosing (<50%) eccentric carotid plaques were recruited
from a single stroke unit. All patients underwent extensive
clinical workup (brain MRI, duplex sonography, electro-
cardiography and Holter monitoring, transthoracic and
transesophageal echocardiography, and laboratory investi-
gations) to exclude other causes of stroke. All patients
received a black-blood carotid MRI at 3-T with fat-
saturated pre- and post-contrast T-1–, proton density–,
and T-2–weighted and time-of-ﬂight images using surface
coils and parallel imaging techniques. Prevalence of AHA
type VI plaque was determined in both carotid arteries on
the basis of previously published MRI criteria.
Results AHA type VI plaques were found in 12 of 32
arteries (37.5%) ipsilateral to the stroke, whereas there were
no AHA type VI plaques contralateral to the stroke
(p ¼ 0.001). The most common diagnostic feature of AHA
type VI plaques was intraplaque hemorrhage (75%), fol-
lowed by ﬁbrous plaque rupture (50%) and luminal
thrombus (33%).
Conclusions This pilot study suggests that arterio-arterial
embolism from complicated, nonstenosing carotid athero-
sclerotic plaques may play a role in a subgroup of patients
previously diagnosed with cryptogenic stroke. To further
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togenic stroke, future studies will have to analyze both
clinical and imaging follow-up data, including event rates for
secondary strokes (111).
Role of FDG PET-CT in Takayasu Arteritis:
Sensitive Detection of Recurrences
Objectives The aim of this study was to investigate
whether the maximum standardized uptake value (max
SUV) of 18F-ﬂuorodeoxyglucose (FDG)-positron emission
tomography (PET)/computed tomography (CT) provides
a quantitative indication of disease activity in Takayasu
arteritis (TA) cases.
Background The clinical value of FDG-PET for assessing
TA has been investigated. Clinical evaluation of disease
activity is often difﬁcult, because most patients develop rec-
urrent inﬂammation while receiving corticosteroid treatment.
Methods Thirty-nine TA patients underwent FDG-PET/
CT at Tokyo Medical and Dental University from 2006 to
2010 (35 women and 4 men; median age, 30 years). Disease
activity was deﬁned according to National Institutes of
Health criteria. Biomarkers including C-reactive protein and
erythrocyte sedimentation rate were measured. Forty sub-
jects without vasculitis served as control subjects.
Results The max SUV was signiﬁcantly higher in active
than in inactive cases and control subjects (active [n ¼ 27],
median value, 2.7 vs. inactive [n ¼ 12], 1.9; control [n ¼
40], 1.8; p < 0.001 each). Given a max SUV cutoff of 2.1,
sensitivity for active-phase TA was 92.6%, speciﬁcity 91.7%,
positive predictive value 96.2%, and negative predictive value
84.6%. In receiver-operating characteristic curves compar-
ison, max SUV was superior to C-reactive protein (p < 0.05)
and erythrocyte sedimentation rate (p < 0.05). Max SUV
was signiﬁcantly higher in relapsing on treatment cases
(n ¼ 17) than in stable on treatment cases (n ¼ 12) (median
value, 2.6 vs. 1.9; p < 0.001).
Conclusions FDG-PET/CT is useful for detection of
active inﬂammation not only in patients with active TA
before treatment but also in relapsing patients receiving
immunosuppressive agents. The max SUV is useful for
assessing subtle activity of TA with high sensitivity (112).
Inﬂuence of Chronic Tethering of the Mitral Valve
on Mitral Leaﬂet Size and Coaptation in Functional
Mitral Regurgitation
Objectives The purposes of this study were to examine
whether tethering of the mitral leaﬂets affects coaptation in
patients with functional mitral regurgitation (FMR) and to
assess the interaction between the mitral coaptation and
mitral regurgitation severity.
Background Functional mitral regurgitation causes res-
triction of leaﬂet closure as a result of enhanced tethering of
the mitral leaﬂets and papillary muscle (PM) displacement.
Methods Three-dimensional transesophageal echocardi-
ography was performed in 44 patients with FMR related tothe bilateral PM displacement and in 56 controls. The
distance between the tip of the anterior or posterior PM and
the intervalvular ﬁbrosa were measured as the lateral or
medial tethering length (TL) in midsystole. To evaluate the
degree of coaptation, coaptation length (CL) at medial,
middle, and lateral sites of mitral valve and an estimate of
coaptation area (CA) were measured.
Results The FMR group showed the signiﬁcantly
decreased CA (1.3  0.4 cm2 vs. 1.6  0.4 cm2, p ¼ 0.005)
and CL (medial 3.2  0.9 mm vs. 4.8  0.6 mm, middle 3.8
 1.3 mm vs. 5.8  0.7 mm, lateral 3.3  0.9 mm vs.
4.8  0.6 mm; all p < 0.0001) compared with the controls.
Each CL correlated negatively and signiﬁcantly with both
medial and lateral TL (all p < 0.0001). Annular area
(p ¼ 0.004) was signiﬁcantly smaller and leaﬂet-to-annular
area ratio (p < 0.0001) was signiﬁcantly larger in patients
with nonsigniﬁcant FMR than in the patients with signiﬁ-
cant (moderate to severe) FMR. Signiﬁcant correlations
were found between effective regurgitant oriﬁce area and CA
or each CL (all p < 0.0001).
Conclusions Coaptation decreased signiﬁcantly in patients
with FMR. The CL at each region was related to PM
displacement and the indexes of coaptation were associated
with mitral regurgitation severity (113).Plaque Features Associated With Increased
Cerebral Infarction After Minor Stroke and TIA:
A Prospective, Case-Control, 3-T Carotid Artery
MR Imaging Study
Objectives The goal of this study was to determine whether
a 3-T magnetic resonance imaging (MRI) protocol
combining carotid atherosclerotic plaque and brain imaging
can identify features of high-risk acutely symptomatic plaque
that correlate with brain injury.
Background It has previously been demonstrated that, in
asymptomatic patients, MRI can identify features of carotid
plaque that are associated with stroke, such as the presence
of a large lipid core. We hypothesized that the early phase
(<7 days) after a cerebrovascular event, when risk of recur-
rence is highest, may be associated with particular plaque
characteristics that associate with cerebral injury.
Methods Eighty-one patients (41 presenting acutely with
transient ischemic attack [TIA] or minor stroke and 40
asymptomatic controls) underwent multicontrast carotid
artery MRI on 2 separate occasions, each accompanied by
diffusion-weighted imaging (DWI) and ﬂuid-attenuated
inversion recovery (FLAIR) imaging of the brain.
Results Complex (American Heart Association [AHA]
type VI) plaques were seen in 22 of 41 patients (54%) in the
symptomatic group versus 8 of 40 (20%) in the asymp-
tomatic group (p < 0.05). They were caused by intraplaque
hemorrhage (34% vs. 18%; p ¼ 0.08), surface rupture (24%
vs. 5%; p ¼ 0.03), or luminal thrombus (7% vs. 0%;
p ¼ 0.24). Noticeably, 17 of 30 (57%) cases of AHA type VI
plaque were in vessels with <70% stenosis. At follow-up
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AHA type VI plaque showed evidence of full healing. The
presence of ﬁbrous cap rupture was associated with higher
DWI brain injury at presentation and higher total cerebral
FLAIR signal at follow-up (p < 0.05).
Conclusions Early carotid wall MRI in patients experi-
encing minor stroke or TIA showed a higher proportion of
“complex” plaques compared with asymptomatic controls;
a majority were in arteries of <70% stenosis. Fibrous cap
rupture was associated with increases in DWI and FLAIR
lesions in the brain. Combined carotid plaque and brain
MRI may aid risk stratiﬁcation and treatment selection in
acute stroke and TIA (114).Molecular Imaging of Human ACE-1 Expression in
Transgenic Rats
Objectives The aim of this study was to develop a molec-
ular imaging strategy that can monitor myocardial
angiotensin-converting enzyme (ACE)-1 upregulation as
a function of progressive heart failure.
Background High-afﬁnity technetium-99m–labeled lisi-
nopril (Tc-Lis) has been shown to speciﬁcally localize in
tissues that express ACE in vivo, such as the lungs. Whether
Tc-Lis can also detect upregulation of ACE in the heart, by
external in vivo imaging, has not been established.
Methods Twenty-one ACE-1 over-expressing transgenic
(Tg) and 18 wild-type control rats were imaged using in vivo
micro single-positron emission computed tomography
(SPECT)-computed tomography (CT) at 10, 30, 60, and 120
min after Tc-Lis injection. A subgroup of rats received non-
radiolabeled (cold) lisinopril before the Tc-Lis injection to
evaluate nonspeciﬁc binding. After imaging, the rat myocar-
dium was explanted, ex vivo images were acquired, and percent
injected dose per gram gamma-well was counted, followed by
an assessment of enzyme-linked immunosorbent assay-veriﬁed
ACE activity and messenger ribonucleic acid expression.
Results On micro SPECT-CT, myocardial ACE-1 uptake
was best visualized in Tg rats at 120 min after Tc-Lis
injection. The quantitative uptake of Tc-Lis in the
myocardium was 5-fold higher in mutant Tg than in control
rats at each time point after tracer injection. The percent
injected dose per gram uptake was 0.74  0.13 in Tg
myocardium at 30 min and was reduced substantially to
0.034  0.003% when pre-treated with cold lisinopril
(p ¼ 0.029). Enzyme activity assay showed a >30-fold
higher level of ACE-1 activity in the myocardium of Tg
rats than in controls. The ACE-1 messenger ribonucleic
acid was quantiﬁed, and lisinopril was found to have no
effect on ACE-1 gene expression.
Conclusions The Tc-Lis binds speciﬁcally to ACE, and the
activity can be localized in Tg rat hearts that over-express
human ACE-1 with a signal intensity that is sufﬁciently
high to allow external imaging. Such a molecular imaging
strategy may help identify susceptibility to heart failure and
may allow optimization of pharmacologic intervention (115).RV Dysfunction In Pulmonary Hypertension Is
Independently Related To Pulmonary Artery
Stiffness
Objectives This study investigated whether right ventric-
ular (RV) adaptation to chronic pressure overload is asso-
ciated with pulmonary artery (PA) stiffness beyond the
degree of severity of pulmonary hypertension (PH).
Background Increased PA stiffness has been associated
with reduced survival in PH. The mechanisms for this
association remain unclear.
Methods Right heart catheterization and cardiac magnetic
resonance were performed within 1 week in 124 patients
with known or suspected chronic PH. Pulmonary vascular
resistance index (PVRI) and PA pressures were quantiﬁed
from right heart catheterization. Cardiac magnetic resonance
included standard biventricular cine sequences and main PA
ﬂow quantiﬁcation with phase-contrast imaging. Indexes of
PA stiffness (elasticity, distensibility, capacitance, stiffness
index beta, and pulse pressure) were quantiﬁed combining
right heart catheterization and cardiac magnetic resonance
data. RV performance and adaptation were measured by RV
ejection fraction, right ventricular mass index (RVMI), RV
end-systolic volume index, and right ventricular stroke work
index (RVSWI).
Results All indexes of PA stiffness were signiﬁcantly corre-
lated with measures of RV performance (Spearman rho coef-
ﬁcients ranging from 0.20 to 0.61, p < 0.05). Using
multivariate regression analysis, PA elasticity, distensibility,
and index beta were independently associated with all mea-
sures of RV performance after adjusting PVRI (p  0.024).
PA capacitance was independently associated with RV ejection
fraction, RVMI, and RVSWI (p < 0.05), whereas PA pulse
pressure was associated with RVMI and RVSWI (p 0.027).
Compared with PVRI, PA elasticity, distensibility, capaci-
tance, and index beta explained 15% to 68% of the variability in
RV ejection fraction, RVMI, and RV end-systolic volume
index. Relative contributions of PA stiffness for RVSWI were
1.2 to 18.0 higher than those of PVRI.
Conclusions PA stiffness is independently associated with
the degree of RV dysfunction, dilation, and hypertrophy in
PH. RV adaptation to chronic pressure overload is related
not only to the levels of vascular resistance (steady afterload),
but also to PA stiffness (pulsatile load) (116).
Prognostic Value of Late Gadolinium Enhancement
in Clinical Outcomes for Hypertrophic
Cardiomyopathy
Objectives The objective of this study was to perform
a systematic review and meta-analysis of the predictive value
of late gadolinium enhancement (LGE) cardiac magnetic
resonance (CMR) for future cardiovascular events and death
in hypertrophic cardiomyopathy (HCM).
Background The utility of LGE for detecting myocardial
ﬁbrosis is well established. The prognostic value of LGE in
HCM has been described in several studies, but controversy
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future events.
Methods We searched multiple databases including PubMed
for studies of LGE in HCM that reported selected clinical
outcomes (cardiovascular mortality, sudden cardiac death
[SCD], aborted SCD, and heart failure death). We performed
a systematic review of the literature and meta-analysis to
determine pooled odds ratios for these clinical events.
Results Four studies evaluated 1,063 patients over an average
follow-up of 3.1 years. The pooled prevalence of LGE was
60%. The pooled odds ratios (OR) demonstrate that LGE by
CMR correlated with cardiac death (pooled OR: 2.92, 95%
conﬁdence interval [CI]: 1.01 to 8.42; p¼ 0.047), heart failure
death (pooled OR: 5.68, 95% CI: 1.04 to 31.07; p ¼ 0.045),
and all-cause mortality (pooled OR: 4.46, 95% CI: 1.53 to
13.01; p¼ 0.006), and showed a trend toward signiﬁcance for
predicting sudden death/aborted sudden death (pooled OR:
2.39, 95% CI: 0.87 to 6.58; p ¼ 0.091).
Conclusions Late gadolinium enhancement by CMR has
prognostic value in predicting adverse cardiovascular events
among HCM patients. There are signiﬁcant relationships
between LGE and cardiovascular mortality, heart failure
death, and all-cause mortality in HCM. Additionally, LGE
and SCD/aborted SCD displayed a trend toward signiﬁ-
cance. The assessment of LGE by CMR has the potential to
provide important information to improve risk stratiﬁcation
in HCM in clinical practice (117).
A Practical Guide to Multimodality Imaging of
Transcatheter Aortic Valve Replacement
The advent of transcatheter aortic valve replacement (TAVR)
is one of the most widely anticipated advances in the care of
patients with severe aortic stenosis. This procedure is unique in
many ways, one of which is the need for a multimodality
imaging team-based approach throughout the continuum of
the care of TAVR patients. Pre-procedural planning, intra-
procedural implantation optimization, and long-term follow-
up of patients undergoing TAVR require the expert use of
various imagingmodalities, each of which has its own strengths
and limitations. Divided into 3 sections (pre-procedural,
intraprocedural, and long-term follow-up), this review offers
a single source for expert opinion and evidence-based guidance
on how to incorporate the various modalities at each step in the
care of a TAVR patient. Although much has been learned in
the short span of time since TAVR was introduced, recom-
mendations are offered for clinically relevant research that will
lead to reﬁnement of best practice strategies for incorporating
multimodality imaging into TAVR patient care (118).
Integrating Noninvasive Absolute Flow, Coronary
Flow Reserve, and Ischemic Thresholds Into
a Comprehensive Map of Physiological Severity
Noninvasive, absolute myocardial perfusion and coronary ﬂow
reserve (CFR) can be imaged by many techniques. However,such data must be interpreted for clinical application
regardless of its source. Currently, no guide exists
for physiological integration. Therefore, we propose 2-
dimensional scatter plots of stress ﬂow and CFR with
superimposed thresholds for normal ﬂow, reduced ﬂow
without ischemia, deﬁnite ischemia, and transmural infarction
to allow for automatic and objective classiﬁcation. Application
of this schema to 1,500 studies demonstrates that ﬂow
capacity relates inversely to risk factors and atherosclerotic
burden. Interpreting stress ﬂow to make clinical decisions
requires rest ﬂow or CFR for broad application to all patients.
Although relative uptake images alone are adequate for some
patients, it can either under- or over-estimate ﬂow capacity in
many persons. Our standardized framework could prompt
future studies leading to a trial of revascularization guided by
absolute ﬂow measurement (119).Consensus Standards for Acquisition,
Measurement, and Reporting of Intravascular
Optical Coherence Tomography Studies: A Report
From the International Working Group for
Intravascular Optical Coherence Tomography
Standardization and Validation
Objectives The purpose of this document is to make the
output of the International Working Group for Intravascular
Optical Coherence Tomography (IWG-IVOCT) Stan-
dardization and Validation available to medical and scientiﬁc
communities, through a peer-reviewed publication, in the
interest of improving the diagnosis and treatment of patients
with atherosclerosis, including coronary artery disease.
Background Intravascular optical coherence tomography
(IVOCT) is a catheter-based modality that acquires images
at a resolution of w10 mm, enabling visualization of blood
vessel wall microstructure in vivo at an unprecedented level
of detail. IVOCT devices are now commercially available
worldwide, there is an active user base, and the interest in
using this technology is growing. Incorporation of IVOCT
in research and daily clinical practice can be facilitated by the
development of uniform terminology and consensus-based
standards on use of the technology, interpretation of the
images, and reporting of IVOCT results.
Methods The IWG-IVOCT, comprising more than 260
academic and industry members from Asia, Europe, and the
United States, formed in 2008 and convened on the topic of
IVOCT standardization through a series of 9 national and
international meetings.
Results Knowledge and recommendations from this group
on key areas within the IVOCT ﬁeld were assembled to
generate this consensus document, authored by the Writing
Committee, composed of academicians who have partici-
pated in meetings and/or writing of the text.
Conclusions This document may be broadly used as
a standard reference regarding the current state of the
IVOCT imaging modality, intended for researchers and
clinicians who use IVOCT and analyze IVOCT data (120).
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Electrocardiographic and Echocardiographic Study
Objectives The goal of this study was to deﬁne electro-
cardiographic (ECG) and echocardiographic characteristics
of adolescent African athletes.
Background Recent observations in African athletes re-
ported large prevalence of left ventricular (LV) hypertrophy
and ECG abnormalities. No data, so far, exist for adolescent
Africans, which comprise a growing proportion of compet-
itive/professional athletes.
Methods The study included 154 soccer players partici-
pating at the 8th African Under-17 Championship of 2009,
representing Algeria, Burkina Faso, Cameroon, Gambia,
Guinea, Malawi, Nigeria, and Zimbabwe. For comparison,
62 Italian players with similar ages, sport achievements, and
training schedules were included.
Results African athletes showed higher R5/S1-wave
voltages than Caucasian athletes (48.6  12.1 mm vs.
34.1  8.9 mm; p < 0.01), larger prevalence of ECG LV
hypertrophy (89% vs. 42%; p < 0.001), ST-segment
elevation (91% vs. 56%; p < 0.001), and deeply inver-
ted, or diffusely ﬂat/biphasic, T waves (14% vs. 3%
[p < 0.05] and 25% vs. 8% [p < 0.008], respectively). LV
wall thicknesses were increased in Africans by 5%
compared with Caucasians, and exceeded normal limits
(13 mm) in 4 Africans but in no Caucasians. No athlete
showed evidence of cardiomyopathies (i.e., hypertrophic
cardiomyopathy, arrhythmogenic right ventricular car-
diomyopathy). On individual analysis, Algerians showed
lower R/S-wave voltages compared with other African
athletes. Increased wall thickness (13 mm) was observed
only in sub-Saharian athletes (from Burkina Faso,
Cameroon, and Niger).
Conclusions African athletes displayed large proportion of
ECG abnormalities, including a striking increase in R/S-
wave voltage, ST-segment elevation, and deeply inverted
or diffusely ﬂat T waves by adolescence. LV remodeling in
African athletes was characterized by a disproportionate wall
thickening than in Caucasians but similar cavity size.
Finally, distinctive peculiarities existed in African athletes
according to the country (and ethnic) origin (121).
Direct Comparison of Different Stem Cell Types
and Subpopulations Reveals Superior Paracrine
Potency and Myocardial Repair Efﬁcacy With
Cardiosphere-Derived Cells
Objectives The goal of this study was to conduct a direct
head-to-head comparison of different stem cell types in vitro
for various assays of potency and in vivo for functional
myocardial repair in the same mouse model of myocardial
infarction.
Background Adult stem cells of diverse origins (e.g., bone
marrow, fat, heart) and antigenic identity have been studied
for repair of the damaged heart, but the relative utility of the
various cell types remains unclear.Methods Human cardiosphere-derived cells (CDCs), bone
marrow–derived mesenchymal stem cells, adipose tissue–
derived mesenchymal stem cells, and bone marrow mono-
nuclear cells were compared.
Results CDCs revealed a distinctive phenotype with
uniform expression of CD105, partial expression of c-kit
and CD90, and negligible expression of hematopoietic
markers. In vitro, CDCs showed the greatest myogenic
differentiation potency, highest angiogenic potential, and
relatively high production of various angiogenic and
antiapoptotic-secreted factors. In vivo, injection of CDCs
into the infarcted mouse hearts resulted in superior
improvement of cardiac function, the highest cell engraft-
ment and myogenic differentiation rates, and the least-
abnormal heart morphology 3 weeks after treatment.
CDC-treated hearts also exhibited the lowest number of
apoptotic cells. The c-kitþ subpopulation puriﬁed from
CDCs produced lower levels of paracrine factors and inferior
functional beneﬁt when compared with unsorted CDCs. To
validate the comparison of cells from various human donors,
selected results were conﬁrmed in cells of different types
derived from individual rats.
Conclusions CDCs exhibited a balanced proﬁle of para-
crine factor production and, among various comparator cell
types/subpopulations, provided the greatest functional
beneﬁt in experimental myocardial infarction (122).Gender and the Extent of Coronary Atherosclerosis,
Plaque Composition, and Clinical Outcomes in
Acute Coronary Syndromes
Objectives This study sought to assess the extent and
composition of atherosclerosis contributing to acute coro-
nary syndrome events in women compared with men.
Background Pathological studies suggest that plaque
composition and burden may differ by sex. It is unclear
whether sex impacts the extent, characteristics, and potential
vulnerability of coronary plaques.
Methods A total of 697 patients (24% women) with acute
coronary syndromes were enrolled in the prospective,
multicenter PROSPECT (Providing Regional Observations
to Study Predictors of Events in the Coronary Tree) study.
Three-vessel multimodality intracoronary imaging (quanti-
tative coronary angiography, grayscale, and radiofrequency
intravascular ultrasound [IVUS]) was performed after
treatment of the culprit lesion(s). Events during a median
3.4-year follow-up were ascribed to recurrent culprit versus
untreated nonculprit lesions. The authors performed a post
hoc, sex-based subgroup analysis.
Results Women were older and had more comorbid disease
than men. By angiography, women had a similar number of
angiographic culprit (p ¼ 0.53) but fewer nonculprit
(p ¼ 0.05) lesions, and fewer vessels with nonculprit lesions
(p ¼ 0.048) compared with men even after multivariable
adjustment (p ¼ 0.002). By IVUS, women had fewer non-
culprit lesions (p ¼ 0.002), but similar plaque burden (PB)
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not predictive of severe (>70%) PB (p ¼ 0.052). Plaque
rupture was less common in women (6.6% vs. 16.3%;
p ¼ 0.002) even after adjusting for comorbidities (p ¼ 0.004),
as was the total necrotic core volume (p < 0.0001). The
frequency of other plaque phenotypes was similar for men and
women including pathological intimal thickening, thin-cap
ﬁbroatheromas (TCFA), and thick-cap ﬁbroatheromas.
Rates of major adverse cardiovascular events attributed to
culprit and nonculprit lesions at 1-, 2-, and 3-year follow-up
were not signiﬁcantly different between men and women,
although women were rehospitalized more frequently due to
culprit lesion–related angina. For men, nonculprit lesion
minimal lumen area 4.0 mm2, PB 70%, and TCFA
predicted nonculprit MACE at 3 years, whereas for women,
only TCFA and PB were predictive.
Conclusions The PROSPECT study validates that despite
having more comorbid risk factors than men, women have
less extensive coronary artery disease by both angiographic
and IVUS measures, and that lesions in women compared
with men have less plaque rupture, less necrotic core and
calcium, similar plaque burden, and smaller lumens. TCFA
may also be a stronger marker of plaque vulnerability in
women than men (123).
Emerging Trends in CV Flow Visualization
Blood ﬂow patterns are closely linked to the morphology and
function of the cardiovascular system. These patterns reﬂect
the exceptional adaptability of the cardiovascular system to
maintain normal blood circulation under a wide range of
workloads. Accurate retrieval and display of ﬂow-related
information remains a challenge because of the processes
involved in mapping the ﬂow velocity ﬁelds within speciﬁc
chambers of the heart. We review the potentials and pitfalls
of current approaches for blood ﬂow visualization, with an
emphasis on acquisition, display, and analysis of multidi-
rectional ﬂow. This document is divided into 3 sections.
First, we provide a descriptive outline of the relevant
concepts in cardiac ﬂuid mechanics, including the emer-
gence of rotation in ﬂow and the variables that delineate
vortical structures. Second, we elaborate on the main
methods developed to image and visualize multidirectional
cardiovascular ﬂow, which are mainly based on cardiac
magnetic resonance, ultrasound Doppler, and contrast
particle imaging velocimetry, with recommendations for
developing dedicated imaging protocols. Finally, we discuss
the potential clinical applications and technical challenges
with suggestions for further investigations (124).
Temporal Enhancement of 3D Echocardiography by
Frame Reordering
We describe a method to increase the frame rate for
3-dimensional ultrasound sequences of periodically moving
cardiac structures by reordering the acquired volume series.The frame rate is especially important in studying intracar-
diac structures such as valve leaﬂet motion in which valve
closing times are on the order of milliseconds. Current
commercially available systems for volumetric ultrasound
imaging are limited to approximately 10 to 20 volumes per
second. Although this frame rate is sufﬁcient for real-time
observation of basic cardiac morphology, understanding
cardiac dynamics requires faster frame rates. The presented
work achieves higher frame rates by sampling over several
beats and using a simultaneous electrocardiography signal to
accurately place the frame within the cardiac cycle. The
proposed method relies on periodicity of the heart motion
and that within the temporal regions of highest velocity, the
structural motions of interest have the lowest beat-to-beat
variability (125).Relation of Torsion and Myocardial Strains to
LV Ejection Fraction in Hypertension
Objectives The goal of this study was to deﬁne the
mechanism of preserved ejection fraction (EF) despite
depressed myocardial strains in hypertension (HTN).
Background Concentric left ventricular (LV) remodeling
in HTN may have normal or supranormal EF despite
depressed myocardial strains. The reason for such discor-
dance is not clear. The aim of this study was to compre-
hensively evaluate the LV mechanics in a well-deﬁned HTN
population to deﬁne underlying reasons for such a paradox.
Methods Sixty-seven patients with resistant HTN and 45
healthy control subjects were studied by cardiac magnetic
resonance imaging and tissue tagging with 3-dimensional
analysis. Amplitude and directional vector of longitudinal
(Ell), circumferential (Ecc), and principal strain for maximal
shortening (E3) were computed at basal, mid, and distal LV
levels, respectively. LV torsion, deﬁned as the rotation angle
of apex relative to base, and LV twist, which accounts for the
effects of differential LV remodeling on torsion for com-
parison among the 2 groups, were also calculated.
Results LV mass index and LV mass/LV end-diastolic
volume ratio were signiﬁcantly higher in the HTN group
compared with controls, consistent with concentric LV
remodeling. Ell and Ecc were signiﬁcantly decreased in
amplitude with altered directional vector in HTN compared
with controls. However, the amplitude of E3 was similar in
the 2 groups. Torsion and twist were signiﬁcantly higher in
HTN, which was mainly due to increase in apical rotation.
The HTN group demonstrated signiﬁcantly increased LV
wall thickening compared with controls that resulted in
greater LVEF in the HTN group compared with controls
(70% vs. 65%, p < 0.001, respectively).
Conclusions In compensated LV remodeling secondary
to HTN, there is increased LV wall thickening with pre-
served E3 and increased torsion compared with normal
controls. This, therefore, contributes to supranormal LVEF
in HTN despite depressed longitudinal and circumferential
strains (126).
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History for Premature Coronary Artery Disease and
Elevated Coronary Calcium Scores Beneﬁt From
Statin Treatment: A Post Hoc Analysis From the
St. Francis Heart Study
Objectives The goal of this study was to evaluate whether
individuals with a positive family history for premature
coronary artery disease (CAD) and coronary calcium scoring
(CCS) above the 80th percentile might beneﬁt from
preventive treatment.
Background First-degree relatives of patients with pre-
mature CAD have an increased risk for cardiovascular
disease (CVD), whereas events are poorly predicted in these
individuals. Surrogate markers, such as CCS, might reﬁne
risk scoring. Nevertheless, the outcome of the St. Francis
Heart trial, which investigated the effect of atorvastatin 20
mg/day in asymptomatic individuals with CCS above the
80th percentile, did not reach statistical signiﬁcance.
Methods We performed a post hoc analysis on the database
of the St. Francis trial to assess efﬁcacy of treatment with
atorvastatin 20 mg/day in those with CCS above the 80th
percentile and presence (n ¼ 543) or absence (n ¼ 462) of
a positive family history for premature CAD. All partici-
pants received aspirin 81 mg/day. Primary outcome included
coronary death, myocardial infarction, coronary revasculari-
zation, stroke, and arterial surgery.
Results A total of 1,005 individuals, with a mean age of
59.0  5.9 years and a median absolute CCS of 370
Agatston units (interquartile range: 183 to 662) participated
in the trial. After a follow-up of 4.3 (interquartile range: 3.5
to 4.5) years, 7.2% of the treated individuals with a positive
family history had a cardiovascular event versus 12.5% of the
placebo group (hazard ratio [HR]: 0.55; 95% conﬁdence
intervals [CI]: 0.31 to 0.97; p ¼ 0.040). This is comparable
with a number needed to treat of 18.9. In individuals
without a family history, events were minimally reduced:
6.6% in the treated versus 6.8% in the placebo group (HR:
1.04; 95% CI: 0.51 to 2.13; p ¼ 0.912).
Conclusions The combination of a positive family history
and CCS above the 80th percentile identiﬁes a subgroup
within the primary prevention population that receives
greater beneﬁt from statin treatment than the population at
large. These results have important implications for future
guidelines concerning individuals with a positive family
history for premature CAD (127).
4-[18F]-Tetraphenylphosphonium as a PET Tracer
for Myocardial Mitochondrial Membrane Potential
Objectives This study tested the hypothesis that 4-[18F]
ﬂuorophenyltriphenylphosphonium (18F-TPP) is useful for
in vivo positron emission tomography (PET) measurement
of mitochondrial membrane potential (DJm). Its utility as
a blood ﬂow tracer also was evaluated.
Background Tetraphenylphosphonium is useful for in vitro
measurement of DJm. In vivo measurement of DJm haspotential value in the assessment of heart failure patho-
physiology and therapy as well as assessment of myocardial
viability and so may be a very useful clinical tool.
Methods Anesthetized swine (N ¼ 6) with a balloon
catheter in the left anterior descending coronary artery were
studied. Microsphere measurements of myocardial blood
ﬂow (MBF) were made after balloon inﬂation (baseline) and
w10 min after intravenous administration of adenosine and
phenylephrine after whichw10 mCi 18F-TPP was injected
intravenously and dynamic PET data acquisition obtained
for 30 min. After the swine were killed, the hearts were
sectioned for microsphere measurement of MBF and 18F-
TPP measured by well counter in these same samples. PET
images provided whole blood and myocardial 18F-TPP
concentration for determination of DJm by the Nernst
equation, corrected for nonspeciﬁc 18F-TPP binding.
Microsphere MBF, absolute (ml/min/g) and relative, was
compared with PET data (standard uptake value and K1).
Results Nonspeciﬁc binding of 18F-TPP overestimated
DJm measured by 37  4 mV (mean  SD). Normal
zone DJm of ex vivo samples (91  11 mV; N ¼ 52;
sample weight, 1.07  0.18 g) correlated strongly (R2¼
0.93) with normal zone by PET (81  13 mV). Both
ex vivo and PET normal zone DJm, although somewhat
lower, compared well with that reported for tritium labeled
triphenylphosphonium in normal working Langendorff rat
heart (100 mV). Although the relative MBF by 18F-
TPP correlated strongly with relative microsphere MBF
(R2¼ 0.83), there was no correlation between absolute MBF
by 18F-TPP and microsphere MBF.
Conclusions 18F-TPP is a promising tracer for noninva-
sive PET measurement of DJm in living subjects. It is
useful as well for assessment of relative but not absolute
MBF (128).Calcium Scoring in Patients With a History of
Kawasaki Disease
Objectives The goal of this study was to assess coronary
artery calciﬁcation in patients 10 years or age with a history
of Kawasaki disease (KD).
Background Patients with a history of KD and coronary
artery aneurysms are at risk for late morbidity from coronary
artery events. It is unknown whether patients with KD with
acutely normal or transiently dilated coronary arteries also
have increased risk of late coronary artery complications.
Coronary calcium scoring using noncontrast computed
tomography is a well-established tool for risk-stratifying
patients with atherosclerotic coronary artery disease, but
there are limited data on its role in evaluating patients with
a history of KD.
Methods We performed coronary artery calcium (CAC)
volume scoring using a low radiation dose computed
tomography protocol on 70 patients (median age 20.0 years)
with a remote history of KD (median interval from acute
KD to imaging 14.8 years). Forty-four (63%) patients had
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transient dilation, and 14 (20%) had coronary aneurysms.
Results All of the patients with normal coronary artery
internal diameter during the acute phase of KD and 11 of 12
patients with transient dilation had CAC scores of zero.
Coronary calciﬁcation was observed in 10 of the 14 patients
with coronary aneurysms, with the degree of calciﬁcation
ranging from mild to severe and occurring years after the
patients’ acute KD.
Conclusions Coronary calciﬁcation was not observed in
patients with a history of KD and normal coronary arteries
during the acute phase. Therefore, CAC scanning may be
a useful tool to screen patients with a remote history of KD
or suspected KD and unknown coronary artery status.
Coronary calciﬁcation, which may be severe, occurs late in
patients with coronary aneurysms. The pathophysiology and
clinical implications of coronary calciﬁcation in patients with
aneurysms are currently unknown and warrant further
study (129).Feasibility, Accuracy, and Reproducibility of Real-
Time Full-Volume 3D Transthoracic Echocardiography
to Measure LV Volumes and Systolic Function:
A Fully Automated Endocardial Contouring Algorithm
in Sinus Rhythm and Atrial Fibrillation
Objectives To assess the feasibility, accuracy, and repro-
ducibility of real-time full-volume 3-dimensional trans-
thoracic echocardiography (3D RT-VTTE) to measure left
ventricular (LV) volumes and ejection fraction (EF) using
a fully automated endocardial contouring algorithm and to
identify and automatically correct the contours to obtain
accurate LV volumes in sinus rhythm and atrial ﬁbrillation
(AF).
Background 3D transthoracic echocardiography is not used
routinely to quantify LV volumes and EF. A fully automated
workﬂow using RT-VTTE may improve clinical adoption.
Methods RT-VTTE was performed and 3D EF and
volumes obtained using an automated trabecular endocardial
contouring algorithm; an automated correction was applied
to track the compacted myocardium. Cardiac magnetic
resonance (CMR) and 2-dimensional biplane Simpson
method were the reference standard.
Results Ninety-one patients (67 in normal sinus rhythm
[NSR], 24 in AF) were included. Among all NSR patients,
there was excellent correlation between RT-VTTE and
CMR for end-diastolic volume (EDV), end-systolic volume
(ESV), and EF (r ¼ 0.90, 0.96, and 0.98, respectively;
p < 0.001). In patients with EF 50% (n ¼ 36), EDV and
ESV were underestimated by 10.7  17.5 ml (p ¼ 0.001)
and by 4.1  6.1 ml (p < 0.001), respectively. In those with
EF <50% (n ¼ 31), EDV and ESV were underestimated by
25.7  32.7 ml (p < 0.001) and by 16.2  24.0 ml
(p ¼ 0.001). Automated contour correction to track the
compacted myocardium eliminated mean volume differences
between RT-VTTE and CMR. In patients with AF, LVvolumes and EF were accurate by RT-VTTE (r ¼ 0.94,
0.94, and 0.91 for EDV, ESV, and EF, respectively;
p < 0.001). Automated 3D LV volumes and EF were highly
reproducible.
Conclusions Rapid, accurate, and reproducible EF can be
obtained by RT-VTTE in NSR and AF patients by using
an automated trabecular edge contouring algorithm.
Furthermore, automated contour correction to detect the
compacted myocardium yields accurate and reproducible 3D
LV volumes (130).
Prognostic Value of Myocardial Viability by
Delayed-Enhanced Magnetic Resonance in
Patients With Coronary Artery Disease and Low
Ejection Fraction: Impact of Revascularization
Therapy
Objectives The purpose of this study was to evaluate the
impact of myocardial viability assessment by delayed-
enhanced cardiac magnetic resonance (DE-CMR) and of
revascularization therapy on survival in patients with coro-
nary artery disease (CAD) and low ejection fraction (EF).
Background Prior studies have shown that DE-CMR
predicts recovery of left ventricular (LV) dysfunction after
revascularization.
Methods The authors prospectively evaluated survival of
144 consecutive patients (130 males, age 65  11 years)
with CAD and LV dysfunction (EF: 24  7%) undergoing
DE-CMR. Eighty-six patients underwent complete revas-
cularization of dysfunctional myocardium (79 coronary
artery bypass grafting, 7 percutaneous coronary interven-
tion), whereas 58 patients remained under medical
treatment.
Results Over the 3-year median follow-up, 49 patients
died. Three-year survival was signiﬁcantly worse in medi-
cally treated patients with dysfunctional viable than with
nonviable myocardium (48% vs. 77% survival, p ¼ 0.02). By
contrast, in revascularized patients, survival was similar
whether myocardium was viable or not (88% and 71%
survival, respectively, p ¼ NS). Hazard of death of viable
myocardium remaining under medical treatment versus
complete revascularization was 4.56 (95% conﬁdence
interval [CI]: 1.93 to 10.8). Cox multivariate analysis indi-
cated that interaction of revascularization and viability
provided signiﬁcant additional value (chi-square test ¼ 13.1,
p ¼ 0.004) to baseline predictors of survival (New York
Heart Association functional class, wall motion score, and
peripheral artery disease). More importantly, in 43 pairs of
propensity score–matched patients, hazard of death (hazard
ratio: 2.5 [95% CI: 1.1 to 6.1], p ¼ 0.02) remained signif-
icantly higher for medically treated patients rather than for
those with fully revascularized viable myocardium.
Conclusions Without revascularization, presence of
dysfunctional viable myocardium by DE-CMR is an inde-
pendent predictor of mortality in patients with ischemic LV
dysfunction. This observation may be useful for pre-
operative selection of patients for revascularization (131).
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After Stress Testing: Results From a Multicenter,
Statewide Registry, ACIC (Advanced
Cardiovascular Imaging Consortium)
Objectives This study was conducted to evaluate the
correlation between stress test results and coronary
computed tomography angiography (CCTA) ﬁndings and
comparative diagnostic performance of the 2 modalities in
patients undergoing invasive coronary angiography (ICA).
Background Recent data suggest that only a third of
patients undergoing ICA have obstructive coronary artery
disease (CAD); accurate pre-ICA risk stratiﬁcation is
needed.
Methods At 47 centers participating in the ACIC
(Advanced Cardiovascular Imaging Consortium) in Michi-
gan, patients without known CAD who were undergoing
CCTA within 3 months of a stress test were studied.
Demographics, risk factors, symptoms, and stress test results
were correlated with obstructive CAD (>50% stenosis) on
CCTA and ICA.
Results Among 6,198 patients (age 56  12 years, 48%
men), >50% stenosis was seen in 1,158 (18.7%) on CCTA.
Independent predictors included male sex (odds ratio
[OR]: 2.37, 95% conﬁdence interval [CI]: 1.83 to 3.06),
current smoking (OR: 2.23, 95% CI: 1.57 to 3.17), older
age (OR per 10-year increment: 2.14, 95% CI: 1.89 to
2.41), hypertension (OR: 1.8, 95% CI: 1.37 to 2.34), and
typical angina (OR: 1.48, 95% CI: 1.03 to 2.12). Stress test
results were not predictive. Among patients undergoing
ICA (n ¼ 621), there was a strong correlation of ICA with
CCTA ﬁndings (OR: 9.09, 95% CI: 5.57 to 14.8,
p < 0.001), but not stress results (OR: 0.79, 95% CI: 0.56
to 1.11, p ¼ 0.17).
Conclusions Stress test ﬁndings did not predict obstructive
CAD on CCTA, observed in <20% of patients in this large
study group. The strong association of CCTA with ICA
suggests that it may serve as an effective “gatekeeper” to
invasive testing in patients needing adjudication of stress test
results. (Advanced Cardiovascular Imaging Consortium: A
Collaborative Quality Improvement Project [ACIC];
NCT00640068) (132).Effects of Radiation Exposure From Cardiac
Imaging: How Good Are the Data?
Concerns about medical exposure to ionizing radiation have
become heightened in recent years as a result of rapid growth
in procedure volumes and the high radiation doses incurred
from some procedures. This paper summarizes the evidence
base undergirding concerns about radiation exposure in
cardiac imaging. After classifying radiation effects, explain-
ing terminology used to quantify the radiation received by
patients, and describing typical doses from cardiac imaging
procedures, this paper will address the major epidemiological
studies having bearing on radiation effects at dosescomparable to those received by patients undergoing cardiac
imaging. These include studies of atomic bomb survivors,
nuclear industry workers, and children exposed in utero to x-
rays, all of which have evidenced increased cancer risks at
low doses. Additional higher-dose epidemiological studies of
cohorts exposed to radiation in the context of medical
treatment are described and found to be generally compat-
ible with these cardiac dose–level studies, albeit with
exceptions. Using risk projection models developed by the
U.S. National Academies that incorporate these data and
reﬂect several evidence-based assumptions, cancer risk from
cardiac imaging can be estimated and compared with the
beneﬁts from imaging. Several ongoing epidemiological
studies will provide better understanding of radiation-
associated cancer risks (133).In Vivo Detection of Oxidation-Speciﬁc Epitopes in
Atherosclerotic Lesions Using Biocompatible
Manganese Molecular Magnetic Imaging Probes
Objectives This study sought to evaluate the in vivo
magnetic resonance imaging (MRI) efﬁcacy of manganese
[Mn(II)] molecular imaging probes targeted to oxidation-
speciﬁc epitopes (OSE).
Background OSE are critical in the initiation, progression,
and destabilization of atherosclerotic plaques. Gadolinium
[Gd(III)]-based MRI agents can be associated with systemic
toxicity. Mn is an endogenous, biocompatible, paramagnetic
metal ion that has poor MR efﬁcacy when chelated, but
strong efﬁcacy when released within cells.
Methods Multimodal Mn micelles were generated to
contain rhodamine for confocal microscopy and conjugated
with either the murine monoclonal IgG antibody MDA2
targeted to malondialdehyde (MDA)-lysine epitopes or the
human single-chain Fv antibody fragment IK17 targeted to
MDA-like epitopes (“targeted micelles”). Micelle formula-
tions were characterized in vitro and in vivo, and their MR
efﬁcacy (9.4-T) evaluated in apolipoprotein-deﬁcient
(apoE/) and low-density lipoprotein receptor negative
(LDLR/) mice (0.05 mmol Mn/kg dose) (total of 120
mice for all experiments). In vivo competitive inhibition
studies were performed to evaluate target speciﬁcity. Un-
targeted, MDA2-Gd, and IK17-Gd micelles (0.075 mmol
Gd/kg) were included as controls.
Results In vitro studies demonstrated that targeted Mn
micelles accumulate in macrophages when pre-exposed to
MDA-LDL with w10 increase in longitudinal relativity.
Following intravenous injection, strong MR signal en-
hancement was observed 48 to 72 h after administration of
targeted Mn micelles, with colocalization within intraplaque
macrophages. Co-injection of free MDA2 with the MDA2-
Mn micelles resulted in full suppression of MR signal in the
arterial wall, conﬁrming target speciﬁcity. Similar MR efﬁ-
cacy was noted in apoE/ and LDLR/ mice with
aortic atherosclerosis. No signiﬁcant differences in MR
efﬁcacy were noted between targeted Mn and Gd micelles.
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multimodal Mn-based molecular imaging probes detect
OSE within atherosclerotic plaques and may facilitate clin-
ical translation of noninvasive imaging of human athero-
sclerosis (134).Functional Assessment of Jailed Side Branches in
Coronary Bifurcation Lesions Using Fractional Flow
Reserve
Objectives This study was designed to assess the functional
signiﬁcance of side branches after stent implantation in main
vessels using fractional ﬂow reserve (FFR).
Background Little is known about the functional signiﬁ-
cance of side branches after stent implantation in main
vessels in coronary bifurcation lesions.
Methods Between May 2007 and January 2011, 230 side
branches in 230 patients after stent implantation in main
vessels were assessed by FFR and were consecutively
enrolled.
Results Median FFR at the side branch was 0.91 (inter-
quartile range: 0.85 to 0.95). There was a negative correla-
tion between the diameter stenosis (DS) by quantitative
coronary angiography (QCA) and FFR of side branch
(r ¼ 0.21, p ¼ 0.002), but only 41 (17.8%) side branches
were functionally signiﬁcant after stent implantation in the
main vessel. Among 67 side branches with >50% DS by
QCA, 19 (28.4%) had FFR 0.80, and among 163 side
branches with 50% DS by QCA, 22 (13.5%) had
FFR 0.80 after stent implantation in main vessels. On the
basis of receiver-operating characteristic curves, the optimal
cutoff value of DS by QCA of the side branch was 54.9%,
and the area under the curve was 0.64 (95% conﬁdence
interval [CI]: 0.58 to 0.71, p < 0.001) with a 41.5%
sensitivity, an 83.1% speciﬁcity, a 34.7% positive predictive
value, an 86.3% negative predictive value, and a 75.7%
accuracy. Multivariate binary logistic regression analysis
identiﬁed DS by QCA (odds ratio [OR]: 1.04, 95%
CI: 1.02 to 1.06, p ¼ 0.001) and reference vessel diameter
(OR: 0.28, 95% CI: 0.10 to 0.77, p ¼ 0.014) before stent
implantation as independent predictors of the side branches
with FFR 0.80 after stent implantation.
Conclusions Most side branch lesions do not have func-
tional signiﬁcance after stent implantation in the main
vessel, and quantitative coronary angiography is unreliable in
assessing the functional severity of these lesions (135).Principles of Percutaneous Paravalvular Leak
Closure
Paravalvular regurgitation affects 5% to 17% of all surgically
implanted prosthetic heart valves. Patients who have para-
valvular regurgitation can be asymptomatic or present with
hemolysis or heart failure, or both. Reoperation is associated
with increased morbidity and is not always successful
because of underlying tissue friability, inﬂammation, orcalciﬁcation. Comprehensive echocardiographic imaging
with transthoracic and real-time 3-dimensional trans-
esophageal echocardiography is key for characterizing the
defect location, size, and shape. For paramitral defects, an
antegrade transseptal approach can usually be guided by
biplane ﬂuoroscopy, and real-time 3-dimensional trans-
esophageal echocardiography can usually be performed
successfully. Alternative approaches to paramitral defects
include retrograde transaortic cannulation or transapical
access and retrograde cannulation. For oblong or crescentic
defects, the simultaneous or sequential deployment of 2
smaller devices, as opposed to 1 large device, results in
a higher degree of procedural success and safety because the
risk of impingement on the prosthetic leaﬂets is minimized.
Most para-aortic defects can be approached in a retrograde
manner and closed with a single device. With careful
anatomical assessment, procedural planning, and procedural
execution, successful closure rates of 90% or more should be
attainable with a low risk of device impingement on the
prosthetic valve or embolization (136).A Quantitative Pixel-Wise Measurement of
Myocardial Blood Flow by Contrast-Enhanced
First-Pass CMR Perfusion Imaging: Microsphere
Validation in Dogs and Feasibility Study in Humans
Objectives The aim of this study was to evaluate fully
quantitative myocardial blood ﬂow (MBF) at a pixel level
based on contrast-enhanced ﬁrst-pass cardiac magnetic
resonance (CMR) imaging in dogs and in patients.
Background Microspheres can quantify MBF in subgram
regions of interest, but CMR perfusion imaging may be able
to quantify MBF and differentiate blood ﬂow at a much
higher resolution.
Methods First-pass CMR perfusion imaging was per-
formed in a dog model with local hyperemia induced by
intracoronary adenosine. Fluorescent microspheres were the
reference standard for MBF validation. CMR perfusion
imaging was also performed on patients with signiﬁcant
coronary artery disease (CAD) by invasive coronary angi-
ography. Myocardial time-signal intensity curves of the
images were quantiﬁed on a pixel-by-pixel basis using
a model-constrained deconvolution analysis.
Results Qualitatively, color CMR perfusion pixel maps
were comparable to microsphere MBF bull’s-eye plots in all
animals. Pixel-wise CMR MBF estimates correlated well
against subgram (0.49  0.14 g) microsphere measurements
(r ¼ 0.87 to 0.90) but showed minor underestimation of
MBF. To reduce bias due to misregistration and minimize
issues related to repeated measures, 1 hyperemic and 1
remote sector per animal were compared with the micro-
sphere MBF, which improved the correlation (r ¼ 0.97 to
0.98), and the bias was close to zero. Sector-wise and
pixel-wise CMR MBF estimates also correlated well
(r ¼ 0.97). In patients, color CMR stress perfusion pixel
maps showed regional blood ﬂow decreases and transmural
JACC Vol. 62, No. 14, 2013 The Editors
October 1, 2013:e29–141 JACC Topic Collection: Cardiac Imaging
e79perfusion gradients in territories served by stenotic coronary
arteries. MBF estimates in endocardial versus epicardial
subsectors, and ischemic versus remote sectors, were all
signiﬁcantly different (p < 0.001 and p < 0.01, respectively).
Conclusions Myocardial blood ﬂow can be quantiﬁed at
the pixel level (w32 ml of myocardium) on CMR perfusion
images, and results compared well with microsphere
measurements. High-resolution pixel-wise CMR perfusion
maps can quantify transmural perfusion gradients in patients
with CAD (137).
Delayed-Enhanced MR Scar Imaging and
Intraprocedural Registration Into an
Electroanatomical Mapping System in
Post-Infarction Patients
Post-infarction arrhythmias are most often conﬁned to scar
tissue. Scar can be detected by delayed-enhanced cardiac
magnetic resonance. The purpose of this study was to assess
the feasibility of pre-procedural scar identiﬁcation and
intraprocedural real-time image registration with an elec-
troanatomical map in 23 patients with previous infarction
and ventricular arrhythmias (VAs). Registration accuracy
and cardiac magnetic resonance/electroanatomical map
correlations were assessed, and critical areas for VA were
correlated with the presence of scar. With a positional
registration error of 3.8  0.8 mm, 86% of low-voltage
points of the electroanatomical map projected onto the
registered scar. The delayed-enhanced cardiac magnetic
resonance–deﬁned scar correlated with the area of low
voltage (R ¼ 0.82, p < 0.001). All sites critical to VAs
projected on the registered scar. Selective identiﬁcation and
extraction of delayed-enhanced cardiac magnetic resonance
deﬁned scar followed by registration into a real-time
mapping system are feasible and help to identify and
display the arrhythmogenic substrate in post-infarction
patients with VAs (138).
Is Discordance of Coronary Flow Reserve and
Fractional Flow Reserve Due to Methodology or
Clinically Relevant Coronary Pathophysiology?
Objectives The purpose of this study was to determine
whether observed discordance between coronary ﬂow reserve
(CFR) and fractional ﬂow reserve (FFR) is due to meth-
odology or reﬂects basic coronary pathophysiology.
Background Despite the clinical importance of coronary
physiological assessment, relationships between its 2 most
common tools, CFR and FFR, remain poorly deﬁned.
Methods The worst CFR and stress relative uptake were
recorded from 1,500 sequential cardiac positron emission
tomography cases from our center. From the literature, we
assembled all combined, invasive CFR-FFR measurements,
including a subset before and after angioplasty. Both datasets
were compared with a ﬂuid dynamic model of the coronary
circulation predicting relationships between CFR and FFR
for variable diffuse and focal narrowing.Results A modest but signiﬁcant linear relationship exists
between CFR and FFR both invasively (r ¼ 0.34,
p < 0.001) and using positron emission tomography
(r ¼ 0.36, p < 0.001). Most clinical patients undergoing
CFR or FFR measurements have diffusely reduced CFR
consistent with diffuse atherosclerosis or small-vessel
disease. The theoretical model predicts linear relationships
between CFR and FFR for progressive stenosis with slopes
dependent on diffuse narrowing, matching observed data.
Reported changes in CFR and FFR with angioplasty agree
with model predictions of removing focal stenosis but
leaving diffuse disease. Although CFR-FFR concordance is
common, discordance is due to dominant or absent diffuse
versus focal disease, reﬂecting basic pathophysiology.
Conclusions CFR is linearly related to FFR for progressive
stenosis superimposed on diffuse narrowing. The relative
contributions of focal and diffuse disease deﬁne the slope
and values along the linear CFR and FFR relationship.
Discordant CFR and FFR values reﬂect divergent extremes
of focal and diffuse disease, not failure of either tool. With
such discordance observed by invasive and noninvasive
techniques and also ﬁtting ﬂuid dynamic predictions, it
reﬂects clinically relevant basic coronary pathophysiology,
not methodology (139).Determinants and Functional Signiﬁcance of
Myocardial Perfusion Reserve in Severe Aortic
Stenosis
Objectives The purpose of this study was to assess the
functional signiﬁcance of cardiac magnetic resonance
(CMR) measures of left ventricular (LV) remodeling and
myocardial perfusion reserve (MPR) in patients with severe
aortic stenosis (AS), without obstructive coronary artery
disease.
Background Measures of stenosis severity do not correlate
well with exercise intolerance in AS. LV remodeling in AS is
associated with myocardial ﬁbrosis and impaired MPR. The
functional signiﬁcance and determinants of MPR in AS are
unclear.
Methods Forty-six patients with isolated severe AS were
prospectively studied before aortic valve replacement. The
following investigations were undertaken: cardiopulmonary
exercise testing to measure aerobic exercise capacity (peak
VO2); CMR to assess left ventricular mass index (LVMI),
myocardial ﬁbrosis with late gadolinium enhancement
(LGE), myocardial blood ﬂow (MBF), and MPR; and
transthoracic echocardiography to assess stenosis severity
and diastolic function.
Results Peak VO2 was associated with sex (b ¼ 0.41),
age (b ¼ 0.32), MPR (b ¼ 0.45), resting MBF
(b ¼ 0.53), and septal transmitral ﬂow velocity to annular
velocity ratio (E/E0) (b ¼ 0.34), but not with LVMI,
LGE, or echocardiographic measures of AS severity. On
stepwise regression analysis, only MPR was independently
associated with age- and sex-corrected peak VO2 (b ¼ 0.46,
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Heart Association functional class (p ¼ 0.001). Univariate
associations with MPR were sex (b ¼ 0.38, p ¼ 0.02), septal
E/E0 (b ¼ 0.30, p ¼ 0.03), peak aortic valve velocity
(b ¼ 0.34, p ¼ 0.02), LVMI (b ¼ 0.51, p < 0.001), and
LGE category (b ¼ 0.46, p ¼ 0.002). On multivariate
analysis, LVMI and LGE were independently associated
with MPR.
Conclusions CMR-quantiﬁed MPR is independently
associated with aerobic exercise capacity in severe AS. LV
remodeling appears to be a more important determinant
of impaired MPR than stenosis severity per se. Further
work is required to determine how CMR assessment
of MPR can aid clinical management of patients with
AS (140).Prediction of Coronary Artery Calcium Progression
in Individuals With Low Framingham Risk Score:
The Multi-Ethnic Study of Atherosclerosis
Objectives This study sought to determine whether novel
markers not involving ionizing radiation could predict
coronary artery calcium (CAC) progression in a low-risk
population.
Background Increase in CAC scores over time (CAC
progression) improves prediction of coronary heart disease
(CHD) events. Due to radiation exposure, CAC measure-
ment represents an undesirable method for repeated risk
assessment, particularly in individuals with low predicted
risk (Framingham Risk Score [FRS] <10%).
Methods From 6,814 participants in MESA (Multi-
Ethnic Study of Atherosclerosis), 2,620 individuals were
classiﬁed as low risk for CHD events (FRS <10%) and
had follow-up CAC measurement. In addition to
traditional risk factors (RFs), various combinations of
novel marker models were selected on the basis of data-
driven, clinical, or backward stepwise selection
techniques.
Results Mean follow-up was 2.5 years. CAC progression
occurred in 574 participants (22% overall; 214 of 1,830 with
baseline CAC ¼ 0 and 360 of 790 with baseline CAC >0).
Addition of various combinations of novel markers to the
base model (c statistic ¼ 0.711) revealed improvements in
discrimination of approximately only 0.005 each (c statistics
0.7158, 0.7160, and 0.7164) for the best-ﬁt models. All 3
best-ﬁt novel marker models calibrated well but were similar
to the base model in predicting individual risk probabilities
for CAC progression. The highest prevalence of CAC
progression occurred in the highest compared with the
lowest probability quartile groups (39.2% to 40.3% vs. 6.4%
to 7.1%).
Conclusions In individuals at low predicted risk according
to FRS, traditional risk factors predicted CAC progression
in the short term with good discrimination and calibration.
Prediction improved minimally when various novel markers
were added to the model (141).Targeted Metabolic Imaging to Improve the
Management of Heart Disease
Tracer techniques are powerful methods for assessing rates
of biological processes in vivo. A case in point is interme-
diary metabolism of energy providing substrates, a central
feature of every living cell. In the heart, the tight coupling
between metabolism and contractile function offers an
opportunity for the simultaneous assessment of cardiac
performance at different levels in vivo: coronary ﬂow,
myocardial perfusion, oxygen delivery, metabolism, and
contraction. Noninvasive imaging techniques used to iden-
tify the metabolic footprints of either normal or perturbed
cardiac function are discussed (142).
Echocardiography, Natriuretic Peptides, and Risk
for Incident Heart Failure in Older Adults:
The Cardiovascular Health Study
Objectives This study sought to examine the potential
utility of echocardiography and N-terminal pro–B-type
natriuretic peptide (NT-proBNP) for heart failure (HF) risk
stratiﬁcation in concert with a validated clinical HF risk
score in older adults.
Background Without clinical guidance, echocardiography
and natriuretic peptides have suboptimal test characteristics
for population-wide HF risk stratiﬁcation. However, the
value of these tests has not been examined in concert with
a clinical HF risk score.
Methods We evaluated the improvement in 5-year HF risk
prediction offered by adding an echocardiographic score
and/or NT-proBNP levels to the clinical Health Aging and
Body Composition (ABC) HF risk score (base model) in
3,752 participants of the CHS (Cardiovascular Health
Study) (age 72.6  5.4 years; 40.8% men; 86.5% white). The
echocardiographic score was derived as the weighted sum of
independent echocardiographic predictors of HF. We
assessed changes in Bayesian information criterion (BIC), C
index, integrated discrimination improvement (IDI), and
net reclassiﬁcation improvement (NRI). We examined also
the weighted NRI across baseline HF risk categories under
multiple scenarios of event versus nonevent weighting.
Results Reduced left ventricular ejection fraction, abnor-
mal E/A ratio, enlarged left atrium, and increased left
ventricular mass were independent echocardiographic
predictors of HF. Adding the echocardiographic score and
NT-proBNP levels to the clinical model improved BIC
(echocardiography: 43, NT-proBNP: 64.1, combi-
ned: 68.9; all p < 0.001) and C index (baseline: 0.746;
echocardiography: þ0.031, NT-proBNP: þ0.027, com-
bined: þ0.043; all p < 0.01), and yielded robust IDI
(echocardiography: 43.3%, NT-proBNP: 42.2%,
combined: 61.7%; all p < 0.001), and NRI (based on
Health ABC HF risk groups; echocardiography: 11.3%;
NT-proBNP: 10.6%, combined: 16.3%; all p < 0.01).
Participants at intermediate risk by the clinical model (5%
to 20% 5-yr HF risk; 35.7% of the cohort) derived the
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modest reclassiﬁcation when used sequentially after NT-
proBNP.
Conclusions In older adults, echocardiography and NT-
proBNP offer signiﬁcant HF risk reclassiﬁcation over
a clinical prediction model, especially for intermediate-risk
individuals (143).Patient Management After Noninvasive Cardiac
Imaging: Results From SPARC (Study of
Myocardial Perfusion and Coronary Anatomy
Imaging Roles in Coronary Artery Disease)
Objectives This study examined short-term cardiac cathe-
terization rates and medication changes after cardiac
imaging.
Background Noninvasive cardiac imaging is widely used in
coronary artery disease, but its effects on subsequent patient
management are unclear.
Methods We assessed the 90-day post-test rates of cathe-
terization and medication changes in a prospective registry
of 1,703 patients without a documented history of coronary
artery disease and an intermediate to high likelihood of coro-
nary artery disease undergoing cardiac single-photon emission
computed tomography, positron emission tomography, or 64-
slice coronary computed tomography angiography.
Results Baseline medication use was relatively infrequent.
At 90 days, 9.6% of patients underwent catheterization.
The rates of catheterization and medication changes
increased in proportion to test abnormality ﬁndings.
Among patients with the most severe test result ﬁndings,
38% to 61% were not referred to catheterization, 20% to
30% were not receiving aspirin, 35% to 44% were not
receiving a beta-blocker, and 20% to 25% were not
receiving a lipid-lowering agent at 90 days after the index
test. Risk-adjusted analyses revealed that compared with
stress single-photon emission computed tomography or
positron emission tomography, changes in aspirin and
lipid-lowering agent use was greater after computed to-
mography angiography, as was the 90-day catheterization
referral rate in the setting of normal/nonobstructive and
mildly abnormal test results.
Conclusions Overall, noninvasive testing had only
a modest impact on clinical management of patients refer-
red for clinical testing. Although post-imaging use of
cardiac catheterization and medical therapy increased
in proportion to the degree of abnormality ﬁndings,
the frequency of catheterization and medication change
suggests possible undertreatment of higher risk patients.
Patients were more likely to undergo cardiac catheterization
after computed tomography angiography than after single-
photon emission computed tomography or positron emis-
sion tomography after normal/nonobstructive and mildly
abnormal study ﬁndings. (Study of Perfusion and Anat-
omy’s Role in Coronary Artery [CAD] [SPARC];
NCT00321399) (144).Diagnostic Accuracy of Computed Tomography
Coronary Angiography According to Pre-Test
Probability of Coronary Artery Disease and
Severity of Coronary Arterial Calciﬁcation:
The CORE-64 (Coronary Artery Evaluation Using
64-Row Multidetector Computed Tomography
Angiography) International Multicenter Study
Objectives The purpose of this study was to assess the
impact of patient population characteristics on accuracy by
computed tomography angiography (CTA) to detect
obstructive coronary artery disease (CAD).
Background The ability of CTA to exclude obstructive
CAD in patients of different pre-test probabilities and in
presence of coronary calciﬁcation remains uncertain.
Methods For the CORE-64 (Coronary Artery Evaluation
Using 64-Row Multidetector Computed Tomography
Angiography) study, 371 patients underwent CTA and
cardiac catheterization for the detection of obstructive CAD,
deﬁned as 50% luminal stenosis by quantitative coronary
angiography (QCA). This analysis includes 80 initially
excluded patients with a calcium score 600. Area under the
receiver-operating characteristic curve (AUC) was used to
evaluate CTA diagnostic accuracy compared to QCA in
patients according to calcium score and pre-test probability
of CAD.
Results Analysis of patient-based quantitative CTA accu-
racy revealed an AUC of 0.93 (95% conﬁdence interval [CI]:
0.90 to 0.95). The AUC remained 0.93 (95% CI: 0.90 to
0.96) after excluding patients with known CAD but
decreased to 0.81 (95% CI: 0.71 to 0.89) in patients with
calcium score 600 (p ¼ 0.077). While AUCs were similar
(0.93, 0.92, and 0.93, respectively) for patients with inter-
mediate, high pre-test probability for CAD, and known
CAD, negative predictive values were different: 0.90, 0.83,
and 0.50, respectively. Negative predictive values decreased
from 0.93 to 0.75 for patients with calcium score <100
or 100, respectively (p ¼ 0.053).
Conclusions Both pre-test probability for CAD and
coronary calcium scoring should be considered before using
CTA for excluding obstructive CAD. For that purpose,
CTA is less effective in patients with calcium score 600
and in patients with a high pre-test probability for
obstructive CAD (145).
Imaging in the Management of Ischemic
Cardiomyopathy: Special Focus on Magnetic
Resonance
Heart failure of ischemic origin has become increasingly
common over the last decade because of the improved survival
of patients with acute myocardial infarction. Revascularization
with coronary bypass grafting or percutaneous coronary
intervention plays a pivotal role in patients with ischemic
cardiomyopathy, although these interventions are often
associated with relatively high peri-procedural risk. The
pathophysiological substrate of ischemic cardiomyopathy is
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myocardium to irreversible scarring. There is evidence to
suggest that patients with hibernating myocardium beneﬁt
most from revascularization, whereas medical therapy is
associated with an adverse prognosis. Therefore, noninvasive
testing is recommended by relevant guidelines to guide
optimal management in these patients. However, the role of
noninvasive testing has recently been challenged. There are
various imaging modalities available that provide information
on different aspects of the disease, and therefore, they differ
signiﬁcantly in sensitivity and speciﬁcity. In clinical practice,
choosing among the different imaging modalities can be
difﬁcult. Cardiac magnetic resonance has evolved into a
comprehensive modality that can accurately determine the
amount of hibernating myocardium as well as the presence
and degree of myocardial ischemia and the extent of the scar.
This paper reviews the indications, accuracy, and clinical
utility of the available imaging techniques, with a special focus
on cardiac magnetic resonance in ischemic cardiomyopathy,
and provides an outlook on how this ﬁeld might evolve in the
future (146).Pulmonary Pressures and Death in Heart Failure:
A Community Study
Objectives The purpose of this study was to determine
among community patients with heart failure (HF) whether
pulmonary artery systolic pressure (PASP) assessed by
Doppler echocardiography was associated with death and
improved risk prediction over established factors, using the
integrated discrimination improvement and net reclassiﬁ-
cation improvement.
Background Although several studies have focused on
idiopathic pulmonary arterial hypertension, less is known
about pulmonary hypertension among patients with HF,
particularly about its prognostic value in the community.
Methods Between 2003 and 2010, Olmsted County resi-
dents with HF prospectively underwent assessment of
ejection fraction, diastolic function, and PASP by Doppler
echocardiography.
Results PASP was recorded in 1,049 of 1,153 patients
(mean age 76  13; 51% women). Median PASP was 48
mm Hg (25th to 75th percentile: 37.0 to 58.0). There were
489 deaths after a follow-up of 2.7  1.9 years. There was
a strong positive graded association between PASP and
mortality. Increasing PASP was associated with an increased
risk of death (hazard ratio [HR]: 1.45, 95% conﬁdence
interval [CI]: 1.13 to 1.85 for tertile 2; HR: 2.07, 95% CI:
1.62 to 2.64 for tertile 3 vs. tertile 1), independently of age,
sex, comorbidities, ejection fraction, and diastolic function.
Adding PASP to models including these clinical charac-
teristics resulted in an increase in the c-statistic from 0.704
to 0.742 (p ¼ 0.007), an integrated discrimination
improvement gain of 4.2% (p < 0.001), and a net reclassi-
ﬁcation improvement of 14.1% (p ¼ 0.002), indicating that
PASP improved prediction of death over traditionalprognostic factors. All results were similar for cardiovascular
death.
Conclusions Among community patients with HF, PASP
strongly predicts death and provides incremental and clini-
cally relevant prognostic information independently of
known predictors of outcomes (147).
PET/MRI of Inﬂammation in Myocardial Infarction
Objectives The aim of this study was to explore post–
myocardial infarction (MI) myocardial inﬂammation.
Background Innate immune cells are centrally involved in
infarct healing and are emerging therapeutic targets in
cardiovascular disease; however, clinical tools to assess their
presence in tissue are scarce. Furthermore, it is currently not
known if the nonischemic remote zone recruits monocytes.
Methods Acute inﬂammation was followed in mice with
coronary ligation by 18-ﬂuorodeoxyglucose (18FDG) posi-
tron emission tomography/magnetic resonance imaging,
ﬂuorescence-activated cell sorting, polymerase chain reac-
tion, and histology.
Results Gd-DTPA–enhanced infarcts showed high
18FDG uptake on day 5 after MI. Cell depletion and
isolation data conﬁrmed that this largely reﬂected inﬂam-
mation; CD11bþ cells had 4-fold higher 18FDG uptake
than the infarct tissue from which they were isolated
(p < 0.01). Surprisingly, there was considerable monocyte
recruitment in the remote myocardium (approximately 104/
mg of myocardium, 5.6-fold increase; p < 0.01), a ﬁnding
mirrored by macrophage inﬁltration in the remote myocar-
dium of patients with acute MI. Temporal kinetics of cell
recruitment were slower than in the infarct, with peak
numbers on day 10 after ischemia. Quantitative polymerase
chain reaction showed a robust increase of recruiting adhe-
sion molecules and chemokines in the remote myocardium
(e.g., 12-fold increase of monocyte chemoattractant protein-
1), although levels were always lower than in the infarct.
Finally, matrix metalloproteinase activity was signiﬁcantly
increased in noninfarcted myocardium, suggesting that
monocyte recruitment to the remote zone may contribute to
post-MI dilation.
Conclusions This study shed light on the innate inﬂam-
matory response in remote myocardium after MI (148).
Examination of the In Vivo Mechanisms of Late
Drug-Eluting Stent Thrombosis: Findings From
Optical Coherence Tomography and Intravascular
Ultrasound Imaging
Objectives This study investigated the role of uncovered
stent struts on late stent thrombosis (LST) after drug-
eluting stent (DES) implantation with optical coherence
tomography (OCT).
Background Autopsy studies have identiﬁed delayed heal-
ing and lack of endothelialization of DES struts as the
hallmarks of LST. DES strut coverage has not previously
been examined in vivo in patients with LST.
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LST (median 615 days after implant) undergoing emergent
percutaneous coronary interventions and 36 matched DES
control subjects undergoing routine repeat OCT and
intravascular ultrasound (IVUS) who did not experience
LST for 3 years. Thrombus aspiration was performed
during emergent percutaneous coronary intervention before
OCT and IVUS assessment.
Results By OCT, patients with LSTdcompared with
control subjectsdhad a higher percentage of uncovered
(median [interquartile range]) (12.27 [5.50 to 23.33] vs. 4.14
[3.00 to 6.22], p< 0.001) andmalapposed (4.60 [1.85 to 7.19]
vs. 1.81 [0.00 to 2.99], p < 0.001) struts. The mean neo-
intimal thickness was similar in the 2 groups (0.23 0.17 mm
vs. 0.17 0.09 mm, p¼ 0.28). By IVUS, stent expansion was
comparable in the 2 groups, although positive remodeling was
increased in patients with LST (mean vessel cross-section area
19.4  5.8 mm2 vs. 15.1  4.6 mm2, p ¼ 0.003). Thrombus
aspiration demonstrated neutrophils and eosinophils in most
cases. By multivariable analysis, the length of segment with
uncovered stent struts by OCT and the remodeling index by
IVUS were independent predictors of LST.
Conclusions In this in vivo case-controlled study, the
presence of uncovered stent struts as assessed by OCT and
positive vessel remodeling as imaged by IVUS were associ-
ated with LST after DES (149).Assessment of the Accuracy and Reproducibility of
RV Volume Measurements by CMR in Congenital
Heart Disease
Objectives The purpose of this study was to determine
whether right ventricular (RV) volumes are more accurately
and reproducibly measured by cardiac magnetic resonance
(CMR) in an axial orientation or in a short-axis orientation
in patients with congenital heart disease (CHD).
Background There is little agreement on the most suitable
imaging plane for RV volumetric analysis in the setting of
abnormal RV physiology.
Methods Measurements of RV volumes from datasets
acquired in axial and short-axis orientations were made in 50
patients with CHD. RV stroke volumes (SV) calculated
using these 2 methods were compared with forward ﬂow
measured in the pulmonary trunk by phase contrast (PC)
imaging. Repeated volume measurements were made to
assess intraobserver and interobserver reliability. Bland-
Altman plots and Lin’s concordance correlation coefﬁcient
(CCC) were used for all analyses of agreement.
Results Analysis of all subjects revealed a statistically
signiﬁcant difference in interobserver reliability of RV end-
systolic volume (ESV) measurements that favored the axial
method (p ¼ 0.047). The magnitude of measurement
differences between observers in this case was small (2.8
ml/m2; 95% conﬁdence interval: 5.6 to 0.0). There was no
difference between the 2 contouring methods in terms of
intraobserver reliability in measurements of RV end-diastolicvolume (EDV), ESV, ejection fraction, or SV (p > 0.05 in
all cases). In subjects with RV EDV 150 ml/m2, RV SV
measured using axial contours yielded better agreement
with forward ﬂow measured in the pulmonary trunk
(CCC ¼ 0.63) than did measurements made using short-
axis contours (CCC ¼ 0.56; p ¼ 0.007).
Conclusions Trends favoring the axial orientation in terms
of reproducibility were not clinically signiﬁcant. In subjects
with RV EDV 150 ml/m2, the axial orientation yields RV
volume measurements that agree more closely with ﬂow
measured in the pulmonary trunk than does the short-axis
orientation (150).Simultaneous Right and Left Heart Real-Time,
Free-Breathing CMR Flow Quantiﬁcation Identiﬁes
Constrictive Physiology
Objectives The purpose of this study was to evaluate the
ability of a novel cardiac magnetic resonance (CMR) real-
time phase contrast (RT-PC) ﬂow measurement technique
to reveal the discordant respirophasic changes in mitral and
tricuspid valve in ﬂow indicative of the abnormal hemody-
namics seen in constrictive pericarditis (CP).
Background Deﬁnitive diagnosis of CP requires identiﬁ-
cation of constrictive hemodynamics with or without peri-
cardial thickening. CMR to date has primarily provided
morphological assessment of the pericardium.
Methods Sixteen patients (age 57  13 years) undergoing
CMR to assess known or suspected CP and 10 controls
underwent RT-PC that acquired simultaneous mitral valve
and tricuspid valve inﬂow velocities over 10 s of unrestricted
breathing. The diagnosis of CP was conﬁrmed via clinical
history, diagnostic imaging, cardiac catheterization, intra-
operative ﬁndings, and histopathology.
Results Ten patients had CP, all with increased pericardial
thickness (6.2  1.0 mm). RT-PC imaging demonstrated
discordant respirophasic changes in atrioventricular valve
inﬂow velocities in all CP patients, with mean  SD mitral
valve and tricuspid valve inﬂow velocity variation of 46
 20% and 60  15%, respectively, compared with 16  8%
and 24  11% in patients without CP (p < 0.004 vs.
patients with CP for both) and 17  5% and 31  13% in
controls (p < 0.001 vs. patients with CP for both). There
was no difference in atrioventricular valve inﬂow velocity
variation between patients without CP compared with
controls (p > 0.3 for both). Respiratory variation exceeding
25% across the mitral valve yielded a sensitivity of 100%,
a speciﬁcity of 100%, and an area under the receiver-
operating characteristic curve of 1.0 to detect CP physi-
ology. Using a cutoff of 45%, variation of transtricuspid valve
velocity had a sensitivity of 90%, a speciﬁcity of 88%, and an
area under the receiver-operating characteristic curve of 0.98.
Conclusions Accentuated and discordant respirophasic
changes in mitral valve and tricuspid valve inﬂow velocities
characteristic of CP can be identiﬁed noninvasively with
RT-PC CMR. When incorporated into existing CMR
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CMR provides important hemodynamic evidence with
which to make a deﬁnite diagnosis of CP (151).Molecular Imaging of Bone Marrow Mononuclear
Cell Survival and Homing in Murine Peripheral
Artery Disease
Objectives This study aims to provide insight into
cellular kinetics using molecular imaging after different
transplantation methods of bone marrow–derived mono-
nuclear cells (MNCs) in a mouse model of peripheral artery
disease (PAD).
Background MNC therapy is a promising treatment for
PAD. Although clinical translation has already been estab-
lished, there is a lack of knowledge about cell behavior after
transplantation and about the mechanism whereby MNC
therapy might ameliorate complaints of PAD.
Methods MNCs were isolated from F6 transgenic mice
(FVB background) that express ﬁreﬂy luciferase (Fluc)
and green ﬂuorescence protein (GFP). Male FVB and
C57Bl6 mice (n ¼ 50) underwent femoral artery
ligation and were randomized into 4 groups receiving
the following: 1) single intramuscular (IM) injection
of 2  106 MNCs; 2) 4 weekly IM injections of 5  105
MNCs; 3) 2  106 MNCs intravenously; and 4)
phosphate-buffered saline as control. Cells were charac-
terized by ﬂow cytometry and in vitro bioluminescence
imaging (BLI). Cell survival, proliferation, and migration
were monitored by in vivo BLI, which was validated
by ex vivo BLI, post-mortem immunohistochemistry,
and ﬂow cytometry. Paw perfusion and neovascularization
was measured with laser Doppler perfusion imaging
(LDPI) and histology, respectively.
Results In vivo BLI revealed near-complete donor cell
death 4 weeks after IM transplantation. After intravenous
transplantation, BLI revealed that cells migrated to the
injured area in the limb, as well as to the liver, spleen, and
bone marrow. Ex vivo BLI showed presence of MNCs in
the scar tissue and adductor muscle. However, no signiﬁcant
effects on neovascularization were observed, as monitored by
LDPI and histology.
Conclusions This is one of the ﬁrst studies to assess kinetics
of transplanted MNCs in PAD using in vivo molecular
imaging. MNC survival is short-lived, MNCs do not prefer-
entially home to injured areas, andMNCs do not signiﬁcantly
stimulate perfusion in this particular model (152).Noninvasive LV Pressure Estimation Using
Subharmonic Emissions From Microbubbles
To develop a new noninvasive approach to quantify left
ventricular (LV) pressures using subharmonic emissions
from microbubbles, an ultrasound scanner was used in
pulse inversion grayscale mode; unprocessed radio-
frequency data were obtained with pulsed wave Dopplerfrom the aorta and/or LV during Sonazoid infusion.
Subharmonic data (in dB) were extracted and processed.
Calibration factor (mm Hg/dB) from the aortic pressure
was used to estimate LV pressures. Errors ranged from
0.19 to 2.50 mm Hg when estimating pressures using
the aortic calibration factor, and were higher (0.64 to
8.98 mm Hg) using a mean aortic calibration factor.
Subharmonic emissions from ultrasound contrast agents
have the potential to noninvasively monitor LV pressures
(153).Correlation Between Arterial FDG Uptake and
Biomarkers in Peripheral Artery Disease
Objectives A prospective, multicenter 18ﬂuorine-ﬂuo-
rodeoxyglucose (18F-FDG) positron emission tomography
(PET)/computed tomography (CT) imaging study was
performed to estimate the correlations among arterial FDG
uptake and atherosclerotic plaque biomarkers in patients
with peripheral artery disease.
Background Inﬂammation within atherosclerotic plaques is
associated with instability of the plaque and future cardio-
vascular events. Previous studies have shown that 18F-
FDG-PET/CT is able to quantify inﬂammation within
carotid artery atherosclerotic plaques, but no studies to date
have investigated this correlation in peripheral arteries with
immunohistochemical conﬁrmation.
Methods Thirty patients across 5 study sites underwent
18F-FDG-PET/CT imaging before SilverHawk atherec-
tomy (FoxHollow Technologies, Redwood City, California)
for symptomatic common or superﬁcial femoral arterial
disease. Vascular FDG uptake (expressed as target-to-
background ratio) was measured in the carotid arteries and
aorta and femoral arteries, including the region of atherec-
tomy. Immunohistochemistry was performed on the excised
atherosclerotic plaque extracts, and cluster of differentiation
68 (CD68) level as a measure of macrophage content was
determined. Correlations between target-to-background
ratio of excised lesions, as well as entire arterial regions,
and CD68 levels were determined. Imaging was performed
during the 2 weeks before surgery in all cases.
Results Twenty-one patients had adequate-quality 18F-
FDG-PET/CT peripheral artery images, and 34 plaque
specimens were obtained. No signiﬁcant correlation between
lesion target-to-background ratio and CD68 level was
observed.
Conclusions There were no signiﬁcant correlations bet-
ween CD68 level (as a measure of macrophage content)
and FDG uptake in the peripheral arteries in this multi-
center study. Differences in lesion extraction technique,
lesion size, the degree of inﬂammation, and imaging cor-
egistration techniques may have been responsible for the
failure to observe the strong correlations with vascular
FDG uptake observed in previous studies of the carotid
artery and in several animal models of atherosclerosis
(154).
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Coronary Stents by Optical Frequency Domain
Imaging
Objectives This study sought to examine the capability of
optical frequency domain imaging (OFDI) to characterize
various morphological and histological responses to stents
implanted in human coronary arteries.
Background A precise assessment of vascular responses to
stents may help stratify the risk of future adverse events in
patients who have been treated with coronary stents.
Methods Fourteen human stented coronary segments with
implant duration 1 month from 10 hearts acquired at
autopsy were interrogated ex vivo by OFDI and intravascular
ultrasound (IVUS). Comparison with histology was assessed
in 134 pairs of images where the endpoints were to inves-
tigate: 1) accuracy of morphological measurements; 2)
detection of uncovered struts; and 3) characterization of
neointima.
Results Although both OFDI and IVUS provided a good
correlation of neointimal area with histology, the correlation
of minimum neointimal thickness was inferior in IVUS
(R2 ¼ 0.39) as compared with OFDI (R2 ¼ 0.67). Similarly,
IVUS showed a weak correlation of the ratio of uncovered to
total stent struts per section (RUTSS) (R2 ¼ 0.24), whereas
OFDI maintained superiority (R2¼ 0.66). In a more detailed
analysis by OFDI, identiﬁcation of individual uncovered
struts demonstrated a sensitivity of 77.9% and speciﬁcity of
96.4%. Other important morphological features such as ﬁbrin
accumulation, excessive inﬂammation (hypersensitivity), and
in-stent atherosclerosis were characterized by OFDI; how-
ever, the similarly dark appearance of these tissues did not
allow for direct visual discrimination. The quantitative anal-
ysis of OFDI signal reﬂections from various in-stent tissues
demonstrated distinct features of organized thrombus and
accumulation of foamy macrophages.
Conclusions The results of the present study reinforce the
potential of OFDI to detect vascular responses that may be
important for the understanding of long-term stent perfor-
mance, and indicate the capability of this technology to serve
as a diagnostic indicator of clinical success (155).
Imaging of Receptors for Advanced Glycation End
Products in Experimental Myocardial Ischemia and
Reperfusion Injury
Objectives The aim of this study was to image expression
of receptor for advanced glycation end products (RAGE) in
a mouse model of myocardial reperfusion injury.
Background RAGE and its ligands are implicated in the
pathogenesis of ischemia/reperfusion injury and infarction.
We hypothesized that RAGE-directed quantitative imaging
of myocardial uptake of technetium-99m (99mTc)-anti-
RAGE F(ab’)2 in a mouse model of myocardial ischemic
injury can detect RAGE expression and show quantitative
differences between early (18 to 20 h) and later times (48 h)
after reperfusion.Methods Twenty-ﬁve wild-type (WT) mice underwent left
anterior descending coronary artery occlusion for 30 min.
Mice were injected with 19.98  1.78 MBq of 99mTc anti-
RAGE F(ab’)2 at 2 time points after reperfusion (at 18 to 20
h [n ¼ 8] and at 48 h [n ¼ 12]) and 5 h later with 6.14 
2.0 MBq of thallium-201 (201Tl). Five WT mice were
injected with nonspeciﬁc F(ab’)2 and 201Tl 18 to 20 h after
reperfusion. Six WT mice underwent sham operation
without coronary intervention. After injection with 201Tl,
all mice immediately underwent dual isotope single-photon
emission computed tomography/computed tomography. At
completion of imaging, hearts were counted and sectioned.
Results The uptake of 99mTc-anti-RAGE F(ab’)2 in the
ischemic zone from the scans as mean percentage injected dose
was signiﬁcantly greater at 18 to 20 h (5.7 2.1 103%) as
compared with at 48 h (1.4  1.1  103%; p < 0.001) after
reperfusion. Disease and antibody controls showed no focal
uptake in the infarct. Gamma well counting of the myocar-
dium supported the quantitative scan data.By immunohisto-
chemical staining there was greater caspase-3 and RAGE
staining at 18 to 20 h versus at 48 h (p ¼ 0.04 and p ¼ 0.01,
respectively). On dual immunoﬂuorescence, RAGE colo-
calized mainly with injured cardiomyocytes undergoing
apoptosis.
Conclusions RAGE expression in myocardial ischemic
injury can be imaged in vivo using a novel 99mTc-anti-
RAGE F(ab’)2. RAGE plays a role in several cardiovascular
diseases and is a potential target for clinical imaging (156).Assessment of Myocardial Ischemic Memory Using
Speckle Tracking Echocardiography
Objectives The aim of this study was to evaluate which
regional myocardial parameters derived from speckle
tracking echocardiography could demonstrate myocardial
ischemic memory in a brief ischemia-reperfusion dog model.
Background Myocardial ischemic memory imaging,
denoting the visualization of abnormalities provoked by
ischemia and sustained even after restoration of perfusion,
can convey important clinical information. We previously
reported that post-systolic shortening (PSS) remains in the
risk area after recovery from brief ischemia. However, it is
still unclear whether abnormalities in other regional defor-
mation parameters persist after relief from brief ischemia.
Methods Echocardiographic data were chronologically
acquired from 11 dogs during 2 min of coronary occlusion
followed by reperfusion. Regional systolic and diastolic
deformation parameters, including parameters related to
PSS, were measured from radial and circumferential strain
and from strain rate analyzed in the risk and normal areas.
Strain imaging diastolic index (SI-DI), which had been
proposed as a parameter for assessing ischemic memory, was
also calculated.
Results Peak systolic strain, end-systolic strain, and peak
systolic strain rate decreased in the risk area during occlusion
but recovered to the baseline level immediately after
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during occlusion; however, the decrease did not persist after
reperfusion. Post-systolic strain index (PSI) and time-to-
peak strain index, which are parameters of PSS, increased
during occlusion. These increases persisted until 10 to 20
min after reperfusion (circumferential PSI: 0.02  0.04
[baseline] vs. 0.08  0.04 [20 min], p < 0.05). SI-DI did
not show a signiﬁcant change during occlusion because of
a large variation.
Conclusions Although abnormalities of PSS-related
parameters alone persisted after recovery from 2-min
occlusion, abnormalities of other deformation parameters,
such as strain rate during early diastole, did not. These data
suggest that assessment of PSS by speckle tracking echo-
cardiography is useful for detecting myocardial ischemic
memory (157).Imaging for Planning of Cardiac Resynchronization
Therapy
Cardiac resynchronization therapy (CRT) is a novel therapy
for patients with refractory heart failure (HF). Large clinical
trials evaluating CRT have demonstrated signiﬁcant
improvements in cardiac survival, decreases in recurrent HF
hospitalization, and improvements in indexes of quality of
life. Although numerous mechanisms are involved in CRT’s
therapeutic effects, correction of both interventricular and
intraventricular mechanical dyssynchrony has been postu-
lated as the key mechanism. To date, most large randomized
controlled trials evaluating CRT have identiﬁed dyssyn-
chronous patients on the basis of prolongation of the QRS
complex from the baseline electrocardiogram. Concerns have
been raised regarding the use of this measure for patient
selection, stemming from a signiﬁcant 30% to 40% nonre-
sponse rate to CRT. Because of the cost and invasive nature
of CRT, optimal patient selection for this therapy has
become a priority for HF specialists and electrophysiologists.
Cardiac imaging modalities have attempted to fulﬁll this
need to improve patient selection by identifying mechanical
dyssynchrony. Although early echocardiographic studies
reported promising results, more recent larger scale studies
have curtailed this enthusiasm, with a lack of established
selection criteria for CRT in the current practice guidelines.
This review summarizes the evidence to date and the
potential role of imaging modalities in the selection and care
of patients with HF referred for CRT (158).Progressive Right Ventricular Dysfunction in
Patients With Pulmonary Arterial Hypertension
Responding to Therapy
Objectives The purpose of this study was to examine the
relationship between changes in pulmonary vascular resis-
tance (PVR) and right ventricular ejection fraction (RVEF)
and survival in patients with pulmonary arterial hypertension
(PAH) under PAH-targeted therapies.Background Despite the fact that medical therapies reduce
PVR, the prognosis of patients with PAH is still poor. The
primary cause of death is right ventricular (RV) failure. One
possible explanation for this apparent paradox is the fact that
a reduction in PVR is not automatically followed by an
improvement in RV function.
Methods A cohort of 110 patients with incident PAH
underwent baseline right heart catheterization, cardiac
magnetic resonance imaging, and 6-min walk testing. These
measurements were repeated in 76 patients after 12 months
of therapy.
Results Two patients underwent lung transplantation, 13
patients died during the ﬁrst year, and 17 patients died in
the subsequent follow-up of 47 months. Baseline RVEF
(hazard ratio [HR]: 0.938; p ¼ 0.001) and PVR (HR:
1.001; p ¼ 0.031) were predictors of mortality. During the
ﬁrst 12 months, changes in PVR were moderately correlated
with changes in RVEF (R ¼ 0.330; p ¼ 0.005). Changes in
RVEF (HR: 0.929; p ¼ 0.014) were associated with
survival, but changes in PVR (HR: 1.000; p ¼ 0.820) were
not. In 68% of patients, PVR decreased after medical
therapy. Twenty-ﬁve percent of those patients with
decreased PVR showed a deterioration of RV function and
had a poor prognosis.
Conclusions After PAH-targeted therapy, RV function
can deteriorate despite a reduction in PVR. Loss of RV
function is associated with a poor outcome, irrespective of
any changes in PVR (159).In Vivo Characterization of a New Abdominal Aortic
Aneurysm Mouse Model With Conventional and
Molecular Magnetic Resonance Imaging
Objectives The goal of this study was to use noninvasive
conventional and molecular magnetic resonance imaging
(MRI) to detect and characterize abdominal aortic aneu-
rysms (AAAs) in vivo.
Background Collagen is an essential constituent of aneu-
rysms. Noninvasive MRI of collagen may represent an
opportunity to help detect and better characterize AAAs and
initiate intervention.
Methods We used an AAA C57BL/6 mouse model in
which a combination of angiotensin II infusion and trans-
forming growth factor–b neutralization results in AAA
formation with incidence of aortic rupture. High-resolution,
multisequence MRI was performed to characterize the
temporal progression of an AAA. To allow molecular MRI
of collagen, paramagnetic/ﬂuorescent micellar nanoparticles
functionalized with a collagen-binding protein (CNA-35)
were intravenously administered. In vivo imaging results
were corroborated with immunohistochemistry and confocal
ﬂuorescence microscopy.
Results High-resolution, multisequence MRI allowed the
visualization of the primary ﬁbrotic response in the aortic
wall. As the aneurysm progressed, the formation of
a secondary channel or dissection was detected. Further
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Injection of CNA-35 micelles resulted in a signiﬁcantly
higher magnetic resonance signal enhancement in the
aneurysmal wall compared with nonspeciﬁc micelles.
Histological studies revealed the presence of collagen in
regions of magnetic resonance signal enhancement, and
confocal microscopy proved the precise co-localization of
CNA-35 micelles with type I collagen. In addition, in
a proof-of-concept experiment, we reported the potential of
CNA-35 micelles to discriminate between stable AAA
lesions and aneurysms that were likely to rapidly progress or
rupture.
Conclusions High-resolution, multisequence MRI allowed
longitudinal monitoring of AAA progression while the
presence of collagen was visualized by nanoparticle-
enhanced MRI (160).Prevalence and Severity of Coronary Artery
Disease and Adverse Events Among Symptomatic
Patients With Coronary Artery Calciﬁcation Scores
of Zero Undergoing Coronary Computed
Tomography Angiography: Results From the
CONFIRM (Coronary CT Angiography Evaluation for
Clinical Outcomes: An International Multicenter)
Registry
Objectives The purpose of this study was to describe the
prevalence and severity of coronary artery disease (CAD) in
relation to prognosis in symptomatic patients without
coronary artery calciﬁcation (CAC) undergoing coronary
computed tomography angiography (CCTA).
Background The frequency and clinical relevance of CAD
in patients without CAC are unclear.
Methods We identiﬁed 10,037 symptomatic patients
without CAD who underwent concomitant CCTA and
CAC scoring. CAD was assessed as <50%, 50%,
and 70% stenosis. All-cause mortality and the composite
endpoint of mortality, myocardial infarction, or late coronary
revascularization (90 days after CCTA) were assessed.
Results Mean age was 57 years, 56% were men, and 51%
had a CAC score of 0. Among patients with a CAC score of
0, 84% had no CAD, 13% had nonobstructive stenosis, and
3.5% had 50% stenosis (1.4% had 70% stenosis) on
CCTA. A CAC score >0 had a sensitivity, speciﬁcity, and
negative and positive predictive values for stenosis 50% of
89%, 59%, 96%, and 29%, respectively. During a median of
2.1 years, there was no difference in mortality among
patients with a CAC score of 0 irrespective of obstructive
CAD. Among 8,907 patients with follow-up for the
composite endpoint, 3.9% with a CAC score of 0 and 50%
stenosis experienced an event (hazard ratio: 5.7; 95%
conﬁdence interval: 2.5 to 13.1; p < 0.001) compared with
0.8% of patients with a CAC score of 0 and no obstructive
CAD. Receiver-operator characteristic curve analysis
demonstrated that the CAC score did not add incremental
prognostic information compared with CAD extent onCCTA for the composite endpoint (CCTA area under the
curve ¼ 0.825; CAC þ CCTA area under the curve ¼
0.826; p ¼ 0.84).
Conclusions In symptomatic patients with a CAC score of
0, obstructive CAD is possible and is associated with
increased cardiovascular events. CAC scoring did not add
incremental prognostic information to CCTA (161).
Cholesterol Acyltransferase Gene Mutations Have
Accelerated Atherogenesis as Assessed by Carotid
3.0-T Magnetic Resonance Imaging: Carriers of
Lecithin
Objectives The aim of this study was to investigate the role
of reduced lecithin: cholesterol acyltransferase (LCAT)
function on atherogenesis using 3.0-T carotid magnetic
resonance imaging (MRI) and B-mode ultrasound.
Background The role of low high-density lipoprotein
cholesterol as a causal factor in atherogenesis has recently
been questioned. LCAT plays a key role in high-density
lipoprotein cholesterol metabolism.
Methods Carotid 3.0-T MRI and B-mode ultrasound
measurements were performed in 40 carriers of LCAT gene
mutations and 40 controls, matched for age. Patients with
cardiovascular disease were excluded.
Results Carriers had 31% lower LCAT activity levels and
38% decreased high-density lipoprotein cholesterol levels
(both p < 0.001 vs. controls). Carriers presented with
a 10% higher normalized wall index (0.34  0.07 vs. 0.31
 0.04, p ¼ 0.002), a 22% higher mean wall area
(17.3  8.5 mm2 vs. 14.2  4.1 mm2, p ¼ 0.01), and a 22%
higher total wall volume (1,039  508 mm3 vs. 851 
247 mm3, p ¼ 0.01 vs. controls) as measured by MRI.
The prevalence (20 vs. 5, p ¼ 0.002) and the total volume
(102 mm3 vs. 3 mm3) of atherosclerotic plaque components
on MRI relating to lipid-rich tissue or calciﬁcation were
also higher in carriers than in controls. All differences
retained signiﬁcance after adjustment for age, sex, blood
pressure, low-density lipoprotein cholesterol, body mass
index, smoking, and family history of cardiovascular
disease. Common carotid intima-media thickness mea-
sured with ultrasound was increased in carriers by 12.5%
(0.72  0.33 mm vs. 0.64  0.15 mm, p ¼ 0.14).
Conclusions Carriers of LCAT gene mutations exhibit
increased carotid atherosclerosis, indicating an increased risk
of cardiovascular disease. The present ﬁndings imply that
increasing LCAT activity may be an attractive target in
cardiovascular prevention strategies (162).
CMR Imaging of Edema in Myocardial Infarction
Using Cine Balanced Steady-State Free Precession
Objectives The aim of this study was to investigate the
capabilities of balanced steady-state free precession (bSSFP)
cardiac magnetic resonance imaging as a novel cine imaging
approach for characterizing myocardial edema in animals
and patients after reperfused myocardial infarction.
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require 2 separate scans for assessment of myocardial edema
and cardiac function.
Methods Mini-pigs (n ¼ 13) with experimentally induced
reperfused myocardial infarction and patients with reper-
fused ST-segment elevation myocardial infarction (n ¼ 26)
underwent cardiac magnetic resonance scans on days 2 to 4
post-reperfusion. Cine bSSFP, T2-weighted short TI
inversion recovery (T2-STIR), and late gadolinium
enhancement were performed at 1.5-T. Cine bSSFP and
T2-STIR images were acquired with a body coil to mitigate
surface coil bias. Signal, contrast, and the area of edema were
compared. Additional patients (n ¼ 10) were analyzed for
the effect of microvascular obstruction on bSSFP. A
receiver-operator characteristic analysis was performed to
assess the accuracy of edema detection.
Results An area of hyperintense bSSFP signal consistent
with edema was observed in the infarction zone (contrast-to-
noise ratio: 37 13) in all animals and correlated well with the
area of late gadolinium enhancement (R¼ 0.83, p< 0.01). In
all patients, T2-STIR and bSSFP images showed regional
hyperintensity in the infarction zone. Normalized contrast-to-
noise ratios were not different between T2-STIR and bSSFP.
On a slice basis, the volumes of hyperintensity on T2-STIR
and bSSFP images correlated well (R ¼ 0.86, p < 0.001),
and their means were not different. When compared with T2-
STIR, bSSFPwas positive for edema in 25 of 26 patients (96%
sensitivity) and was negative in all controls (100% speciﬁcity).
All patients with microvascular obstruction showed a signiﬁ-
cant reduction of signal in the subendocardial infarction zone
compared with infarcted epicardial tissue without microvas-
cular obstruction (p < 0.05).
Conclusions Myocardial edema from ST-segment eleva-
tion myocardial infarction can be detected using cine bSSFP
imaging with image contrast similar to T2-STIR. This new
imaging approach allows evaluation of cardiac function and
edema simultaneously, thereby reducing patient scan time
and increasing efﬁciency. Further work is necessary to
optimize edema contrast in bSSFP images (163).A Randomized Study of the Beneﬁcial Effects of
Aldosterone Antagonism on LV Function,
Structure, and Fibrosis Markers in Metabolic
Syndrome
Objectives The purpose of this study was to identify the
effects of spironolactone on left ventricular (LV) structure
and function, and serological ﬁbrosis markers in patients with
metabolic syndrome (MS) taking angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers.
Background Myocardial ﬁbrosis may be an important
contributor to myocardial impairment in MS, and aldoste-
rone antagonism may reduce ﬁbrosis.
Methods Eighty patients (age 59  11 years) with MS,
already being treated with angiotensin II inhibition, were
randomized to spironolactone 25 mg/day or placebo for6 months. Each patient underwent baseline and follow-up
conventional echocardiography and color tissue Doppler
imaging. Raw data ﬁles were used to measure calibrated
integrated backscatter and to calculate radial and longitu-
dinal strain. Blood was obtained at baseline and follow-up to
measure ﬁbrosis markers (procollagen type III amino-
terminal propeptide and procollagen type I carboxy-
terminal propeptide [PICP]).
Results The spironolactone group showed signiﬁcant
improvement of LV function, myocardial reﬂectivity, and
LV hypertrophy, with a parallel decrease in levels of PICP
and procollagen type III amino-terminal propeptide. No
analogous changes were seen in the placebo group. Baseline
strain (b ¼ 0.47, p < 0.0001), spironolactone therapy
(b ¼ 0.38, p < 0.0001), and change in PICP level
(b ¼ 0.19, p < 0.03) were independently associated with
LV systolic function improvement (increase in strain).
Correlates of LV diastolic function improvement (increase
in early diastolic mitral annular velocity) were baseline early
diastolic mitral annular velocity (b ¼ 0.47, p < 0.0001),
spironolactone therapy (b ¼ 0.21, p < 0.03), change in
PICP level (b ¼ 0.23, p < 0.02), and age (b ¼ 0.22,
p < 0.04). Favorable effects of spironolactone on cardiac
function were not demonstrated in patients with less ﬁbrosis
(the lower baseline PICP tertile) or preserved function (the
upper baseline strain tertile).
Conclusions Addition of spironolactone to standard
angiotensin II inhibition improved myocardial abnormalities
and decreased ﬁbrotic markers in MS. The magnitude of
beneﬁt on cardiac performance is determined mainly by
baseline LV dysfunction and collagen turnover as well its
response to intervention (164).Arterial Spin Labeled CMR Detects Clinically
Relevant Increase in Myocardial Blood Flow With
Vasodilation
Objectives This study sought to determine whether arterial
spin labeled (ASL) cardiac magnetic resonance (CMR) is
capable of detecting clinically relevant increases in regional
myocardial blood ﬂow (MBF) with vasodilator stress testing
in human myocardium.
Background Measurements of regional myocardial perfu-
sion at rest and during vasodilatation are used to determine
perfusion reserve, which indicates the presence and distri-
bution of myocardial ischemia. ASL CMR is a perfusion
imaging technique that does not require any contrast agents,
and is therefore safe for use in patients with end-stage renal
disease, and capable of repeated or continuous measurement.
Methods Myocardial ASL scans at rest and during aden-
osine infusion were incorporated into a routine CMR
adenosine induced vasodilator stress protocol and was per-
formed in 29 patients. Patients who were suspected of
having ischemic heart disease based on ﬁrst-pass imaging
also underwent x-ray angiography. Myocardial ASL was
performed using double-gated ﬂow-sensitive alternating
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precession imaging at 3-T.
Results Sixteen patients were found to be normal and 13
patients were found to have visible perfusion defect based on
ﬁrst-pass CMR using intravenous gadolinium chelate. In the
normal subjects, there was a statistically signiﬁcant difference
between MBF measured by ASL during adenosine infusion
(3.67 1.36 ml/g/min), compared to at rest (0.97 0.64 ml/
g/min), with p < 0.0001. There was also a statistically
signiﬁcant difference in perfusion reserve (MBFstress/
MBFrest) between normal myocardial segments (3.18
 1.54) and the most ischemic segments in the patients with
coronary artery disease identiﬁed by x-ray angiography (1.44
 0.97), with p ¼ 0.0011.
Conclusions This study indicates that myocardial ASL is
capable of detecting clinically relevant increases in MBF
with vasodilatation and has the potential to identify
myocardial ischemia (165).Inotropic Contractile Reserve Can Risk-Stratify
Patients With HIV Cardiomyopathy: A Dobutamine
Stress Echocardiography Study
Objectives The purpose of this study was to assess whether
inotropic contractile reserve (ICR) during dobutamine stress
echocardiography (DSE) could risk-stratify patients with
human immunodeﬁciency virus (HIV) cardiomyopathy and
predict improvement of left ventricular ejection fraction
(LVEF).
Background HIV cardiomyopathy is an important cause of
heart failure and death. ICR is associated with better survival
and improvement of LVEF in patients with ischemic and
nonischemic cardiomyopathies. However, the prognostic
value of ICR in patients with HIV cardiomyopathy is
unknown.
Methods Patients with HIV cardiomyopathy and
a LVEF <45% who were referred for DSE were enrolled.
ICR was evaluated by the delta wall motion score index
(DWMSI), calculated as the difference between rest and
peak WMSI. Patients were followed for cardiac death and
change in LVEF on follow-up.
Results Sixty patients (75% men; age, 54  9 years) with
HIV cardiomyopathy (mean LVEF, 28  11%) formed the
study group. After 2.4  2.1 years, 11 cardiac deaths
occurred (event rate of 7.6%/year). A receiver-operating
characteristic curve identiﬁed a DWMSI of 0.38 as an
optimal cut point for the presence of ICR, with a speciﬁcity
of 88% and a sensitivity of 73% for the prediction of cardiac
death. On univariable analysis, the absence of ICR (hazard
ratio: 6.6; 95% conﬁdence interval: 1.93 to 22.62;
p ¼ 0.003) and New York Heart Association functional
class IV (hazard ratio: 7.2; 95% conﬁdence interval: 2.20 to
23.65; p ¼ 0.001) were the only predictors of cardiac death.
After 2.1  1.8 years, 41 patients had a follow-up echo-
cardiogram. LVEF improvement from baseline occurred in
23 patients (56%), more so in patients with ICR thanwithout ICR. A DWMSI of 0.59 predicted improvement in
the LVEF with a speciﬁcity of 78% and a sensitivity of 74%.
Conclusions The presence of ICR during DSE can risk-
stratify and predict subsequent improvement in LVEF in
patients with HIV cardiomyopathy (166).CT for Evaluation of Myocardial Cell Therapy in
Heart Failure: A Comparison With CMR Imaging
Objectives The aim of this study was to use multidetector
computed tomography (MDCT) to assess therapeutic
effects of myocardial regenerative cell therapies.
Background Cell transplantation is being widely investi-
gated as a potential therapy in heart failure. Noninvasive
imaging techniques are frequently used to investigate
therapeutic effects of cell therapies in the preclinical and
clinical settings. Previous studies have shown that cardiac
MDCT can accurately quantify myocardial scar tissue and
determine left ventricular (LV) volumes and ejection frac-
tion (LVEF).
Methods Twenty-two minipigs were randomized to intra-
myocardial injection of phosphate-buffered saline (placebo,
n ¼ 9) or 200 million mesenchymal stem cells (MSC,
n ¼ 13) 12 weeks after myocardial infarction (MI). Cardiac
magnetic resonance and MDCT acquisitions were performed
before randomization (12 weeks after MI induction) and at
the study endpoint 24 weeks after MI induction. None of the
animals received medication to control the intrinsic heart rate
during ﬁrst-pass acquisitions for assessment of LV volumes
and LVEF. Delayed-enhancement MDCT imaging was
performed 10 min after contrast delivery. Two blinded
observers analyzed MDCT acquisitions.
Results MDCT demonstrated that MSC therapy resulted in
a reduction of infarct size from 14.3 1.2% to 10.3 1.5% of
LV mass (p ¼ 0.005), whereas infarct size increased in non-
treated animals (from 13.8 1.3% to 16.5 1.5%; p ¼ 0.02)
(placebo vs. MSC; p ¼ 0.003). Both observers had excellent
agreement for infarct size (r ¼ 0.96; p < 0.001). LVEF
increased from 32.6  2.2% to 36.9  2.7% in MSC-treated
animals (p ¼ 0.03) and decreased in placebo animals (from
33.3 1.4% to 29.1 1.5%; p¼ 0.01; at week 24: placebo vs.
MSC; p ¼ 0.02). Infarct size, end-diastolic LV volume, and
LVEF assessed by MDCT compared favorably with those
assessed by cardiac magnetic resonance acquisitions (r ¼ 0.70,
r ¼ 0.82, and r ¼ 0.902, respectively; p < 0.001).
Conclusions This study demonstrated that cardiac MDCT
can be used to evaluate infarct size, LV volumes, and LVEF
after intramyocardial-delivered MSC therapy. These ﬁnd-
ings support the use of cardiac MDCT in preclinical and
clinical studies for novel myocardial therapies (167).Stress Myocardial Perfusion Imaging for Assessing
Prognosis: An Update
A strength of nuclear myocardial perfusion imaging (MPI) is
the wealth of prognostic data accumulated over 30 years of
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outcomes and guide revascularization decisions in symp-
tomatic patients and is well validated in special populations
such as patients with diabetes and chronic renal disease.
Known limitations, such as underestimation of ischemia and
radiation burden, are being progressively reduced through
advances such as positron emission tomography absolute
ﬂow quantiﬁcation and fusion with computed tomography,
new camera hardware and software, and stress-only proto-
cols. Advanced statistical techniques and increasing focus on
comparative effectiveness and appropriateness will continue
to optimize nuclear cardiology going forward (168).Direct Percutaneous Left Ventricular Access and
Port Closure: Pre-Clinical Feasibility
Objectives This study sought to evaluate feasibility of
nonsurgical transthoracic catheter-based left ventricular
(LV) access and closure.
Background Implanting large devices, such as mitral or
aortic valve prostheses, into the heart requires surgical
exposure and repair. Reliable percutaneous direct trans-
thoracic LV access and closure would allow new nonsurgical
therapeutic procedures.
Methods Percutaneous direct LV access was performed in
19 swine using real-time magnetic resonance imaging
(MRI) and an “active” MRI needle antenna to deliver an
18-F introducer sheath. The LV access ports were closed
percutaneously using a commercial ventricular septal defect
occluder and an “active” MRI delivery cable for enhanced
visibility. We used “permissive pericardial tamponade”
(temporary ﬂuid instillation to separate the 2 pericardial
layers) to avoid pericardial entrapment by the epicardial disk.
Techniques were developed in 8 animals, and 11 more were
followed up to 3 months by MRI and histopathology.
Results Imaging guidance allowed 18-F sheath access and
closure with appropriate positioning of the occluder inside
the transmyocardial tunnel. Of the survival cohort, imme-
diate hemostasis was achieved in 8 of 11 patients. Failure
modes included pericardial entrapment by the epicardial
occluder disk (n ¼ 2) and a true-apex entry site that
prevented hemostatic apposition of the endocardial disk
(n ¼ 1). Reactive pericardial effusion (192  118 ml)
accumulated 5  1 days after the procedure, requiring
1-time drainage. At 3 months, LV function was preserved,
and the device was endothelialized.
Conclusions Direct percutaneous LV access and closure is
feasible using real-time MRI. A commercial occluder ach-
ieved hemostasis without evident deleterious effects on the
LV. Having established the concept, further clinical devel-
opment of this approach appears realistic (169).
Intracoronary Optical Diagnostics: Current Status,
Limitations, and Potential Optical coherence tomography
(OCT), is a novel intravascular imaging modality analogous
to intravascular ultrasound but uses light instead of sound.
This review details the background, development, and statusof current investigation using OCT, and discusses advan-
tages, limitations, and likely future developments. It provides
indications for possible future clinical use, and places OCT
in the context of current intravascular imaging in what is
a rapidly changing ﬁeld of investigation (170).
Closed-Chest Transthoracic Magnetic Resonance
Imaging-Guided Ventricular Septal Defect Closure
in Swine
Objectives The aim of this study was to close ventricular
septal defects (VSDs) directly through the chest wall using
magnetic resonance imaging (MRI) guidance, without
cardiopulmonary bypass, sternotomy, or radiation exposure.
Background Surgical, percutaneous, and hybrid manage-
ment of VSD each have limitations and known morbidity.
Methods Percutaneous muscular VSDs were created in 10
naive Yorkshire swine using a transjugular laser catheter.
Under real-time MRI guidance, a direct transthoracic
vascular access sheath was introduced through the chest into
the heart along a trajectory suitable for VSD access and
closure. Through this transthoracic sheath, muscular VSDs
were occluded using a commercial nitinol device. Finally, the
right ventricular free wall was closed using a commercial
collagen plug intended for arterial closure.
Results Anterior, posterior, and mid-muscular VSDs (6.8
 1.8 mm) were created. VSDs were closed successfully in
all animals. The transthoracic access sheath was displaced in
2, both fatal. Thereafter, we tested an intracameral retention
sheath to prevent this complication. Right ventricular access
ports were closed successfully in all, and after as many as 30
days, healed successfully.
Conclusions Real-time MRI guidance allowed closed-
chest transthoracic perventricular muscular VSD closure in
a clinically meaningful animal model. Once applied to
patients, this approach may avoid traditional surgical,
percutaneous, or open-chest transcatheter (“hybrid”)
risks (171).
Prognostic Assessment of Coronary Artery Bypass
Patients With 64-Slice Computed Tomography
Angiography: Anatomical Information Is
Incremental to Clinical Risk Prediction
Objectives We sought to determine the incremental
prognostic value of 64 multi-slice coronary computed
tomography angiography (CCTA) in coronary artery bypass
graft (CABG) patients.
Background Prognostication in CABG patients can be
difﬁcult. Anatomical assessment of native coronary artery
disease and graft patency might provide useful information,
but the utility of CCTA in the assessment of CABG
patients is unknown.
Methods Six hundred ﬁfty-seven CABG patients with all-
cause mortality follow-up were identiﬁed from a multicenter
CCTA registry, of 10,628 patients from 5 CCTA centers.
Clinical risk was proﬁled with modiﬁed logistic and additive
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Risk Evaluations). The CCTA deﬁned coronary anatomy.
Patients were classiﬁed by unprotected coronary territory
(UCT) or a summary of native vessel disease and graft
patency: the coronary artery protection score (CAPS).
Results Forty-four deaths occurred during a mean follow-
up of 20 months. Left ventricular ejection fraction, creati-
nine, age, severity of native vessel disease, UCT, CAPS, and
EuroSCOREs were univariate predictors of mortality
(p < 0.001). In multivariate analysis with additive Euro-
SCORE, UCT (p ¼ 0.004) and CAPS were predictive of
events (p < 0.001). In comparison with additive Euro-
SCORE, CAPS score was associated with a 27% net
reclassiﬁcation index.
Conclusions Coronary computed tomography angiography
provides incremental anatomical data to clinical risk assess-
ment to help determine the prognosis of patients after
CABG. The CAPS evaluation with CCTA might help
identify those patients at highest risk (172).Clinical Outcomes in Patients Undergoing
Percutaneous Closure of Periprosthetic
Paravalvular Leaks
Objectives The purpose of this study was to evaluate the
feasibility and efﬁcacy of the percutaneous device closure of
a consecutive series of patients with periprosthetic para-
valvular leaks referred to our structural heart disease center
with congestive heart failure and hemolytic anemia.
Background Clinically signiﬁcant periprosthetic para-
valvular leak is an uncommon but serious complication after
surgical valve replacement. Percutaneous closure has been
utilized as an alternative to surgical repair of this defect in
high-risk surgical patients.
Methods This is a retrospective review of 57 percutaneous
paravalvular leak closures that were performed in 43 patients
(67% male, mean age 69.4  11.7 years) between April 2006
and September 2010. Integrated imaging modalities were
used for the evaluation, planning, and guidance of the
interventions.
Results Closure was successful in 86% of leaks and in 86%
of patients. Twenty-eight of 35 patients improved by at least
1 New York Heart Association functional class. The
percentage of patients requiring blood transfusions and/or
erythropoietin injections post-procedure decreased from
56% to 5%. Clinical success was achieved in 89% of the
patients in whom procedure was successful. The survival
rates for patients at 6, 12, and 18 months after paravalvular
leak closures were 91.9%, 89.2%, and 86.5%, respectively.
Freedom from cardiac-related death at 42 months post-
procedure was 91.9%.
Conclusions Percutaneous closure of symptomatic para-
valvular leaks, facilitated by integrated imaging modalities
has a high rate of acute and long-term success and appears to
be effective in managing symptoms of heart failure and
hemolytic anemia (173).Multimodality Imaging in Transcatheter Aortic
Valve Implantation and Post-Procedural Aortic
Regurgitation: Comparison Among Cardiovascular:
Magnetic Resonance, Cardiac Computed
Tomography, and Echocardiography
Objectives The purpose of this study was to determine
imaging predictors of aortic regurgitation (AR) after trans-
catheter aortic valve implantation (TAVI) and the agreement
and reproducibility of cardiovascular magnetic resonance
(CMR), cardiac computed tomography (CCT), and trans-
thoracic echocardiography (TTE) in aortic root assessment.
Background The optimal imaging strategy for planning
TAVI is unclear with a paucity of comparative multi-
modality imaging data. The association between aortic root
morphology and outcomes after TAVI also remains
incompletely understood.
Methods A total of 202 consecutive patients assessed by
CMR, CCT, and TTE for TAVI were studied. Agreement
and variability among and within imaging modalities was
assessed by Bland-Altman analysis. Postoperative AR was
assessed by TTE.
Results Of the 202 patients undergoing TAVI assessment
with both CMR and TTE, 133 also underwent CCT. Close
agreement was observed between CMR and CCT in
dimensions of the aortic annulus (bias, 0.4 mm; 95% limits
of agreement: 5.7 to 5.0 mm), and similarly for sinus of
Valsalva, sinotubular junction, and ascending aortic
measures. Agreement between TTE-derived measures and
either CMR or CCT was less precise. Intraobserver and
interobserver variability were lowest with CMR. The pres-
ence and severity of AR after TAVI were associated with
larger aortic valve annulus measurements by both CMR
(p ¼ 0.03) and CCT (p ¼ 0.04) but not TTE-derived
measures (p ¼ 0.10). Neither CCT nor CMR measures of
annulus eccentricity, however, predicted AR after TAVI
(p ¼ 0.33 and p ¼ 0.78, respectively).
Conclusions In patients undergoing imaging assessment
for TAVI, the presence and severity of AR after TAVI were
associated with larger aortic annulus measurements by both
CMR and CCT, but not TTE. Both CMR and CCT
provide highly reproducible information in the assessment of
patients undergoing TAVI (174).
Reduced Collagen Deposition in Infarcted
Myocardium Facilitates Induced Pluripotent Stem
Cell Engraftment and Angiomyogenesis for
Improvement of Left Ventricular Function
Objectives The purpose of this study was to assess the effect
of scar tissue composition on engraftment of progenitor cells
into infarcted myocardium.
Background Scar tissue formation after myocardial infarc-
tion creates a barrier that severely compromises tissue
regeneration, limiting potential functional recovery.
Methods In vitro: A tricell patch (Tri-P) was created from
peritoneum seeded and cultured with induced pluripotent
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mouse embryonic ﬁbroblasts. The expression of ﬁbrosis-
related molecules from mouse embryonic ﬁbroblasts and
infarcted heart was measured by Western blot and quanti-
tative reverse transcriptase polymerase chain reaction.
In vivo: A Tri-P was afﬁxed over the entire infarcted area 7
days after myocardial infarction in mice overexpressing
adenylyl cyclase 6 (AC6). Engraftment efﬁciency of pro-
genitor cells in hearts of AC6 mice was compared with that
of control wild-type (WT) mice using a combination of
in vivo bioluminescence imaging, post-mortem ex vivo tissue
analysis, and the number of green ﬂuorescent protein–
positive cells. Echocardiography of left ventricular (LV)
function was performed weekly. Hearts were harvested for
analysis 4 weeks after Tri-P application. Mouse embryonic
ﬁbroblasts were stimulated with forskolin before an anoxia/
reoxygenation protocol. Fibrosis-related molecules were
analyzed.
Results In AC6 mice, infarcted hearts treated with Tri-P
showed signiﬁcantly higher bioluminescence imaging
intensity and numbers of green ﬂuorescent protein–positive
cells than in WT mice. LV function improved progressively
in AC6 mice from weeks 2 to 4 and was associated with
reduced LV ﬁbrosis.
Conclusions Application of a Tri-P in AC6 mice resulted
in signiﬁcantly higher induced pluripotent stem cell
engraftment accompanied by angiomyogenesis in the
infarcted area and improvement in LV function (175).Diagnosis of Ischemia-Causing Coronary Stenoses
by Noninvasive Fractional Flow Reserve Computed
From Coronary Computed Tomographic
Angiograms: Results From the Prospective
Multicenter DISCOVER-FLOW (Diagnosis of
Ischemia-Causing Stenoses Obtained Via
Noninvasive Fractional Flow Reserve) Study
Objectives The aim of this study was to determine the
diagnostic performance of a new method for quantifying
fractional ﬂow reserve (FFR) with computational ﬂuid
dynamics (CFD) applied to coronary computed tomography
angiography (CCTA) data in patients with suspected or
known coronary artery disease (CAD).
Background Measurement of FFR during invasive coro-
nary angiography is the gold standard for identifying coro-
nary artery lesions that cause ischemia and improves clinical
decision-making for revascularization. Computation of FFR
from CCTA data (FFRCT) provides a noninvasive method
for identifying ischemia-causing stenosis; however, the
diagnostic performance of this new method is unknown.
Methods Computation of FFR from CCTA data was
performed on 159 vessels in 103 patients undergoing
CCTA, invasive coronary angiography, and FFR. Inde-
pendent core laboratories determined FFRCT and CAD
stenosis severity by CCTA. Ischemia was deﬁned by an
FFRCT and FFR 0.80, and anatomically obstructiveCAD was deﬁned as a CCTA with stenosis 50%. Diag-
nostic performance of FFRCT and CCTA stenosis was
assessed with invasive FFR as the reference standard.
Results Fifty-six percent of patients had 1 vessel with
FFR 0.80. On a per-vessel basis, the accuracy, sensitivity,
speciﬁcity, positive predictive value, and negative predictive
value were 84.3%, 87.9%, 82.2%, 73.9%, 92.2%, respec-
tively, for FFRCT and were 58.5%, 91.4%, 39.6%, 46.5%,
88.9%, respectively, for CCTA stenosis. The area under the
receiver-operator characteristics curve was 0.90 for FFRCT
and 0.75 for CCTA (p ¼ 0.001). The FFRCT and FFR
were well correlated (r ¼ 0.717, p < 0.001) with a slight
underestimation by FFRCT (0.022  0.116, p ¼ 0.016).
Conclusions Noninvasive FFR derived from CCTA is
a novel method with high diagnostic performance for the
detection and exclusion of coronary lesions that cause
ischemia. (The Diagnosis of ISChemia-Causing Stenoses
Obtained Via NoninvasivE FRactional FLOW Reserve;
NCT01189331) (176).
Valvular Heart Disease: The Value of 3-
Dimensional Echocardiography
Signiﬁcant advances in 3-dimensional echocardiography
(3DE) technology have ushered its use into clinical practice.
The recent advent of real-time 3DE using matrix array
transthoracic and transesophageal transducers has resulted in
improved image spatial resolution, and therefore, enhanced
visualization of the pathomorphological features of the
cardiac valves compared with previously used sparse array
transducers. It has enabled an unparalleled real-time visu-
alization of valves and subvalvular anatomic features from
a single volume acquisition without the need for ofﬂine
reconstruction. On-cart or ofﬂine post-processing using
commercially available and custom 3-dimensional analysis
software allows the quantiﬁcation of multiple parameters,
such as oriﬁce area, prolapse height and volume in mitral
valve disease, area of the left ventricular outﬂow tract, and
tricuspid annular geometry. In this review, we discuss the
incremental role of 3DE in evaluating valvular anatomic
features, volumetric quantiﬁcation, pre-surgical planning,
intraprocedural guidance, and post-procedural assessment of
valvular heart disease (177).
Nephrogenic Systemic Fibrosis: Review of 370
Biopsy-Conﬁrmed Cases
Discovery of an association between gadolinium-based
contrast agents (GBCAs) and nephrogenic systemic
ﬁbrosis (NSF) has led to less use of GBCA-enhanced
magnetic resonance imaging in dialysis patients and
patients with severe renal failure at risk of NSF, and the
virtual elimination of new cases of NSF. But shifting
patients with renal failure to alternative imaging methods
may subject patients to other risks (e.g., ionizing radiation or
iodinated contrast). This review paper examines 370 NSF
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Eliminating multiple risk factors by limiting GBCA dose to
a maximum of 0.1 mmol/kg, dialyzing patients undergoing
dialysis quickly following GBCA administration, delaying
GBCA in acute renal failure until after renal function
returns or dialysis is initiated, and avoiding nonionic linear
GBCA in patients with renal failure especially when there
are proinﬂammatory conditions may substantially reduce the
risk of NSF (178).Intracoronary Transluminal Attenuation Gradient in
Coronary CT Angiography for Determining Coronary
Artery Stenosis
Coronary computed tomography angiography (CTA)
assessment of calciﬁed or complex coronary lesions is
frequently challenging. Transluminal attenuation gradient
(TAG), deﬁned as the linear regression coefﬁcient between
luminal attenuation and axial distance, has a potential to
evaluate the degree of coronary stenosis. We examined the
value of TAG in determining the stenosis severity on 64-
slice coronary CTA. The value of TAG of 370 major
coronary arteries was measured from 7,263 intervals of
5-mm length. Compared with coronary CTA and invasive
coronary angiography, TAG decreased consistently and
signiﬁcantly with maximum stenosis severity on a per-vessel
basis, from 1.91  4.25 Hounsﬁeld units/10 mm for
diameter stenosis of 0% to 49% to 13.37  9.81 Houns-
ﬁeld units/10 mm for diameter stenosis of 100%
(p < 0.0001). Adding TAG to the interpretation of coro-
nary CTA improved diagnostic accuracy (p ¼ 0.001),
especially in vessels with calciﬁed lesions (N ¼ 127; net
reclassiﬁcation improvement 0.095; p ¼ 0.046). TAG
appears to be able to contribute to improved classiﬁcation of
coronary artery stenosis severity in coronary CTA, especially
in severely calciﬁed lesions (179).Aortic Annulus Diameter Determination by
Multidetector Computed Tomography:
Reproducibility, Applicability, and Implications for
Transcatheter Aortic Valve Implantation
Objectives This study sought to determine the most
reproducible multidetector computed tomography (MDCT)
measurements of the aortic annulus and to determine
methods to improve the applicability of these measurements
for transcatheter aortic valve implantation.
Background The reproducibility and applicability of
MDCT annular measurements to guide transcatheter aortic
valve implantation remain unclear.
Methods Annular measurements were performed in 50
patients planed for transcatheter aortic valve implantation in
multiple planes: basal ring (short- and long-axis, mean
diameter, area-derived diameter), coronal, sagittal, and
3-chamber projections. A theoretical model was developed
taking into account the differences between the mostreproducible MDCT measurements and transesophageal
echocardiography to guide valve size choice.
Results The most reproducible measurements were the
area-derived diameter and basal ring average diameter (inter-
reader intraclass correlation coefﬁcient: 0.87 [95% conﬁ-
dence interval: 0.81 to 0.92] and 0.80 [95% conﬁdence
interval: 0.70 to 0.87]; respectively; intrareader >0.90 for all
readers). These were generally larger than transesophageal
echocardiography diameters (mean difference of 1.5  1.6
mm and 1.1  1.7 mm, respectively). When a strategy of
valve-sizing is undertaken using these CT measurements
using an echocardiographic sizing scale, a different THV
size would be selected in 44% and 40% of cases, respectively.
When adjusting the sizing cutoffs to account for the
differences in observed diameters, this was reduced to 10%
to 12% (p < 0.01 for both, respectively).
Conclusions The most reproducible MDCT measure-
ments of the annulus are the area-derived diameter and basal
ring average diameter, with derived values generally larger
than those obtained with echocardiography. If MDCT is
used for valve sizing, a strategy incorporating these differ-
ences may be important. MDCT using these easily derived
measurements may be ideally suited to sizing transcatheter
aortic valves as they account for the eccentricity of the aortic
annulus, are reproducible, and are noninvasive (180).Acute Adverse Reactions to Gadolinium-Based
Contrast Agents in CMR: Multicenter Experience
With 17,767 Patients From the EuroCMR Registry
Objectives The purpose of this study was to assess the
frequency, manifestation, and severity of acute adverse
reactions associated with administration of several
gadolinium-based contrast agents to patients who under-
went cardiac magnetic resonance (CMR) imaging in the
EuroCMR (European Cardiovascular Magnetic Resonance)
Registry multinational and multicenter setting.
Background The frequency, manifestations, and severity of
acute adverse reactions associated with gadolinium-based
contrast agents in the speciﬁc setting of cardiovascular
magnetic resonance have not been systematically evaluated
yet.
Methods This is a multicenter and multinational registry
with consecutive enrollment of patients in 45 European
centers. During the current observation, 17,767 doses of
gadolinium-based contrast agent were administered to
17,767 patients. The mean dose was 25.6 ml (range 5 to
80 ml), which is equivalent to 0.128 mmol/kg (range 0.012
to 0.3 mmol/kg).
Results Thirty acute adverse reactions due to contrast
administration occurred (0.17%). All reactions were classi-
ﬁed as mild according to the American College of Radiology
deﬁnition. The most frequent complaints following contrast
administration were rashes and hives (9 of 30), followed by
nausea (7 of 30), and anxiety (6 of 30). The event rate
ranged from 0.06% (linear nonionic agent gadodiamide) to
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estingly, we also found different event rates between the
three main indications for CMR imaging, ranging from
0.1% (risk stratiﬁcation in suspected coronary artery disease)
to 0.42% (viability in known coronary artery disease).
Conclusions The incidence of acute adverse reactions after
administration of gadolinium-based contrast in the “off-
label” setting of CMR in our population was not different
from the incidence in the U.S. Food and Drug Adminis-
tration–approved general radiology setting. Thus, the off-
label use of gadolinium-based contrast in CMR should be
regarded as safe concerning the frequency, manifestation,
and severity of acute events (181).Prevalence and Risk Factors of Carotid Vessel
Wall Inﬂammation in Coronary Artery Disease
Patients: FDG-PET and CT Imaging Study
Objectives We investigated the prevalence and clinical risk
factors of carotid vessel wall inﬂammation by means of 18F-
ﬂuorodeoxyglucose positron emission tomography (FDG-
PET) in a population consisting of coronary artery disease
(CAD) patients.
Background The atherosclerotic disease process is charac-
terized by inﬁltration and retention of oxidized lipids in the
artery wall, triggering a disproportionate inﬂammatory
response. Efforts have been made to use noninvasive
imaging to quantify this inﬂammatory response in the vessel
wall. Recently, carotid FDG-PET has been shown to reﬂect
the metabolic rate of glucose, a process known to be
enhanced in inﬂamed tissue.
Methods Carotid inﬂammation was quantiﬁed in 82 CAD
patients (age 62  10 years) as the maximum target-to-
background ratio (wholevesselTBRmax). Furthermore, we
assessed the maximal standardized uptake value values
(wholevesselSUVmax), the single hottest segment (SHS),
and the percent active segments (PAS) of the FDG uptake
in the artery wall, measured by FDG-PET.
Results Whole-vesselTBRmax>1.8waspresent in 67%,>2.0
in 39%, >2.2 in 23%, and >2.4 in 12% of the population.
Multiple linear regression analysis with backward elimination
revealed that body mass index (BMI)30 kg/m2 (p< 0.0001),
age>65 years (p¼ 0.01), smoking (p¼ 0.02), and hypertension
(p ¼ 0.01) were associated with wholevesselTBRmax. The
number of components of the metabolic syndrome was also
associated with wholevesselTBRmax (p ¼ 0.02). In similar
analyses, wholevesselSUVmax was associated with BMI
30kg/m2 (p< 0.0001), age>65years (p¼ 0.004),male gender
(p¼ 0.02),andhypertension(p¼ 0.04);SHSwithBMI30kg/m2
(p < 0.0001), age >65 years (p ¼ 0.02), smoking (p ¼ 0.04),
and hypertension (p ¼ 0.05); PAS with BMI 30 kg/m2
(p¼ 0.001), smoking (p¼ 0.03), and hypertension (p¼ 0.01).
Conclusions Carotid inﬂammation as revealed by FDG-
PET is highly prevalent in the CAD population and is
associated with obesity, age over 65 years, history of
hypertension, smoking, and male gender. Artery wall FDGuptake increased when components of the metabolic
syndrome clustered (182).
Pericardial Delayed Hyperenhancement With CMR
Imaging in Patients With Constrictive Pericarditis
Undergoing Surgical Pericardiectomy: A Case
Series With Histopathological Correlation
Objectives The purpose of this study was to examine the
prevalence and histopathologic correlates of pericardial
delayed hyperenhancement (DHE) seen with cardiac
magnetic resonance imaging (CMR) among patients with
constrictive pericarditis (CP) undergoing pericardiectomy.
Background Constrictive pericarditis patients studied by
CMR will occasionally demonstrate pericardial DHE
following gadolinium contrast administration.
Methods We identiﬁed 25 CP patients who underwent
pericardiectomy following CMR-gadolinium study. We also
assessed 10 control subjects with no evidence of pericardial
disease referred for cardiac viability imaging. A novel 14-
segment pericardial model was used to determine pericar-
dial DHE score and thickness score. Histopathology of
pericardial specimens was reviewed and evaluated semi-
quantitatively on a 4-point scale for the extent of calciﬁca-
tion, ﬁbrosis, inﬂammation, and neovascularization.
Results DHE was present in 12 (48%) CP patients
(DHEþ group), and absent in 13 CP patients (DHE–
group) and all control patients. The DHEþ group had
greater ﬁbroblastic proliferation and neovascularization, as
well as more prominent chronic inﬂammation and granu-
lation tissue. Fibroblastic proliferation and chronic inﬂam-
mation correlated with DHE presence quantitated by DHE
score (Spearman r ¼ 0.578, p < 0.002, and r ¼ 0.590,
p < 0.002, respectively), but not with pericardial thickness.
Segmental analysis demonstrated no signiﬁcant difference in
the percentage of patients with different pericardial seg-
mental thickness; however, overall, in each segment, the
DHEþ group tended to have greater pericardial thickness.
Conclusions The presence of pericardial DHE on CMR is
common in patients with CP, and its presence is associated
with histological features of organizing pericarditis, which
may be a target for future focused pharmacological inter-
ventions. Patients with CP without pericardial DHE had
more pericardial ﬁbrosis and calciﬁcation, as well as lesser
degrees of pericardial thickening (183).
Quantitative Relationship Between the Extent and
Morphology of Coronary Atherosclerotic Plaque
and Downstream Myocardial Perfusion
Objectives The purpose of this study was to quantify the
effects of coronary atherosclerosis morphology and extent on
myocardial ﬂow reserve (MFR).
Background Although the relationship between coronary
stenosis and myocardial perfusion is well established, little is
known about the contribution of other anatomic descriptors
of atherosclerosis burden to this relationship.
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sclerosis plaque burden, morphology, and composition and
regional MFR (MFRregional) in 73 consecutive patients
undergoing Rubidium-82 positron emission tomography
and coronary computed tomography angiography for the
evaluation of known or suspected coronary artery disease.
Results Atherosclerosis was seen in 51 of 73 patients and in
107 of 209 assessable coronary arteries. On a per-vessel basis,
the percentage diameter stenosis (p ¼ 0.02) or summed
stenosis score (p ¼ 0.002), integrating stenoses in series, was
the best predictor of MFRregional. Importantly, MFRre-
gional varied widely within each coronary stenosis category,
even in vessels with nonobstructive plaques (n¼ 169), 38% of
which had abnormal MFRregional (<2.0). Total plaque
length, composition, and remodeling index were not associ-
ated with lower MFR. On a per-patient basis, the modiﬁed
Duke CAD (coronary artery disease) index (p ¼ 0.04) and
the number of segments with mixed plaque (p ¼ 0.01) were
the best predictors of low MFRglobal.
Conclusions Computed tomography angiography descrip-
tors of atherosclerosis had only amodest effect on downstream
MFR. On a per-patient basis, the extent and severity of
atherosclerosis as assessed by the modiﬁed Duke CAD index
and the number of coronary segments withmixed plaque were
associated with decreased MFR (184).Left Ventricular Structural Remodeling in Health
and Disease: With Special Emphasis on Volume,
Mass, and Geometry
The changes in left ventricular (LV) structure and geometry
that evolve after myocardial injury or overload usually involve
chamber dilation and/or hypertrophy. Such architectural
remodeling can be classiﬁed as eccentric or concentric.
Consideration of LV volume, mass, and relative wall thickness
(or mass/volume) allows classiﬁcation of LV remodeling that
includes virtually all LV remodeling changes that are seen in
health and disease. These various architectural changes gener-
ally include the development of LV hypertrophy in a pattern
that is closely related to the type of injury or overload, and they
are accompanied by differences in cardiac function and
hemodynamics. Some patterns of remodeling are associated
with adverse outcomeswhereas others appear tobe adaptive and
physiologic without adverse consequences. Considering all
patients with LV hypertrophy as a homogenous group is
inconsistent with our understanding of the various remodeling
patterns that are discussed in this review (185).Evaluation of the Second Generation of
a Bioresorbable Everolimus-Eluting Vascular
Scaffold for the Treatment of De Novo Coronary
Artery Stenosis: 12-Month Clinical and Imaging
Outcomes
Objectives The aim of this study was to demonstrate that
the prevention of early scaffold area shrinkage of theABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara,
California) was sustained and not simply delayed by a few
months.
Background With improved scaffold design and modiﬁed
manufacturing process of its polymer, the second iteration of
ABSORB (BVS 1.1) has improved performance to prevent
a scaffold area reduction at 6 months.
Methods Fifty-six patients were enrolled and received 57
ABSORB scaffolds. Quantitative coronary angiography,
intravascular ultrasound (IVUS), analysis of radiofrequency
backscattering, echogenicity and optical coherence tomog-
raphy (OCT) were performed at baseline and at 12-month
follow-up.
Results Overall the scaffold area remained unchanged with
IVUS as well as with OCT, whereas the radiofrequency
backscattering and the echogenicity of the struts decreased
by 16.8% (p < 0.001) and 20% (p < 0.001), respectively;
more speciﬁcally, the strut core area on OCT decreased by
11.4% (p ¼ 0.003). Despite the absence of scaffold area loss,
pharmacological vasomotion was restored. On an intention-
to-treat basis, the angiographic late lumen loss amounted to
0.27  0.32 mm with an IVUS relative decrease in minimal
lumen area of 1.94% (p ¼ 0.12), without signiﬁcant changes
in mean lumen area. The OCT at follow-up showed that
96.69% of the struts were covered and that malapposition,
initially observed in 18 scaffolds was only detected at follow-
up in 4 scaffolds. Two patients experienced peri-procedural
and iatrogenic myocardial infarction, respectively, whereas 2
underwent repeat intervention, resulting in the major
adverse cardiac event rate of 7.1% (4 of 56).
Conclusions The 12-month performance of the second-
generation ABSORB bioresorbable everolimus-eluting
scaffold justiﬁes the conduct of a randomized trial against
current best standards. (A Clinical Evaluation of the Bio-
absorbable Everolimus Eluting Coronary Stent System
[BVS EECSS] in the Treatment of Patients With de Novo
Native Coronary Artery Lesions; NCT00856856) (186).Left Atrial Compression and the Mechanism of
Exercise Impairment in Patients With a Large
Hiatal Hernia
Objectives The purpose of this study was to determine the
association between cardiac compression and exercise
impairment in patients with a large hiatal hernia (HH).
Background Dyspnea and exercise impairment are
common symptoms of a large HH with unknown patho-
physiology. Studies evaluating the contribution of cardiac
compression to the pathogenesis of these symptoms have not
been performed.
Methods We collected clinical data from a consecutive
series of 30 patients prospectively evaluated with resting and
stress echocardiography, cardiac computed tomography, and
respiratory function testing before and after laparoscopic
HH repair. Left atrial (LA), inferior pulmonary vein, and
coronary sinus compression was analyzed in relation to
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on Bruce treadmill protocol).
Results Exertional dyspnea was present in 25 of 30 patients
(83%) despite normal mean baseline respiratory function.
Moderate to severe LA compression was qualitatively
present in 23 of 30 patients (77%) on computed tomog-
raphy. Right and left inferior pulmonary vein and coronary
sinus compression was present in 11 of 30 (37%), 12 of 30
(40%), and 26 of 30 (87%) patients, respectively. Post-
operatively, New York Heart Association functional class
and exercise capacity improved signiﬁcantly (number of
patients in New York Heart Association functional classes I,
II, III, and IV: 6, 11, 11, and 2 vs. 26, 4, 0, and 0,
respectively, p < 0.001; METs [percentage predicted]: 75
 24% vs. 112  23%, p < 0.001) and resolution of cardiac
compression was observed. Absolute change in LA diameter
on the echocardiogram was the only independent cardiore-
spiratory predictor of exercise capacity improvement post-
operatively (p ¼ 0.006).
Conclusions We demonstrate, for the ﬁrst time, marked
exercise impairment and cardiac compression in patients
with a large HH and normal respiratory function. After HH
repair, exercise capacity improves signiﬁcantly and correlates
with resolution of LA compression (187).Pioglitazone Modulates Vascular Inﬂammation in
Atherosclerotic Rabbits: Noninvasive Assessment
With FDG-PET-CT and Dynamic Contrast-Enhanced
MR Imaging
Objectives We sought to determine the antiatherosclerotic
properties of pioglitazone using multimethod noninvasive
imaging techniques.
Background Inﬂammation is an essential component of
vulnerable or high-risk atheromas. Pioglitazone, a peroxi-
some proliferator-activated receptor-gamma agonist,
possesses potent anti-inﬂammatory properties. We aimed to
quantify noninvasively the anti-inﬂammatory effects of
pioglitazone on atheroma using 18F-ﬂuorodeoxyglucose
(18F-FDG) positron emission tomography (PET)/
computed tomography (CT) and dynamic contrast-
enhanced (DCE) magnetic resonance imaging (MRI).
Methods Atherosclerotic plaques were induced in the aorta
of 15 New Zealand white rabbits by a combination of
a hyperlipidemic diet and 2 balloon endothelial denudations.
Nine rabbits continued the same diet, whereas 6 rabbits
received pioglitazone (10 mg/kg orally) in addition to the
diet. Twelve animals underwent 18F-FDG-PET/CT, and
15 animals underwent DCE-MRI at baseline, 1 month, and
3 months after treatment initiation. Concomitantly, serum
metabolic parameters were monitored. After imaging was
completed, aortic histologic analysis and correlation analysis
were performed.
Results The 18F-FDG-PET/CT imaging detected an
increase in average standardized uptake value in the control
group (p < 0.01), indicating progressive inﬂammation,whereas stable standardized uptake values were observed in
the treatment group, indicating no progression. The DCE-
MRI analysis detected a signiﬁcant decrease in the area
under the curve for the pioglitazone group (p < 0.01).
Immunohistologic examination of the aortas demonstrated
a signiﬁcant decrease in macrophage and oxidized phos-
pholipid immunoreactivity in the pioglitazone group
(p ¼ 0.04 and p ¼ 0.01, respectively) with respect to control
animals, underlining the imaging results. Serum metabolic
parameters showed no difference between groups. Strong
positive correlations between standardized uptake value and
macrophage density and between area under the curve and
neovessels were detected (r2 ¼ 0.86 and p < 0.0001, and
r2 ¼ 0.66 and p ¼ 0.004, respectively).
Conclusions Both 18F-FDG-PET/CT and DCE-MRI
demonstrate noninvasively the anti-inﬂammatory effects of
pioglitazone on atheroma. Both imaging methods seem
suited to monitor inﬂammation in atherosclerosis (188).Direct Visualization of Regurgitant Oriﬁce by CMR
Reveals Differential Asymmetry According to
Etiology of Mitral Regurgitation
Objectives This study sought to characterize the shape of
regurgitant oriﬁce area (ROA) and mitral apparatus in
various forms of mitral regurgitation (MR) by cardiac
magnetic resonance (CMR).
Background ROA is an accepted parameter of MR
severity. However, there are little data on the shape of the
ROA in various forms of MR.
Methods Direct assessment of ROA was performed with
a 1.5-T CMR scanner using a breath-hold fast imaging with
steady-state free precession. The regurgitant oriﬁce shape
and the anatomy of the mitral valve apparatus including
mitral annulus, mitral leaﬂet angles, and mitral valve tenting
area were assessed.
Results We studied 74 patients. MR severity was mild in
39%, moderate in 27%, and moderate-to-severe or severe in
34%.Mitral valve pathology was degenerative in 26%, prolapse
in 22%, ﬂail in 33%, and functional in 19%. For all patients,
ROA correlated signiﬁcantly with regurgitant fraction
(r ¼ 0.80, p < 0.001). The ROA shape index as expressed by
the ratio of the larger length to the smaller length was a median
of 2.04 (interquartile range [IQR]: 1.49 to 3.08) over all
patients. CMR revealed signiﬁcant asymmetry of the ROA
geometry in functional MR 3.91 (IQR: 2.79 to 4.84)
compared with prolapse 2.14 (IQR: 1.80 to 3.04), ﬂail 2.20
(IQR: 1.69 to 2.91), and degenerative MR 1.24 (IQR: 1.09 to
1.57), all p < 0.01. The assessment of mitral valve geometry
demonstrated that patients with functional MR had signiﬁ-
cantly increased leaﬂet angles, mitral valve tenting area, and
mitral annulus area (all p < 0.05). Of note, the oriﬁce shape
index correlated with increasing leaﬂet angles in patients with
functional MR (r ¼ 0.68, p ¼ 0.005).
Conclusions Direct assessment of ROA by CMR revealed
signiﬁcant asymmetry of ROA in various forms of MR,
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appearance in functional MR correlates with a distended
mitral apparatus (189).Validation and Characterization of Transcatheter
Aortic Valve Effective Oriﬁce Area Measured by
Doppler Echocardiography
Objectives The objectives were to compare different
Doppler echocardiographic methods for the measurement of
prosthetic valve effective oriﬁce area (EOA) following
transcatheter aortic valve implantation (TAVI) and to de-
termine the factors inﬂuencing the EOA of transcatheter
balloon expandable valves.
Background Previous studies have used different methods
for the measurement of the valve EOA following TAVI.
Factors inﬂuencing the EOA of transcatheter valves are
unknown.
Methods A total of 122 patients underwent TAVI with the
use of the Edwards-SAPIEN valve (Edwards Lifesciences,
Irvine, California). The EOA was measured by transthoracic
echocardiography at hospital discharge, 6 months and 1 year
after TAVI with the use of 2 methods as described in
previous studies. In Method #1 (EOA1), LVOT diameter
(LVOTd) entered in the continuity equation was measured
at the base of prosthesis cusps whereas, in Method #2
(EOA2), LVOTd was measured immediately proximal to
the prosthesis stent.
Results The average EOA2 (1.57  0.41 cm2) was larger
(p < 0.01) than the EOA1 (1.21  0.38 cm2). Accordingly,
incidence of severe PPM (indexed EOA 0.65 cm2/m2)
was 3-fold lower with the use of EOA2 than with EOA1
(9% vs. 33%; p < 0.001). Mean transprosthetic gradient
correlated better (p ¼ 0.03) with indexed EOA2
(r ¼ 0.70, p < 0.0001) than with indexed EOA1
(r ¼ 0.58, p < 0.0001). Intraobserver and interobserver
variability were lower for EOA2 compared to EOA1 (intra:
5% vs. 7%, p ¼ 0.06; inter: 6% vs. 14%; p < 0.001). Aortic
annulus size was the sole independent determinant
(p ¼ 0.01) of prosthetic valve EOA2. The average EOA
varied from 1.37  0.23 cm2 for aortic annulus size <19 mm
up to 1.90  0.17 cm2 for size >23 mm.
Conclusions When estimating the EOA of Edwards-
SAPIEN valves by Doppler-echocardiography, it is recom-
mended to use the LVOT diameter and velocity measured
immediately proximal to the stent. The main determinant of
the EOA of transcatheter valves is the patient’s annulus size
and these valves provide excellent hemodynamics even in
patients with a small aortic annulus (190).Cardiac Magnetic Resonance in Hypertrophic
Cardiomyopathy
Hypertrophic cardiomyopathy is a complex genetic cardio-
vascular disorder with substantial variability in phenotypic
expression and natural progression. Recent researchdemonstrates the incremental utility of cardiac magnetic
resonance in the diagnosis, therapeutic planning, and
prognostication of this disease. The increasing incorporation
of multimodality imaging of hypertrophic cardiomyopathy
in clinical practice will continue to improve our under-
standing of the subtle morphologic differences and their
prognostic implications (191).Presence of Extensive LV Remodeling Limits the
Beneﬁts of CRT in Patients With Intraventricular
Dyssynchrony
Objectives The aim of this study was to evaluate whether,
in patients with evidence of both electrical and mechanical
left ventricular (LV) dyssynchrony, extensive LV dilation
would affect response to cardiac resynchronization therapy
(CRT).
Background Cardiac resynchronization therapy is effective
in heart failure patients with LV dysfunction and wide QRS
complex. However, many patients still fail to respond. We
hypothesized that presence of extensive LV dilation might
prevent response to CRT, despite LV mechanical
dyssynchrony.
Methods We studied 78 heart failure patients (68  9 years
of age, 77% men) with both electrical (QRS width >120
ms) and mechanical intraventricular dyssynchrony (by tissue
Doppler imaging and/or left lateral wall post-systolic
contraction). Echocardiographic evaluation was performed
at baseline and 6 to 8 months after CRT. As an indication of
LV remodeling, end-diastolic volume index and end-systolic
volume index (ESVI) and sphericity index were measured.
Long-term (40  23 months) clinical follow-up (events:
cardiac death and hospital admission for heart failure) was
also obtained.
Results At follow-up after CRT, in the overall population,
ejection fraction increased from 26  6% to 35  11%
(p < 0.0001), whereas end-diastolic volume index (from 144
 43ml/m2 to 119 55ml/m2), ESVI (from108 37ml/m2
to 82 49 ml/m2, p< 0.0001 for both), and sphericity index
(from 0.60 0.22 to 0.53 0.15, p¼ 0.0036) all signiﬁcantly
decreased. By multiple linear regression analysis, after
controlling for confounding factors, change in LV ejection
fraction at follow-up resulted independently and negatively
associated with baseline ESVI (p ¼ 0.001), with much lower
improvement after implant in the highest tertile of baseline
ESVI. During follow-up, 31 patients (39.7%) had a cardiac
event. By Cox regression model, baseline ESVI was the most
powerful predictor of events, with event-rate/year increasing
with increasing tertiles of ESVI (6.3%, 10.1%, and 23.8%,
respectively, p < 0.05).
Conclusions In this nonrandomized, open-label clinical
study, despite intraventricular electrical and mechanical
dyssynchrony, extensive LV remodeling at baseline nega-
tively impacted CRT results in terms of LV function
improvement and incidence of cardiac events at follow-
up (192).
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Inﬂammation in Patients With Impaired Glucose
Tolerance or Diabetes: A Prospective,
Randomized, Comparator-Controlled Study Using
Serial FDG PET/CT Imaging Study of Carotid Artery
and Ascending Aorta
Objectives The aim of this study was to compare the effect
of pioglitazone, an insulin sensitizer, with glimepiride, an
insulin secretagogue, on atherosclerotic plaque inﬂammation
by using serial 18F-ﬂuorodeoxyglucose positron emission
tomography (FDG-PET) imaging.
Background Atherosclerosis is intrinsically an inﬂammatory
disease. Although hyperglycemia is associated with an increased
risk of atherosclerotic cardiovascular disease, there are no clinical
data to show the preference of any speciﬁc oral hypoglycemic
agents to prevent atherosclerotic plaque inﬂammation.
Methods A total of 56 impaired glucose tolerant or diabetic
patients with carotid atherosclerosis underwent a complete
history, determinations of blood chemistries, anthropometric
variables, and FDG-PET. They were randomly assigned to
receive either pioglitazone (15 to 30 mg) or glimepiride (0.5
to 4.0 mg) for 4 months with titration to optimal dosage.
Effects of the drugs on atherosclerotic plaque inﬂammation
were evaluated by FDG-PET at study completion. Plaque
inﬂammation was measured by blood-normalized standard-
ized uptake value, known as a target-to-background ratio.
Results The study was completed in 31 pioglitazone-
treated patients and 21 glimepiride-treated patients.
Although both treatments reduced fasting plasma glucose
and hemoglobin A1c values comparably, pioglitazone, but
not glimepiride, decreased atherosclerotic plaque inﬂam-
mation. Compared with glimepiride, pioglitazone signiﬁ-
cantly increased high-density lipoprotein cholesterol level.
High-sensitivity C-reactive protein was decreased by pio-
glitazone, whereas it was increased by glimepiride. Multiple
stepwise regression analysis revealed that the increase in
high-density lipoprotein cholesterol level was independently
associated with the attenuation of plaque inﬂammation.
Conclusions Our present study suggests that pioglitazone
could attenuate atherosclerotic plaque inﬂammation in
patients with impaired glucose tolerance or in diabetic
patients independent of glucose lowering effect. Pioglitazone
may be a promising strategy for the treatment of athero-
sclerotic plaque inﬂammation in impaired glucose tolerance
or diabetic patients. (Detection of Plaque Inﬂammation and
Visualization of Anti-Inﬂammatory Effects of Pioglitazone
on Plaque Inﬂammation in Subjects With Impaired Glucose
Tolerance and Type 2 Diabetes Mellitus by FDG-PET/
CT; NCT00722631) (193).
Effective Use of Radiation Shields to Minimize
Operator Dose During Invasive Cardiology
Procedures
Objectives This study sought to measure the protection
from scatter radiation offered to the primary physician bya variety of available shields and to provide best practice
guidelines for shield use during invasive cardiology
procedures.
Background It is accepted that exposure to radiation
includes a predicted increase in cancer risk. In the cardiac
interventional laboratories, radiation shields are widely
available; however, proper use of the shields to optimize
protection during cardiac interventional procedures is not
well understood.
Methods The protection from scatter radiation offered by
a variety of shields used alone and in combination was
measured. Protection was assessed from air-kerma mea-
surements of scatter radiation from a phantom performed
without and with the shields. Protection was assessed for 3
patient- access locations (right jugular vein, right femoral
artery, and left anterior chest) and for elevations ranging
from 25 to 175 cm from the ﬂoor. The inﬂuence of precise
placement of the ceiling-mounted upper body shield was
speciﬁcally assessed.
Results The utility and protection of shielding varied for
the 3 access points and with elevation. For femoral artery
access locations, the shields can provide at least 80%
protection from scatter at all elevations; however, protection
depends substantially on upper body shield position. A
disposable radiation-absorbing pad can provide 35% to 70%
upper body protection for procedures during which the
upper body shield cannot be used effectively.
Conclusions Radiation shields can provide substantial
protection from radiation during cardiac interventional
procedures. Shields must be thoughtfully and actively
managed to provide optimum protection. Best practice
guidelines for shield use are provided (194).The CT-STAT (Coronary Computed Tomographic
Angiography for Systematic Triage of Acute Chest
Pain Patients to Treatment) Trial
Objectives The purpose of this study was to compare the
efﬁciency, cost, and safety of a diagnostic strategy employing
early coronary computed tomographic angiography (CCTA)
to a strategy employing rest-stress myocardial perfusion
imaging (MPI) in the evaluation of acute low-risk chest
pain.
Background In the United States, >8 million patients
require emergency department evaluation for acute chest
pain annually at an estimated diagnostic cost of >$10
billion.
Methods This multicenter, randomized clinical trial in 16
emergency departments ran between June 2007 and
November 2008. Patients were randomly allocated to
CCTA (n ¼ 361) or MPI (n ¼ 338) as the index nonin-
vasive test. The primary outcome was time to diagnosis; the
secondary outcomes were emergency department costs of
care and safety, deﬁned as freedom from major adverse
cardiac events in patients with normal index tests, including
6-month follow-up.
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diagnosis compared with MPI (median 2.9 h [25th to 75th
percentile: 2.1 to 4.0 h] vs. 6.3 h [25th to 75th percentile:
4.2 to 19.0 h], p < 0.0001). Costs of care were 38% lower
compared with standard (median $2,137 [25th to 75th
percentile: $1,660 to $3,077] vs. $3,458 [25th to 75th
percentile: $2,900 to $4,297], p < 0.0001). The diagnostic
strategies had no difference in major adverse cardiac events
after normal index testing (0.8% in the CCTA arm vs. 0.4%
in the MPI arm, p ¼ 0.29).
Conclusions In emergency department acute, low-risk
chest pain patients, the use of CCTA results in more
rapid and cost-efﬁcient safe diagnosis than rest-stress MPI.
Further studies comparing CCTA to other diagnostic
strategies are needed to optimize evaluation of speciﬁc
patient subsets. (Coronary Computed Tomographic Angi-
ography for Systematic Triage of Acute Chest Pain Patients
to Treatment [CT-STAT]; NCT00468325) (195).
Prevalence of Unrecognized Myocardial Infarction
Detected With Magnetic Resonance Imaging and
its Relationship to Cerebral Ischemic Lesions in
Both Sexes
Objectives The purpose of this study was to investigate the
prevalence of unrecognized myocardial infarction (UMI)
detected with magnetic resonance imaging (MRI) and
whether it is related to cerebral ischemic lesions on MRI in
an elderly population–based cohort.
Background There is a correlation between stroke and
recognized myocardial infarction (RMI) and between stroke
and UMI detected with electrocardiography, whereas the
prevalence of stroke in subjects with MRI-detected UMI is
unknown.
Methods Cerebral MRI and cardiac late-enhancement
MRI were performed on 394 randomly selected 75-year-
old subjects (188 women, 206 men). Images were assessed
for cerebral ischemic lesions and myocardial infarction (MI)
scars. Medical records were scrutinized. Subjects with MI
scars, with or without a hospital diagnosis of MI, were
classiﬁed as RMI or UMI, respectively.
Results UMIs were found in 120 subjects (30%) and RMIs
in 21 (5%). The prevalence of UMIs (p ¼ 0.004) and RMIs
(p ¼ 0.02) was greater in men than in women. Men with
RMI displayed an increased prevalence of cortical and
lacunar cerebral infarctions, whereas women with UMI more
frequently had cortical cerebral infarctions (p ¼ 0.003).
Conclusions MI scars are more frequent in men than in
women at 75 years of age. The prevalence of RMI is related
to that of cerebral infarctions (196).
Age-Related Changes in Aortic Arch Geometry:
Relationship With Proximal Aortic Function and
Left Ventricular Mass and Remodeling
Objectives We sought to deﬁne age-related geometric
changes of the aortic arch and determine their relationshipto central aortic stiffness and left ventricular (LV)
remodeling.
Background The proximal aorta has been shown to
thicken, enlarge in diameter, and lengthen with aging in
humans. However, no systematic study has described age-
related longitudinal and transversal remodeling of the
aortic arch and their relationship with LV mass and
remodeling.
Methods We studied 100 subjects (55 women, 45 men,
average age 46  16 years) free of overt cardiovascular
disease using magnetic resonance imaging to determine
aortic arch geometry (length, diameters, height, width, and
curvature), aortic arch function (local aortic distensibility and
arch pulse wave velocity [PWV]), and LV volumes and
mass. Radial tonometry was used to calculate central blood
pressure.
Results Aortic diameters and arch length increased
signiﬁcantly with age. The ascending aorta length increased
most, with age leading to aortic arch widening and
decreased curvature. These geometric changes of the aortic
arch were signiﬁcantly related to decreased ascending aortic
distensibility, increased aortic arch PWV (p < 0.001), and
increased central blood pressures (p < 0.001). Increased
ascending aortic diameter, lengthening, and decreased
curvature of the aortic arch (unfolding) were all signiﬁ-
cantly associated with increased LV mass and concentric
remodeling independently of age, sex, body size, and
central blood pressure (p < 0.01).
Conclusions Age-related unfolding of the aortic arch is
related to increased proximal aortic stiffness in individuals
without cardiovascular disease and associated with increased
LV mass and mass-to-volume ratio independent of age,
body size, central pressure, and cardiovascular risk
factors (197).Strain-Encoded Cardiac Magnetic Resonance
During High-Dose Dobutamine Stress Testing for
the Estimation of Cardiac Outcomes: Comparison
to Clinical Parameters and Conventional Wall
Motion Readings
Objectives The purpose of this study was to determine the
prognostic value of strain-encoded magnetic resonance
imaging (SENC) during high-dose dobutamine stress
cardiac magnetic resonance imaging (DS-MRI) compared
with conventional wall motion readings.
Background Detection of inducible ischemia by DS-MRI
on the basis of assessing cine images is subjective and
depends on the experience of the readers, which may
inﬂuence not only the diagnostic classiﬁcation but also the
risk stratiﬁcation of patients with ischemic heart disease.
Methods In all, 320 consecutive patients with suspected or
known coronary artery disease underwent DS-MRI, using
a standard protocol in a 1.5T MR scanner. Wall motion
abnormalities (WMA) and myocardial strain were assessed
at baseline and during stress, and outcome data including
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events”), and revascularization procedures performed >90
days after the MR scans were collected.
Results Thirty-ﬁve hard events occurred during a 28  9
month follow-up period, including 10 cardiac deaths and 25
nonfatal myocardial infarctions, and 32 patients under-
went coronary revascularization. Using a series of Cox
proportional-hazardsmodels, both resting and inducibleWMA
offered incremental information for the assessment of hard
cardiac events compared to clinical variables (chi-square ¼ 13.0
for clinical vs. chi-square ¼ 26.1 by adding resting WMA,
p < 0.001, vs. chi-square ¼ 39.3 by adding inducible WMA,
p < 0.001). Adding visual SENC or quantitative strain rate
reserve to thismodel further improved the prediction of outcome
(chi-square ¼ 50.7 vs. chi-square ¼ 52.5, p < 0.001 for both).
In a subset of patients (n ¼ 175) who underwent
coronary angiography, SENC yielded signiﬁcantly higher
sensitivity for coronary artery disease detection (96% vs. 84%,
p< 0.02), whereas speciﬁcity and accuracy were not signiﬁcantly
different (88% vs. 94% and 93% vs. 88%, p ¼ NS for both).
Conclusions Strain-encoded MRI aids the accurate iden-
tiﬁcation of patients at high risk for future cardiac events and
revascularization procedures, beyond the assessment of
conventional atherogenic risk factors and resting or inducible
WMA on cine images. (Strain-Encoded Cardiac Magnetic
Resonance Imaging as an Adjunct for Dobutamine Stress
Testing; NCT00758654) (198).Physiological Basis for Angina and ST-Segment
Change: PET-Veriﬁed Thresholds of Quantitative
Stress Myocardial Perfusion and Coronary Flow
Reserve
Objectives This study aimed to determine the quantitative
low-ﬂow threshold for stress-induced perfusion defects with
severe angina and/or signiﬁcant ST-segment depression
during dipyridamole hyperemia.
Background Vasodilator stress reveals differences in regional
perfusion without ischemia in most patients. However, in
patients with a perfusion defect, angina, and/or signiﬁcant ST-
segment depression during dipyridamole stress, quantitative
absolute myocardial perfusion and coronary ﬂow reserve
(CFR) at the exact moment of deﬁnite ischemia have not been
established. Deﬁning these low-ﬂow thresholds of angina or
ST-segment changes may offer insight into physiological
disease severity in patients with atherosclerosis.
Methods Patients underwent rest–dipyridamole stress
positron emission tomography (PET) with absolute ﬂow
quantiﬁcation in ml/min/g. Deﬁnite ischemia was deﬁned as
a new or worse perfusion defect during dipyridamole stress
with signiﬁcant ST-segment depression and/or severe
angina requiring pharmacological treatment. Indeterminate
clinical features required only 1 of these 3 abnormalities.
The comparison group included patients without prior
myocardial infarction, or angina or electrocardiographic
changes after dipyridamole.Results In 1,674 sequential PET studies, we identiﬁed 194
(12%) with deﬁnite ischemia, 840 (50%) studies with no
ischemia, and 301 (18%) that were clinically indeterminate. A
vasodilator stress perfusion cutoff of 0.91 ml/min/g optimally
separated deﬁnite from no ischemia with an area under the
receiver-operator characteristic curve (AUC) of 0.98 and
a CFR cutoff of 1.74 with an AUC¼ 0.91, reﬂecting excellent
discrimination at the exact moment of deﬁnite ischemia.
Conclusions Thresholds of low myocardial vasodilator
stress perfusion in ml/min/g and CFR sharply separate
patients with angina or ST-segment change from those
without these manifestations of ischemia during dipyr-
idamole stress with excellent discrimination. Stress ﬂow
below 0.91 ml/min/g in dipyridamole-induced PET perfu-
sion defects causes signiﬁcant ST-segment depression and/
or severe angina. However, when the worst vasodilator stress
ﬂow exceeds 1.12 ml/min/g, these manifestations of
ischemia occur rarely (199).Correlation of Angiographic Late Loss With
Neointimal Proliferation in Stents Evaluated by
OCT and Histology in Porcine Coronary Arteries
Objectives We aimed to evaluate the correlation of
angiographic late loss (LL) with the degree of in-stent
neointimal proliferation assessed by optical coherence
tomography (OCT) and histology.
Background Angiographic LL is the most common endpoint
used in clinical trials for the evaluation of the efﬁcacy of drug-
eluting stents (DES). However, there are few data in regards to
the accuracy of angiographic LL in the evaluation of DES dis-
playing lower degrees of neointimal proliferation.
Methods A total of 49 stents (36 DES and 13 bare-metal
stents) were deployed in coronary arteries of 23 domestic
swine and followed up for 28 or 90 days, thus obtaining
different degrees of neointimal proliferation. Each stent was
divided into 8 to 9 segments along the longitudinal axis to
match corresponding histological cross sections. Angio-
graphic LL was calculated at each segment throughout the
entire length of the stent and compared with in-stent neo-
intimal thickness (NT) obtained by OCT and histology.
Results A total of 382 angiographic segments were suitable
for matched comparison with both OCT and histological
ﬁndings. The mean LL at follow-up was 0.60  0.57 mm
(range: 0.46 to 2.3 mm) for all segments. Approximately
13.9% of stent segments had a LL between 0.5 and 0 mm,
and 22.5% had a LL greater than 1.0 mm. The correlation
between OCT and histology for the evaluation of NT was
adequate regardless the level of angiographic LL. In addi-
tion, overall correlations between angiographic LL and NT
by OCT or histology were adequate (R ¼ 0.77 and 0.63,
respectively). However, angiographic LL showed a poor
correlation with NT by OCT or histology at a value<0.55 mm
(R ¼ 0.38 and 0.15, respectively).
Conclusions Angiographic LL below a threshold value of
0.55 mm correlates poorly with NT obtained by OCT and
JACC Vol. 62, No. 14, 2013 The Editors
October 1, 2013:e29–141 JACC Topic Collection: Cardiac Imaging
e101histology. These results suggest a cautious interpretation is
needed to evaluate angiographic endpoints in DES trials in
which LL values below this threshold are reported (200).
3D Echocardiography to Evaluate Right Atrial
Pressure in Acutely Decompensated Heart Failure:
Correlation With Invasive Hemodynamics
Objectives This study examined the utility of 3-dimensional
right atrial volume index (3D-RAVi), combined with
2-dimensional echocardiographic (2DE) parameters, for the
identiﬁcation of elevated right atrial pressure (RAP) in patients
with heart failure.
Background Accurate noninvasive determination of RAP
is clinically important for the management of patients with
heart failure. Although 2DE methods have been used to
noninvasively estimate RAP, the accuracy of these parame-
ters has limitations when estimating RAP in an individual
patient. Three-dimensional echocardiography (3DE)
provides tomographic imaging of right atrial volume that
may be helpful in reﬁning the noninvasive assessment of
hemodynamics in patients with heart failure.
Methods 2DE and 3DE studies were examined in 40 initial
patients who were admitted for acutely decompensated heart
failure. Simultaneous pulmonary artery catheter monitoring
was performed. The relationship between echocardiographic
parameters and RAP was examined in this derivation group.
The ﬁndings from the derivation group were then prospec-
tively tested in a validation group of 40 additional patients.
Results Mean RAP was 11  5 mm Hg (range 2 to
22 mm Hg). 3D-RAVi correlated with RAP (r ¼ 0.51,
p < 0.001), whereas 2-dimensional right atrial volume index
did not. Inferior vena cava (IVC) diameter 2 cm and IVC
respirophasic collapse <40% also correlated with RAP
(p < 0.001 and p ¼ 0.028, respectively). Based on receiver-
operator characteristic curve analysis, 3D-RAVi 35 ml/m2
was the optimal 3D-RAVi cutpoint for identifying
RAP >10 mm Hg. The value of 3D-RAVi 35 ml/m2,
combined with IVC measures, for predicting RAP >10
mm Hg was prospectively tested in the validation group.
3D-RAVi 35 ml/m2 in combination with IVC 2 cm had
a high accuracy (88%) for identifying RAP >10 mm Hg and
had a higher accuracy than the combination of IVC 2 cm
and IVC collapse <40% (accuracy: 68%, p ¼ 0.038).
Conclusions In patients with heart failure, 3D-RAVi in
conjunction with IVC parameters has a high accuracy for
detection of elevated RAP. The addition of 3D-RAVi to
2DE methods may be helpful in the noninvasive estimation
of right atrial pressure (201).
MR Imaging of Carotid Plaque Composition During
Lipid-Lowering Therapy: A Prospective Assessment
of Effect and Time Course
Objectives The purpose of this study was to test the lipid
depletion hypothesis and to establish the time course of
change in carotid plaque morphology and compositionduring lipid therapy using high-resolution magnetic reso-
nance imaging (MRI).
Background Lipid therapy is thought to improve plaque
stability and reduce cardiovascular events by targeting the
plaque rupture risk features such as large lipid core, thin
ﬁbrous cap, and high level of inﬂammatory inﬁltrates.
However, the plaque stabilizing process during lipid therapy
has not been clearly demonstrated in humans and in vivo.
Methods Subjects with coronary or carotid artery disease,
apolipoprotein B 120 mg/dl, and lipid treatment
history <1 year, were randomly assigned to atorvastatin
monotherapy or to atorvastatin-based combination therapies
with appropriate placebos for 3 years. All subjects underwent
high-resolution, multicontrast bilateral carotid MRI scans at
baseline and annually for 3 years. All images were analyzed
for quantiﬁcation of wall area and plaque composition
blinded to therapy, laboratory results, and clinical course.
Results After 3 years of lipid therapy, the 33 subjects with
measurable lipid-rich necrotic core (LRNC) at baseline had
a signiﬁcant reduction in plaque lipid content: LRNC volume
decreased from 60.4  59.5 mm3 to 37.4  69.5 mm3
(p < 0.001) and %LRNC (LRNC area/wall area in the lipid-
rich regions) from 14.2  7.0% to 7.4  8.2% (p < 0.001).
The time course showed that %LRNC decreased by 3.2
(p < 0.001) in the ﬁrst year, by 3.0 (p ¼ 0.005) in the second
year, and by 0.91 (p ¼ 0.2) in the third year. Changes in
LRNC volume followed the same pattern. Percent wall
volume (100 wall/outer wall, a ratio of volumes) in the lipid-
rich regions signiﬁcantly decreased from 52.3  8.5% to 48.6
 9.7% (p ¼ 0.002). Slices containing LRNC had signiﬁ-
cantly more percent wall volume reduction than those without
(4.7% vs. 1.4%, p ¼ 0.02).
Conclusions Intensive lipid therapy signiﬁcantly depletes
carotid plaque lipid. Statistically signiﬁcant plaque lipid deple-
tion is observed after 1 year of treatment and continues in the
second year, and precedes plaque regression. (Using Magnetic
Resonance Imaging to Evaluate Carotid Artery Plaque
Composition in People Receiving Cholesterol-Lowering
Medications [The CPC Study]; NCT00715273) (202).Contribution of Ventricular Diastolic Dysfunction
to Pulmonary Hypertension Complicating Chronic
Systolic Heart Failure
Objectives The aim of the study is to clarify the clinical role
of Doppler-echocardiographic parameters of left ventricular
diastolic dysfunction (LVDD) as determinants of pulmonary
hypertension in patients experiencing left ventricular systolic
dysfunction (LVSD) with and without the presence of
functional mitral valve regurgitation (FMR).
Background Pulmonary hypertension (pulmonary venous
or mixed pulmonary venous-arterial hypertension) compli-
cating LVSD is associated with poor outcomes beyond that
of LVSD alone. The view of the contribution of LVDD as
a determinant of pulmonary hypertension is controversial
and not well deﬁned as a tool in clinical practice.
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going Doppler-echocardiography evaluations during the
period from August 2001 to December 2004 were analyzed.
Pulmonary systolic pressure (PSP), parameters of diastolic
function (mitral valve [MV] transmitral ﬂow velocity [E]/
mitral annular diastolic velocity [e0] ratio, MV deceleration
time [DT]), quantitated effective regurgitant oriﬁce area
(EROA) of FMR, and clinical characteristics were evalu-
ated. Pulmonary hypertension was deﬁned as an estimated
PSP 45 mm Hg.
Results Criteria were met in 1,541 patients; one-third (n ¼
533) demonstrating PSP 45 mm Hg (58  10 mm Hg,
range 45 to 102 mm Hg). Patients with pulmonary hyper-
tension were older with higher E/e0 ratio, EROA, and lower
DT and LVEF. In multivariate analysis, pulmonary hyper-
tension was independently predicted not only by severity of
FMR (EROA 20 mm2, odds ratio: 3.8, p < 0.001) but
also by parameters of LVDD (E/e0 ratio 15, odds ratio:
3.31, p < 0.001; DT 150 ms, odds ratio: 3.8, p < 0.001).
Receiver-operating characteristics curve analysis showed that
EROA, E/e0 ratio, and DT provided signiﬁcant incremental
value in predicting pulmonary hypertension (c-statistic
0.830, p < 0.001).
Conclusions Patients with LVSD commonly have
secondary pulmonary hypertension, which is largely deter-
mined by the severity of LVDD even with adjustment for
FMR and low LVEF. Thus, measures of LVDD in routine
clinical practice where PSP may not be estimated are
important physiologic descriptors of hemodynamic status
and are cumulatively linked in the prediction of pulmonary
hypertension (203).Serial Doppler Echocardiography and Tissue
Doppler Imaging in the Detection of Elevated
Directly Measured Left Atrial Pressure in Ambulant
Subjects With Chronic Heart Failure
Objectives This study sought to determine the accuracy of
Doppler echocardiography and tissue Doppler imaging
(TDI) measurements in detecting elevated left atrial pressure
(LAP) in ambulant subjects with chronic heart failure using
directly measured LAP as the reference.
Background Echocardiographic indexes including the ratio
of transmitral to annular early diastolic velocities (E/e0) may
identify raised invasively measured left ventricular ﬁlling
pressures when tested in cross-sectional studies in some
populations. The accuracy of these indexes when measured
sequentially remains untested. We determined the accuracy
of Doppler echocardiography and TDI measurements in
detecting elevated directly measured LAP in ambulant
subjects with stable chronic heart failure.
Methods Fifteen patients with New York Heart Associa-
tion functional class II to III heart failure and a permanently
implanted direct LAP monitoring device underwent
serial echocardiography. Simultaneous resting mean LAP,
Doppler mitral inﬂow, mitral annular TDI, and pulmonaryvenous inﬂow velocities were obtained on each occasion.
Receiver-operator characteristic curve analysis was used to
compare the accuracy of the Doppler variables to detect an
elevated device LAP 15 and 20 mm Hg.
Results The patients (13 men, mean age: 71 years, mean
left ventricular ejection fraction: 32  12%) underwent 60
simultaneous echocardiographic studies and LAP measure-
ments with a median of 4 (1 to 7) studies per patient. Mean
LAP was 16.9 (range 5 to 39 mm Hg) at echocardiography
(n ¼ 60). E/e0 had the greatest accuracy for detection of
LAP 15 mm Hg with an area beneath the receiver-
operator characteristic curve >0.9. In comparison, area
under the curve for mitral E velocity and mitral E/A were
0.77 and 0.76, respectively (p < 0.008 vs. E/e0 medial and
average).
Conclusions Single and serial measurements of mitral
inﬂow and mitral annular TDI velocities (E/e0) can reliably
detect raised directly measured LAP in ambulant subjects
with compensated chronic heart failure. (Hemodynamically
Guided Home Self-Therapy in Severe Heart Failure
Patients [HOMEOSTASIS]; NCT00547729) (204).Myocardium at Risk in ST-Segment Elevation
Myocardial Infarction: Comparison of T2-Weighted
Edema Imaging With the MR-Assessed Endocardial
Surface Area and Validation Against Angiographic
Scoring
Objectives The objective of this study was to assess the area
at risk (AAR) in ST-segment elevation myocardial infarc-
tion with 2 different cardiac magnetic resonance (CMR)
imaging methods and to compare them with the validated
angiographic Alberta Provincial Project for Outcome
Assessment in Coronary Heart Disease Score
(APPROACH-score) in a large consecutive patient cohort.
Background Edema imaging with T2-weighted CMR and
the endocardial surface area (ESA) assessed by late gadoli-
nium enhancement have been introduced as relatively new
methods for AAR assessment in ST-segment elevation
myocardial infarction. However, data on the utility and
validation of these techniques are limited.
Methods A total of 197 patients undergoing primary
percutaneous coronary intervention in acute ST-segment
elevation myocardial infarction were included. AAR
(assessed with T2-weighted edema imaging and the ESA
method), infarct size, and myocardial salvage (AAR minus
infarct size) were determined by CMR 2 to 4 days after
primary angioplasty. Angiographic AAR scoring was per-
formed by use of the APPROACH-score. All measure-
ments were done ofﬂine by blinded observers.
Results The AAR assessed by T2-weighted imaging
showed good correlation with the angiographic AAR
(r ¼ 0.87; p < 0.001), whereas the ESA showed only
a moderate correlation either to T2-weighted imaging
(r ¼ 0.56; p < 0.001) or the APPROACH-score (r ¼ 0.44;
p < 0.001). Mean AAR by ESA (20.0  11.7% of left
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the AAR assessed by T2-weighted imaging (35.6  10.9% of
left ventricular mass) or the APPROACH-score (27.9
 10.5% of left ventricular mass) and showed a signiﬁcant
negative dependence on myocardial salvage index. In contrast,
no dependence of T2-weighted edema imaging or the
APPROACH-score on myocardial salvage index was seen.
Conclusions The AAR can be reliably assessed by T2-
weighted CMR, whereas assessment of the AAR by ESA
seems to be dependent on the degree of myocardial salvage,
thereby underestimating the AAR in patients with high
myocardial salvage such as aborted infarction. Thus,
assessment of the AAR with the ESA method cannot be
recommended. (Myocardial Salvage and Contrast Dye
Induced Nephropathy Reduction by N-Acetylcystein
[LIPSIA-N-ACC]; NCT00463749) (205).Coronary CT Angiography in Takayasu Arteritis
Objectives The aim of this study was to use coronary
computed tomographic (CT) angiography to characterize
coronary artery involvement in patients with known
Takayasu arteritis who present with anginal chest pain or
shortness of breath.
Background Takayasu arteritis is a primary vasculitis of the
large vessels, which mainly affects the aorta and its branches
but can also involve the coronary arteries. Coronary CT
angiography allows visualization of the coronary vessels and
can be used to detect both stenotic and nonstenotic coronary
artery lesions.
Methods Eighteen consecutive patients with Takayasu
arteritis and angina (typical or atypical) and/or dyspnea
underwent contrast-enhanced 64-slice coronary CT angi-
ography. The arterial injury was classiﬁed according to the
Numano classiﬁcation. Three patients had prior known
coronary artery disease. Coronary arteries were evaluated
concerning the presence of obstructive and nonobstructive
lesions, and differences between the clinical presentations of
patients with and without coronary artery involvement on
CT angiography were analyzed.
Results Coronary artery involvement was found in 8
patients (44.4%), 3 of them with clinical activity. A total of
19 coronary lesions were present (13 in ostial locations, 5 in
proximal coronary artery segments, and 1 in a mid segment).
Eight lesions exceeded 50% diameter reduction (2 in ostial
locations and 6 in proximal coronary artery segments).
Median disease duration was signiﬁcantly different between
patients with coronary artery involvement (176 months;
range 13 to 282 months) compared with those without (21
months; range 1 to 142 months) (p ¼ 0.013).
Conclusions Coronary CT angiography allows the assess-
ment of coronary artery involvement in patients with
Takayasu arteritis. These data conﬁrm prior observations
that most coronary lesions are in ostial or proximal coronary
artery locations. Disease duration in patients with coronary
artery involvement is longer than in patients without (206).Impact of Intravascular Ultrasound Imaging on
Early and Late Clinical Outcomes Following
Percutaneous Coronary Intervention With
Drug-Eluting Stents
Objectives This study sought to assess the impact of
intravascular ultrasound (IVUS)-guided versus angiography-
guided drug-eluting stent (DES) implantation.
Background There are limited data on IVUS guidance in
the DES era. Therefore, we investigated the impact of IVUS
guidance on clinical outcomes in the MATRIX (Compre-
hensive Assessment of Sirolimus-Eluting Stents in Complex
Lesions) registry.
Methods The MATRIX registry prospectively enrolled
consecutive, unselected patients treated with sirolimus-
eluting stents (SES) (n ¼ 1,504); 631 patients (42%)
underwent IVUS-guided stenting, and 873 (58%) had only
angiographic guidance. We assessed 30-day, 1-year, and
2-year rates of death/myocardial infarction (MI), major
adverse cardiac events (cardiac death, MI, or target vessel
revascularization), and deﬁnite/probable stent thrombosis in
548 propensity-score matched patient pairs.
Results After matching, baseline and angiographic char-
acteristics were similar in IVUS and no-IVUS groups.
Patients in the IVUS group had signiﬁcantly less death/MI
at 30 days (1.5% vs. 4.6%, p < 0.01), 1 year (3.3% vs. 6.5%,
p < 0.01), and 2 years (5.0% vs. 8.8%, p < 0.01). Patients in
the IVUS group had signiﬁcantly less major adverse cardiac
events at 30 days (2.2% vs. 4.8%, p ¼ 0.04) and numerically
less major adverse cardiac events at 1 year (9.1% vs. 13.5%,
p ¼ 0.07) and 2 years (12.9% vs. 16.7%, p ¼ 0.18). Rates of
MI were signiﬁcantly lower in the IVUS group at 30 days
(1.5% vs. 4.0%, p < 0.01), 1 year (1.8% vs. 4.8%, p < 0.01),
and 2 years (2.1% vs. 5.7%, p < 0.01).
Conclusions IVUS-guided stent implantation appears to
be associated with a reduction in both early and long-term
clinical events. Further investigation in randomized
controlled trials is warranted (207).
Characterization of Cardiac Tumors in Children by
Cardiovascular Magnetic Resonance Imaging:
A Multicenter Experience
Objectives The aim of this study was to report the results
of an international multicenter experience of cardiac
magnetic resonance imaging (MRI) evaluation of cardiac
tumors in children, each with histology correlation or
a diagnosis of tuberous sclerosis, and to determine which
characteristics are predictive of tumor type.
Background Individual centers have relatively little expe-
rience with diagnostic imaging of cardiac tumors in children,
because of their low prevalence. The accuracy of cardiac
MRI diagnosis on the basis of a pre-deﬁned set of criteria
has not been tested.
Methods An international group of pediatric cardiac
imaging centers was solicited for case contribution. Inclusion
criteria comprised: 1) age at diagnosis 18 years; 2) cardiac
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or diagnosis of tuberous sclerosis. Data from the cardiac
MRI images were analyzed for mass characteristics. On the
basis of pre-deﬁned cardiac MRI criteria derived from
published data, 3 blinded investigators determined tumor
type, and their consensus diagnoses were compared with
histologic diagnoses.
Results Cases (n ¼ 78) submitted from 15 centers in 4
countries had the following diagnoses: ﬁbroma (n ¼ 30),
rhabdomyoma (n ¼ 14), malignant tumor (n ¼ 12),
hemangioma (n ¼ 9), thrombus (n ¼ 4), myxoma (n ¼ 3),
teratoma (n ¼ 2), and paraganglioma, pericardial cyst,
Purkinje cell tumor, and papillary ﬁbroelastoma (n ¼ 1,
each). Reviewers who were blinded to the histologic diag-
noses correctly diagnosed 97% of the cases but included
a differential diagnosis in 42%. Better image quality grade
and more complete examination were associated with higher
diagnostic accuracy.
Conclusions Cardiac MRI can predict the likely tumor
type in the majority of children with a cardiac mass. A
comprehensive imaging protocol is essential for accurate
diagnosis. However, histologic diagnosis remains the gold
standard, and in some cases malignancy cannot be deﬁni-
tively excluded on the basis of cardiac MRI images
alone (208).Endogenous Cardiac Stem Cell Activation by
Insulin-Like Growth Factor-1/Hepatocyte Growth
Factor Intracoronary Injection Fosters Survival and
Regeneration of the Infarcted Pig Heart
Objectives The purpose of this study was to test the ability
of insulin-like growth factor (IGF)-1/hepatocyte growth
factor (HGF) to activate resident endogenous porcine
cardiac stem/progenitor cells (epCSCs) and to promote
myocardial repair through a clinically applicable intra-
coronary injection protocol in a pig model of myocardial
infarction (MI) relevant to human disease.
Background In rodents, cardiac stem/progenitor cell
(CSC) transplantation as well as in situ activation through
intramyocardial injection of speciﬁc growth factors has been
shown to result in myocardial regeneration after acute
myocardial infarction (AMI).
Methods Acute MI was induced in pigs by a 60-min
percutaneous transluminal coronary angiography left ante-
rior descending artery occlusion. The IGF-1 and HGF were
co-administered through the infarct-related artery in a single
dose (ranging from 0.5 to 2 mg HGF and 2 to 8 mg IGF-1)
30 min after coronary reperfusion. Pigs were sacriﬁced 21
days later for dose-response relationship evaluation by
immunohistopathology or 2 months later for cardiac func-
tion evaluation by cardiac magnetic resonance imaging.
Results The IGF-1/HGF activated c-kit positive–CD45
negative epCSCs and increased their myogenic differentia-
tion in vitro. The IGF-1/HGF, in a dose-dependent
manner, improved cardiomyocyte survival, and reducedﬁbrosis and cardiomyocyte reactive hypertrophy. It signiﬁ-
cantly increased c-kit positive–CD45 negative epCSC
number and fostered the generation of new myocardium
(myocytes and microvasculature) in infarcted and peri-
infarct/border regions at 21 and 60 days after AMI. The
IGF-1/HGF reduced infarct size and improved left
ventricular function at 2 months after AMI.
Conclusions In an animal model of AMI relevant to the
human disease, intracoronary administration of IGF-1/
HGF is a practical and effective strategy to reduce patho-
logical cardiac remodeling, induce myocardial regeneration,
and improve ventricular function (209).Age- and Sex-Related Differences in All-Cause
Mortality Risk Based on Coronary Computed
Tomography Angiography Findings: Results From
the International Multicenter CONFIRM (Coronary
CT Angiography Evaluation for Clinical Outcomes:
An International Multicenter Registry) of 23,854
Patients Without Known Coronary Artery Disease
Objectives We examined mortality in relation to coronary
artery disease (CAD) as assessed by 64-detector row
coronary computed tomography angiography (CCTA).
Background Although CCTA has demonstrated high
diagnostic performance for detection and exclusion of
obstructive CAD, the prognostic ﬁndings of CAD by
CCTA have not, to date, been examined for age- and sex-
speciﬁc outcomes.
Methods We evaluated a consecutive cohort of 24,775
patients undergoing 64-detector row CCTA between
2005 and 2009 without known CAD who met inclusion
criteria. In these patients, CAD by CCTA was deﬁned as
none (0% stenosis), mild (1% to 49% stenosis), moderate
(50% to 69% stenosis), or severe (70% stenosis). CAD
severity was judged on a per-patient, per-vessel, and per-
segment basis. Time to mortality was estimated using
multivariable Cox proportional hazards models.
Results At a 2.3  1.1-year follow-up, 404 deaths had
occurred. In risk-adjusted analysis, both per-patient
obstructive (hazard ratio [HR]: 2.60; 95% conﬁdence
interval [CI]: 1.94 to 3.49; p < 0.0001) and nonobstructive
(HR: 1.60; 95% CI: 1.18 to 2.16; p ¼ 0.002) CAD
conferred increased risk of mortality compared with patients
without evident CAD. Incident mortality was associated
with a dose-response relationship to the number of coronary
vessels exhibiting obstructive CAD, with increasing risk
observed for nonobstructive (HR: 1.62; 95% CI: 1.20 to
2.19; p ¼ 0.002), obstructive 1-vessel (HR: 2.00; 95% CI:
1.43 to 2.82; p < 0.0001), 2-vessel (HR: 2.92; 95% CI: 2.00
to 4.25; p < 0.0001), or 3-vessel or left main (HR: 3.70;
95% CI: 2.58 to 5.29; p < 0.0001) CAD. Importantly, the
absence of CAD by CCTA was associated with a low rate of
incident death (annualized death rate: 0.28%). When
stratiﬁed by age <65 years versus 65 years, younger
patients experienced higher hazards for death for 2-vessel
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95% CI: 1.51 to 4.02; p ¼ 0.0003) and 3-vessel (HR: 6.19;
95% CI: 3.43 to 11.2; p < 0.0001 vs. HR: 3.10; 95% CI:
1.95 to 4.92; p < 0.0001) CAD. The relative hazard for 3-
vessel CAD (HR: 4.21; 95% CI: 2.47 to 7.18; p < 0.0001
vs. HR: 3.27; 95% CI: 1.96 to 5.45; p < 0.0001) was higher
for women as compared with men.
Conclusions Among individuals without known CAD,
nonobstructive and obstructive CAD by CCTA are associ-
ated with higher rates of mortality, with risk proﬁles
differing for age and sex. Importantly, absence of CAD is
associated with a very favorable prognosis (210).
Impaired Myocardial Flow Reserve on Rubidium-82
Positron Emission Tomography Imaging Predicts
Adverse Outcomes in Patients Assessed for
Myocardial Ischemia
Objectives We evaluated the prognostic value of myocardial
ﬂow reserve (MFR) using rubidium-82 (82Rb) positron
emission tomography (PET) in patients assessed for ischemia.
Background The clinical value of MFR quantiﬁcation
using 82Rb PET beyond relative myocardial perfusion
imaging remains uncertain.
Methods We prospectively enrolled 704 consecutive patients;
677 (96%) completed follow-up (median 387 days [interquartile
range: 375 to 416 days]). Patients were divided into 4 groups: I,
normal summed stress score (SSS) (<4) and normal myocardial
ﬂow reserve (MFR) (>2); II, normal SSS and MFR <2; III,
SSS 4 and MFR2; IV, SSS 4 and MFR <2.
Results For patients with a normal SSS and those with an
abnormal SSS, there were signiﬁcant differences in outcomes
for hard events (cardiac death and myocardial infarction)
between patients with MFR 2 and those with MFR <2 (I:
1.3% vs. II: 2% [p ¼ 0.029]; III: 1.1% vs. IV: 11.4%
[p ¼ 0.05]) and for major adverse cardiac events (MACE)
(p ¼ 0.003 and p < 0.001, respectively). In the adjusted Cox
model, MFR was an independent predictor of hard events
(hazard ratio: 3.3; 95% conﬁdence interval: 1.1 to 9.5;
p ¼ 0.029) and MACE (hazard ratio: 2.4, 95% conﬁdence
interval: 1.4 to 4.4, p ¼ 0.003). The incremental prognostic
value of the MFR over the SSS was demonstrated by
comparing the adjusted SSS model with and without the
MFR for hard events (p ¼ 0.0197) and MACE (p ¼ 0.002).
Conclusions MFR quantiﬁed using 82Rb PET predicts
hard cardiac events and MACE independent of the SSS and
other parameters. Routine assessment of 82Rb PET–quan-
tiﬁed MFR could improve risk stratiﬁcation for patients
being investigated for ischemia (211).
Hypoxia But Not Inﬂammation Augments Glucose
Uptake in Human Macrophages: Implications for
Imaging Atherosclerosis With 18Fluorine-Labeled
2-Deoxy-D-Glucose Positron Emission Tomography
Objectives This study investigated the regulation of
glucose uptake in cells that participate in atherogenesis bystimuli relevant to this process, to gain mechanistic insight
into the origin of the 18ﬂuorine-labeled 2-deoxy-D-glucose
(FdG) uptake signals observed clinically.
Background Patient studies suggest that positron emission
tomography (PET) using FdG can detect “active” athero-
sclerotic plaques, yet the mechanism giving rise to FdG
signals remains unknown.
Methods We exposed cells to conditions thought to
operate in atheroma and determined rates of glucose uptake.
Results Hypoxia, but not pro-inﬂammatory cytokines,
potently stimulated glucose uptake in human macrophages
and foam cells. Statins attenuated this process in vitro, sug-
gesting that these agents have a direct effect on human
macrophages. Immunohistochemical study of human plaques
revealed abundant expression of proteins regulating glucose
utilization, predominantly in macrophage-rich regions of the
plaquesdregions previously proved hypoxic. Smooth-muscle
cells and endothelial cells markedly increased rates of
glucose uptake when exposed to pro-inﬂammatory cytokines.
Conclusions Glucose uptake and, probably, FdG uptake
signals in atheroma may reﬂect hypoxia-stimulated macro-
phages rather than mere inﬂammatory burden. Cytokine-
activated smooth-muscle cells also may contribute to the
FdG signal (212).Can a Teaching Intervention Reduce Interobserver
Variability in LVEF Assessment: A Quality Control
Exercise in the Echocardiography Lab
Objectives This study sought to determine whether
a formalized teaching intervention could reduce the inter-
observer variability (IOV) in visual estimation of left
ventricular ejection fraction (LVEF) within a group of
sonographers and physicians with a spectrum of experience.
Background Precise and reliable echocardiographic assess-
ment of LVEF is necessary for clinical decision-making and
minimizing duplicative testing. Skill in the visual estimation of
LVEF varies depending on experience and is critical for
corroborating EF quantiﬁcation. IOV may also lead to incon-
sistency ifmultiple readers are assessing the EF on serial exams.
Methods Fourteen cases of 2-dimensional echocardiograms
were shown to 25 participants who estimated the EF based on
a complete assessment of LV wall motion including para-
sternal, short-axis, apical, and subcostal views. The cases
represented a spectrum of EF range, image quality, and
clinical context. Following the initial interpretations, partici-
pants underwent a teaching intervention involving tutorial
review of reference cases and group discussion of each case
with determination of the EF guided by quantitative measure
(biplane Simpson method). Three months after the teaching
intervention, 14 new cases were shown to the 25 participants
following the same methodology.
Results IOV was quantiﬁed before and after the teaching
intervention with the use of a 3-factor, nested analysis of
variance. The factors were: observer, patient, and pre- and
post-intervention (time). The analysis of variance showed
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between the pre- and post-intervention assessments
(F ¼ 2.8, p ¼ 0.007). The IOV decreased from 14% EF
prior to intervention to 8.4% EF following intervention (a
40% reduction in IOV).
Conclusions In a large echocardiography laboratory with
a wide range of training levels and experience, a simple,
formalized teaching intervention can successfully diminish
IOV of LVEF assessment. This intervention provides not
only discrete quality measures, but also serves as a practical
tool to document and improve quality of reporting, poten-
tially reducing clinical inefﬁciencies and repeat testing (213).
Myocardial Perfusion Imaging Is a Strong Predictor
of Death in Women
Objectives We sought to assess the prognostic value and
risk classiﬁcation improvement using contemporary single-
photon emission computed tomography myocardial perfu-
sion imaging (SPECT-MPI) to predict all-cause mortality.
Background Myocardial perfusion is a strong estimator of
prognosis. Evidence published to date has not established
the added prognostic value of SPECT-MPI nor deﬁned an
approach to detect improve classiﬁcation of risk in women
from a developing nation.
Methods A total of 2,225 women referred for SPECT-MPI
were followed by a mean period of 3.7  1.4 years. SPECT-
MPI results were classiﬁed as abnormal on the presence of
any perfusion defect. Abnormal scans were further classiﬁed
as with mild/moderate reversible, severe reversible, partial
reversible, or ﬁxed perfusion defects. Risk estimates for inci-
dent mortality were categorized as <1%/year, 1% to 2%/year,
and >2%/year using Cox proportional hazard models. Risk-
adjusted models incorporated clinical risk factors, left
ventricular ejection fraction (LVEF), and perfusion variables.
Results All-cause death occurred in 139 patients. SPECT-
MPI signiﬁcantly risk stratiﬁed the population; patients with
abnormal scans had signiﬁcantly higher death rates compared
with patients with normal scans, 13.1% versus 4.0%, respec-
tively (p < 0.001). Cox analysis demonstrated that after
adjusting for clinical risk factors and LVEF, SPECT-MPI
improved the model discrimination (integrated discrimina-
tion index ¼ 0.009; p ¼ 0.02), added signiﬁcant incremental
prognostic information (global chi-square increased from 87.7
to 127.1; p < 0.0001), and improved risk prediction (net
reclassiﬁcation improvement ¼ 0.12; p ¼ 0.005).
Conclusions SPECT-MPI added signiﬁcant incremental
prognostic information to clinical and left ventricular func-
tional variables while enhancing the ability to classify this
Brazilian female population into low- and high-risk cate-
gories of all-cause mortality (214).
CT Signs of Right Ventricular Dysfunction:
Prognostic Role in Acute Pulmonary Embolism
Objectives The purpose of this study was to compare the
prognostic role of various computed tomography (CT)signs of right ventricular (RV) dysfunction, including
3-dimensional ventricular volume measurements, to predict
adverse outcomes in patients with acute pulmonary embo-
lism (PE).
Background Three-dimensional ventricular volume measure-
ments based on chest CT have become feasible for routine
clinical application; however, their prognostic role in patients
with acute PE has not been assessed.
Methods We evaluated 260 patients with acute PE for the
following CT signs of RV dysfunction obtained on routine
chest CT: abnormal position of the interventricular septum,
inferior vena cava contrast reﬂux, right ventricle diameter
(RVD) to left ventricle diameter (LVD) ratio on axial
sections and 4-chamber (4-CH) views, and 3-dimensional
right ventricle volume (RVV) to left ventricle volume
(LVV) ratio. Comorbidities and fatal and nonfatal adverse
outcomes according to the MAPPET-3 (Management
Strategies and Prognosis in Pulmonary Embolism Trial-3)
criteria within 30 days were recorded.
Results Fifty-seven patients (21.9%) had adverse outcomes,
including 20 patients (7.7%) who died within 30 days. An
RVDaxial/LVDaxial ratio >1.0 was not predictive for
adverse outcomes. On multivariate analysis (adjusting for
comorbidities), abnormal position of the interventricular
septum (hazard ratio [HR]: 2.07; p ¼ 0.007), inferior vena
cava contrast reﬂux (HR: 2.57; p ¼ 0.001), RVD4-CH/
LVD4-CH ratio >1.0 (HR: 2.51; p ¼ 0.009), and RVV/
LVV ratio >1.2 (HR: 4.04; p < 0.001) were predictive of
adverse outcomes, whereas RVD4-CH/LVD4-CH ratio
>1.0 (HR: 3.68; p ¼ 0.039) and RVV/LVV ratio >1.2
(HR: 6.49; p ¼ 0.005) were predictive of 30-day death.
Conclusions Three-dimensional ventricular volume
measurement on chest CT is a predictor of early death in
patients with acute PE, independent of clinical risk factors
and comorbidities. Abnormal position of the interventricular
septum, inferior vena cava contrast reﬂux, and RVD4-CH/
LVD4-CH ratio are predictive of adverse outcomes, whereas
RVDaxial/LVDaxial ratio >1.0 is not (215).Prediction of Life-Threatening Arrhythmic Events in
Patients With Chronic Myocardial Infarction by
Contrast-Enhanced CMR
Objectives We hypothesized that infarct transmurality
assessed with late gadolinium enhancement cardiac magnetic
resonance (LGE-CMR) predicts arrhythmic events in
patients with chronic myocardial infarction.
Background Patients with decreased left ventricular func-
tion due to chronic myocardial infarction are at increased risk
for life-threatening arrhythmias related to infarcted tissue.
LGE-CMR accurately detects infarct morphology.
Methods We prospectively enrolled 52 patients with
chronic myocardial infarction referred for primary preventive
implantable cardioverter-deﬁbrillator (ICD) implantation
following MADIT (Multicenter Automatic Deﬁbrillator
Implantation Trial) study criteria. Using LGE-CMR, left
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assessed including calculation of total and relative infarct
mass, infarct border, infarct border zone, and infarct
transmurality.
Results Patients were followed for 1,235  341 days. The
primary combined endpoint including appropriate device
therapy (ICD discharge or antitachycardia pacing) or death
from cardiac cause occurred in 16 individuals resulting in
an annual event rate of 4.7%. Six patients received an
appropriate shock, 7 patients received recurrent appropriate
antitachycardia pacing for sustained ventricular tachycardia,
and 3 patients died of cardiac cause. There was a signiﬁcant
association to relative infarct mass (38  8% vs. 28  14%,
p ¼ 0.02), infarct transmurality (24  8 g vs. 16  12 g,
p ¼ 0.02), and relative infarct transmurality (RIT) (63
 12% vs. 48  23%, p ¼ 0.01). In separate logistic
regression models, no variable emerged as signiﬁcant when
combined with RIT. As a single effect, RIT emerged as
a predictor of the primary endpoint (p ¼ 0.02). A RIT
cutoff at 43% resulted in a sensitivity of 88%, a speciﬁcity of
50%, a positive predictive value of 44%, and a negative
predictive value of 90%.
Conclusions In patients with chronic myocardial infarction
scheduled for primary preventive ICD implantation, infarct
transmurality as deﬁned by LGE-CMR identiﬁes
a subgroup with increased risk for life-threatening arrhyth-
mias and cardiac death.(216)Stress Myocardial Perfusion Imaging by CMR
Provides Strong Prognostic Value to Cardiac
Events Regardless of Patient’s Sex
Objectives The major aim of this study is to test the
hypothesis that stress cardiac magnetic resonance (CMR)
imaging can provide robust prognostic value in women
presenting with suspected ischemia, to the same extent as in
men.
Background Compelling evidence indicates that women
with coronary artery disease (CAD) experience worse
outcomes than men owing to a lack of early diagnosis and
management. Numerous clinical studies have shown that
stress CMR detects evidence of myocardial ischemia and
infarction at high accuracy. Compared to nuclear scintig-
raphy, CMR is free of ionizing radiation, has high spatial
resolution for imaging small hearts, and overcomes breast
attenuation artifacts, which are substantial advantages when
imaging women for CAD.
Methods We performed stress CMR in 405 patients (168
women, mean age 58  14 years) referred for ischemia
assessment. CMR techniques included cine cardiac function,
perfusion imaging during vasodilating stress, and late
gadolinium enhancement imaging. All patients were fol-
lowed for major adverse cardiac events (MACE).
Results At a median follow-up of 30 months, MACE
occurred in 36 patients (9%) including 21 cardiac deaths and
15 acute myocardial infarctions. In women, CMR evidenceof ischemia (ISCHEMIA) demonstrated strong association
with MACE (unadjusted hazard ratio: 49.9, p < 0.0001).
While women with ISCHEMIA(þ) had an annual MACE
rate of 15%, women with ISCHEMIA() had very low
annual MACE rate (0.3%), which was not statistically
different from the low annual MACE rate in men with
ISCHEMIA() (1.1%). CMR myocardial ischemia score
was the strongest multivariable predictor of MACE in this
cohort, for both women and men, indicating robust cardiac
prognostication regardless of sex.
Conclusions In addition to avoiding exposure to ionizing
radiation, stress CMR myocardial perfusion imaging is an
effective and robust risk-stratifying tool for patients of either
sex presenting with possible ischemia (217).Stress CMR Imaging Observation Unit in the
Emergency Department Reduces 1-Year Medical
Care Costs in Patients With Acute Chest Pain:
A Randomized Study for Comparison With
Inpatient Care
Objectives This study sought to compare the direct cost of
medical care and clinical events during the ﬁrst year after
patients with intermediate risk acute chest pain were
randomized to stress cardiac magnetic resonance (CMR)
observation unit (OU) testing versus inpatient care.
Background In a recent study, randomization to OU-
CMR reduced median index hospitalization cost compared
with the cost of inpatient care in patients presenting to the
emergency department with intermediate risk acute chest
pain.
Methods Emergency department patients with interme-
diate risk chest pain were randomized to OU-CMR (OU
care, cardiac markers, stress CMR) or inpatient care
(admission, care per admitting provider). This analysis
reports the direct cost of cardiac-related care and clinical
outcomes (myocardial infarction, revascularization, cardio-
vascular death) during the ﬁrst year of follow-up subsequent
to discharge. Consistent with health economics literature,
provider cost was calculated from work-related relative value
units using the Medicare conversion factor; facility charges
were converted to cost using departmental-speciﬁc cost-to-
charge ratios. Linear models were used to compare cost
accumulation among study groups.
Results We included 109 randomized subjects in this
analysis (52 OU-CMR, 57 inpatient care). The median age
was 56 years; baseline characteristics were similar in both
groups. At 1 year, 6% of OU-CMR and 9% of inpatient care
participants experienced a major cardiac event (p ¼ 0.72)
with 1 patient in each group experiencing a cardiac event
after discharge. First-year cardiac-related costs were signif-
icantly lower for participants randomized to OU-CMR
than for participants receiving inpatient care (geometric
mean ¼ $3,101 vs. $4,742 including the index visit
[p ¼ 0.004] and $29 vs. $152 following discharge
[p ¼ 0.012]). During the year following randomization, 6%
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enced a major cardiac event (p ¼ 0.72).
Conclusions An OU-CMR strategy reduces cardiac-
related costs of medical care during the index visit and
over the ﬁrst year subsequent to discharge, without an
observed increase in major cardiac events. (Cost Comparison
of Cardiac Magnetic Resonance Imaging [MRI] Use in
Emergency Department [ED] Patients With Chest Pain;
NCT00678639) (218).
Clinical Experience With Percutaneous Left
Ventricular Transapical Access for Interventions in
Structural Heart Defects: A Safe Access and
Secure Exit
Objectives This study sought to evaluate the safety of
percutaneous direct left ventricular access for interventional
procedures.
Background Experience with percutaneous access of the
left ventricle (LV) for interventional procedures has been
limited and associated with a high percentage of major
complications. We report our clinical experience with
percutaneous direct LV access for interventional procedures.
Methods Between March 2008 and December 2010, there
were 32 percutaneous transapical punctures in 28 consecu-
tive patients (16 males, mean age 68.2  10.8 years). The
delivery sheath sizes ranged from 5- to 12-F.
Results All transapical punctures were successfully per-
formed, and safe closure of the access sites was achieved. Total
procedural time was 153.6  49.4 min for procedures con-
verted from conventional approaches to a transapical approach,
129.5  29.6 min for the transapical approach with trans-
septal rail support, and 109.3  41.4 min for the planned
transapical approach. Fluoroscopy time was 61.3  26.1 min,
29.7  20.8 min, and 27.4  21.4 min, respectively. Fluo-
roscopy time for closure of mitral paravalvular leaks was
reduced by 35%, from 42.6  29.9 min to 27.4  15.6 min.
Complications were observed in 2 patients (7.1%).
Conclusions With meticulous planning, transapical punc-
ture is safe. The transapical access provides a more direct
approach to the LV targets for intervention and leads to
a signiﬁcant decrease in the procedural and ﬂuoroscopy times.
Device closure of the direct LV access site is a reliable and safe
method of hemostasis. Placement of a closure device should
be considered if sheaths larger than 5-F are used. Although
we used this technique only for paravalvular leak and LV
pseudoaneurysm closure, it may have application for other
percutaneous structural heart interventions (219).
Mortality Risk in Symptomatic Patients With
Nonobstructive Coronary Artery Disease:
A Prospective 2-Center Study of 2,583 Patients
Undergoing 64-Detector Row Coronary Computed
Tomographic Angiography
Objectives We examined mortality risk in relation to
extent and composition of nonobstructive plaques by64-detector row coronary computed tomographic angiog-
raphy (CCTA).
Background The prognostic signiﬁcance of nonobstructive
coronary artery plaques by CCTA is poorly understood.
Methods We prospectively evaluated consecutive adults
from 2 centers undergoing 64-detector row CCTA without
prior documented coronary artery disease (CAD) and
without obstructive (50%) CAD by CCTA. Luminal
diameter stenosis severity was classiﬁed for each segment as
none (0%) or mild (1% to 49%), and plaque composition was
classiﬁed as noncalciﬁed, calciﬁed, or mixed.
Results During 3.1  0.5 years, 54 intermediate-term
(90 days) deaths occurred among 2,583 patients (2.09%),
with 4 early (<90 days) deaths. Adjusted for CAD risk
factors, the presence of any nonobstructive plaque was
associated with higher mortality (hazard ratio [HR]: 1.98,
95% conﬁdence Interval [CI]: 1.06 to 3.69, p ¼ 0.03), with
the highest risk among those exhibiting nonobstructive
CAD in 3 epicardial vessels (HR: 4.75, 95% CI: 2.10 to
10.75, p ¼ 0.0002) or 5 segments (HR: 5.12, 95% CI:
2.16 to 12.10, p ¼ 0.0002). Higher mortality for non-
obstructive CAD was observed even among patients with
low 10-year Framingham risk (3.4%, p < 0.0001) as well as
those with no traditional, medically treatable CAD risk
factors, including diabetes mellitus, hypertension, and dys-
lipidemia (6.7%, p < 0.0001). No independent relationship
between plaque composition and incident mortality was
observed. Importantly, patients without evident plaque
experienced a low rate of incident death during follow-up
(0.34%/year).
Conclusions The presence and extent of nonobstructive
plaques augment prediction of incident mortality beyond
conventional clinical risk assessment (220).High-Intensity Signals in Carotid Plaques on
T1-Weighted Magnetic Resonance Imaging Predict
Coronary Events in Patients With Coronary Artery
Disease
Objectives The purpose of this study was to determine
whether high-intensity carotid plaques visualized by a non-
contrast T1-weighted imaging technique, magnetization-
prepared rapid acquisition with gradient echo (MPRAGE),
predict future coronary events in patients with clinically stable
coronary artery disease (CAD).
Background Coronary plaque vulnerability to rupture can
be assessed by examining for the presence of atherosclerosis
and measuring intima media thickness (IMT) in surrogate
vessels such as the carotid arteries. We previously showed
that MPRAGE successfully identiﬁes vulnerable carotid
plaques as high-intensity signals. It remains unclear,
however, if the presence of carotid high-intensity plaques
(HIP) is associated with an increased risk of coronary events.
Methods We examined the signal intensity of carotid pla-
ques in 217 patients with clinically stable CAD using
MPRAGE with magnetic resonance imaging and measured
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a signal >200% that of the adjacent muscle. All patients
were divided into 2 groups according to the presence or
absence of HIP, namely, the HIP group (n ¼ 116) and the
non-HIP group (n ¼ 101), and were followed up for as long
as 72 months.
Results The presence of HIP was signiﬁcantly associated
with cardiac events compared to the non-HIP group (log-
rank p < 0.0001). Furthermore, multivariate Cox regression
analysis identiﬁed the presence of HIP as the strongest
independent predictor of cardiac events (hazard ratio: 3.15;
95% conﬁdence interval: 1.93 to 5.58, p < 0.0001)
compared with IMT (hazard ratio: 1.62, 95% conﬁdence
interval: 0.97 to 2.44, p ¼ 0.055) and other coronary risk
factors.
Conclusions Characterization of carotid plaques using
magnetic resonance imaging with MPRAGE provides more
clinically relevant information for the risk assessment of
CAD patients than IMT (221).
Superiority of Simulator-Based Training Compared
With Conventional Training Methodologies in the
Performance of Transseptal Catheterization
Objectives This study aims to compare the performance of
electrophysiology fellows in transseptal catheterization
(TSP-C) after conventional (Conv-T) or simulator training
(Sim-T).
Background Current training for TSP-C, an increasingly
used procedure, relies on performance on patients with
supervision by an experienced operator. Virtual reality, a new
training option, could improve post-training performance.
Methods Fellows inexperienced in TSP-C were enrolled
and randomly assigned to Conv-T or Sim-T. The post-
training performance of each fellow was evaluated and
scored in 3 consecutive patient-based procedures by an
experienced operator blinded to the fellow’s training
assignment.
Results Fourteen fellows were randomized to Conv-T (n ¼
7) or to Sim-T (n ¼ 7) and, after training, performed 42
TSP-Cs independently. Training time was signiﬁcantly
longer for Conv-T than for Sim-T (median 30 days vs. 4
days; p ¼ 0.0175). The Conv-T fellows had signiﬁcantly
lower post-training performance scores (median 68 vs. 95;
p ¼ 0.0001) and a higher number of recurrent errors
(median 3 vs. 0; p ¼ 0.0006) when compared with Sim-T
fellows.
Conclusions The TSP-C training with virtual reality
results in shorter training times and superior post-training
performance (222).
Dark Regions of No-Reﬂow on Late Gadolinium
Enhancement Magnetic Resonance Imaging Result
in Scar Formation After Atrial Fibrillation Ablation
Objectives The aim of this study was to assess acute
ablation injuries seen on late gadolinium enhancement(LGE) magnetic resonance imaging (MRI) immediately
post-ablation (IPA) and the association with permanent scar
3 months post-ablation (3moPA).
Background Success rates for atrial ﬁbrillation catheter
ablation vary signiﬁcantly, in part because of limited infor-
mation about the location, extent, and permanence of
ablation injury at the time of procedure. Although the
amount of scar on LGE MRI months after ablation corre-
lates with procedure outcomes, early imaging predictors of
scar remain elusive.
Methods Thirty-seven patients presenting for atrial ﬁbril-
lation ablation underwent high-resolution MRI with a 3-
dimensional LGE sequence before ablation, IPA, and
3moPA using a 3-T scanner. The acute left atrial wall
injuries on IPA scans were categorized as hyperenhancing
(HE) or nonenhancing (NE) and compared with scar
3moPA.
Results Heterogeneous injuries with HE and NE regions
were identiﬁed in all patients. Dark NE regions in the left
atrial wall on LGE MRI demonstrate ﬁndings similar to the
“no-reﬂow” phenomenon. Although the left atrial wall
showed similar amounts of HE, NE, and normal tissue IPA
(37.7  13%, 34.3  14%, and 28.0  11%, respectively;
p ¼ NS), registration of IPA injuries with 3moPA scarring
demonstrated that 59.0  19% of scar resulted from NE
tissue, 30.6  15% from HE tissue, and 10.4  5% from
tissue identiﬁed as normal. Paired t-test comparisons were
all statistically signiﬁcant among NE, HE, and normal tissue
types (p < 0.001). Arrhythmia recurrence at 1-year follow-
up correlated with the degree of wall enhancement
3moPA (p ¼ 0.02).
Conclusions Radiofrequency ablation results in heteroge-
neous injury on LGE MRI with both HE and NE wall
lesions. The NE lesions demonstrate no-reﬂow character-
istics and reveal a better predictor of ﬁnal scar at 3 months.
Scar correlates with procedure outcomes, further high-
lighting the importance of early scar prediction (223).LV Thrombus Detection by Routine
Echocardiography: Insights Into Performance
Characteristics Using Delayed Enhancement CMR
Objectives This study sought to evaluate performance
characteristics of routine echo for left ventricular thrombus
(LVT).
Background Although the utility of dedicated echocardi-
ography (echo) for LVT is established, echo is widely used as
a general test for which LVT is rarely the primary indication.
We used delayed-enhancement cardiac magnetic resonance
(DE-CMR) as a reference to evaluate LVT detection by
routine echo.
Methods Dedicated LVT assessment using DE-CMR was
prospectively performed in patients with left ventricular
systolic dysfunction. Echoes were done as part of routine
clinical care. Echo and CMR were independently read for
LVT and related indexes of LVT size, shape, and image
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embolic events and pathology validation of LVT.
Results In this study, 243 patients had routine clinical echo
and dedicated CMR within 1 week without intervening
events. Follow-up supported DE-CMR as a reference stan-
dard, with >5-fold difference in endpoints between patients
with versus without LVT by DE-CMR (p ¼ 0.02). LVT
prevalence was 10% by DE-CMR. Echo contrast was used in
4% of patients. Echo sensitivity and speciﬁcity were 33% and
91%, with positive and negative predictive values of 29% and
93%. Among patients with possible LVT as the clinical
indication for echo, sensitivity and positive predictive value
were markedly higher (60%, 75%). Regarding sensitivity, echo
performance related to LVT morphology and mirrored cine-
CMR, with protuberant thrombus typically missed when
small (p  0.02). There was also a strong trend to miss mural
thrombus irrespective of size (p ¼ 0.06). Concerning positive
predictive value, echo performance related to image quality,
with lower diagnostic conﬁdence scores for echoes read
positive for LVT in discordance with DE-CMR compared
with echoes concordant with DE-CMR (p < 0.02).
Conclusions Routine echo with rare contrast use can yield
misleading results concerning LVT. Echo performance is
improved when large protuberant thrombus is present
and when the clinical indication is speciﬁcally for LVT
assessment (224).Feasibility and Acute Efﬁcacy of Radiofrequency
Ablation of Cavotricuspid Isthmus–Dependent
Atrial Flutter Guided by Real-Time 3D TEE
Objectives The aim of this study was to evaluate the
feasibility and acute efﬁcacy of real-time 3-dimensional
transesophageal echocardiography (RT3DTEE)–guided
ablation of the cavotricuspid isthmus (CVTI).
Background The use of RT3DTEE to guide a trans-
catheter radiofrequency ablation procedure has never been
systematically investigated.
Methods Seventy consecutive patients with CVTI-dependent
atrial ﬂutter underwent CVTI ablation. Procedural monitoring
using RT3DTEE was assigned to patients who requested
general anesthesia for the procedure (n¼ 21 [30%]). In the other
49 patients (the control group), the procedures were monitored
using the standard ﬂuoroscopic approach. Procedural time was
considered as skin-to-skin electrophysiological procedure dura-
tion, not including anesthesia preparation; adequate radio-
frequency ablation applications (with ﬁxed temperature and
power settings) were considered as lesions lasting 60 s.
Results RT3DTEE allowed visualization of the CVTI and
identiﬁed related structures in most patients (20 of 21);
anatomic features such as long CVTI (n ¼ 11), prominent
Eustachian ridge (n¼ 9), prominent Eustachian valve (n¼ 6),
septal recess (n ¼ 8), and pectinate muscles (n ¼ 10) were
frequent. Also, RT3DTEE allowed continuous visualization
of ablation catheter movement and contact. Compared with
the control group, RT3DTEE was equally effective inachieving CVTI bidirectional block (100% in both groups),
and no complications occurred. RT3DTEE shortened
procedural time (median 73.0 min, interquartile range [IQR]
60.0 to 90.0 min, vs. median 115.0 min, IQR 85.0 to 133.0
min, p < 0.001), reduced radiation exposure (median ﬂuo-
roscopy time 4.2 min, IQR 3.1 to 8.4 min, vs. median 19.3
min, IQR 12.9 to 36.4 min, p < 0.001; median ﬂuoroscopy
dose 575.4 cGy $ cm2, IQR 428.5 to 1,299.4 cGy $ cm2, vs.
median 3,520.7 cGy $ cm2, IQR 1,700.0 to 6,709.0 cGy $
cm2, p < 0.001), and reduced the number of radiofrequency
applications to achieve bidirectional block (median 7, IQR 6 to
10, vs. median 12, IQR 10 to 22, p ¼ 0.007). A strong
learning curve was detected by comparing procedural data
between the ﬁrst and last patients treated using RT3DTEE.
Conclusions RT3DTEE-guided ablation of CVTI was
feasible, allowing real-time detailed morphological CVTI char-
acterization as well as continuous visualization of the ablation
catheter during radiofrequency ablation. This approach entailed
marked reductions in procedural time, radiation exposure, and
the number of radiofrequency applications (225).
Real-Time Assessment of Myocardial Contractility
Using Shear Wave Imaging
Objectives The goal of this study was to assess whether
myocardial stiffness could be measured by shear wave
imaging (SWI) and whether myocardial stiffness accurately
quantiﬁed myocardial function.
Background SWI is a novel ultrasound-based technique for
quantitative, local, and noninvasive mapping of soft tissue
elastic properties.
Methods SWI was performed in Langendorff perfused iso-
lated rat hearts (n¼ 6). Shear wave was generated and imaged
in the left ventricular myocardium using a conventional
ultrasonic probe connected to an ultrafast scanner (12,000
frames/s). The local myocardial stiffness was derived from
shear wave velocity every 7.5 ms during 1 single cardiac cycle.
Results The average myocardial stiffness was 8.6  0.7 kPa
in systole and 1.7  0.8 kPa in diastole. Myocardial stiffness
was compared with isovolumic systolic pressure at rest and
during administration of isoproterenol (109, 108, and
107 mol/l, 5 min each). Systolic myocardial stiffness
increased strongly up to 23.4  3.4 kPa. Myocardial stiffness
correlated strongly with isovolumic systolic pressure (r2 ¼
[0.94; 0.98], p < 0.0001).
Conclusions Myocardial stiffness can be measured in real
time over the cardiac cycle using SWI, which allows quan-
tiﬁcation of stiffness variation between systole and diastole.
Systolic myocardial stiffness provides a noninvasive index of
myocardial contractility (226).
Two-Dimensional Intravascular Near-Infrared
Fluorescence Molecular Imaging of Inﬂammation in
Atherosclerosis and Stent-Induced Vascular Injury
Objectives This study sought to develop a 2-dimensional
(2D) intravascular near-infrared ﬂuorescence (NIRF)
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coronary-sized vessels.
Background Molecular imaging of arterial inﬂammation
could provide new insights into the pathogenesis of acute
myocardial infarction stemming from coronary atheromata
and implanted stents. Presently, few high-resolution ap-
proaches can image inﬂammation in coronary-sized arteries
in vivo.
Methods A new 2.9-F rotational, automated pullback 2D
imaging catheter was engineered and optimized for 360
viewing intravascular NIRF imaging. In conjunction with the
cysteine protease-activatable imaging reporter Prosense
VM110 (VisEn Medical, Woburn, Massachusetts), intra-
arterial 2D NIRF imaging was performed in rabbit aortas
with atherosclerosis (n¼10) or implanted coronary bare-metal
stents (n ¼ 10, 3.5-mm diameter, day 7 post-implantation).
Intravascular ultrasound provided coregistered anatomical
images of arteries. After sacriﬁce, specimens underwent ex vivo
NIRF imaging, ﬂuorescence microscopy, and histological and
immunohistochemical analyses.
Results Imaging of coronary artery–scaled phantoms
demonstrated 8-sector angular resolution and submillimeter
axial resolution, nanomolar sensitivity to NIR ﬂuorochromes,
and modest NIRF light attenuation through blood. High-
resolution NIRF images of vessel wall inﬂammation with
signal-to-noise ratios >10 were obtained in real-time
through blood, without ﬂushing or occlusion. In athero-
sclerosis, 2D NIRF, intravascular ultrasound–NIRF fusion,
microscopy, and immunoblotting studies provided insight
into the spatial distribution of plaque protease activity. In
stent-implanted vessels, real-time imaging illuminated an
edge-based pattern of stent-induced arterial inﬂammation.
Conclusions A new 2D intravascular NIRF imaging
strategy provides high-resolution in vivo spatial mapping of
arterial inﬂammation in coronary-sized arteries and reveals
increased inﬂammation-regulated cysteine protease activity
in atheromata and stent-induced arterial injury (227).Imaging of the Aortic Valve Using
Fluorodeoxyglucose Positron Emission
Tomography: Increased Valvular
Fluorodeoxyglucose Uptake in Aortic Stenosis
Objectives Because ﬂuorodeoxyglucose positron emission
tomography (FDG-PET) imaging provides a noninvasive
index of inﬂammation, we sought to assess whether
FDG uptake in the aortic valve (AV) is increased in aortic
stenosis (AS).
Background AS is associated with valvular inﬂammation.
Methods FDG-PET/computed tomography data were
retrospectively evaluated in 84 patients (age 73  9 years,
45% female), 42 patients with AS, and 42 age-matched
controls. FDG uptake was determined within the AV
while blinded to AS severity. Target-to-background ratio
(TBR) was calculated as valvular/blood activity. Stenosis
severity was established on echocardiography, and presenceof AV calciﬁcation was independently assessed on computed
tomography.
Results The aortic valve PET signal (TBR) was increased
in AS compared with controls (median 1.53 [interquartile
range (IQR): 1.42 to 1.76] vs. 1.34 [IQR: 1.20 to 1.55];
p < 0.001). Further, compared with controls, TBR was
increased in mild (median 1.50 [IQR: 1.36 to 1.75];
p ¼ 0.01) and moderate (median 1.70 [IQR: 1.52 to 1.94];
p < 0.001), but not in severe AS (median 1.49 [IQR: 1.40
to 1.54]; p ¼ 0.08). When subjects were categorized
according to AV calciﬁcation, valvular FDG uptake was
increased in mildly (median 1.50 [IQR: 1.36 to 1.79];
p < 0.01) and moderately (median 1.67 [IQR: 1.50 to
1.85]; p < 0.001), but not severely calciﬁed valves (median
1.51 [IQR: 1.38 to 1.54]; p ¼ 0.15), compared with
noncalciﬁed valves (median 1.35 [IQR: 1.20 to 1.52]).
Conclusions This study supports the hypothesis that AS is
an inﬂammatory condition and suggests that inﬂammation
may be reduced in late-stage disease. This may have impor-
tant implications in the design of studies assessing the effect
of therapeutic agents in modifying progression of AS (228).Meta-Analysis and Systematic Review of the Long-
Term Predictive Value of Assessment of Coronary
Atherosclerosis by Contrast-Enhanced Coronary
Computed Tomography Angiography
Objectives We conducted a systematic review and meta-
analysis to determine the predictive value of ﬁndings of
coronary computed tomography angiography for incident
cardiovascular events.
Background Initial studies indicate a prognostic value of
the technique; however, the level of evidence as well as exact
independent risk estimates remain unclear.
Methods We searched PubMed, EMBASE, and the
Cochrane Library through January 2010 for studies that
followed up 100 subjects for 1 year and reported at 1
hazard ratio (HR) of interest. Risk estimates for the presence
of signiﬁcant coronary stenosis (primary endpoint; 50%
diameter stenosis), left main coronary artery stenosis, each
coronary stenosis, 3-vessel disease, any plaque, per coronary
segment containing plaque, and noncalciﬁed plaque were
derived in random effect regression analysis, and causes of
heterogeneity were determined in meta-regression analysis.
Results We identiﬁed 11 eligible articles including 7,335
participants (age 59.1  2.6 years, 62.8% male) with sus-
pected coronary artery disease. The presence of 1 signiﬁ-
cant coronary stenosis (9 studies, 3,670 participants, and 252
outcome events [6.8%] with 62% revascularizations) was
associated with an annualized event rate of 11.9% (6.4% in
studies excluding revascularization). The corresponding HR
was 10.74 (98% conﬁdence interval [CI]: 6.37 to 18.11) and
6.15 (95% CI: 3.22 to 11.74) in studies excluding revascu-
larization. Adjustment for coronary calciﬁcation did not
attenuate the prognostic signiﬁcance (p ¼ 0.79). The esti-
mated HRs for left main stenosis, presence of plaque, and
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CI: 2.6 to 17.3), 4.51 (95% CI: 2.2 to 9.3), and 1.23 (95%
CI: 1.17 to 1.29), respectively.
Conclusions Presence and extent of coronary artery disease
on coronary computed tomography angiography are strong,
independent predictors of cardiovascular events despite
heterogeneity in endpoints, categorization of computed
tomography ﬁndings, and study population (229).
Peri-Infarct Zone on Early Contrast-Enhanced CMR
Imaging in Patients With Acute Myocardial
Infarction
Objectives The aims of this study were to evaluate hyper-
enhanced regions on contrast-enhanced cardiovascular
magnetic resonance (CE-CMR) imaging in patients with
acute myocardial infarction (AMI) between early contrast-
enhanced cardiovascular magnetic resonance (ECE) (2
min) and late contrast-enhanced cardiovascular magnetic
resonance (LCE) (10 to 15 min) after gadolinium admin-
istration, and to compare the CE-CMR images with area at
risk (AAR) derived from T2-weighted (T2W) CMR.
Background Although CE-CMR imaging can demarcate
the infarcted myocardium, the value of hyperenhancement
in AMI is still in dispute. The size of hyperenhanced regions
may vary with time, and overestimation can be often
observed with early acquisition.
Methods Thirty-four patients with successfully reperfused
AMI underwent CMR within 4 days after the event.
Myocardial regions as percentage of left ventricular (LV)
myocardium were quantiﬁed on CE and T2W images.
Relative peri-infarct zone was calculated as the difference in
hyperenhanced regions between ECE and LCE, normalized
to the individual infarct size.
Results Both ECE and LCE images revealed hyper-
enhancement in the territory of the infarct-related artery in all
patients. The hyperenhanced region on ECE extended
transmurally and was consistently larger than that on LCE (39
 12% vs. 27  12% of LV myocardium, p < 0.001). The
relative peri-infarct zone was inversely correlated with the
transmurality of infarction (r ¼ 0.59, p < 0.001) and the
time from symptom to reperfusion (r¼0.46, p< 0.01). The
hyperenhanced region on ECE was correlated with the T2W
CMR-derived AAR (r ¼ 0.86, p < 0.001) with the average
difference of 0.8% and the limits of agreement of 11.9%.
Conclusions ECE depicts ischemically injured but
salvaged myocardium, as well as infarcted myocardium in
patients with AMI. The myocardium at risk and infarcted
myocardium after reperfusion can be retrospectively assessed
by the combination of ECE and LCE (230).
Role of 99mTc-DPD Scintigraphy in Diagnosis and
Prognosis of Hereditary Transthyretin-Related
Cardiac Amyloidosis
Objectives In a cohort of patients with hereditary
transthyretin-related amyloidosis (ATTR), we aimed to assessthe role of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic
acid (99mTc-DPD) in detecting myocardial amyloid inﬁl-
tration across a wide spectrum of cardiac involvement and in
predicting major adverse cardiac events (MACE).
Background Hereditary transthyretin-related amyloidosis
is a challenging and underdiagnosed condition where both
early diagnosis and prognosis remain problematic.
Methods We evaluated 63 patients with ATTR: 40 with
and 23 without echocardiographically diagnosed amyloidotic
cardiomyopathy (AC). Myocardial uptake of 99mTc-DPD
scintigraphy was semiquantitatively and visually assessed at
5 min and 3 h.
Results All patients with AC showed moderate-to-severe
myocardial tracer uptake (i.e., visual score 2). Within the
subgroup without AC, only 4 patients (with Ala36Pro,
Gly47Ala, Thr49Ala, and Glu89Gln transthyretin muta-
tions) showed myocardial tracer uptake and abnormal heart/
whole body retention (H/WB) values: in all these cases
endomyocardial biopsies showed amyloidotic inﬁltration.
The H/WB was positively correlated with left ventricular
(LV) mean wall thickness (Pearson’s r ¼ 0.695, p < 0.001)
and negatively with LV ejection fraction (r ¼ 0.368,
p ¼ 0.004). The H/WB was an unfavorable predictor of
MACE-free survival at Cox univariate analysis and
contributed to the multivariate model. Notably, LV wall
thickness >12 mm in combination with H/WB >7.5 was
associated with the highest event rate.
Conclusions In ATTR, 99mTc-DPD scintigraphy can
identify myocardial inﬁltration across a wide spectrum of
morphologic/functional cardiac involvement, allowing an
early diagnosis of the disease (even before the appearance
of echocardiographic abnormalities). The 99mTc-DPD
myocardial uptake is a prognostic determinant of “cardiac”
outcome in ATTR, either alone or in combination with LV
wall thickness (231).Do Imaging Studies Performed in Physician Ofﬁces
Increase Downstream Utilization? An Empiric
Analysis of Cardiac Stress Testing With Imaging
Objectives The goal of this study was to compare patterns
of downstream testing and procedures after stress testing
with imaging performed at physician ofﬁces versus at
hospital-outpatient facilities.
Background Stress testing with imaging has grown
dramatically in recent years, but whether the location of
where the test is performed correlates with different patterns
for subsequent cardiac testing and procedures is unknown.
Methods We identiﬁed 82,178 adults with private health
insurance from 2005 to 2007 who underwent ambulatory
myocardial perfusion imaging (MPI) or stress echocardiog-
raphy (SE). Subsequent MPI, SE, cardiac catheterization or
revascularization within 6 months was compared between
physician ofﬁce and hospital outpatient settings.
Results Overall, 85.1% of MPI and 84.9% of SE were
performed in physician ofﬁces. The proportion of patients
JACC Vol. 62, No. 14, 2013 The Editors
October 1, 2013:e29–141 JACC Topic Collection: Cardiac Imaging
e113who underwent subsequent MPI, SE, or cardiac catheteri-
zation was not statistically different between physician ofﬁce
and hospital outpatient settings for MPI (14.2% vs. 13.9%,
p ¼ 0.44) or SE (7.9% vs. 8.6%, p ¼ 0.21). However,
patients with physician ofﬁce imaging had slightly higher
rates of repeat MPI within 6 months compared with
hospital-outpatient imaging for both index MPI (3.5% vs.
2.0%, p < 0.001) and SE (3.4% vs. 2.1%, p < 0.001), and
slightly lower rates of cardiac catheterization after index
MPI (11.4% vs. 12.2%, p ¼ 0.04) and SE (4.5% vs. 7.0%,
p < 0.001). Differences in 6-month utilization were
observed across the 5 healthcare markets after index MPI
but not after index SE.
Conclusions Physician ofﬁce imaging is associated with
slightly higher repeat MPI and fewer cardiac catheterizations
than hospital outpatient imaging, but no overall difference in
the proportion of patients undergoing additional further
testing or procedures. Although regional variation exists,
especially for MPI, the relationship between physician ofﬁce
location of stress testing with imaging and greater down-
stream resource utilization appears modest (232).Real-Time 3D Transesophageal Echocardiography
for the Evaluation of Rheumatic Mitral Stenosis
Objectives The aims of this study were: 1) to assess the
feasibility and reliability of performing mitral valve area
(MVA) measurements in patients with rheumatic mitral
valve stenosis (RhMS) using real-time 3-dimensional
transesophageal echocardiography (3DTEE) planimetry
(MVA3D); 2) to compare MVA3D with conventional
techniques: 2-dimensional (2D) planimetry (MVA2D),
pressure half-time (MVAPHT), and continuity equation
(MVACON); and 3) to evaluate the degree of mitral
commissural fusion.
Background 3DTEE is a novel technique that provides
excellent image quality of the mitral valve. Real-time
3DTEE is a relatively recent enhancement of this tech-
nique. To date, there have been no feasibility studies
investigating the utility of real-time 3DTEE in the assess-
ment of RhMS.
Methods Forty-three consecutive patients referred for
echocardiographic evaluation of RhMS and suitability for
percutaneous mitral valvuloplasty were assessed using 2D
transthoracic echocardiography and real-time 3DTEE.
MVA3D, MVA2D, MVAPHT, MVACON, and the
degree of commissural fusion were evaluated.
Results MVA3D assessment was possible in 41 patients
(95%). MVA3D measurements were signiﬁcantly lower
compared with MVA2D (mean difference: 0.16  0.22;
n ¼ 25, p < 0.005) and MVAPHT (mean difference: 0.23
 0.28 cm2; n ¼ 39, p < 0.0001) but marginally greater
than MVACON (mean difference: 0.05  0.22 cm2;
n ¼ 24, p ¼ 0.82). MVA3D demonstrated best agreement
with MVACON (intraclass correlation coefﬁcient [ICC]
0.83), followed by MVA2D (ICC 0.79) and MVAPHT(ICC 0.58). Interobserver and intraobserver agreement was
excellent for MVA3D, with ICCs of 0.93 and 0.96,
respectively. Excellent commissural evaluation was possible
in all patients using 3DTEE. Compared with 3DTEE,
underestimation of the degree of commissural fusion using
2D transthoracic echocardiography was observed in 19%,
with weak agreement between methods (k < 0.4).
Conclusions MVA planimetry is feasible in the majority of
patients with RhMS using 3DTEE, with excellent repro-
ducibility, and compares favorably with established methods.
Three-dimensional transesophageal echocardiography allows
excellent assessment of commissural fusion (233).High-Pitch Thoracic CT With Simultaneous
Assessment of Coronary Arteries: Effect of Heart
Rate and Heart Rate Variability on Image Quality
and Diagnostic Accuracy
Objectives The aim of this study was to evaluate the mean
heart rate and heart rate variability (HRV) required for
diagnostic imaging of the coronary arteries simultaneously
with thoracic computed tomography for noncardiac
purposes, applying a high-pitch spiral image acquisition
protocol for computed tomography angiography (CTA)
using a dual-source system.
Background For the primary prevention of coronary heart
disease, screening methods to identify currently asymp-
tomatic people who are at high risk for developing coronary
heart disease are essential. Coronary CTA can rule out
coronary artery stenoses with high negative predictive value.
Methods High-pitch thoracic computed tomography was
performed in 111 consecutive patients (mean age 60.2 
11.5 years; range 37 to 81 years) using a dual-source system
(2  128 0.6-mm sections, 38.4-mm collimation width,
0.28-s rotation time). Data acquisition was prospectively
electrocardiographically triggered at 60% of the R-R interval
using a pitch of 3.2. Image quality was evaluated using
a 3-point scale (1 ¼ excellent, 2 ¼ moderate, 3 ¼ poor).
Results Close interobserver agreement for image quality
scores of 1,998 evaluated coronary segments was found
(k ¼ 0.93). Image quality was of diagnostic value in 828 of
1,739 segments (47.6%). In 29 of 111 patients (26%),
diagnostic image quality was observed for all segments.
Average heart rate and HRV were signiﬁcantly (p < 0.001)
higher in patients with at least 1 nondiagnostic coronary
segment compared with those without. All patients with
mean heart rates <64 beats/min and HRV <13 beats/min
had diagnostic image quality in all coronary segments.
Effective radiation dose for thoracic CTA was 1.9  0.66
mSv. The mean scan time was 0.9  0.1 s.
Conclusions Simultaneous evaluation of coronary arteries
in high-pitch dual-source CTA of the thorax for noncardiac
purposes is consistently diagnostic in patients with low heart
rates and HRV, whereas most patients not receiving beta-
blockers had at least 1 segment that was not diagnos-
tic because of heart rate and HRV. Beta blockers are
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interpretation is anticipated (234).
Validation of Minimal Luminal Area Measured by
Intravascular Ultrasound for Assessment of
Functionally Signiﬁcant Coronary Stenosis:
Comparison With Myocardial Perfusion Imaging
Objectives This study sought to evaluate the ability of
minimal luminal area (MLA) measured by intravascular
ultrasound (IVUS) to assess the functional signiﬁcance of
coronary artery disease.
Background The use of IVUS to determine the functional
signiﬁcance of coronary artery lesions remains a matter for
debate.
Methods From our prospective IVUS imaging database,
between July 2009 and April 2010, 170 coronary lesions in
150 patients who underwent stress myocardial single-photon
emission computed tomography (SPECT) performed
within 1 month of IVUS evaluation were identiﬁed and
analyzed. MLA and other parameters were measured by
IVUS and compared with the results of myocardial SPECT.
Results Overall, 45 lesions had positive SPECT, and 125
lesions had negative SPECT. The MLA of lesions with
positive SPECT was smaller than the MLA of those with
negative SPECT (1.7  0.5 mm2 vs. 2.3  1.1 mm2,
p < 0.001). By logistic regression analysis, MLA (odds ratio:
3.1 by decrease of 1 mm2, 95% conﬁdence interval [CI]:
1.75 to 5.5, p < 0.01) was an independent predictor of the
positive SPECT. Using receiver-operator characteristic
curve analysis, the best cutoff value of MLA was 2.1 mm2
with an 86.7% sensitivity, a 50.4% speciﬁcity, a 38.6%
positive predictive value, and a 91.3% negative predictive
value versus lesions with a positive SPECT (area under the
curve: 0.690, 95% CI: 0.615 to 0.759, p < 0.01).
Conclusions The best cutoff value of MLA measured by
IVUS to predict myocardial ischemia was 2.1 mm2. The
IVUS-measured MLA appeared to play a limited role in
detecting functionally signiﬁcant lesions assessed by
myocardial SPECT (235).
The Utility of Cardiac Biomarkers, Tissue Velocity
and Strain Imaging, and Cardiac Magnetic
Resonance Imaging in Predicting Early Left
Ventricular Dysfunction in Patients With Human
Epidermal Growth Factor Receptor II–Positive
Breast Cancer Treated With Adjuvant Trastuzumab
Therapy
Objectives The aim of this study was to evaluate whether
cardiac biomarkers, tissue velocity (TVI) and strain imaging,
and cardiac magnetic resonance imaging can predict early
left ventricular (LV) dysfunction in human epidermal
growth factor receptor II–positive breast cancer patients
treated with trastuzumab in the adjuvant setting.
Background Early indexes of LV systolic dysfunction with
noninvasive cardiac imaging would be useful for addressingthe cardiac safety proﬁle of trastuzumab, potentially avoiding
the detrimental effects of heart failure.
Methods We used cardiac biomarkers, TVI and strain
imaging, and cardiac magnetic resonance imaging to detect
pre-clinical changes in LV systolic function, before
conventional changes in left ventricular ejection fraction
(LVEF) in human epidermal growth factor receptor II–
positive breast cancer patients treated with trastuzumab in
the adjuvant setting.
Results Of 42 patients (mean age 47  9 years) prospec-
tively followed between 2007 and 2009, 10 (25%) developed
trastuzumab-mediated cardiomyopathy (CM). Troponin T,
C-reactive protein, and brain natriuretic peptide did not
change over time. Within 3 months of adjuvant therapy with
trastuzumab, there was a signiﬁcant difference in the lateral
S0 between the normal cohort and the CM group (9.1  1.6
cm/s and 6.4  0.6 cm/s, respectively, p < 0.05). Similarly,
the peak global longitudinal and radial strain decreased as
early as 3 months in the trastuzumab-mediated cardiotox-
icity group. As compared with both global longitudinal and
radial strain, only S0 was able to identify all 10 patients who
developed trastuzumab-mediated CM. The LVEF subse-
quently decreased at 6 months of follow-up in all 10
patients, necessitating discontinuation of the drug. All 10
patients demonstrated delayed enhancement of the lateral
wall of the LV within the mid-myocardial portion, consis-
tent with trastuzumab-induced CM.
Conclusions Both TVI and strain imaging were able to
detect pre-clinical changes in LV systolic function, before
conventional changes in LVEF, in patients receiving tras-
tuzumab in the adjuvant setting (236).Association of Annular Calciﬁcation and Aortic
Valve Sclerosis With Brain Findings on Magnetic
Resonance Imaging in Community Dwelling Older
Adults: The Cardiovascular Health Study
Objectives The objective of this study was to investigate
the associations of mitral annular calciﬁcation, aortic annular
calciﬁcation, and aortic valve sclerosis with covert magnetic
resonance imaging (MRI)–deﬁned brain infarcts.
Background Clinically silent brain infarcts deﬁned by MRI
are associated with increased risk for cognitive decline,
dementia, and future overt stroke. Left-sided cardiac valvular
and annular calciﬁcations are suspected as risk factors for
clinical ischemic stroke.
Methods A total of 2,680 CHS (Cardiovascular Health
Study) participants without clinical histories of stroke or
transient ischemic attack underwent brain MRI in 1992 and
1993, 1 to 2 years before echocardiographic exams (1994 to
1995).
Results The mean age of the participants was 74.5  4.8
years, and 39.3% were men. The presence of any annular or
valvular calciﬁcation (mitral annular calciﬁcation, aortic
annular calciﬁcation, or aortic valve sclerosis), mitral annular
calciﬁcation alone, or aortic annular calciﬁcation alone was
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brain infarcts in unadjusted analyses (p < 0.01 for all). In
models adjusted for age, sex, race, body mass index, physical
activity, creatinine, systolic blood pressure, total cholesterol,
high-density lipoprotein cholesterol, smoking, diabetes,
coronary heart disease, and congestive heart failure, the
presence of any annular or valve calciﬁcation remained
associated with covert brain infarcts (risk ratio: 1.24; 95%
conﬁdence interval: 1.05 to 1.47). The degree of annular or
valvular calciﬁcation severity showed a direct relation with
the presence of covert MRI ﬁndings.
Conclusions Left-sided cardiac annular and valvular calci-
ﬁcations are associated with covert MRI-deﬁned brain
infarcts. Further study is warranted to identify mechanisms
and determine whether intervening in the progression of
annular and valvular calciﬁcation could reduce the incidence
of covert brain infarcts as well as the associated risk for
cognitive impairment and future stroke (237).The Primary Beneﬁts of Angiotensin-Converting
Enzyme Inhibition on Cardiac Remodeling Occur
During Sleep Time in Murine Pressure Overload
Hypertrophy
Objectives Our objective was to test the hypothesis that
there is a signiﬁcant diurnal variation for the therapeutic
beneﬁt of angiotensin-converting enzyme (ACE) inhibitors
on pressure-overload cardiovascular hypertrophy.
Background Physiological and molecular processes exhibit
diurnal rhythms that may affect efﬁcacy of disease treatment
(chronotherapy). Evidence suggests that the heart primarily
remodels during sleep. Although a growing body of clinical
and epidemiological evidence suggests that the timing of
therapy, such as ACE inhibition, alters diurnal blood pres-
sure patterns in patients with hypertension, the beneﬁts of
chronotherapy on myocardial and vascular remodeling have
not been studied.
Methods We examined the effects of the short-acting
ACE inhibitor, captopril, on the structure and function of
cardiovascular tissue subjected to pressure overload by
transverse aortic constriction (TAC) in mice. Captopril (15
mg/kg intraperitoneally) or placebo was administered at
either murine sleep time or wake time for 8 weeks starting
1 week after surgery.
Results TAC mice given captopril at sleep time had
improved cardiac function and signiﬁcantly decreased heart:
body weight ratios, myocyte cross-sectional areas, intra-
myocardial vascular medial wall thickness, and perivascular
collagen versus TAC mice given captopril or placebo during
wake time. Captopril induced similar drops in blood pres-
sure at sleep or wake time, suggesting that time-of-day
differences were not attributable to blood pressure changes.
These beneﬁcial effects of captopril were correlated with
diurnal changes in ACE mRNA expression in the heart.
Conclusions The ACE inhibitor captopril beneﬁted
cardiovascular remodeling only when administered duringsleep; wake-time captopril ACE inhibition was identical to
that of placebo. These studies support the hypothesis that
the heart (and vessels) remodel during sleep time and also
illustrate the importance of diurnal timing for some
cardiovascular therapies (238).Adenylyl Cyclase 6 Improves Calcium Uptake and
Left Ventricular Function in Aged Hearts
Objectives This study tested the hypothesis that activation
of adenylyl cyclase 6 (AC6) expression in cardiac myocytes
improves calcium uptake and left ventricular (LV) function
in aging mice.
Background Aging hearts exhibit impaired b-adrenergic
receptor signaling and LV dysfunction.
Methods Twenty-month-old mice with cardiac-directed
and regulated AC6 expression were randomized into 2
groups, and AC6 expression was activated in 1 group (AC6-
On) but not the other (AC6-Off). One month later, LV
function and sarcoplasmic reticulum calcium uptake were
assessed.
Results AC6 expression was associated with increased LV
contractility, as reﬂected by ejection fraction (p ¼ 0.02), rate
of pressure development (p ¼ 0.002), and slope of the LV
end-systolic pressure-volume relationship (p ¼ 0.04). No
changes in LV weight to tibial length ratio, LV ﬁbrosis, and
expression of fetal genes (atrial natriuretic factor, a-skeletal
muscle actin, and b-myosin heavy chain) and collagens were
observed between AC6-On and AC6-Off groups. However,
LV samples from AC6-On mice showed increases in:
isoproterenol-stimulated cAMP production (p ¼ 0.04),
cAMP-dependent protein kinase activity (p < 0.0004),
phosphorylation of phospholamban (at Ser16 site; p ¼ 0.04)
and cardiac troponin I (at Ser23/24 sites; p ¼ 0.01), velocity
of sarcoplasmic reticulum calcium uptake (p < 0.0001), and
sarcoplasmic reticulum calcium-ATPase2a (SERCA2a)
afﬁnity for calcium (p < 0.0001). Finally, we found that
AC6 expression increased sarcoplasmic reticulum calcium
storage in cardiac myocytes isolated from 23-month-old rats.
In contrast, AC6 expression in 7-month-old mice did not
change LV function and calcium uptake.
Conclusions These results indicate that activation of
cardiac AC6 expression improves impaired function of aged
hearts through improved calcium uptake (239).Assessment of Echo-Attenuated Plaque by Optical
Coherence Tomography and its Impact on Post-
Procedural Creatine Kinase-Myocardial Band
Elevation in Elective Stent Implantation
Objectives This study examined morphological character-
istics of echo-attenuated plaques by optical coherence
tomography (OCT) and evaluated their inﬂuence on crea-
tine kinase-myocardial band (CK-MB) elevation after
percutaneous coronary intervention (PCI) in patients with
elective stent implantation.
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described atherosclerotic plaques with echo attenuation
(EA) without associated bright echoes that are correlated
with no-reﬂow phenomenon after PCI.
Methods We studied 135 native de novo culprit coronary
lesions in 135 patients with normal pre-PCI CK-MB levels
(28 with unstable angina; 107 with stable angina) who
underwent intravascular ultrasound and OCT examinations
before elective stent implantation. The lesions were divided
into 2 groups based on the presence or absence of EA, and
OCT ﬁndings were compared. We then determined
predictors of post-PCI CK-MB elevation.
Results EA was found in 47 (34.8%) lesions and was associ-
ated with the presence of OCT-derived thin-capped ﬁbroa-
theroma, ruptured plaques, greater lipid content, intravascular
ultrasound–derived large reference and plaque area, lesion
eccentricity, and microcalciﬁcation. Elevated CK-MB levels
were observed in 36 (26.7%) lesions, and signiﬁcantly more
frequently in lesions with EA than without. In multivariable
analysis, EA (odds ratio [OR]: 3.49; 95% conﬁdence interval
[CI]: 1.53 to 7.93; p ¼ 0.003) and OCT-derived ruptured
plaque (OR: 2.92; 95% CI: 1.21 to 7.06; p ¼ 0.017) were
independent predictors of post-PCI CK-MB elevation.
Conclusions Atherosclerotic plaques with EA were asso-
ciated with characteristics considered to be high risk or
unstable. OCT examination showed an additive predictive
value to the presence of EA for post-PCI CK-MB
elevation (240).Prognostic Value of CT Angiography for Major
Adverse Cardiac Events in Patients With Acute
Chest Pain From the Emergency Department:
2-Year Outcomes of the ROMICAT Trial
Objectives The aim of this study was to determine the 2-
year prognostic value of cardiac computed tomography
(CT) for predicting major adverse cardiac events (MACE)
in patients presenting to the emergency department (ED)
with acute chest pain.
Background CT has high potential for early triage of acute
chest pain patients. However, there is a paucity of data
regarding the prognostic value of CT in this ED cohort.
Methods We followed 368 patients from the ROMICAT
(Rule Out Myocardial Infarction Using Computer Assisted
Tomography) trial (age 53  12 years; 61% male) who pre-
sented to the ED with acute chest pain, negative initial
troponin, and a nonischemic electrocardiogram for 2 years.
Contrast-enhanced 64-slice CT was obtained during index
hospitalization, and caregivers and patients remained blinded
to the results. CT was assessed for the presence of plaque,
stenosis (>50% luminal narrowing), and left ventricular
regional wall motion abnormalities (RWMA). The primary
endpoint was MACE, deﬁned as composite cardiac death,
nonfatal myocardial infarction, or coronary revascularization.
Results Follow-up was completed in 333 patients (90.5%)
with a median follow-up period of 23 months. At the end ofthe follow-up period, 25 patients (6.8%) experienced 35
MACE (no cardiac deaths, 12 myocardial infarctions, and 23
revascularizations). Cumulative probability of 2-year MACE
increased across CT strata for coronary artery disease (CAD)
(no CAD 0%; nonobstructive CAD 4.6%; obstructive CAD
30.3%; log-rank p < 0.0001) and across combined CT strata
for CAD and RWMA (no stenosis or RWMA 0.9%; 1
featuredeither RWMA [15.0%] or stenosis [10.1%], both
stenosis and RWMA 62.4%; log-rank p < 0.0001). The c
statistic for predicting MACE was 0.61 for clinical
Thrombolysis In Myocardial Infarction risk score and
improved to 0.84 by adding CT CAD data and improved
further to 0.91 by adding RWMA (both p < 0.0001).
Conclusions CT coronary and functional features predict
MACE and have incremental prognostic value beyond
clinical risk score in ED patients with acute chest pain. The
absence of CAD on CT provides a 2-year MACE-free
warranty period, whereas coronary stenosis with RWMA
is associated with the highest risk of MACE (241).Differential Branch Pulmonary Artery Regurgitant
Fraction Is a Function of Differential Pulmonary
Arterial Anatomy and Pulmonary Vascular
Resistance
Objectives We sought to investigate whether differential
branch pulmonary artery (BPA) regurgitation correlates with
differences in BPA anatomy and physiology.
Background Patients with repaired conotruncal anomalies
such as Tetralogy of Fallot frequently have residual BPA
stenosis or BPA size differences. Previous reports have
demonstrated an increased left pulmonary artery (LPA)
regurgitant fraction (RF) in these patients.
Methods We retrospectively reviewed 76 consecutive cardiac
magnetic resonance (CMR) studies for BPA size and phase-
contrast magnetic resonance data, including 13 consecutive
patients who underwent both CMR and catheterization.
Results Thirty of the 76 patients had either BPA stenosis or
signiﬁcant size discrepancy. Whereas previous studies had
shown an increased RF in the LPA, patients with BPA
stenosis or size discrepancy showed no signiﬁcant difference
between right and left BPA RF (30% vs. 30%, p ¼ 0.985).
However, there was a signiﬁcantly increased RF of the larger
versus smaller BPA (39% vs. 21%, p < 0.001), resulting in an
insigniﬁcant deviation from normal fractional ﬂow distribu-
tion (RPA 63% vs. LPA 37%; normal net fractional ﬂow
distribution RPA 55% vs. LPA 45%). Retrospective review of
patients who underwent both CMR and catheterization
provides support for the preceding ﬁndings and validates
differential BPA RF as strongly correlating with differential
pulmonary vascular resistance (PVR) (r¼ 0.8364, p< 0.001).
Conclusions BPA RF is a function of the relative PVR and
the presence of BPA stenosis or size discrepancy. Contrary
to prior reports, the LPA RF is only elevated in patients
with relatively equal sized BPAs. In the setting of BPA
stenosis or size discrepancy the larger BPA has a relatively
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important tool for screening patients with unilateral stenosis
for contralateral increases in PVR that cannot be identiﬁed
with net ﬂows alone. This can affect the indication and
timing for BPA intervention (242).Mechanical and Structural Characteristics of
Carotid Plaques by Combined Analysis With
Echotracking System and MR Imaging
Objectives The purpose of this study was to correlate the
arterial mechanics of carotid atherosclerotic plaques assessed
from echotracking with their composition by high-
resolution magnetic resonance imaging (HR-MRI).
Background Analysis of the relationship between mechanical
parameters and structure of the plaque allows better under-
standing of the mechanisms leading to mechanical fatigue of
plaque material, plaque rupture, and ischemic events. A speciﬁc
longitudinal gradient of strain (reduced strain, i.e., lower radial
strain at the plaque level than at the adjacent segment) has been
shown in atherosclerotic plaques on the common carotid artery
(CCA) in patients with hypertension, dyslipidemia, or type 2
diabetes mellitus. The structural abnormalities underlying this
functional behavior have not been determined.
Methods Forty-six carotid plaques from 27 patients were eval-
uated;plaqueswerepresent at the siteof the carotidbifurcationand
extended to the CCA. Among the 27 patients, 9 had previous
ischemic stroke ipsilateral to carotid stenosis (symptomatic) and18
hadnot (asymptomatic).Mechanical parametersweremeasuredat
128 sites on a 4-cm long CCA segment by noninvasive echo-
tracking system, and strain gradient was calculated. Plaque
composition was noninvasively determined by HR-MRI.
Results Complex plaques at HR-MRI (i.e., American
Heart Association [AHA] stages IV to VIII) more often
displayed a reduced strain than the simple plaques (i.e.,
AHA stages I to III; p ¼ 0.046). HR-MRI veriﬁed complex
plaques were associated with an outer remodeling upon
echotracking, and had a lower distensibility than adjacent
CCA (17.0  5.0 MPa1 vs. 21.7  7.3 MPa1;
p ¼ 0.007). An outer remodeling was observed in plaques
with a lipid core at HR-MRI and was more frequent in
symptomatic carotids.
Conclusions These ﬁndings indicate that the longitudinal
mechanics of “complex” plaques follows a speciﬁc pattern of
reduced strain. They also suggest that reduced strain, asso-
ciated with an outer remodeling, may be a feature of high-
risk plaques (243).Cost-Effectiveness of Coronary Computed
Tomography and Cardiac Stress Imaging in the
Emergency Department: A Decision Analytic Model
Comparing Diagnostic Strategies for Chest Pain in
Patients at Low Risk of Acute Coronary Syndromes
Emergency department presentations with chest pain are
expensive and often unrelated to coronary artery disease(CAD). Coronary computed tomographic angiography
(CTA) may allow earlier discharge of low-risk patients,
resulting in cost savings. We modeled clinical and economic
outcomes of diagnostic strategies in patients with chest pain
and at low risk of CAD: exercise electrocardiography
(ECG), stress single-photon emission computed tomog-
raphy (SPECT), stress echocardiography, and a CTA
strategy comprising an initial CTA scan with conﬁrmatory
SPECT for indeterminate results. Our results suggest that
a 2-step diagnostic strategy of CTA with SPECT for
intermediate scans is likely to be less costly and more
effective for the diagnosis of a patient group at low risk of
CAD and a prevalence of 2% to 30%. The CTA strategies
were cost saving (lower costs, higher quality-adjusted life-
years) compared with stress ECG, echocardiography, and
SPECT. Conﬁrming intermediate/indeterminate CTA
scans with SPECT results in cost savings and quality-
adjusted life-year gains due to reduced hospitalization of
patients who returned false-positive initial CTA test.
However, CTA may be associated with a higher event rate
in negative patients than SPECT, and the diagnostic and
prognostic information for the use of CTA in the emergency
department is evolving. Large comparative, randomized,
controlled trials of the different diagnostic strategies are
needed to compare the long-term costs and consequences of
each strategy in a population of deﬁned low-risk patients in
the emergency department (244).Effect of Recommendations on Interobserver
Consistency of Diastolic Function Evaluation
Objectives We sought the impact of recent recommenda-
tions on observer concordance on interpretation of diastolic
stage and assessment of ﬁlling pressure.
Background Worsening stages of diastolic dysfunction are
associated with worsening outcome. However, the echo-
cardiographic classiﬁcation of diastolic function is complex,
and parameters may be discordant. The interobserver
agreement of diastolic assessment is undeﬁned.
Methods A complete diastolic evaluation (transmitral ﬂow,
left atrial volume, tissue Doppler, pulmonary venous ﬂow,
mitral ﬂow propagation, and left ventricular images) was
obtained in 20 patients and interpreted by 14 experts in 8
countries (280 case reads). Each investigator was asked to
interpret diastolic class and left ventricular ﬁlling pressure.
Brain natriuretic peptide level was drawn on the same day of
the echocardiogram to corroborate ﬁlling pressures obtained
by the echocardiogram. Concordance was assessed as kappa,
and accuracy was compared with speciﬁc application of the
recommendations by 2 investigators.
Results For recognition of raised ﬁlling pressure, the
sensitivity and speciﬁcity of readers for raised ﬁlling pressure
deﬁned by the reference read were 66  37% and 88  26%,
respectively. Complete agreement among all readers was
obtained in 10 of 20 cases. Diagnosis of normal and cate-
gories of abnormal ﬁlling was correct in 71% to 95%, with
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ﬁlling. There was no difference between U.S. and interna-
tional readers. Not all patients in each diastolic stage showed
all of the changes that are typical of that stage, and variations
appeared to be attributable to differences in weighting of
conﬂicting observations. Overall, kappa values for ﬁlling
pressure and diastolic class were 0.71 (range 0.60 to 0.80)
and 0.68 (range 0.54 to 0.86).
Conclusions Correct results for estimation of ﬁlling pres-
sure were obtained by a high proportion of readers. Classi-
ﬁcation of diastolic stages continues to be variable and might
be addressed by provision of a uniform hierarchy of obser-
vations (245).The Acute Hemodynamic Effects of MitraClip
Therapy
Objectives The objective of this study was to evaluate the
acute hemodynamic consequences of mitral valve (MV)
repair with the MitraClip device (Abbott Vascular, Menlo
Park, California).
Background Whether surgical correction of mitral regur-
gitation (MR) results in a low cardiac output (CO) state
because of an acute increase in afterload remains contro-
versial. The acute hemodynamic consequences of MR
reduction with the MitraClip device have not been studied.
Methods We evaluated 107 patients with cardiac cathe-
terization before and immediately following percutaneous
MV repair with the MitraClip device. In addition, pre- and
post-procedural hemodynamic parameters were studied by
transthoracic echocardiography.
Results MitraClip treatment was attempted in 107
patients, and in 96 (90%) patients, a MitraClip was
deployed. Successful MitraClip treatment resulted in: 1) an
increase in CO from 5.0  2.0 l/min to 5.7  1.9 l/min
(p ¼ 0.003); 2) an increase in forward stroke volume (FSV)
from 57  17 ml to 65  18 ml (p < 0.001); and 3)
a decrease in systemic vascular resistance from 1,226  481
dyn$s/cm5 to 1,004  442 dyn$s/cm5 (p < 0.001). In
addition, there was left ventricular (LV) unloading man-
ifested by a decrease in LV end-diastolic pressure from 11.4
 9.0 mm Hg to 8.8  5.8 mm Hg (p ¼ 0.016) and
a decrease in LV end-diastolic volume from 172  37 ml to
158  38 ml (p < 0.001). None of the patients developed
acute post-procedural low CO state.
Conclusions Successful MV repair with the MitraClip
system results in an immediate and signiﬁcant improvement
in FSV, CO, and LV loading conditions. There was no
evidence of a low CO state following MitraClip treatment
for MR. These favorable hemodynamic effects with the
MitraClip appear to reduce the risk of developing a low CO
state, a complication occasionally observed after surgical MV
repair for severe MR. (A Study of the Evalve Cardiovascular
Valve Repair System Endovascular Valve Edge-to-Edge
Repair Study [EVEREST I]; NCT00209339 and EVER-
EST II; NCT00209274) (246).Systematic Review of Guidelines on Imaging of
Asymptomatic Coronary Artery Disease
Objectives The purpose of this study was to critically
appraise guidelines on imaging of asymptomatic coronary
artery disease (CAD).
Background Various imaging tests exist to detect CAD in
asymptomatic persons. Because randomized controlled trials
are lacking, guidelines that address the use of CAD imaging
tests may disagree.
Methods Guidelines in English published between January
1, 2003, and February 26, 2010, were retrieved using
MEDLINE, Cumulative Index to Nursing and Allied
Health Literature, the National Guideline Clearinghouse,
the National Library for Health, the Canadian Medication
Association Infobase, and the Guidelines International
Network International Guideline Library. Guidelines
developed by national and international medical societies
from Western countries, containing recommendations on
imaging of asymptomatic CAD were included. Rigor of
development was scored by 2 independent reviewers using
the Appraisal of Guidelines Research and Evaluation
(AGREE) instrument. One reviewer performed full
extraction of recommendations, which was checked by
a second reviewer.
Results Of 2,415 titles identiﬁed, 14 guidelines met our
inclusion criteria. Eleven of 14 guidelines reported rela-
tionship with industry. The AGREE scores varied across
guidelines from 21% to 93%. Two guidelines considered
cost effectiveness. Eight guidelines recommended against or
found insufﬁcient evidence for testing of asymptomatic
CAD. The other 6 guidelines recommended imaging
patients at intermediate or high CAD risk based on the
Framingham risk score, and 5 considered computed to-
mography calcium scoring useful for this purpose.
Conclusions Guidelines on risk assessment by imaging of
asymptomatic CAD contain conﬂicting recommendations.
More research, including randomized controlled trials,
evaluating the impact of imaging on clinical outcomes and
costs is needed (247).
Endocardial Surface Area Tracking for Assessment
of Regional LV Wall Deformation With 3D Speckle
Tracking Imaging
Objectives The aim of this experimental study was to
validate area tracking by 3-dimensional (3D) speckle
tracking imaging (STI) as a method to measure changes in
regional left ventricular (LV) endocardial surface area with
sonomicrometry and to assess the usefulness as a wall motion
evaluation method compared with 1-dimensional strain
parameters.
Background A 3D-STI allows for tracking a regional
endocardial surface area during a cardiac cycle. Area tracking
is a new concept that regional wall motion is quantiﬁed
through the magnitude of deformation in an endocardial
surface area.
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crystals were implanted on the endocardium at the LV mid
and apical anterior walls. Area change ratio (ACR) that was
a novel parameter obtained by area tracking was measured as
percentage change in a segmental area during systole.
Segmental longitudinal (LS) and circumferential strain (CS)
also were measured by 3D-STI. The ACR, LS, and CS
were compared with those by sonomicrometry at baseline
and during pharmacological stress tests (dobutamine and
propranolol infusion) and acute myocardial ischemia
induced by occlusion of mid-left ascending artery.
Results The strong correlation was observed between ACR
measurements by 3D-STI and those by sonomicrometry
(Y ¼ 4.20 þ 0.84X, r ¼ 0.87, p < 0.001). The ACR
showed signiﬁcant relations with both LS and CS (LS:
Y ¼ 15.1 þ 1.73X, r ¼ 0.73, p < 0.001; CS:
Y ¼ 5.85 þ 1.06X, r ¼ 0.79, p < 0.001). ACR showed
signiﬁcant differences among baseline, pharmacological
stress, and acute myocardial ischemia. In contrast, LS and
CS were reduced signiﬁcantly during acute ischemia studies
compared with those during the other studies; no differences
were observed among baseline, propranolol infusion, and
dobutamine infusion studies.
Conclusions Area tracking by 3D-STI can estimate
changes in LV regional area and might be promising for
regional wall motion evaluations (248).Impact of Unexpected Factors on Quantitative
Myocardial Perfusion and Coronary Flow Reserve
in Young, Asymptomatic Volunteers
Objectives We sought to quantify ranges of normal
myocardial perfusion and ﬂow reserve in young, asymp-
tomatic volunteers after systematic historical and laboratory
screening for unexpected factors affecting coronary ﬂow.
Background Noninvasive cardiac positron emission
tomography (PET) quantiﬁes absolute ﬂow and coronary
ﬂow reserve (CFR), thereby deﬁning physiological severity
of coronary artery disease for clinical studies or management.
Deﬁning “normal” coronary ﬂow is a necessary prerequisite
to its broad clinical application.
Methods Volunteers aged 20 to 40 years of age without
cardiac disease or other conditions underwent rest–dipyr-
idamole stress cardiac PET with absolute quantitative ﬂow
measurements using Rb-82 in paired studies at least 7 days
apart for reproducibility. The presence of coronary calcium,
detectable blood nicotine or caffeine, dyslipidemia, and an
extended family history of early clinical atherosclerosis were
objectively and systematically examined for grouping sub-
jects as true normal or not normal.
Results We enrolled 125 volunteers, 107 (86%) underwent
2 PET scans. Fifty-six (45%) were classiﬁed as true normal,
whereas 69 (55%) were classiﬁed as not normal. True
normals had higher high-density lipoprotein and less PET
scan heterogeneity. Hemodynamic responses to dipyr-
idamole stress were similar. Rest ﬂow was the same in bothgroups (0.72  0.17 ml/min/g vs. 0.69  0.14 ml/min/g,
p ¼ 0.164). However, stress ﬂow (2.89  0.50 ml/min/g vs.
2.63  0.61 ml/min/g, p ¼ 0.005) and CFR (4.17  0.80
vs. 3.91  0.86, p ¼ 0.047) were higher in true normals.
Paired studies were performed a median of 22 days (inter-
quartile range: 15 to 39) apart. Reproducibility was
improved in the true normal group.
Conclusions One-half of young, asymptomatic volunteers
from the community harbor unexpected factors that mildly
but systematically reduce stress ﬂow, CFR, and reproduc-
ibility. This study establishes normal ranges and reproduc-
ibility for ﬂow and CFR as the basis for clinical
applications (249).Left Atrial Passive Emptying Function During
Dobutamine Stress MR Imaging Is a Predictor of
Cardiac Events in Patients With Suspected
Myocardial Ischemia
Objectives The aim of this study was to determine the
prognostic value of assessing left atrial function during
dobutamine stress testing.
Background Left ventricular diastolic dysfunction precedes
systolic wall motion abnormalities in the ischemic cascade.
Severity of left ventricular diastolic function during cardiac
stress is not characterized well by current clinical imaging
protocols but may be an important prognostic factor. We
hypothesized that abnormal early left atrial emptying
measured during dobutamine stress cardiac magnetic reso-
nance will reﬂect these diastolic changes and may be asso-
ciated with cardiovascular outcomes.
Methods We enrolled 122 consecutive patients referred for
dobutamine stress cardiac magnetic resonance for suspected
myocardial ischemia. Left atrial volumes were retrospectively
measured by the biplane area-length method at left ventric-
ular end-systole (VOLmax) and before atrial contraction
(VOLbac). Left atrial passive emptying fraction deﬁned by
(VOLmax – VOLbac)  100%/VOLmax and the absolute
percent increase in left atrial passive emptying fraction during
dobutamine stress (DLAPEF) were quantiﬁed.
Results Twenty-nine major adverse cardiac events
(MACE) occurred during follow-up (median 23 months).
By Kaplan-Meier analysis, patients with DLAPEF <10.8
(median) experienced higher incidence of MACE than did
patients with a DLAPEF >10.8 (p ¼ 0.004). By univariable
analysis, DLAPEF was strongly associated with MACE
(unadjusted hazard ratio for every 10% decrease ¼ 1.56,
p < 0.005). By multivariable analysis, every 10% decrease in
DLAPEF carried a 57% increase in MACE, after adjust-
ment to presence of myocardial ischemia and infarction.
Conclusions Reduced augmentation of left atrial passive
emptying fraction during dobutamine stress demonstrated
strong association with MACE. We speculate that reduced
left atrial passive emptying reserve during inotropic stress
may represent underlying diastolic dysfunction and warrants
further investigation (250).
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on Myocardial Viability at the LV Lead Position
Objectives This study sought to analyze the effectiveness of
cardiac resynchronization therapy (CRT) related to the
viability in the segment of left ventricular (LV) lead position
deﬁned by myocardial deformation imaging.
Background Echocardiographic myocardial deformation
analysis allows determination of LV lead position as well as
extent of myocardial viability.
Methods Myocardial deformation imaging based on
tracking of acoustic markers within 2-dimensional echo
images (GE Ultrasound, GE Healthcare, Horton, Norway)
was performed in 65 heart failure patients (54  6 years of
age, 41 men) before and 12 months after CRT implantation.
In a 16-segment model, the LV lead position was deﬁned
based on the segmental strain curve with earliest peak strain,
whereas the CRT system was programmed to pure LV
pacing. Nonviability of a segment (transmural scar forma-
tion) was assumed if the peak systolic circumferential strain
was >–11.1%.
Results In 47 patients, the LV lead was placed in a viable
segment, and in 18 patients, it was placed in a nonviable
segment. At 12-month follow-up there was greater decrease
of LV end-diastolic volumes (58  13 ml vs. 44  12 ml,
p ¼ 0.0388) and greater increase of LV ejection fraction (11
 4% vs. 5  4%, p ¼ 0.0343) and peak oxygen
consumption (2.5  0.9 ml/kg/min vs. 1.7  1.1 ml/kg/
min, p ¼ 0.0465) in the viable compared with the nonviable
group. The change in LV ejection fraction and the reduction
in LV end-diastolic volumes at follow-up correlated to an
increasing peak systolic circumferential strain in the segment
of the LV pacing lead (r ¼ 0.61, p ¼ 0.0274 and r ¼ 0.64,
p ¼ 0.0412, respectively). Considering only patients with
ischemic heart disease, differences between viable and
nonviable LV lead position group were even greater.
Conclusions Preserved viability in the segment of the CRT
LV lead position results in greater LV reverse remodeling
and functional beneﬁt at 12-month follow-up. Deformation
imaging allows analysis of viability in the LV lead segment
(251).
Detection of Coronary Artery Stenoses by Low-
Dose, Prospectively ECG-Triggered, High-Pitch
Spiral Coronary CT Angiography
Objectives We sought to evaluate the diagnostic accuracy
of a new prospectively electrocardiogram (ECG)-triggered
high-pitch scan mode for coronary computed tomography
angiography (CTA), which allows an effective dose of less
than 1 mSv.
Background Coronary CTA provides increasingly reliable
image quality, but the associated radiation exposure can be
high.
Methods Seventy-ﬁve patients with suspected coronary
artery disease and in sinus rhythm were screened for
participation. After exclusion of 25 patients for body weight>100 kg or failure to lower heart rate to 60 beats/min, 50
patients were studied by prospectively ECG-triggered high-
pitch spiral computed tomography (CT). Coronary CTA
was performed using a dual-source CT system with
2  128 0.6-mm collimation, 0.28-s rotation time, a pitch
of 3.4, 100-kVp tube voltage, and current of 320 mA. Data
acquisition was prospectively triggered at 60% of the R-R
interval and completed within 1 cardiac cycle. Diagnostic
accuracy for detection of coronary artery stenoses 50%
diameter stenosis was determined by comparison to invasive
coronary angiography. Per-patient diagnostic performance
was the primary form of analysis.
Results In all 50 patients (34 males, 59  12 years of age),
imaging was successful. For the detection of 16 patients with
at least 1 coronary artery stenosis, CT demonstrated
a sensitivity of 100% (95% conﬁdence interval [CI]: 79% to
100%) and speciﬁcity of 82% (95% CI: 65% to 93%). The
positive predictive value was 72% (95% CI: 49% to 89%) and
the negative predictive value was 100% (95% CI: 87% to
100%). Sensitivity was 100% (95% CI: 88% to 100%) and
speciﬁcity was 94% (95% CI: 89% to 97%) on a per-vessel
basis. Per-segment sensitivity was 92% (95% CI: 80%
to 97%), and speciﬁcity was 98% (95% CI: 96% to 98%).
Mean dose-length product for coronary CTA was 54  6
mGy $ cm, the effective dose was 0.76  0.08 mSv (0.64 to
0.95 mSv).
Conclusions In nonobese patients with a low and stable
heart rate, prospectively ECG-triggered high-pitch spiral
coronary CTA provides high diagnostic accuracy for the
detection of coronary artery stenoses (252).Can Differences in Corrected Coronary
Opaciﬁcation Measured With Computed
Tomography Predict Resting Coronary Artery Flow?
Objectives A proof-of-concept study was undertaken to
determine whether differences in corrected coronary opaci-
ﬁcation (CCO) within coronary lumen can identify arteries
with abnormal resting coronary ﬂow.
Background Although computed tomographic coronary
angiography can be used for the detection of obstructive
coronary artery disease, it cannot reliably differentiate
between anatomical and functional stenoses.
Methods Computed tomographic coronary angiography
patients (without history of revascularization, cardiac trans-
plantation, and congenital heart disease) who underwent
invasive coronary angiography were enrolled. Attenuation
values of coronary lumen were measured before and after
stenoses and normalized to the aorta. Changes in CCO were
calculated, and CCO differences were compared with
severity of coronary stenosis and Thrombolysis In Myocar-
dial Infarction (TIMI) ﬂow at the time of invasive coronary
angiography.
Results One hundred four coronary arteries (n ¼ 52, mean
age ¼ 60.0  9.5 years; men ¼ 71.2%) were assessed.
Compared with normal arteries, the CCO differences were
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angiography diameter stenoses 50%. Similarly, CCO
differences were greater in arteries with TIMI ﬂow grade <3
(0.406  0.226) compared with those with normal ﬂow
(TIMI ﬂow grade 3) (0.078  0.078, p < 0.001). With
CCO differences, abnormal coronary ﬂow (TIMI ﬂow
grade <3) was identiﬁed with a sensitivity and speciﬁcity,
positive predictive value, and negative predictive value of
83.3% (95% conﬁdence interval [CI]: 57.7 to 95.6%), 91.2%
(95% CI: 75.2% to 97.7%), 83.3% (95% CI: 57.7% to
95.6%), and 91.2% (95% CI: 75.2% to 97.7%), respectively.
Accuracy of this method was 88.5% with very good agree-
ment (kappa ¼ 0.75, 95% CI: 0.55 to 0.94).
Conclusions Changes in CCO across coronary stenoses
seem to predict abnormal (TIMI ﬂow grade <3) resting
coronary blood ﬂow. Further studies are needed to under-
stand its incremental diagnostic value and its potential to
measure stress coronary blood ﬂow (253).Inﬂammation is Related to Coronary Flow Reserve
Detected by Positron Emission Tomography in
Asymptomatic Male Twins
Objectives This study sought to examine the relationship
between inﬂammation and coronary microvascular function in
asymptomatic individuals using positron emission tomography
(PET) and assessment of coronary ﬂow reserve (CFR).
Background Coronary microvascular dysfunction is an
early precursor of coronary artery disease (CAD) thought to
result from endothelial cell activation and inﬂammation, but
data are limited.
Methods We examined 268 asymptomatic male mono-
zygotic and dizygotic twins. Plasma biomarkers of inﬂam-
mation and endothelial cell activation included C-reactive
protein (CRP), interleukin (IL)-6, white blood cell count
(WBC), vascular cell adhesion molecule (VCAM)-1, and
intercellular adhesion molecule (ICAM)-1. Blood ﬂow
quantitation was obtained with [13N] ammonia PET at rest
and after adenosine stress. CFR was measured as the ratio of
maximum ﬂow to baseline ﬂow at rest; abnormal CFR was
deﬁned as a ratio <2.5. A summed stress score for visible
perfusion defects was calculated.
Results In within-pair analyses, all biomarkers, except
VCAM-1, were higher in twins with lower CFR than their
brothers with higher CFR (p < 0.05). This was observed in
the entire sample, as well as within pairs discordant for
a CFR of <2.5. Associations persisted after adjusting for
summed stress score and CAD risk factors. In contrast no
biomarker, except IL-6, was related to the summed stress
score of visible defects.
Conclusions Even in asymptomatic subjects, a decrease in
coronary microvascular function is accompanied by a
systemic inﬂammatory response, independent of CAD risk
factors. Our results, using a controlled twin design, highlight
the importance of coronary microvascular function in the
early phases of CAD (254).Prognostic Value of Cardiac Computed
Tomography Angiography: A Systematic Review
and Meta-Analysis
Objectives The purpose of this study was to systematically
review and perform a meta-analysis of the ability of cardiac
computed tomography angiography (CCTA) to predict
future cardiovascular events and death.
Background The diagnostic accuracy of CCTA is well
reported. The prognostic value of CCTA has been described
in several studies, but many were underpowered. Pooling
outcomes increases the power to predict rare events.
Methods We searched multiple databases for longitudinal
studies of CCTA with at least 3 months follow-up of
symptomatic patients with suspected coronary artery disease
(CAD) reporting major adverse cardiovascular events
(MACE), consisting of death, myocardial infarction (MI),
and revascularization. Annualized event rates were pooled
using a bivariate mixed-effects binomial regression model to
calculate summary likelihood ratios and receiver-operating
characteristic curves.
Results Eighteen studies evaluated 9,592 patients with
a median follow-up of 20 months. The pooled annualized
event rate for obstructive (any vessel with >50% luminal
stenosis) versus normal CCTA was 8.8% versus 0.17% per
year for MACE (p < 0.05) and 3.2% versus 0.15% for
death or MI (p < 0.05). The pooled negative likelihood
ratio for MACE after normal CCTA ﬁndings was 0.008
(95% conﬁdence interval [CI]: 0.0004 to 0.17, p < 0.001),
the positive likelihood ratio was 1.70 (95% CI: 1.42
to 2.02, p < 0.001), sensitivity was 0.99 (95% CI: 0.93 to
1.00, p < 0.001), and speciﬁcity was 0.41 (95% CI: 0.31 to
0.52, p < 0.001). Stratifying by no CAD, nonobstructive
CAD (worst stenosis <50%), or obstructive CAD, there
were incrementally increasing adverse events.
Conclusions Adverse cardiovascular events among patients
with normal ﬁndings on CCTA are rare. There are incre-
mentally increasing future MACE with increasing CAD by
CCTA (255).
Direct T2 Quantiﬁcation of Myocardial Edema in
Acute Ischemic Injury
Objectives To evaluate the utility of rapid, quantitative T2
mapping compared with conventional T2-weighted imaging
in patients presenting with various forms of acute myocardial
infarction.
Background T2-weighted cardiac magnetic resonance
(CMR) identiﬁes myocardial edema before the onset of
irreversible ischemic injury and has shown value in risk-
stratifying patients with chest pain. Clinical acceptance
of T2-weighted CMR has, however, been limited by
well-known technical problems associated with existing
techniques. T2 quantiﬁcation has recently been shown to
overcome these problems; we hypothesized that T2 mea-
surement in infarcted myocardium versus remote regions
versus zones of microvascular obstruction in acute myocardial
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tation of T2-weighted images.
Methods T2 values using a novel mapping technique were
prospectively recorded in 16 myocardial segments in 27
patients admitted with acute myocardial infarction. Regional
T2 values were averaged in the infarct zone and remote
myocardium, both deﬁned by a reviewer blinded to the
results of T2 mapping. Myocardial T2 was also measured in
a group of 21 healthy volunteers.
Results T2 of the infarct zone was 69  6 ms compared
with 56  3.4 ms for remote myocardium (p < 0.0001). No
difference in T2 was observed between remote myocardium
and myocardium of healthy volunteers (56  3.4 ms and
55.5  2.3 ms, respectively, p ¼ NS). T2 mapping allowed
for the detection of edematous myocardium in 26 of 27
patients; by comparison, segmented breath-hold T2-
weighted short tau inversion recovery images were negative
in 7 and uninterpretable in another 2 due to breathing
artifacts. Within the infarct zone, areas of microvascular
obstruction were characterized by a lower T2 value (59  6
ms) compared with areas with no microvascular obstruction
(71.6  10 ms, p < 0.0001). T2 mapping provided
consistent high-quality results in patients unable to breath-
hold and in those with irregular heart rhythms, in whom
short tau inversion recovery often yielded inadequate
imaging.
Conclusions Quantitative T2 mapping reliably identiﬁes
myocardial edema without the limitations encountered by
T2-weighted short tau inversion recovery imaging, and may
therefore be clinically more robust in showing acute ischemic
injury (256).Echocardiographic Predictors of Adverse
Outcomes After Continuous Left Ventricular
Assist Device Implantation
Objectives The purpose of the study was to identify
echocardiographic predictors of adverse outcome in patients
implanted with continuous-ﬂow left ventricular assist
devices (LVAD).
Background Continuous ﬂow LVAD have become part of
the standard of care for the treatment of advanced heart
failure. However, knowledge of echocardiographic predictors
of outcome after LVAD are lacking.
Methods Overall, 83 patients received continuous-ﬂow
LVAD (HeartMate II, Thoratec Corporation, Pleasanton,
California) from February 2007 to June 2010. The LVAD
database, containing various echocardiographic parameters,
was examined to analyze their inﬂuence on in-hospital
mortality, a compound cardiac event (in-hospital mortality
or acute right ventricular [RV] dysfunction), and long-term
mortality.
Results Eight patients died before discharge (operative
mortality 9.6%), and another 15 patients were considered to
have acute RV dysfunction immediately after surgery.
Patients with relatively small left ventricular end-diastolicdiameters (<63 mm) had signiﬁcantly higher risk for in-
hospital mortality (odds ratio [OR]: 0.9; 95% conﬁdence
interval [CI]: 0.83 to 0.99; p ¼ 0.04) or occurrence of the
compound cardiac event (OR: 0.89; 95% CI: 0.84 to 0.95;
p < 0.001). The most signiﬁcant predictor of outcome was
the decreased timing interval between the onset and the
cessation of tricuspid regurgitation ﬂow corrected for heart
rate (TRDc), a surrogate for early systolic equalization of RV
and right atrial pressure. Short TRDc predicted in-hospital
mortality (OR: 0.85; 95% CI: 0.74 to 0.97; p ¼ 0.01) and
the compound cardiac event (OR: 0.83; 95% CI: 0.74 to
0.91; p < 0.0001). Multivariate analysis based on a logistic
regression model demonstrated that the accuracy of pre-
dicting the 30-day compound adverse outcome was
improved with the addition of echocardiographic variables
when added to the commonly used hemodynamic or clinical
scores. TRDc predicted long-term survival, with adjusted
risk ratios of 0.89 for death from any cause (95% CI: 0.83 to
0.96; p¼ 0.003) and 0.88 for cardiac-related death (95% CI:
0.77 to 0.98; p ¼ 0.03).
Conclusions The presence of either a relatively small left
ventricle (<63 mm) or early systolic equalization of RV and
right atrial pressure (short TRDc) demonstrated by echo-
cardiography is associated with increased 30-day morbidity
and mortality. Prediction of early adverse outcomes by
echocardiographic parameters is additive to laboratory or
hemodynamic variables (257).Speckle-Tracking Echocardiography for Predicting
Outcome in Chronic Aortic Regurgitation During
Conservative Management and After Surgery
Objectives The aim of this study was to test myocardial
deformation imaging using speckle-tracking echocardiog-
raphy for predicting outcomes in chronic aortic
regurgitation.
Background In chronic aortic regurgitation, left ventricular
(LV) dysfunction must be detected early to allow timely
surgery. Speckle-tracking echocardiography has been
proposed for this purpose, but the clinical value of this
method in aortic regurgitation has not been established.
Methods A longitudinal study was performed in 64
patients with moderate to severe aortic regurgitation. Thirty-
ﬁve patients were managed conservatively with frequent
clinical visits and sequential echocardiography and followed
for an average of 19  8 months, while 29 patients under-
went surgery for the valve lesion and were followed for 6
months post-operatively. Baseline LV function by speckle-
tracking and conventional echocardiography was compared
with impaired outcome after surgery (deﬁned as persisting
symptoms or persisting LV dilation [LV end-diastolic
volume index 87 ml/m2] or dysfunction [LV ejection
fraction <50%]) and with disease progression during
conservative management (deﬁned as development of
symptoms, increase in LV volume >15%, or decrease in LV
ejection fraction >10%).
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and early diastolic strain rate by speckle-tracking echocardi-
ography was associated with disease progression during
conservative management (16.3% vs. 19.0%,
p ¼ 0.02; 1.04 vs. 1.19 s1, p ¼ 0.02; and 1.20 vs. 1.60
s1, p¼ 0.002, respectively) and with impaired outcome after
surgery (11.5% vs.15.6%, p¼ 0.01;0.88 vs.1.01 s1,
p ¼ 0.04; and 0.98 vs. 1.33 s1, p ¼ 0.01, respectively).
Conventional parameters of LV function and size (LV ejection
fraction and LV end-diastolic volume index) were
associated with outcome after surgery (p ¼ 0.04 and
p ¼ 0.01, respectively) but not with outcome during conser-
vative management (p ¼ 0.57 and p ¼ 0.39, respectively).
Conclusions Speckle-tracking echocardiography is useful
for the early detection of LV systolic and diastolic
dysfunction in chronic aortic regurgitation (258).Feasibility of Diastolic Function Assessment With
Cardiac CT: Feasibility Study in Comparison With
Tissue Doppler Imaging
Objectives This study aimed to demonstrate the feasibility
of multidetector row computed tomography (CT) for
assessment of diastolic function in comparison with
2-dimensional (2D) echocardiography using tissue Doppler
imaging (TDI).
Background Diastolic left ventricular (LV) function plays
an important role in patients with cardiovascular disease. 2D
echocardiography using TDI has been used most commonly
to evaluate diastolic LV function. Although the role of
cardiac CT imaging for evaluation of coronary atheroscle-
rosis has been explored extensively, its feasibility to evaluate
diastolic function has not been studied.
Methods Patients who had undergone 64-multidetector
row CT and 2D echocardiography with TDI were
enrolled. Diastolic function was evaluated using early (E)
and late (A) transmitral peak velocity (cm/s) and peak mitral
septal tissue velocity (Ea; cm/s). Peak transmitral velocity
(cm/s) was calculated by dividing peak diastolic transmitral
ﬂow (ml/s) by the corresponding mitral valve area (cm2).
Mitral septal tissue velocity was calculated from changes in
LV length per cardiac phase. Subsequently, the estimation of
LV ﬁlling pressures (E/Ea) was determined.
Results Seventy patients (46 men; mean age 55  11 years)
who had undergone cardiac CT and 2D echocardiography
with TDI were included. Good correlations were observed
between cardiac CT and 2D echocardiography for assessment
of E (r ¼ 0.73; p < 0.01), E/A (r ¼ 0.87; p < 0.01), Ea
(r ¼ 0.82; p < 0.01), and E/Ea (r ¼ 0.81; p < 0.01).
Moreover, a good diagnostic accuracy (79%) was found for
detection of diastolic dysfunction using cardiac CT. Finally,
the study showed a low intraobserver and interobserver vari-
ability for assessment of diastolic function on cardiac CT.
Conclusions Cardiac CT imaging showed good correla-
tions for transmitral velocity, mitral septal tissue velocity,
and estimation of LV ﬁlling pressures when compared with2D echocardiography. Additionally, cardiac CT and 2D
echocardiography were comparable for assessment of dia-
stolic dysfunction. Accordingly, cardiac CT may provide
information on diastolic dysfunction (259).
Atrial Dilation and Altered Function Are Mediated
by Age and Diastolic Function But Not Before the
Eighth Decade
Objectives This study investigated changes in left atrial
(LA) volumes and phasic atrial function, by deciles, with
normal aging.
Background LA volume increase is a sensitive independent
marker for cardiovascular disease and adverse outcomes. To
use this variable more effectively as a marker of pathology
and a gauge of outcome, physiological changes due to aging
alone need to be quantitated.
Methods A detailed transthoracic echocardiogram was
performed in 220 normal subjects; 89 (41%) were male
and their age ranged from 20 to 80 years (mean 45  17
years). Maximum (end-ventricular systole), minimum
(end-ventricular diastole), and pre–a-wave volumes were
measured using the biplane method of disks. LA ﬁlling,
passive emptying, conduit and active emptying volumes, and
fractions were calculated. Transmitral inﬂow, pulmonary
vein ﬂow, and pulsed-wave Doppler tissue imaging param-
eters were measured as expressions of left ventricular dia-
stolic function. For purposes of analysis, subjects were
divided by age deciles.
Results LA indexed maximum (0.05 ml/m2 per year) and
minimum (0.06 ml/m2 per year) volume increased with age
but only became signiﬁcant in the eighth decade (26.0  6.3
ml/m2, p ¼ 0.02, and 13.5  3.9 ml/m2, respectively;
p < 0.001). Impaired left ventricular diastolic relaxation was
apparent in decade 6 and was associated with a shift in
phasic LA volumes so that LA expansion index and passive
emptying decreased with increasing age, whereas active
emptying volume increased.
Conclusions In normal healthy subjects, LA indexed
volumes remain nearly stable until the eighth decade when
they increase signiﬁcantly. Therefore, an increase in LA size
that occurs before the eighth decade is likely to represent
a pathological change. Changes in phasic atrial volumes
develop earlier consequent to age-related alteration in LV
diastolic relaxation (260).
Contrast-Enhanced C-Arm CT Evaluation of
Radiofrequency Ablation Lesions in the Left
Ventricle
Objectives The purpose of this study was to evaluate use of
cardiac C-arm computed tomography (CT) in the assess-
ment of the dimensions and temporal characteristics of
radiofrequency ablation (RFA) lesions. This imaging
modality uses a standard C-arm ﬂuoroscopy system rotating
around the patient, providing CT-like images during the
RFA procedure.
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CT can be used to assess myocardial necrotic tissue. Several
studies have reported visualizing cardiac RFA lesions with
CMR; however, obtaining CMR images during interven-
tional procedures is not common practice. Direct visualiza-
tion of RFA lesions using C-arm CT during the procedure
may improve outcomes and circumvent complications
associated with cardiac ablation procedures.
Methods RFA lesions were created on the endocardial
surface of the left ventricle of 9 swine using a 7-F RFA
catheter. An electrocardiographically gated C-arm CT
imaging protocol was used to acquire projection images
during iodine contrast injection and after the injection every
5 min for up to 30 min, with no additional contrast.
Reconstructed images were analyzed ofﬂine. The mean and
SD of the signal intensity of the lesion and normal
myocardium were measured in all images in each time series.
Lesion dimensions and area were measured and compared in
pathologic specimens and C-arm CT images.
Results All ablation lesions (n ¼ 29) were visualized and
lesion dimensions, as measured on C-arm CT, correlated
well with postmortem tissue measurements (linear dimen-
sions: concordance correlation ¼ 0.87; area: concordance
correlation ¼ 0.90. Lesions were visualized as a perfusion
defect on ﬁrst-pass C-arm CT images with a signal intensity
of 95 HU lower than that of normal myocardium (95%
conﬁdence interval: 111 HU to 79 HU). Images
acquired at 1 and 5 min exhibited an enhancing ring
surrounding the perfusion defect in 24 lesions (83%).
Conclusions RFA lesion size, including transmurality, can
be assessed using electrocardiographically gated cardiac C-
arm CT in the interventional suite. Visualization of RFA
lesions using cardiac C-arm CT may facilitate the assess-
ment of adequate lesion delivery and provide valuable
feedback during cardiac ablation procedures (261).Impact of the Revision of Arrhythmogenic Right
Ventricular Cardiomyopathy/Dysplasia Task Force
Criteria on Its Prevalence by CMR Criteria
Objectives The purpose of our study was to assess the impact
of revised versus original criteria on the prevalence of arrhyth-
mogenic right ventricular cardiomyopathy/dysplasia (ARVC/
D) criteria in cardiac magnetic resonance (CMR) studies.
Background Recently, the ARVC/D task force criteria
have been revised, aiming for a better diagnostic sensitivity.
The implications of this revision on clinical decision making
are unknown.
Methods We retrospectively evaluated the CMR scans of
294 patients referred for ARVC/D between 2005 and 2010,
and determined the presence or absence of major and minor
CMR criteria using the original and the revised task force
criteria. Previously, major and minor abnormalities were
identiﬁed by the presence of right ventricle dilation (global
or segmental), right ventricle microaneurysm, or regional
hypokinesis. The revised criteria require the combination ofsevere regional wall motion abnormalities (akinesis or dys-
kinesis or dyssynchrony) with global right ventricle dilation
or dysfunction (quantitative assessment).
Results Applying the original criteria, 69 patients (23.5%)
had major original criteria, versus 19 patients (6.5%) with
the revised criteria. Forty-three patients (62.3%) with major
original criteria did not meet any of the revised criteria.
Using the original criteria, 172 patients (58.5%) had at least
1 minor criterion versus 12 patients (4%) with the revised
task force criteria; 167 patients (97%) with minor original
criteria did not meet any of the revised criteria. In the
subgroup of 134 patients with complete diagnostic work-up
of ARVC, 10 patients met the diagnosis of proven ARVC/
D without counting imaging criteria. Only 4 of 10 met
major criteria according to the revised CMR criteria; none
met minor criteria. However, 112 of 124 patients without
ARVC/D were correctly classiﬁed as negative by major and
minor criteria (speciﬁcity 94% and 96%, respectively).
Conclusions In our experience, the revision of the ARVC/
D task force imaging criteria signiﬁcantly reduced the overall
prevalence of major and minor criteria. The revision, although
maintaining a high speciﬁcity, may not have improved the
sensitivity for identifying patients with ARVC/D. Larger
studies including follow-up are required (262).Positron Emission Tomography Measurement of
Periodontal 18F-Fluorodeoxyglucose Uptake Is
Associated With Histologically Determined Carotid
Plaque Inﬂammation
Objectives This study aimed to test the hypothesis that
metabolic activity within periodontal tissue (a possible
surrogate for periodontal inﬂammation) predicts inﬂamma-
tion in a remote atherosclerotic vessel, utilizing 18F-ﬂuo-
rodeoxyglucose (FDG) positron emission tomography
(PET) imaging.
Background Several lines of evidence establish periodontal
disease as an important risk factor for atherosclerosis. FDG-
PET imaging is an established method for measuring
metabolic activity in human tissues and blood vessels.
Methods One hundred twelve patients underwent FDG-
PET imaging 92  5 min after FDG administration (13
to 25 mCi). Periodontal FDG uptake was measured by
obtaining standardized uptake values from the periodontal
tissue of each patient, and the ratio of periodontal to back-
ground (blood) activity was determined (TBR). Standard-
ized uptake value measurements were obtained in the carotid
and aorta as well as in a venous structure. Localization of
periodontal, carotid, and aortic activity was facilitated by
PET coregistration with computed tomography or magnetic
resonance imaging. A subset of 16 patients underwent
carotid endarterectomy within 1 month of PET imaging,
during which atherosclerotic plaques were removed and
subsequently stained with anti-CD68 antibodies to quantify
macrophage inﬁltration. Periodontal FDG uptake was
compared with carotid plaque macrophage inﬁltration.
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carotid TBR (R ¼ 0.64, p < 0.0001), as well as aortic TBR
(R ¼ 0.38; p ¼ 0.029). Moreover, a strong relationship was
observed between periodontal TBR and histologically
assessed inﬂammation within excised carotid artery plaques
(R ¼ 0.81, p < 0.001).
Conclusions FDG-PET measurements of metabolic
activity within periodontal tissue correlate with macrophage
inﬁltration within carotid plaques. These ﬁndings provide
direct evidence for an association between periodontal
disease and atherosclerotic inﬂammation (263).
Prevalence and Predictors of Concomitant Carotid
and Coronary Artery Atherosclerotic Disease
Objectives The purpose of this research was to evaluate the
relationship between coronary and carotid atherosclerotic
disease using current guidelines for the deﬁnition of carotid
artery stenosis (CAS).
Background The reported prevalence of concomitant
coronary and carotid atherosclerotic disease has varied
among studies due to differences in study populations and
methodologies used.
Methods We performed a retrospective analysis of
prospectively collected data obtained between January 2007
and May 2009 from consecutive patients undergoing same-
day coronary angiography and carotid Doppler studies.
Spearman correlations and multinomial logistic regression
models were used to identify independent correlates of CAS.
Results The study included 1,405 patients (age 65  11
years, 77.2% male), of whom 12.8% had signiﬁcant CAS
(peak systolic velocity [PSV] >125 cm/s) and 4.6% had
severe CAS (PSV >230 cm/s). Mild CAS (PSV <125 cm/s
and the presence of a sonographic atherosclerotic lesion) was
present in 58%. The severity of CAS and the extent of
coronary artery disease (CAD) were signiﬁcantly correlated
(r ¼ 0.255, p < 0.001). Independent predictors of severe
CAS deﬁned by PSV were the presence of left-main or 3-
vessel CAD, increasing age, a history of stroke, smoking
status, and diabetes mellitus.
Conclusions The degree of internal carotid artery (ICA)
stenosis is related to the extent of CAD, though the prev-
alence of clinically signiﬁcant ICA stenosis is lower in
speciﬁc CAD subsets than previously reported (264).
Association of Left Atrial Fibrosis Detected by
Delayed-Enhancement Magnetic Resonance
Imaging and the Risk of Stroke in Patients With
Atrial Fibrillation
Objectives This study tried to determine the association
between left atrial (LA) ﬁbrosis, detected using delayed-
enhanced magnetic resonance imaging (DE-MRI), and
the CHADS2 score (point system based on individual
clinical risk factors including congestive heart failure,
hypertension, age, diabetes, and prior stroke) variables,
speciﬁcally stroke.Background In patients with atrial ﬁbrillation (AF),
conventional markers for the risk of stroke base their higher
predictive effect on clinical features, particularly previous
stroke history, and not individual LA pathophysiological
properties. We aimed to determine the association between
LA ﬁbrosis, detected using DE-MRI, and the CHADS2
score variables, speciﬁcally stroke.
Methods Patients with AF who presented to the AF clinic
and received a DE-MRI of the LA were evaluated. Their
risk factor proﬁles, including a CHADS2 score, were cata-
logued. The degree of LA ﬁbrosis was determined as
a percentage of the LA area. Any history of previous strokes,
warfarin use, or cerebrovascular disease was recorded.
Results A total of 387 patients, having a mean age of 65 12
years, 36.8% female, were included in this study. A history of
previous stroke was present in 36 (9.3%) patients. Those
patients with previous strokes had a signiﬁcantly higher
percentage of LA ﬁbrosis (24.4  12.4% vs. 16.2  9.9%,
p < 0.01). A larger amount of LA ﬁbrosis was also seen in
those patients with a higher CHADS2 score (2: 18.7 11.4
vs. <2: 14.7 9.2, p < 0.01). A logistic regression analysis of
all variables except strokes (CHAD score) demonstrated that
LA ﬁbrosis independently predicted cerebrovascular events
(p ¼ 0.002) and signiﬁcantly increased the predictive perfor-
mance of the score (area under the curve ¼ 0.77).
Conclusions Our preliminary, multicenter results suggest
DE-MRI–based detection of LA ﬁbrosis is independently
associated with prior history of strokes. We propose that the
amount of DE-MRI–determined LA ﬁbrosis could repre-
sent a marker for stroke and a possible therapeutic target
with potential applicability for clinical treatment for patients
with AF (265).Impaired Left Ventricular Stroke Volume Reserve
During Clinical Dobutamine Stress Predicts Future
Episodes of Pulmonary Edema
Objectives The purpose of this study was to determine
whether dobutamine-induced abnormal stress changes in
left ventricular stroke volume (LVSV) and aortic stiffness
predict future pulmonary edema.
Background Increased aortic stiffness that decreases LVSV
during adrenergic stress may serve as a marker for future
pulmonary edema (PE).
Methods We measured LVSV, ventriculovascular stiffness
(pulse pressure/LVSVindex), and aortic distensibility at rest
and during intravenous dobutamine administration using
cardiovascular magnetic resonance. Personnel blinded to
dobutamine cardiovascular magnetic resonance followed
participants longitudinally over time to identify those
admitted to the hospital with PE. Data for 44 participants
who had a hospital admission for PE were compared with
data for 72 participants of similar age, sex, and resting left
ventricular ejection fraction who remained PE free.
Results Expressed as median and interquartile range,
participants with and without PE exhibited a decreased
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0.9 to 1.2], respectively; p ¼ 0.002), an increased ven-
triculovascular stiffness stress/rest ratio (1.4 [range 1.0 to
1.6] vs. 1.0 [range 0.8 to 1.3], respectively; p  0.001); and
a decreased stress-induced measure of aortic distensibility
(0.8 mmHg3 [range 0.3 to 1.3 mmHg3] vs. 1.6 mmHg3
[range 1.2 to 3.2 mm Hg3], respectively; p ¼ 0.002).
After accounting for age, sex, left ventricular ejection fraction,
risk factors for PE, and the presence of dobutamine-
induced ischemia, LVSV reserve and the stress/rest ven-
triculovascular stiffness ratio still differed (p< 0.008 for both)
in those with and without PE.
Conclusions In patients without inducible ischemia during
dobutamine stress testing in whom one might otherwise
assume a favorable prognosis, the failure to increase LVSV
or an increase in ventriculovascular stiffness indicates
patients at risk of subsequent PE (266).Clinical Characteristics, Management, and
Outcomes of Patients Diagnosed With Acute
Pulmonary Embolism in the Emergency
Department: Initial Report of EMPEROR
(Multicenter Emergency Medicine Pulmonary
Embolism in the Real World Registry)
Objectives In a large U.S. sample, this study measured the
presentation features, testing, treatment strategies, and
outcomes of patients diagnosed with pulmonary embolism
(PE) in the emergency department (ED).
Background No data have quantiﬁed the demographics,
clinical features, management, and outcomes of outpatients
diagnosed with PE in the ED in a large, multicenter U.S.
study.
Methods Patients of any hemodynamic status were
enrolled from the ED after conﬁrmed acute PE or with
a high clinical suspicion prompting anticoagulation before
imaging for PE. Exclusions were inability to provide
informed consent (where required) or unavailability for
follow-up.
Results A total of 1,880 patients with conﬁrmed acute PE
were enrolled from 22 U.S. EDs. Diagnosis of PE was based
upon positive results of computerized tomographic pulmo-
nary angiogram in most cases (n ¼ 1,654 [88%]). Patients
represented both sexes equally, and racial and ethnic
composition paralleled the overall U.S. ED population.
Most (79%) patients with PE were employed, and one-third
were older than age 65 years. The mortality rate directly
attributed to PE was 20 in 1,880 (1%; 95% conﬁdence
interval [CI]: 0% to 1.6%). Mortality from hemorrhage was
0.2%, and the all-cause 30-day mortality rate was 5.4% (95%
CI: 4.4% to 6.6%). Only 3 of 20 patients with major PE that
ultimately proved fatal had systemic anticoagulation initiated
before diagnostic conﬁrmation, and another 3 of these 20
received a ﬁbrinolytic agent.
Conclusions Patients diagnosed with acute PE in U.S.
EDs have high functional status, and their mortality rate islow. These registry data suggest that appropriate initial
medical management of ED patients with severe PE with
anticoagulation is poorly standardized and indicate a need
for research to determine the appropriate threshold for
empiric treatment when PE is suspected before diagnostic
conﬁrmation (267).
Early Versus Late Functional Outcome After
Successful Percutaneous Pulmonary Valve
Implantation: Are the Acute Effects of Altered
Right Ventricular Loading All We Can Expect?
Objectives The purpose of this study was to assess the
potential of late positive functional remodeling after percu-
taneous pulmonary valve implantation (PPVI) in right
ventricular outﬂow tract dysfunction.
Background PPVI has been shown to impact acutely on
biventricular function and exercise performance, but the
potential for further late functional remodeling remains
unknown.
Methods Sixty-ﬁve patients with sustained hemodynamic
effects of PPVI at 1 year were included. Patients were
divided into 2 subgroups based on pre-procedural predom-
inant pulmonary stenosis (PS) (n ¼ 35) or predominant
pulmonary regurgitation (PR) (n ¼ 30). Data from magnetic
resonance imaging and cardiopulmonary exercise testing
were compared at 3 time points: before PPVI, within 1
month (early) and at 12 months (late) after PPVI.
Results There was a signiﬁcant decrease in right ventricle
end-diastolic volume early after PPVI in both subgroups of
patients. Right ventricle ejection fraction improved early only
in the PS group (51  11% vs. 58  11% and 51  12% vs.
50  11%, p < 0.001 for PS, p ¼ 0.13 for PR). Late after
intervention, there were no further changes in magnetic
resonance parameters in either group (right ventricle ejection
fraction, 58  11% in the PS group and 52  11% in the PR
group, p ¼ 1.00 and p ¼ 0.13, respectively). In the PS group
at cardiopulmonary exercise testing, there was a signiﬁcant
improvement in peak oxygen uptake early (24  8 ml/kg/min
vs. 27  9 ml/kg/min, p ¼ 0.008), with no further signiﬁcant
change late (27  9 ml/kg/min, p ¼ 1.00). In the PR group,
no signiﬁcant changes in peak oxygen uptake from early to
late could be demonstrated (25  8 ml/kg/min vs. 25  8
ml/kg/min vs. 26  9 ml/kg/min, p ¼ 0.48).
Conclusions In patients with a sustained hemodynamic
result 1 year after PPVI, a prolonged phase of maintained
cardiac function is observed. However, there is no evidence
for further positive functional remodeling beyond the acute
effects of PPVI (268).
Favorable Changes in Cardiac Geometry and
Function Following Gastric Bypass Surgery:
2-Year Follow-Up in the Utah Obesity Study
Objectives The objective of this study was to test the
hypothesis that gastric bypass surgery (GBS) would favor-
ably impact cardiac remodeling and function.
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obesity, but there are limited outcome data.
Methods We prospectively studied 423 severely obese
patients undergoing GBS and a reference group of severely
obese subjects that did not have surgery (n ¼ 733).
Results At a 2-year follow up, GBS subjects had a large
reduction in body mass index compared with the reference
group (15.4  7.2 kg/m2 vs. 0.03  4.0 kg/m2;
p < 0.0001), as well as signiﬁcant reductions in waist
circumference, systolic blood pressure, heart rate, triglycer-
ides, low-density lipoprotein cholesterol, and insulin resis-
tance. High-density lipoprotein cholesterol increased. The
GBS group had reductions in left ventricular (LV) mass
index and right ventricular (RV) cavity area. Left atrial
volume did not change in GBS but increased in reference
subjects. In conjunction with reduced chamber sizes, GBS
subjects also had increased LV midwall fractional shortening
and RV fractional area change. In multivariable analysis, age,
change in body mass index, severity of nocturnal hypoxemia,
E/E0, and sex were independently associated with LV mass
index, whereas surgical status, change in waist circumfer-
ence, and change in insulin resistance were not.
Conclusions Marked weight loss in patients undergoing
GBS was associated with reverse cardiac remodeling and
improved LV and RV function. These data support the use
of bariatric surgery to prevent cardiovascular complications
in severe obesity (269).Novel Insights Into RV Adaptation and Function in
Hypoplastic Left Heart Syndrome Between the
First 2 Stages of Surgical Palliation
Objectives This study sought to examine the changes in
ventricular function of hypoplastic left heart syndrome
(HLHS) between the ﬁrst 2 stages of surgical palliation.
Background The mortality risk between ﬁrst and second
stages of surgical palliation in HLHS remains high. Right
ventricular (RV) dysfunction predicts mortality. Postulated
mechanisms include a maladaptive contraction pattern,
myocardial ischemia, or contraction asynchrony. Speckle
tracking imaging allows accurate measurement of myocardial
deformation without geometric assumptions.
Methods Prospective echocardiography pre-Norwood and
pre-bidirectional cavopulmonary anastomosis (BCPA)
examinations were performed in 20 HLHS patients, with
comparisons made between stages. Measurements of
ventricular function included: longitudinal/circumferential
strain ratio, reﬂecting changes in contraction pattern; post-
systolic strain index, a potential marker of myocardial
ischemia; and mechanical dyssynchrony index. Relationships
between echocardiographic variables and magnetic reso-
nance imaging RV parameters before BCPA were examined.
Results Before BCPA, myocardial contractility estimated by
isovolumic acceleration and strain rate was reduced, paralleled
by an increased in post-systolic strain index (p < 0.01). Right
ventricular longitudinal/circumferential strain ratio decreased,becoming similar to a left ventricle–like contraction pattern,
and this correlated with decreased mechanical dyssynchrony
index (r ¼ 0.65, p < 0.01), magnetic resonance imaging RV
end-diastolic volume (r¼ 0.65, p< 0.05) and mass (r¼ 0.71,
p < 0.01). Ventricular strain (r ¼ –0.72, p < 0.01), strain rate
(r ¼ –0.85, p < 0.001), and mechanical dyssynchrony index
(r ¼ –0.73, p < 0.01) correlated linearly with magnetic reso-
nance imaging–derived RV ejection fraction.
Conclusions Reduced RV contractility occurred before
BCPA. RV with a left ventricle–like contraction pattern was
associated with improved contraction synchrony as well as
a reduction in RV size and mass in HLHS. The ﬁnding of
increased post-systolic strain index before BCPA is novel
and its potential link with myocardial ischemia warrants
further investigation. RV strain, strain rate, and contraction
synchrony measured by speckle tracking imaging correlated
closely with ventricular function and might be useful for
monitoring ventricular function in HLHS (270).Usefulness of TEE as the Primary Imaging
Technique to Guide Transcatheter Transapical
Aortic Valve Implantation
Objectives The aim of this study was to: 1) determine the
usefulness of transesophageal echocardiography (TEE) as
the primary technique to guide transapical (TA) trans-
catheter aortic valve implantation (TAVI); and 2) to
compare TEE with angiography as the primary imaging
modality for TA-TAVI guidance.
Background TEE has been routinely used as an adjunct to
angiography during TA-TAVI procedures, but very few data
exist on the use of TEE as the primary imaging technique
guiding TA-TAVI.
Methods One hundred consecutive high-risk patients
(mean age 79  9 years, mean logistic EuroSCORE: 25.8 
17.6%) who underwent TA-TAVI in our center were
included. The Edwards valve was used in all cases, and all
procedures were performed in an operating room without
hybrid facilities. The TA-TAVI was primarily guided by
angiography in the ﬁrst 25 patients (A-TAVI group) and by
TEE in the last 75 patients (TEE-TAVI group). Proce-
dural, 30-day, and follow-up results were evaluated.
Results No differences were observed between groups at
baseline except for a higher (p ¼ 0.001) prevalence of
moderate or severe mitral regurgitation in the TEE-TAVI
group. The procedure was successful in 97.3% and 100%
of the patients in the TEE-TAVI and A-TAVI groups,
respectively (p ¼ 1.0), and a lower contrast volume was used
in the TEE-TAVI group (12 [5 to 20] ml vs. 40 [20 to 50]
ml, p < 0.0001). There were no differences between groups
in the occurrence of valve malposition needing a second
valve (TEE-TAVI: 5.3%; A-TAVI: 4%; p ¼ 1.0) or valve
embolization (TEE-TAVI: 1.3%; A-TAVI: 4%; p ¼ 0.44).
The results regarding post-procedural valve hemodynamic
status and aortic regurgitation were similar between groups.
The survival rates at 30-day and 1-year follow-up were 87%
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TAVI group, respectively (log-rank ¼ 0.49).
Conclusions TEE-TAVI was associated with similar acute
and midterm results as A-TAVI and signiﬁcantly reduced
contrast media use during the procedures. These results
suggest the feasibility and safety of performing TA-TAVI
procedures in an operating room without hybrid facilities,
but larger studies are needed to conﬁrm these ﬁndings (271).
Long-Term Prognostic Value of Dobutamine
Stress CMR
Objectives The aim of this study was to assess the long-term
value of high-dose dobutamine cardiac magnetic resonance
(DCMR) for the prediction of cardiac events in a large cohort
of patients with known or suspected coronary artery disease.
Background High-dose DCMR has been shown to be
a useful technique for diagnosis and intermediate-term
prognostic stratiﬁcation.
Methods Clinical data and DCMR results were analyzed in
1,463 consecutive patients undergoing DCMR between
2000 and 2004. Ninety-four patients were lost to follow-up.
The remaining 1,369 patients were followed up for a mean
of 44  24 months. Cardiac events, deﬁned as cardiac death
and nonfatal myocardial infarction, were related to clinical
and DCMR results.
Results Three-hundred ﬁfty-two patients underwent early
revascularization (3 months of DCMR) and were excluded
from analysis. Of the remaining 1,017 patients, 301 patients
(29.6%) experienced inducible wall motion abnormalities
(WMA). Forty-six cardiac events were reported. In those
with and without inducible WMA, the proportion of
patients with cardiac events was 8.0% versus 3.1%, respec-
tively, p ¼ 0.001 (hazard ratio: 3.3; 95% conﬁdence interval:
1.8 to 5.9 for the presence of inducible WMA; p < 0.001).
A DCMR without inducible WMA carried an excellent
prognosis, with a 6-year cardiac event-free survival of 96.8%.
In all 1,369 patients in the patient group with stress-
inducible WMA, those patients with medical therapy
demonstrated a trend to a higher cardiac event rate (8.0%)
than those with early revascularization (5.4%) (p ¼ 0.234).
Patients with normal DCMR and medical therapy or early
revascularization demonstrated similar cumulative cardiac
event rates (3.1% vs. 3.2%, p ¼ 0.964).
Conclusions In a large cohort of patients, DCMR has an
added value for predicting cardiac events during long-term
follow-up, improving the differentiation between high-risk
and low-risk patients. Patients with inducible WMA and
following early revascularization, demonstrate lower cardiac
event rates than patients with medical therapy alone (272).
Evaluation of Techniques for the Quantiﬁcation of
Myocardial Scar of Differing Etiology Using Cardiac
Magnetic Resonance
Objectives The aim of this study was to compare the
reproducibility of 7 late gadolinium enhancement (LGE)quantiﬁcation techniques across 3 conditions in which LGE
is known to be important: acute myocardial infarction
(AMI), chronic myocardial infarction (CMI), and hyper-
trophic cardiomyopathy (HCM).
Background LGE by cardiac magnetic resonance is the
gold-standard technique for assessing myocardial scar. No
consensus exists on the best method for its quantiﬁcation,
and research in this area is scant. Techniques include manual
quantiﬁcation, thresholding by 2, 3, 4, 5, or 6 SDs above
remote myocardium, and the full width at half maximum
(FWHM) technique. To date, LGE has been linked to
outcome in 3 conditions: AMI, CMI, and HCM.
Methods Sixty patients with 3 LGE etiologies (AMI,
n ¼ 20; CMI, n ¼ 20; HCM, n ¼ 20) were scanned for
LGE. LGE volume was quantiﬁed using the 7 techniques.
Mean LGE volume, interobserver and intraobserver repro-
ducibility, and impact on sample size were assessed.
Results LGE volume varied signiﬁcantly with the quanti-
ﬁcation method used. There was no statistically signiﬁcant
difference between LGE volume by the FWHM, manual,
and 6-SD or 5-SD techniques. The 2-SD technique
generated LGE volumes up to 2 times higher than the
FWHM, 6-SD, and manual techniques. The reproducibility
of all techniques was worse in HCM than AMI or CMI.
The FWHM technique was the most reproducible in all 3
conditions compared with any other method (p < 0.001).
Use of the FWHM technique for LGE quantiﬁcation in
paired analysis would lead to at least a 60% reduction in
required sample size compared with any other method.
Conclusions Regardless of the disease under study, the
FWHM technique for LGE quantiﬁcation gives LGE
volume mean results similar to manual quantiﬁcation and is
statistically the most reproducible, reducing required sample
sizes by up to one-half (273).Prospective Validation of Standardized,
3-Dimensional, Quantitative Coronary Computed
Tomographic Plaque Measurements Using
Radiofrequency Backscatter Intravascular
Ultrasound as Reference Standard in Intermediate
Coronary Arterial Lesions: Results From the
ATLANTA (Assessment of Tissue Characteristics,
Lesion Morphology, and Hemodynamics by
Angiography With Fractional Flow Reserve,
Intravascular Ultrasound and Virtual Histology,
and Noninvasive Computed Tomography in
Atherosclerotic Plaques) I Study
Objectives This study sought to determine the accuracy of
3-dimensional, quantitative measurements of coronary pla-
que by computed tomography angiography (CTA) against
intravascular ultrasound with radiofrequency backscatter
analysis (IVUS/VH).
Background Quantitative, 3-dimensional coronary CTA
plaque measurements have not been validated against
IVUS/VH.
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coronary X-ray angiography, IVUS/VH, and coronary
CTA. Plaque geometry and composition was quantiﬁed
after spatial coregistration on segmental and slice-by-slice
bases. Correlation, mean difference, and limits of agree-
ment were determined.
Results There was signiﬁcant correlation for all pre-
speciﬁed parameters by segmental and slice-by-slice anal-
yses (r ¼ 0.41 to 0.84; all p < 0.001). On a segmental basis,
CTA underestimated minimal lumen diameter by 21% and
overestimated diameter stenosis by 39%. Minimal lumen
area was overestimated on CTA by 27% but area stenosis
was only underestimated by 5%. Mean difference in non-
calciﬁed plaque volume and percent and calciﬁed plaque
volume and percent were 38%, 22%, 104%, and 64%. On
a slice-by-slice basis, lumen, vessel, noncalciﬁed-, and
calciﬁed-plaque areas were overestimated on CTA by 22%,
19%, 44%, and 88%. There was signiﬁcant correlation for
percentage of atheroma volume (0.52 vs. 0.54; r ¼ 0.51;
p < 0.001). Compositional analysis suggested that high-
density noncalciﬁed plaque on CTA best correlated with
ﬁbrous tissue and low-density noncalciﬁed plaque correlated
with necrotic core plus ﬁbrofatty tissue by IVUS/VH.
Conclusions This is the ﬁrst validation that standardized,
3-dimensional, quantitative measurements of coronary pla-
que correlate with IVUS/VH. Mean differences are small,
whereas limits of agreement are wide. Low-density non-
calciﬁed plaque correlates with necrotic core plus ﬁbrofatty
tissue on IVUS/VH (274).Dynamic 3-Dimensional Stress Cardiac Magnetic
Resonance Perfusion Imaging: Detection of
Coronary Artery Disease and Volumetry of
Myocardial Hypoenhancement Before and After
Coronary Stenting
Objectives The aim of this study was to establish a new,
dynamic 3-dimensional cardiac magnetic resonance (3D-
CMR) perfusion scan technique exploiting data correlation
in k-space and time with sensitivity-encoding and to
determine its value for the detection of coronary artery
disease (CAD) and volumetry of myocardial hypoenhance-
ment (VOLUMEhypo) before and after percutaneous
coronary stenting.
Background Dynamic 3D-CMR perfusion imaging might
improve detection of myocardial perfusion deﬁcits and could
facilitate direct volumetry of myocardial hypoenhancement.
Methods In 146 patients with known or suspected CAD,
a 3.0-T CMR examination was performed including cine
imaging, 3D-CMR perfusion under adenosine stress and at
rest followed by delayed enhancement imaging. Quantitative
invasive coronary angiography deﬁned signiﬁcant CAD
(50% luminal narrowing). Forty-eight patients underwent
an identical repeat CMR examination after percutaneous
stenting of at least 1 coronary lesion. The 3D-CMR
perfusion scans were visually classiﬁed as pathologic if 1segment showed an inducible perfusion deﬁcit in the
absence of delayed enhancement. The VOLUMEhypo was
measured by segmentation of the area of inducible hypo-
enhancement and normalized to left-ventricular myocardial
volume (%VOLUMEhypo).
Results The 3D-CMR perfusion resulted in a sensitivity,
speciﬁcity, and diagnostic accuracy of 91.7%, 74.3%, and
82.9%, respectively. Before and after coronary stenting, %
VOLUMEhypo averaged to 14.2  9.5% and 3.2  5.2%,
respectively, with a relative VOLUMEhypo reduction of
79.4  25.4%. Intrareader and inter-reader reproducibility
of VOLUMEhypo measurements was high (Lin’s concor-
dance correlation coefﬁcient, 0.96 and 0.96, respectively).
Conclusions The 3D-CMR stress perfusion provided high
image quality and high diagnostic accuracy for the detection
of signiﬁcant CAD. The VOLUMEhypo measurements
were highly reproducible and allowed for the assessment of
the treatment effect achievable by percutaneous coronary
stenting (275).Low-Dose Computed Tomography Coronary
Angiography With Prospective Electrocardiogram
Triggering: Feasibility in a Large Population
Objectives We sought to assess the feasibility of prospective
electrocardiogram triggering for achieving low-dose
computed tomography coronary angiography (CTCA) in
a large population.
Background Prospective electrocardiogram triggering
dramatically reduces radiation exposure for CTCA but
requires heart rate (HR) control to obtain diagnostic image
quality. Its feasibility in daily clinical routine has therefore
remained to be elucidated.
Methods We evaluated 612 patients consecutively referred
for CTCA by 64-slice computed tomography. Intravenous
metoprolol (2 to 30 mg) was administered if necessary to
achieve a target HR below 65 beats/min. Image quality was
assessed on a semiquantitative 4-point scale for each coro-
nary segment.
Results Forty-six (7.5%) patients were deemed ineligible
due to irregular heart rhythm (n ¼ 19), insufﬁcient response
to metoprolol (n ¼ 21), renal insufﬁciency (n ¼ 3), or
inability to follow breath-hold commands (n ¼ 3). Mean
effective radiation dose was 1.8  0.6 mSv with a diagnostic
image quality in 96.2% of segments. Finally, low-dose
CTCA allowed a ﬁrm diagnosis with regard to the pres-
ence or absence of coronary artery disease in 527 (86.1%)
patients. Intravenous metoprolol to achieve an HR below 65
beats/min was used in 64.4% of patients. Incidence of
nondiagnostic segments was inversely related to HR
(r ¼ 0.809, p < 0.001). Below an HR cutoff of 62 beats/
min, only 1.2% of coronary segments were nondiagnostic.
Conclusions Low-dose CTCA by electrocardiogram trig-
gering is feasible in the vast majority of an every-day pop-
ulation. However, HR control is crucial, as an HR below 62
beats/min favors diagnostic image quality (276).
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e130Targeted Iron Oxide Particles for In Vivo Magnetic
Resonance Detection of Atherosclerotic Lesions
With Antibodies Directed to Oxidation-Speciﬁc
Epitopes
Objectives The aim of this study was to determine whether
iron oxide particles targeted to oxidation-speciﬁc epitopes
image atherosclerotic lesions.
Background Oxidized low-density lipoprotein plays a major
role in atherosclerotic plaque progression and destabilization.
Prior studies indicate that gadolinium micelles labeled with
oxidation-speciﬁc antibodies allow for in vivo detection of
vulnerable plaques with magnetic resonance imaging (MRI).
However, issues related to biotransformation/retention of
gadolinium might limit clinical translation. Iron oxides are
recognized as safe and effective contrast agents for MRI.
Because the efﬁcacy of passively targeted iron particles remains
variable, it was hypothesized that iron particles targeted to
oxidation-speciﬁc epitopes might increase the utility of this
platform.
Methods Lipid-coated ultra-small superparamagnetic iron
particles (LUSPIOs) (<20 nm) and superparamagnetic iron
particles (<40 nm) were conjugated with antibodies targeted
to either malondialdehyde-lysine or oxidized phospholipid
epitopes. All formulations were characterized, and their
in vivo efﬁcacy evaluated in apolipoprotein E deﬁcient mice
24 h after bolus administration of a 3.9-mg Fe/kg dose with
MRI. In vivo imaging data were correlated with the presence
of oxidation-speciﬁc epitopes with immunohistochemistry.
Results MRI of atherosclerotic lesions, as manifested by signal
loss, was observed after administration of targeted LUSPIOs.
Immunohistochemistry conﬁrmed the presence of
malondialdehyde-epitopes and iron particles. Limited signal
attenuation was observed for untargeted LUSPIOs. Addition-
ally, no signiﬁcant arterial wall uptake was observed for targeted
or untargeted lipid-coated superparamagnetic iron oxide parti-
cles, due to their limited ability to penetrate the vessel wall.
Conclusions This study demonstrates that LUSPIOs tar-
geted to oxidation-speciﬁc epitopes image atherosclerotic
lesions and suggests a clinically translatable platform for the
detection of atherosclerotic plaque (277).
Noninvasive Identiﬁcation of Ventricular
Tachycardia-Related Conducting Channels Using
Contrast-Enhanced Magnetic Resonance Imaging
in Patients With Chronic Myocardial Infarction:
Comparison of Signal Intensity Scar Mapping and
Endocardial Voltage Mapping
Objectives We performed noninvasive identiﬁcation of
post-infarction sustained monomorphic ventricular tachy-
cardia (SMVT)–related slow conduction channels (CC) by
contrast-enhanced magnetic resonance imaging (ceMRI).
Background Conduction channels identiﬁed by voltage
mapping are the critical isthmuses of most SMVT. We
hypothesized that CC are formed by heterogeneous tissue
(HT) within the scar that can be detected by ceMRI.Methods We studied 18 consecutive VT patients (SMVT
group) and 18 patients matched for age, sex, infarct location,
and left ventricular ejection fraction (control group). We
used ceMRI to quantify the infarct size and differentiate it
into scar core and HT based on signal-intensity (SI)
thresholds (>3 SD and 2 to 3 SD greater than remote
normal myocardium, respectively). Consecutive left ventricle
slices were analyzed to determine the presence of continuous
corridors of HT (channels) in the scar. In the SMVT group,
color-coded shells displaying ceMRI subendocardial SI were
generated (3-dimensional SI mapping) and compared with
endocardial voltage maps.
Results No differences were observed between the 2 groups
in myocardial, necrotic, or heterogeneous mass. The HT
channels were more frequently observed in the SMVT group
(88%) than in the control group (33%, p < 0.001). In the
SMVT group, voltage mapping identiﬁed 26 CC in 17 of 18
patients. All CC corresponded, in location and orientation,
to a similar channel detected by 3-dimensional SI mapping;
15 CC were related to 15 VT critical isthmuses.
Conclusions SMVT substrate can be identiﬁed by ceMRI
scar heterogeneity analysis. This information could help
identify patients at risk of VT and facilitate VT ablation (278).High-Resolution Magnetic Resonance Myocardial
Perfusion Imaging at 3.0-Tesla to Detect
Hemodynamically Signiﬁcant Coronary Stenoses
as Determined by Fractional Flow Reserve
Objectives The objective of this study was to compare
visual and quantitative analysis of high spatial resolution
cardiac magnetic resonance (CMR) perfusion at 3.0-T
against invasively determined fractional ﬂow reserve (FFR).
Background High spatial resolution CMR myocardial
perfusion imaging for the detection of coronary artery
disease (CAD) has recently been proposed but requires
further clinical validation.
Methods Forty-two patients (33 men, age 57.4  9.6
years) with known or suspected CAD underwent rest and
adenosine-stress k-space and time sensitivity encoding
accelerated perfusion CMR at 3.0-T achieving in-plane
spatial resolution of 1.2  1.2 mm2. The FFR was
measured in all vessels with >50% severity stenosis. Frac-
tional ﬂow reserve <0.75 was considered hemodynamically
signiﬁcant. Two blinded observers visually interpreted the
CMR data. Separately, myocardial perfusion reserve (MPR)
was estimated using Fermi-constrained deconvolution.
Results Of 126 coronary vessels, 52 underwent pressure
wire assessment. Of these, 27 lesions had an FFR <0.75.
Sensitivity and speciﬁcity of visual CMR analysis to detect
stenoses at a threshold of FFR <0.75 were 0.82 and 0.94
(p < 0.0001), respectively, with an area under the receiver-
operator characteristic curve of 0.92 (p < 0.0001). From
quantitative analysis, the optimum MPR to detect such
lesions was 1.58, with a sensitivity of 0.80, speciﬁcity of 0.89
(p < 0.0001), and area under the curve of 0.89 (p < 0.0001).
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used to detect ﬂow-limiting CAD as deﬁned by FFR, using
both visual and quantitative analyses (279).
Description and Assessment of a Common
Reference Method for Fluoroscopic and
Transesophageal Echocardiographic Localization
and Guidance of Mitral Periprosthetic
Transcatheter Leak Reduction
Objectives This study sought to describe and compare
a novel ﬂuoroscopic method and a 2-dimensional trans-
esophageal echocardiographic (TEE) method to localize
mitral periprosthetic leaks (PPLs) for transcatheter
reduction.
Background Transcatheter reduction of signiﬁcant regur-
gitation represents a modern and attractive alternative to
surgery for the treatment of mitral PPL in high-risk
patients. Accurate localization and precise communication
between the echocardiographer and the interventional
cardiologist are essential for procedural success.
Methods We analyzed TEE and ﬂuoroscopic studies of
patients with mitral PPL who underwent multiplane 2-
dimensional TEE–guided transcatheter reduction in our
institution. Periprosthetic leaks were routinely localized
using the “surgeon’s-view” time-clock method during peri-
procedural TEE assessments. The 2-dimensional TEE
examinations were later retrospectively reviewed by an
echocardiographer blinded to procedural TEE ﬁndings. A
corresponding surgeon’s-view time-clock method was
plotted for ﬂuoroscopic PPL localization. Using this ﬂuo-
roscopic method, ofﬂine ﬂuoroscopic images were reviewed
by an independent interventional cardiologist blinded to
TEE results. Agreement between methods was evaluated.
Results Complete imaging data were available for analysis
in 20 patients who, between 2002 and 2009, underwent
transcatheter reduction in which the defect was successfully
crossed. There was excellent agreement between procedural
TEE and retrospective TEE review for PPL localization
(100%; p < 0.0001) and between ﬂuoroscopic and proce-
dural TEE localization (90%; 95% conﬁdence interval [CI]:
77% to 100%; p ¼ 0.0003). In the 2 cases where there was
disagreement, ﬂuoroscopic PPL localization was adjacent to
TEE localization.
Conclusions The surgeon’s-view time-clock method of
localizing PPL using 2-dimensional TEE is highly repro-
ducible and allows ﬂuoroscopic localization using the same
reference system with very good agreement (280).
Myocardial Ischemia in the Absence of Obstructive
Coronary Artery Disease in Systemic Lupus
Erythematosus
Objectives The purpose of this study was to evaluate the
presence of myocardial ischemia measured by adenosine stress
cardiac magnetic resonance (CMR) using visual myocardial
perfusion and a quantitative myocardial perfusion reserveindex (MPRI) in the absence of obstructive coronary artery
disease (CAD) in women with systemic lupus erythematosus
(SLE) with anginal chest pain (CP).
Background Ischemic heart disease is a leading cause of
morbidity and mortality in SLE. Previous studies demon-
strated the presence of perfusion defects using adenosine
stress CMR in patients with CP and no obstructive CAD,
consistent with microvascular coronary dysfunction in
patients without SLE.
Method Twenty female SLE patients with typical and
atypical anginal CP were prospectively enrolled. Patients with
established cardiovascular disease were excluded. CMR was
performed with 0.05 mmol/kg gadolinium adenosine stress
ﬁrst-pass perfusion in SLE patients and in 10 asymptomatic
reference control women. SLE patients also underwent 64-
slice coronary computed tomography angiography. CMR
was scored visually and quantitatively (MPRI).
Results Among 18 patients with complete data, no patient
had obstructive CAD; however, 8 of 18 (44%) displayed
visual perfusion defects on stress CMR compared with 0 in
10 control subjects (p ¼ 0.014). The mean MPRI in
patients versus controls was 2.0  0.4 versus 2.4  0.4
(p ¼ 0.031) in the subepicardium and 1.8  0.3 versus 2.1
 0.4 (p ¼ 0.24) in the subendocardium. Multivariate linear
regression revealed that SLE was the only predictor of
subepicardial (p < 0.0025; b ¼ 1.059) and subendocardial
(p < 0.05; b ¼ 0.529) MPRIs.
Conclusions We observed a 44% prevalence of abnormal
stress myocardial perfusion by CMR in the absence of
obstructive CAD in SLE patients with anginal CP.
Compared with controls, reduced MPRI was observed in
SLE patients, and SLE presence was a signiﬁcant predictor
of an abnormal MPRI. These ﬁndings are consistent with
the hypothesis that anginal CP in SLE patients without
obstructive CAD is due to myocardial ischemia potentially
caused by microvascular coronary dysfunction. Further
research in a larger SLE population is warranted (281).Evaluation of LV Diastolic Function From Color
M-Mode Echocardiography
Objectives This study evaluated early diastolic ﬁlling
dynamics using a semiautomated objective analysis of ﬁlling
velocities obtained from color M-mode echocardiography.
Background Diastolic function can be evaluated from color
M-mode echocardiography by measuring the early diastolic
ﬂow propagation velocity (Vp) from the slope of a single
linear approximation of an isovelocity contour. However,
this method has limitations and may not accurately represent
diastolic ﬁlling.
Methods We used a semiautomated objective analysis of
color M-mode echocardiograms from a development cohort
of 125 patients with varying diastolic function to quantify left
ventricular ﬁlling velocities. Early diastolic ﬁlling was
not accurately described with a single propagation velocity;
instead, the rapid initial ﬁlling velocity abruptly decelerated to
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of diastolic function in a separate group of 160 patients.
Results Compared with normal ﬁlling, diastolic dysfunction
with restricted ﬁlling had a lower initial velocity (53  21 cm/
s vs. 87  29 cm/s, p < 0.001), and the deceleration point
occurred closer to the mitral annulus (2.4  0.6 cm vs. 3.1 
0.7 cm, p < 0.05). The product of the initial velocity and the
distance to the deceleration point from the mitral annulus,
indicating the strength of the early ﬁlling (Vs), was progres-
sively reduced with diastolic dysfunction. In a separate vali-
dation cohort of 160 patients, Vs better recognized diastolic
dysfunction (classiﬁed by reduced diastolic intraventricular
pressure gradient, elevated pulmonary capillary wedge pres-
sure, or elevated B-type natriuretic peptide) than Vp did.
Conclusions Early diastolic ﬂow propagation occurs with
an initial rapid velocity that abruptly decelerates to
a terminal velocity. With diastolic dysfunction, the initial
velocity is slower and the deceleration point occurs closer to
the mitral annulus than with normal ﬁlling. A new param-
eter that combines these 2 effects (Vs) provides a more
accurate assessment of diastolic function than the conven-
tional propagation velocity (282).Real-Time 3D Echo in Patient Selection for Cardiac
Resynchronization Therapy
Objectives This study investigated the use of 3-
dimensional (3D) echo in quantifying left ventricular
mechanical dyssynchrony (LVMD), its interhospital agree-
ment, and potential impact on patient selection.
Background Assessment of LVMD has been proposed as
an improvement on conventional criteria in selecting
patients for cardiac resynchronization therapy (CRT).
Three-dimensional echo offers a reproducible assessment of
left ventricular (LV) structure, function, and LVMD and
may be useful in selecting patients for this intervention.
Methods We studied 187 patients at 2 institutions. Three-
dimensional data from baseline and longest follow-up were
quantiﬁed for volume, left ventricular ejection fraction
(LVEF), and systolic dyssynchrony index (SDI). New York
Heart Association (NYHA) functional class was assessed
independently. Several outcomes from CRT were consid-
ered: 1) reduction in NYHA functional class; 2) 20% relative
increase in LVEF; and 3) 15% reduction in LV end-systolic
volume. Sixty-two cases were shared between institutions to
analyze interhospital agreement.
Results There was excellent interhospital agreement for 3D–
derived LV end-diastolic and end- systolic volumes, EF, and
SDI (variability: 2.9%, 1%, 7.1%, and 7.6%, respectively).
Reduction in NYHA functional class was found in 78.9% of
patients. Relative improvement in LVEF of 20% was found
in 68% of patients, but signiﬁcant reduction in LV end-
systolic volume was found in only 41.5%. The QRS dura-
tion was not predictive of any of the measures of outcome
(area under the curve [AUC]: 0.52, 0.58, and 0.57 for NYHA
functional class, LVEF, and LV end-systolic volume),whereas SDI was highly predictive of improvement in these
parameters (AUC: 0.79, 0.86, and 0.66, respectively). For
patients not fulﬁlling traditional selection criteria (atrial
ﬁbrillation, QRS duration <120 ms, or undergoing device
upgrade), SDI had similar predictive value. A cutoff of 10.4%
for SDI was found to have the highest accuracy for predicting
improvement following CRT.
Conclusions The LVMD quantiﬁcation by 3D echo is
reproducible between centers. SDI was an excellent
predictor of response to CRT in this selected patient cohort
and may be valuable in identifying a target population for
CRT irrespective of QRS morphology and duration (283).A Prospective Study for Comparison of MR and CT
Imaging for Detection of Coronary Artery Stenosis
Objectives The purpose of the present study was to directly
compare the diagnostic accuracy of magnetic resonance
imaging (MRI) and multislice computed tomography (CT)
for the detection of coronary artery stenosis.
Background Both imaging modalities have emerged as
potential noninvasive coronary imaging modalities; however,
CTdunlike MRIdexposes patients to radiation and
iodinated contrast agent.
Methods One hundred twenty consecutive patients with
suspected or known coronary artery disease prospectively
underwent 32-channel 3.0-T MRI and 64-slice CT before
elective X-ray angiography. The diagnostic accuracy of the 2
modalities for detecting signiﬁcant coronary stenosis (50%
luminal diameter stenosis) in segments 1.5 mm diameter
was compared with quantitative invasive coronary angiog-
raphy as the reference standard.
Results In the patient-based analysis MRI and CT angi-
ography showed similar diagnostic accuracy of 83% (95%
conﬁdence interval [CI]: 75 to 87) versus 87% (95% CI: 80 to
92), p ¼ 0.38; sensitivity of 87% (95% CI: 76 to 93) versus
90% (95% CI: 80 to 95), p ¼ 0.16; and speciﬁcity of 77%
(95% CI: 63 to 87) versus 83% (95% CI: 70 to 91), p ¼ 0.06,
respectively. All cases of left main or 3-vessel disease were
correctly diagnosed by MRI and CT angiography. In the
patient-based analysis MRI and CT angiography were similar
in their ability to identify patients who subsequently under-
went revascularization: the area under the receiver-operator
characteristic curve was 0.78 (95% CI: 0.69 to 0.87) for
MRI and 0.82 (95% CI: 0.74 to 0.90) for CT angiography.
Conclusions Thirty-two channel 3.0-T MRI and 64-slice
CT angiography similarly identify signiﬁcant coronary
stenosis in patients with suspected or known coronary artery
disease scheduled for elective coronary angiography.
However, CT angiography showed a favorable trend toward
higher diagnostic performance (284).
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